FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Moreira, MEL
   Lucena, SL
   de Magalhaes, PSC
   Rocha, AD
   Costa, ACC
   Soares, FVM
AF Lopes Moreira, Maria Elisabeth
   Lucena, Sabrina Lopes
   Coelho de Magalhaes, Patricia Sffeir
   Rocha, Adriana Duarte
   Carioca Costa, Ana Carolina
   Mendes Soares, Fernanda Valente
TI Macronutrients of mothers' milk of very low birth weight infants:
   analysis according to gestational age and maternal variables
SO REVISTA PAULISTA DE PEDIATRIA
LA Portuguese
DT Article
DE Macronutrients; Milk; human; Infant; premature
ID PRETERM INFANTS; NUTRITION
AB Objective: To analyze the composition of macronutrients present in the milk of mothers of preterm newborn infants (PTNB) - protein, fat, carbohydrate, and calories - by gestational age (GA), chronological age (CA) and maternal variables.
   Methods: Longitudinal study that analyzed 215 milk sam ples from the 51 mothers of PTNB admitted in three Neonatal Intensive Care Units of Rio de Janeiro from May/2013-January/2014. Milk collection was performed by pickup pump, on a fixed day of each week until discharge. The spectrophotometric technique with Infrared Analysis (MilkoScan Minor 104) was used for the quantitative analysis. A sample of 7 mL of human milk was taken from the total volume of milk extracted by the mother. The data was grouped by GA (25-27, 28-31, 32-36, 37-40 weeks) and by CA (zero to 4, 5-8, 9-12, 13-16 weeks).
   Results: Protein, carbohydrate, fat and calories did not show any pattern of change, with no difference among groups of GA. When the macronutrients were analyzed by groups of CA, protein decreased, with significant difference between the first two groups of CA. Carbohydrates, fat and calories presented increasing values in all groups, without significant differences. Weight gain during pregnancy, maternal hypertension and maternal age were associated with changes in fat and calories in the first moment of the analysis of milk.
   Conclusions: There was a significant decrease in the levels of protein during the first eight weeks after birth. CA may be an important factor in the composition of human milk.
C1 [Lopes Moreira, Maria Elisabeth; Lucena, Sabrina Lopes; Coelho de Magalhaes, Patricia Sffeir; Rocha, Adriana Duarte; Carioca Costa, Ana Carolina; Mendes Soares, Fernanda Valente] Inst Nacl Saude Mulher & Crianca Fernandes Figuei, Rio De Janeiro, RJ, Brazil.
RP Soares, FVM (corresponding author), Inst Nacl Saude Mulher & Crianca Fernandes Figuei, Rio De Janeiro, RJ, Brazil.
EM fevalente@gmail.com
OI /0000-0002-2034-0294; Carioca da Costa, Ana Carolina/0000-0002-9456-3319
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   de Acosta TA, 2009, ARCH LATINOAM NUTR, V59, P159
   ANDERSON DM, 1983, AM J CLIN NUTR, V37, P810
   Argov-Argaman N, 2017, J MATERN-FETAL NEO M, V30, P34, DOI 10.3109/14767058.2016.1140142
   Arslanoglu S, 2010, J PERINAT MED, V38, P233, DOI [10.1515/JPM.2010.073, 10.1515/jpm.2010.073]
   Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003
   Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2
   Brazil-Ministerio da Saude, 2012, CAD AT BAS AT PREN B
   Lafuente MC, 2019, J PERINAT MED, V47, P106, DOI 10.1515/jpm-2017-0334
   Codo Carla Regina Bianchi, 2018, Rev. paul. pediatr., V36, P141, DOI 10.1590/1984-0462/;2018;36;2;00015
   Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044
   De Curtis M, 2012, EARLY HUM DEV, V88, pS5, DOI 10.1016/j.earlhumdev.2011.12.020
   Dritsakou K, 2017, J MATERN-FETAL NEO M, V30, P1302, DOI 10.1080/14767058.2016.1212329
   Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216
   Hahn WH, 2018, J MATERN-FETAL NEO M, V31, P1385, DOI 10.1080/14767058.2017.1315660
   Horbar JD, 2015, PEDIATRICS, V136, pE84, DOI 10.1542/peds.2015-0129
   Jung YH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217739
   Kociszewska-Najman B, 2012, J MATERN-FETAL NEO M, V25, P1599, DOI 10.3109/14767058.2011.648239
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Massmann PF, 2013, FRONT LIFE SCI, V7, P155, DOI 10.1080/21553769.2013.876451
   Raiten DJ, 2016, AM J CLIN NUTR, V103, p648S, DOI 10.3945/ajcn.115.117309
   Ramel SE, 2014, WORLD REV NUTR DIET, V110, P190, DOI 10.1159/000358467
   Soto- Sanabria I, 2001, ARCH VEN PUER PED S3, V64, P14
   Tremblay Genevieve, 2017, Neonatology, V111, P214, DOI 10.1159/000450882
   Uthaya S, 2014, EARLY HUM DEV, V90, P747, DOI 10.1016/j.earlhumdev.2014.09.002
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Vieira AA, 2005, THESIS
   Villela LD, 2018, J PERINAT MED, V46, P804, DOI 10.1515/jpm-2017-0175
   Weber A, 2001, ACTA PAEDIATR, V90, P772, DOI 10.1080/080352501750315681
   Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381
NR 30
TC 0
Z9 0
U1 16
U2 16
PU SOC PEDIATRIA SAO PAULO
PI SAO PAULO SP
PA ALAMEDA SANTOS 211, 5O ANDAR, SAO PAULO SP, 01419-000, BRAZIL
SN 0103-0582
EI 1984-0462
J9 REV PAUL PEDIATR
JI Rev. Paul. Pediatr.
PY 2021
VL 39
AR e2019097
DI 10.1590/1984-0462/2021/39/2019097
PG 7
WC Pediatrics
SC Pediatrics
GA NO0KL
UT WOS:000569176100010
PM 32578667
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Simas, C
   Penn-Kekana, L
   Kuper, H
   Lyra, TM
   Moreira, MEL
   de Albuquerque, MDV
   de Araujo, TVB
   de Melo, APL
   Mendes, CHF
   Moreira, MCN
   do Nascimento, MAF
   Pimentel, C
   Pinto, M
   Valongueiro, S
   Larson, H
AF Simas, Clarissa
   Penn-Kekana, Loveday
   Kuper, Hannah
   Lyra, Tereza Maciel
   Lopes Moreira, Maria Elisabeth
   Veloso de Albuquerque, Maria do Socorro
   Barreto de Araujo, Thalia Velho
   Lopes de Melo, Ana Paula
   Figueira Mendes, Corina Helena
   Nunes Moreira, Martha Cristina
   Ferreira do Nascimento, Marcos Antonio
   Pimentel, Camila
   Pinto, Marcia
   Valongueiro, Sandra
   Larson, Heidi
TI Hope and trust in times of Zika: the views of caregivers and healthcare
   workers at the forefront of the epidemic in Brazil
SO HEALTH POLICY AND PLANNING
LA English
DT Article
DE Hope; trust; Zika virus; microcephaly; congenital Zika syndrome;
   caregivers; healthcare workers
ID VIRUS-INFECTION; CHILDREN; DIVORCE; ANTHROPOLOGY; FAMILIES; MOTHERS;
   FAITH; RISK; RACE
AB This article investigates how hope and trust played out for two groups at the forefront of the Zika epidemic: caregivers of children with congenital Zika syndrome and healthcare workers. We conducted 76 in-depth interviews with members of both groups to examine hope and trust in clinical settings, as well as trust in public institutions, in the health system and in the government of Brazil. During and after the Zika epidemic, hope and trust were important to manage uncertainty and risk, given the lack of scientific evidence about the neurological consequences of Zika virus infection. The capacity of healthcare workers and caregivers to trust and to co-create hope seems to have allowed relationships to develop that cushioned social impacts, reinforced adherence to therapeutics and enabled information flow. Hope facilitated parents to trust healthcare workers and interventions. Hope and trust appeared to be central in the establishment of support networks for caregivers. At the same time, mistrust in the government and state institutionsmay have allowed rumours and alternative explanations about Zika to spread. It may also have strengthened activism in mother's associations, which seemed to have both positive and negative implications for healthcare service delivery. The findings also point to distrust in international health actors and global health agenda, which can impact community engagement in future outbreak responses in Brazil and other countries in Latin America.
C1 [Simas, Clarissa; Penn-Kekana, Loveday; Larson, Heidi] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Clin Res Dept, Int Ctr Evidence Disabil, Keppel St, London WC1E 7HT, England.
   [Lyra, Tereza Maciel; Lopes de Melo, Ana Paula; Pimentel, Camila] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes Fiocruz, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50740465 Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Univ Fed Pernambuco, Fac Med, Dept Social Med, Ave Engn S-N,Bloco D,1 Andar,Cidade Univ, BR-740600 Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth; Figueira Mendes, Corina Helena; Nunes Moreira, Martha Cristina; Ferreira do Nascimento, Marcos Antonio; Pinto, Marcia] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Ave Rui Barbosa 716, BR-20021140 Rio De Janeiro, RJ, Brazil.
   [Veloso de Albuquerque, Maria do Socorro; Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Ctr Med Sci, Postgrad Programme Publ Hlth, Hosp Clin, Ave Prof Moraes Rego S-N,Bloco E,4 Andar, BR-50670901 Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Nucleo Saude Colet, R Alto Reservatorio Alto Jose Leal, BR-55608250 Vitoria De Santo Anta, PE, Brazil.
RP Simas, C (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
EM clarissa.simas@lshtm.ac.uk
OI Simas, Clarissa/0000-0003-0035-8419
FU Wellcome TrustWellcome Trust; UK Department for International
   Development [205377/Z/16/Z]
FX We would like to thank the caregivers of children with CZS and health
   professionals who participated in this study for giving us their
   precious time and insights. This work was supported by the Wellcome
   Trust and the UK Department for International Development
   (205377/Z/16/Z). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   BECKER G, 1994, MED ANTHROPOL Q, V8, P383, DOI 10.1525/maq.1994.8.4.02a00040
   Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016
   Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5
   Braithwaite VA, 1998, TRUST GOVERNANCE
   Brownlie J, 2005, SOCIOLOGY, V39, P221, DOI 10.1177/0038038505050536
   Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7
   Chandra S, 2018, J HEALTH COMMUN, V3, P36, DOI [10.4172/2472-1654.100146, DOI 10.4172/2472-1654.100146]
   Cooper RS, 2014, J ONCOL PRACT, V10, pE191, DOI 10.1200/JOP.2014.001375
   Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458
   de Souza LEC, 2018, J CHILD FAM STUD, V27, P1207, DOI 10.1007/s10826-017-0969-0
   Curi Martin, 2013, Horiz. antropol., V19, P65, DOI 10.1590/S0104-71832013000200003
   DeBruin D, 2012, AM J PUBLIC HEALTH, V102, P586, DOI 10.2105/AJPH.2011.300483
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250
   Frank A. W., 1995, WOUNDED STORYTELLER
   Fusch PI, 2015, QUAL REP, V20, P1408
   Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773
   Lederman VRG, 2015, CIENC SAUDE COLETIVA, V20, P1362, DOI 10.1590/1413-81232015205.13932014
   Giallo R, 2013, AUTISM, V17, P465, DOI 10.1177/1362361311416830
   Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9
   Gois C, 2017, INEQUALITIVES BRAZIL
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Gondim Linda M. P, 2016, Polis, V15, P357
   GOOD MJD, 1994, SOC SCI MED, V38, P855, DOI 10.1016/0277-9536(94)90157-0
   Halbert CH, 2006, ARCH INTERN MED, V166, P896, DOI 10.1001/archinte.166.8.896
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hartley SL, 2010, J FAM PSYCHOL, V24, P449, DOI 10.1037/a0019847
   Joesch JM, 1997, SOC BIOL, V44, P159
   Kleinman A., 1989, ILLNESS NARRATIVES S
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252
   Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475
   Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829
   Mattingly C, 2010, PARADOX OF HOPE: JOURNEYS THROUGH A CLINICAL BORDERLAND, P1
   MATTINGLY C, 1994, SOC SCI MED, V38, P811, DOI 10.1016/0277-9536(94)90153-8
   Mattingly Cheryl, 1998, HEALING DRAMAS CLIN
   McGeer V, 2008, AUSTRALAS J PHILOS, V86, P237, DOI 10.1080/00048400801886413
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Moreira MCN, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00058017
   Rothstein B, 2008, COMP POLIT, V40, P441
   Russell BH., 2006, RES METHODS ANTHR QU, P342
   SCHEPERHUGHES N, 1995, CURR ANTHROPOL, V36, P409, DOI 10.1086/204378
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Stolle D., 2001, TRUST SOC, P202
   Taussig KS, 2013, CURR ANTHROPOL, V54, pS3, DOI 10.1086/671401
   Tengbeh AF, 2018, SOC SCI MED, V203, P35, DOI 10.1016/j.socscimed.2018.03.008
   Tracy SJ, 2017, COMMUN MONOGR, V84, P30, DOI 10.1080/03637751.2016.1218642
   Ventura F., 2016, CAD SAUDE PUBLICA, V32, P1
   Vouga M, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31827-0
   Watts J, 2016, LANCET, V387, P1603, DOI 10.1016/S0140-6736(16)30249-5
NR 58
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1080
EI 1460-2237
J9 HEALTH POLICY PLANN
JI Health Policy Plan.
PD OCT
PY 2020
VL 35
IS 8
BP 953
EP 961
DI 10.1093/heapol/czaa042
PG 9
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA OW6XZ
UT WOS:000593028300007
PM 32681164
OA Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU Mendes, AG
   Campos, DD
   Silva, LB
   Moreira, MEL
   de Arruda, LO
AF Mendes, Alessandra Gomes
   Campos, Daniel de Souza
   Silva, Leticia Batista
   Lopes Moreira, Maria Elisabeth
   de Arruda, Luana Oliveira
TI Facing a new reality from the Zika Virus Congenital Syndrome: the
   families' perspective
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Child; Care; Public policy; Zika
ID CHILDREN; CARE; NEWS
AB This paper presents the partial results of the research on the social implications of addressing the Zika Virus Congenital Syndrome (ZVCS). This study aimed to analyze the repercussions of the diagnosis on the life of the families attended at an Institute of reference in Rio de Janeiro, based on a qualitative study built on the thematic analysis of the data collected through semi-structured interviews with 15 mothers from October 2017 to June 2018. The results revealed the helplessness of families and health professionals faced with the revelation of an unprecedented and challenging diagnosis, the lack of a structured referral and counter-referral network in the care of children when newly diagnosed, the imposition of an exhaustive care routine, generating social isolation, exhaustion and overload of these women, and the difficult access to public policies. Among the primary resources to cope with these adversities were the religiosity and articulation with other women who experienced the same situation.
C1 [Mendes, Alessandra Gomes; Campos, Daniel de Souza; Lopes Moreira, Maria Elisabeth; de Arruda, Luana Oliveira] Fiocruz MS, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Silva, Leticia Batista] Fiocruz MS, Escola Politecn Saude Joaquim Venancio, Rio De Janeiro, RJ, Brazil.
RP Mendes, AG (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM alesgomen@gmail.com
OI /0000-0002-2034-0294; de Souza Campos, Daniel/0000-0002-8937-7474;
   Mendes, ALESSANDRA/0000-0002-3693-2673; Oliveira de Arruda,
   Luana/0000-0003-2657-7185; Silva, Leticia Batista da/0000-0003-2520-2621
CR Aquino VV, 2007, REV LAT-AM ENFERM, V15, P42, DOI 10.1590/S0104-11692007000100007
   Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302
   Bardin L., 1977, ANALISE CONTEUDO, P70
   Brasil. Ministerio da Saude (MS), 2015, PLAN NAC ENFR MICR
   Brasil. Ministerio da Saude (MS), 2016, DIR EST PREC CRIANC
   Bury M, 2001, SOCIOL HEALTH ILL, V23, P263, DOI 10.1111/1467-9566.00252
   Carneiro R, 2018, INTERFACE-BOTUCATU, V22, P709, DOI 10.1590/1807-57622017.0857
   Afonso SBC, 2013, CIENC SAUDE COLETIVA, V18, P2605, DOI 10.1590/S1413-81232013000900015
   Costa AM, 2017, CADERNOS TRABALHO RE, V3, P44
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Cunha AMFV, 2010, CIENC SAUDE COLETIVA, V15, P445, DOI 10.1590/S1413-81232010000200021
   GIBBS G., 2009, ANALISE DADOS QUALIT
   Looman WS, 2009, J PEDIATR HEALTH CAR, V23, P117, DOI 10.1016/j.pedhc.2008.03.001
   Martins AJ, 2012, CIENC SAUDE COLETIVA, V17, P545, DOI 10.1590/S1413-81232012000200027
   Minayo MCS, 1992, DESAFIO CONHECIMENTO
   Moreira MCN, 2018, INTERFACE-BOTUCATU, V22, P697, DOI 10.1590/1807-57622017.0930
   Moreira MCN, 2014, CIENC SAUDE COLETIVA, V19, P2083, DOI 10.1590/1413-81232014197.20122013
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Saffioti HIB, 1989, CRIANCAS VITIMIZADAS, P25
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Scott RP, 2018, INTERFACE-BOTUCATU, V22, P673, DOI 10.1590/1807-57622017.0425
   Silva ACR, 2017, REV ANTHR, V28, P1
   Velho G., 1994, PROJETO METAMORFOSE
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD OCT
PY 2020
VL 25
IS 10
BP 3783
EP 3792
DI 10.1590/1413-812320202510.00962019
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NY2YC
UT WOS:000576260700010
PM 32997012
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Oliveira, E
   Marano, D
   Amaral, YND
   Abranches, A
   Soares, FVM
   Moreira, MEL
AF Oliveira, Elissa
   Marano, Daniele
   di Villarosa Amaral, Yasmin Notarbartolo
   Abranches, Andrea
   Mendes Soares, Fernanda Valente
   Lopes Moreira, Maria Elisabeth
TI Overweight modifies the nutritional composition of human milk? A
   systematic review
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Review
DE Overweight; Human milk; Nutritional Composition; Systematic Review
ID BREAST-MILK; NORMAL-WEIGHT; FATTY-ACIDS; MASS; OBESITY; MOTHERS;
   MACRONUTRIENTS; MICROBIOME; INSULIN; WOMEN
AB This paper aims to identify the association between overweight and the nutritional composition of human milk. A systematic review was performed by searching on PubMed, Virtual Health Library (BVS), EMBASE, Web of Science, and SCOPUS databases, from May to June 2018, using keywords "Human Milk" AND "Overweight" OR "Obesity" OR "Body Mass Index". The bibliographic search returned 435 papers after the duplicates were removed. Of this total, 12 papers were selected for abstract reading, and nine works were incorporated into this systematic review. Eight papers showed that overweight increased the total concentration of lipids or glucose or macronutrient fractions, and only one study found no association between overweight and the nutritional composition of human milk. Most works selected evidenced that obesity changed the total concentration of lipids and their fractions. Thus, we recommend that women's weight and height be evaluated in the pregestational visit to identify and monitor nutritional deviations, contributing to weight adequacy before pregnancy and assisting in the production of milk with adequate nutritional composition.
C1 [Oliveira, Elissa] Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Marano, Daniele; di Villarosa Amaral, Yasmin Notarbartolo; Abranches, Andrea; Mendes Soares, Fernanda Valente; Lopes Moreira, Maria Elisabeth] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
RP Oliveira, E (corresponding author), Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM elissa.c.oliveira@gmail.com
OI Amaral, Yasmin/0000-0001-8159-0564; Oliveira,
   Elissa/0000-0002-7771-658X; Dunshee de Abranches,
   Andrea/0000-0002-9323-3297; /0000-0002-2034-0294
CR de Acosta TA, 2013, ARCH LATINOAM NUTR, V63, P46
   Argov-Argaman N, 2017, J MATERN-FETAL NEO M, V30, P34, DOI 10.3109/14767058.2016.1140142
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Brasil. Ministerio da Saude (MS), 2004, VIG AL NUTR SISVAN O
   Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382
   Correia LL, 2011, CIENC SAUDE COLETIVA, V16, P133, DOI 10.1590/S1413-81232011000100017
   De Luca A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168568
   De Luca A, 2016, NUTRITION, V32, P1295, DOI 10.1016/j.nut.2016.05.013
   Dritsakou K, 2016, J MATERN-FETAL NEO M, V2, P1
   Fujimori M., 2016, THESIS
   Fujimori M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0574-4
   Garcia-Mantrana I, 2016, MOL NUTR FOOD RES, V60, P1865, DOI 10.1002/mnfr.201501018
   Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216
   Hahn WH, 2018, J MATERN-FETAL NEO M, V31, P1385, DOI 10.1080/14767058.2017.1315660
   Heerman WJ, 2014, ACAD PEDIATR, V14, P463, DOI 10.1016/j.acap.2014.05.005
   Kugananthan S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030252
   Linderborg KM, 2014, FOOD CHEM, V146, P583, DOI 10.1016/j.foodchem.2013.09.092
   Lindholm ES, 2013, PROSTAG LEUKOTR ESS, V88, P211, DOI 10.1016/j.plefa.2012.11.007
   Lubetzky R, 2015, BREASTFEED MED, V10, P433, DOI 10.1089/bfm.2015.0072
   Makela J, 2013, EUR J NUTR, V52, P727, DOI 10.1007/s00394-012-0378-5
   Marin MC, 2005, PROSTAG LEUKOTR ESS, V73, P355, DOI 10.1016/j.plefa.2005.07.005
   Marshall NE, 2016, AM J CLIN NUTR, V103, P1055, DOI 10.3945/ajcn.115.113464
   Massmann PF, 2013, FRONT LIFE SCI, V7, P155, DOI 10.1080/21553769.2013.876451
   McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x
   Nyuar KB, 2010, ACTA PAEDIATR, V99, P1824, DOI 10.1111/j.1651-2227.2010.01940.x
   Panagos PG, 2016, J PERINATOL, V36, P284, DOI 10.1038/jp.2015.199
   Garcia-Lara NR, 2012, BREASTFEED MED, V7, P295, DOI 10.1089/bfm.2011.0079
   Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2
   Valentine CJ, 2010, J PEDIATR-US, V157, P906, DOI 10.1016/j.jpeds.2010.06.017
   Costa AGV, 2010, REV NUTR, V23, P445, DOI 10.1590/S1415-52732010000300012
   World Health Organization, 2017, GUID PROT PROM SUPP
   Young BE, 2017, EUR J CLIN NUTR, V71, P1094, DOI 10.1038/ejcn.2017.75
NR 32
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD OCT
PY 2020
VL 25
IS 10
BP 3967
EP 3978
DI 10.1590/1413-812320202510.29902018
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NY2YC
UT WOS:000576260700026
PM 32997028
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Souza, RT
   Vieira, MC
   Esteves-Pereira, AP
   Domingues, RMSM
   Moreira, MEL
   da Cunha, EV
   Sandall, J
   Cecatti, JG
   Leal, MD
   Dias, MAB
   Pasupathy, D
AF Souza, Renato T.
   Vieira, Matias C.
   Esteves-Pereira, Ana Paula
   Soares Madeira Domingues, Rosa Maria
   Lopes Moreira, Maria Elisabeth
   da Cunha Filho, Edson Vieira
   Sandall, Jane
   Cecatti, Jose G.
   Leal, Maria do Carmo
   Bastos Dias, Marcos Augusto
   Pasupathy, Dharmintra
TI Risk stratification for small for gestational age for the Brazilian
   population: a secondary analysis of the Birth in Brazil study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEALTH
AB Risk-stratification screening for SGA has been proposed in high-income countries to prevent perinatal morbidity and mortality. There is paucity of data from middle-income settings. The aim of this study is to explore risk factors for SGA in Brazil and assess potential for risk stratification. This population-based study is a secondary analysis of Birth in Brazil study, conducted in 266 maternity units between 2011 and 2012. Univariate and multivariate logistic regressions were performed, and population attributable fraction estimated for early and all pregnancy factors. We calculated absolute risk, odds ratio, and population prevalence of single or combined factors stratified by parity. Factors associated with SGA were maternal lupus (ORadj 4.36, 95% CI [2.32-8.18]), hypertensive disorders in pregnancy (ORadj 2.72, 95% CI [2.28-3.24]), weight gain<5 kg (ORadj 2.37, 95% CI [1.99-2.83]), smoking at late pregnancy (ORadj 2.04, 95% CI [1.60-2.59]), previous low birthweight (ORadj 2.22, 95% CI [1.79-2.75]), nulliparity (ORadj 1.81, 95% CI [1.60-2.05]), underweight (ORadj 1.61, 95% CI [1.36-1.92]) and socioeconomic status (SES)<5th centile (ORadj 1.23, 95% CI [1.05-1.45]). Having two or more risk factors (prevalence of 4.4% and 8.0%) was associated with a 2 and fourfold increase in the risk for SGA in nulliparous and multiparous, respectively. Early and all pregnancy risk factors allow development of risk-stratification for SGA. Implementation of risk stratification coupled with specific strategies for reduction of risk and increased surveillance has the potential to contribute to the reduction of stillbirth in Brazil through increased detection of SGA, appropriate management and timely delivery.
C1 [Souza, Renato T.; Vieira, Matias C.; Cecatti, Jose G.; Pasupathy, Dharmintra] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, 101 Alexander Fleming St,Cidade Univ, Campinas, SP, Brazil.
   [Vieira, Matias C.; Sandall, Jane; Pasupathy, Dharmintra] Kings Coll London, Womens Hlth Acad Ctr KHP, Dept Women & Childrens Hlth,Sch Life Course Sci, Fac Life Sci & Med,St Thomas Hosp, 10th Floor North Wing,Westminster Bridge Rd, London SE1 7EH, England.
   [Vieira, Matias C.; da Cunha Filho, Edson Vieira] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Sao Lucas Hosp, Dept Obstet & Gynaecol, 6690 Ipiranga Ave, Porto Alegre, RS, Brazil.
   [Esteves-Pereira, Ana Paula; Leal, Maria do Carmo] Oswaldo Cruz Fdn FIOCRUZ, Natl Sch Publ Hlth, 1480 Leopoldo Bulhoes St, Rio De Janeiro, RJ, Brazil.
   [Soares Madeira Domingues, Rosa Maria] Oswaldo Cruz Fdn FIOCRUZ, Fernandes Figueira Inst, Dept Neonatol, 716 Rui Barbosa St, Rio De Janeiro, RJ, Brazil.
   [Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn FIOCRUZ, Fernandes Figueira Inst, 716 Rui Barbosa st, Rio De Janeiro, Brazil.
   [Bastos Dias, Marcos Augusto] Univ Sydney, Westmead Clin Sch, Discipline Obstet Gynaecol & Neonatol, Sydney, NSW 2145, Australia.
RP Pasupathy, D (corresponding author), Kings Coll London, Womens Hlth Acad Ctr KHP, Dept Women & Childrens Hlth,Sch Life Course Sci, Fac Life Sci & Med,St Thomas Hosp, 10th Floor North Wing,Westminster Bridge Rd, London SE1 7EH, England.
EM Dharmintra.Pasupathy@sydney.edu.au
RI Souza, Renato Teixeira/G-4205-2017
OI Souza, Renato Teixeira/0000-0002-9075-9269; Reis,
   AlessanRSS/0000-0001-8486-7469
FU Medical Research Council (MRC) UK (Confidence in Concept
   AwardMQABARR)Medical Research Council UK (MRC); National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Brazilian Ministry of
   Health; National School of Public Health, Oswaldo Cruz Foundation (INOVA
   Project); Foundation for supporting Research in the State of Rio de
   Janeiro (Faperj)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); CAPES, BrazilCAPES; Tommy's
   Charity, UK; National Institute for Health Research (NIHR) Applied
   Research Collaboration South London (NIHR ARC South London) at King's
   College Hospital NHS Foundation Trust
FX The current study was funded by the Medical Research Council (MRC) UK
   (Confidence in Concept AwardMQABARR). Birth in Brazil survey was funded
   by National Council for Scientific and Technological Development (CNPq);
   Brazilian Ministry of Health; National School of Public Health, Oswaldo
   Cruz Foundation (INOVA Project); and Foundation for supporting Research
   in the State of Rio de Janeiro (Faperj). MCV was supported by CAPES,
   Brazil. DP was supported by Tommy's Charity, UK. JS is an NIHR Senior
   Investigator and is also supported by the National Institute for Health
   Research (NIHR) Applied Research Collaboration South London (NIHR ARC
   South London) at King's College Hospital NHS Foundation Trust. The views
   expressed are those of the author[s] and not necessarily those of the
   NIHR or the Department of Health and Social Care.
CR American College of Obstetricians and Gynecologists' Committee on Practice BulletinsObstetrics and the Society forMaternal-FetalMedicin, 2019, Obstet Gynecol, V133, pe97, DOI 10.1097/AOG.0000000000003070
   [Anonymous], 2013, GREEN TOP GUID
   Brazilian Ministry of Health, 2016, SINASC NAT INF SYST
   Brazilian Ministry of Health, 2016, SIM NAT INF SYST MOR
   Cui YC, 2018, EXP THER MED, V15, P4361, DOI 10.3892/etm.2018.5972
   FEBRASGO, 2014, ANT CAR GUID
   Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806
   Ludvigsson JF, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002717
   McCowan LM, 2018, AM J OBSTET GYNECOL, V218, pS855, DOI 10.1016/j.ajog.2017.12.004
   MCCOWAN LM, 2009, BRIT MED J, V338, P1, DOI DOI 10.1136/BMJ.B1081
   Ministry of Health Brazil, 2012, HIGH RISK PREGN GUID
   da Silva AAM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00129613
   O'Connor D, 2016, NHS ENGLAND SAVING B
   Roberge S, 2016, CLIN LAB MED, V36, P319, DOI 10.1016/j.cll.2016.01.013
   Royal College of Obstetricians and Gynaecologists, 2015, GREEN TOP GUID
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Sureau C., 2005, RAPPORT COMITE NATL
   Tan MY, 2018, ULTRASOUND OBST GYN, V52, P52, DOI 10.1002/uog.19077
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   Widdows K, 2018, EVALUATION IMPLEMENT
   Widdows K, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1672-x
NR 25
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 7
PY 2020
VL 10
IS 1
AR 14725
DI 10.1038/s41598-020-71252-y
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NQ6HC
UT WOS:000570970200020
PM 32895438
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nehab, SR
   Villela, LD
   Soares, FVM
   Abranches, AD
   Araujo, DMR
   da Silva, LML
   Amaral, YNV
   Junior, SG
   Meio, MDBB
   Moreira, ME
AF Nehab, Sylvia R.
   Villela, Leticia D.
   Soares, Fernanda V. M.
   Abranches, Andrea D.
   Araujo, Daniele M. R.
   da Silva, Leila M. L.
   Amaral, Yasmin N., V
   Junior, Saint Clair G.
   Meio, Maria Dalva B. B.
   Moreira, Maria Elisabeth
TI Gestational weight gain and body composition of full-term newborns and
   infants: a cohort study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Adiposity; Body composition; Gestational weight gain; Pregnancy
ID AIR-DISPLACEMENT PLETHYSMOGRAPHY; NEONATAL ADIPOSITY; PREGNANCY;
   OBESITY; FETAL; BMI
AB Background: The association between gestational weight gain and neonatal body composition has been inconsistent, exposing the need for further research. The aim of this study was to evaluate whether gestational weight gain influences the body composition of full-term newborns and infants up to 4 months old.
   Methods: A cohort study was performed with 124 participants divided into categories of gestational weight gain according to the 2009 Institute of Medicine guidelines. The anthropometric and body composition data of newborns and infants acquired using air displacement plethysmography (PeaPod (R)) were collected at 96 h, 1 month, 2 months and 4 months of life. In the statistical analysis, the chi-square test was used to analyze categorical variables, and ANOVA was used to analyze numerical variables. Univariate analysis was performed, and the absolute and relative frequencies of the categorical variables, as well as mean and standard deviation of the numerical variables, were obtained. Bivariate analysis was performed for the categories of gestational weight gain and gestational and neonatal characteristics. When adjustments to gestational hypertension, gestational diabetes, and pregestational body mass index (BMI) were analyzed by linear regression, gestational weight gain remained a significant variable for newborn percent fat mass. For all analyses, a significance level of 5% was adopted.
   Results: Gestational weight gain was adequate in 33.8% of the participants, excessive in 41.1% and insufficient in 25%. Women with excessive weight gain had higher pregestational BMIs and a higher incidence of gestational hypertension. Their newborns had a higher body mass, body fat mass in grams and percent fat mass than the infants born to mothers with adequate or insufficient gestational weight gain. No significant differences were observed in body composition at 1, 2 and 4 months of life during infant follow-up.
   Conclusion: Excessive gestational weight gain may alter the body composition of newborns at birth. Further studies are required to better evaluate infant follow-up.
C1 [Nehab, Sylvia R.; Villela, Leticia D.; Soares, Fernanda V. M.; Abranches, Andrea D.; Araujo, Daniele M. R.; da Silva, Leila M. L.; Amaral, Yasmin N., V; Junior, Saint Clair G.; Meio, Maria Dalva B. B.; Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Ave Rui Barbosa 716 Flamengo, Rio De Janeiro, RJ, Brazil.
RP Moreira, ME (corresponding author), Inst Fernandes Figueira Fiocruz, Ave Rui Barbosa 716 Flamengo, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI de Abranches, Andrea Dunshee/ABA-8578-2020
OI /0000-0002-2034-0294; Dunshee de Abranches, Andrea/0000-0002-9323-3297;
   BARBOSA BAKER MEIO, MARIA DALVA/0000-0002-7290-9091; Amaral,
   Yasmin/0000-0001-8159-0564; Nehab, Sylvia/0000-0003-0194-6060
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [441098/2016-9]; FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E_18/2015TXB];
   CAPESCAPES; IFF/Fiocruz PIP program
FX Sources of Support.; -CNPq 441098/2016-9.; -Faperj E_18/2015TXB.;
   -CAPES.; -IFF/Fiocruz PIP program.; These sources of support are a
   Brazilian governmental agencies and provide support to food and
   transportation for parents. They had no role in the data analysis or
   writing the paper.
CR Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS137, DOI 10.2337/dc18-S013
   Au CP, 2013, EARLY HUM DEV, V89, P839, DOI 10.1016/j.earlhumdev.2013.07.028
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019
   Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128
   da Silva AP, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e438
   Ellis KJ, 2007, AM J CLIN NUTR, V85, P90
   Gaillard R, 2014, ACTA OBSTET GYN SCAN, V93, P1085, DOI 10.1111/aogs.12506
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133
   Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004
   Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGNANC
   Josefson JL, 2013, PEDIATR OBES, V8, pe33, DOI 10.1111/j.2047-6310.2012.00132.x
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Magee LA, 2018, MAYO CLIN PROC, V93, P1664, DOI 10.1016/j.mayocp.2018.04.033
   McDermott M, 2019, JAMA-J AM MED ASSOC, V321, P1715, DOI 10.1001/jama.2019.3821
   National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN DIAB, P2
   Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007
   Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448
   Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007
   Raiten DJ, 2016, AM J CLIN NUTR, V103, p648S, DOI 10.3945/ajcn.115.117309
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Ruchat SM, 2016, J OBSTET GYNAECOL CA, V38, P108, DOI 10.1016/j.jogc.2015.12.014
   Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946
   Urlando A, 2003, PEDIATR RES, V53, P486, DOI 10.1203/01.PDR.0000049669.74793.E3
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Waters TP, 2012, J CLIN ENDOCR METAB, V97, P3648, DOI 10.1210/jc.2012-1781
   Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522
NR 29
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 20
PY 2020
VL 20
IS 1
AR 474
DI 10.1186/s12884-020-03145-x
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA NL1JT
UT WOS:000567180800002
PM 32819310
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zhao, ZQ
   Shang, ZW
   Vasconcelos, Z
   Li, CF
   Jiang, YS
   Zu, SL
   Zhang, JY
   Wang, FC
   Yao, L
   Jung, JU
   Brasil, P
   Moreira, ME
   Qin, CF
   Kerin, T
   Nielsen-Saines, K
   Cheng, GH
   Zhang, XH
   Xu, ZH
AF Zhao, Ziqi
   Shang, Ziwei
   Vasconcelos, Zilton
   Li, Chunfeng
   Jiang, Yisheng
   Zu, Shulong
   Zhang, Jingyi
   Wang, Fengchao
   Yao, Li
   Jung, Jae U.
   Brasil, Patricia
   Moreira, Maria Elisabeth
   Qin, Cheng-Feng
   Kerin, Tara
   Nielsen-Saines, Karin
   Cheng, Genhong
   Zhang, Xiaohui
   Xu, Zhiheng
TI Zika Virus Infection Leads to Variable Defects in Multiple Neurological
   Functions and Behaviors in Mice and Children
SO ADVANCED SCIENCE
LA English
DT Article
DE abnormal behaviors; microcephaly; neurological functions; visual
   cortical functions; Zika virus
ID CRITICAL PERIOD PLASTICITY; CORTEX
AB Zika virus (ZIKV) has evolved into a global health threat because of its causal link to congenital Zika syndrome. ZIKV infection of pregnant women may cause a spectrum of abnormalities in children. In the studies in Brazil, a large cohort of children with perinatal exposure to ZIKV is followed, and a spectrum of neurodevelopmental abnormalities is identified. In parallel, it is demonstrated that infection of the mouse neonatal brain by a contemporary ZIKV strain instead of an Asian ancestral strain can cause microcephaly and various abnormal neurological functions. These include defects in social interaction and depression, impaired learning and memory, in addition to severe motor defects, which are present in adult mice as well as in the prospective cohort of children. Importantly, although mouse brains infected later after birth do not have apparent abnormal brain structure, those mice still show significant impairments of visual cortical functions, circuit organization, and experience-dependent plasticity. Thus, the study suggests that special attention should be paid to all children born to ZIKV infected mothers for screening of abnormal behaviors and sensory function during childhood.
C1 [Zhao, Ziqi; Jiang, Yisheng; Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Sch Future Technol, Inst Genet & Dev Biol,State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Shang, Ziwei; Zhang, Jingyi; Wang, Fengchao; Yao, Li; Zhang, Xiaohui] Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.
   [Vasconcelos, Zilton; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz FIOCRUZ, Inst Fernandes Figueira, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Li, Chunfeng] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.
   [Zu, Shulong; Cheng, Genhong] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Zu, Shulong; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Obstet & Gynecol,Div Maternal Fetal Med, Los Angeles, CA 90033 USA.
   [Brasil, Patricia] Fondacao Oswaldo Cruz FIOCRUZ, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Kerin, Tara; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Mattel Childrens Hosp, Los Angeles, CA 90095 USA.
   [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Sch Future Technol, Inst Genet & Dev Biol,State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Zhang, XH (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Li, CF (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Cheng, GH (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Mattel Childrens Hosp, Los Angeles, CA 90095 USA.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM chunfeng@stanford.edu; KNielsen@mednet.ucla.edu; GCheng@mednet.ucla.edu;
   xhzhang@bnu.edu.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China (NSFC) [31921002, 31730108, 91854118,
   U170220023, 81772176, 31670883, 91542201, 81590765]; Chinese Academy of
   SciencesChinese Academy of Sciences [XDB32020100, QYZDJ-SSW-SMC007];
   Beijing Municipal Science & Technology CommissionBeijing Municipal
   Science & Technology Commission [Z181100001518001]; Interdisciplinary
   Research Funds of Beijing Normal University; CAMS Initiative Innovative
   Medicine [2016-I2M-1-005]; Major Project for "Significant New Drugs
   Innovation and Development" [2015ZX09102023]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI140718, AI069120, AI078389, AI028697, AI129534, EY028318]; MOST
   (China)Ministry of Science and Technology, China [2016YFD0500304]
FX This work was supported by the Strategic Priority Research Program and
   Innovation Program of the National Natural Science Foundation of China
   (NSFC) (31921002, 31730108, 91854118, U170220023, 81772176, 31670883,
   91542201, 81590765), the Chinese Academy of Sciences (No. XDB32020100,
   QYZDJ-SSW-SMC007), the Beijing Municipal Science & Technology Commission
   (Z181100001518001), the Interdisciplinary Research Funds of Beijing
   Normal University, the CAMS Initiative Innovative Medicine (No.
   2016-I2M-1-005), Major Project for "Significant New Drugs Innovation and
   Development" (2015ZX09102023), NIH AI140718, AI069120, AI078389,
   AI028697, AI129534, and EY028318 awards, and MOST (China,
   2016YFD0500304). The infant study protocol was approved by the
   institutional review boards at FundacAo Oswaldo Cruz (Fiocruz) and the
   University of California, Los Angeles (UCLA IRB#17-000104). All mothers
   provided written informed consent for themselves and for their children.
   The experimental procedures on mice were performed under biosafety level
   2 (BSL-2) at Beijing Institute of Microbiology and Epidemiology with
   Institutional Biosafety Committee approval. The mouse care and
   experimentation were approved by the Animal Care and Use Committees of
   the Institutional Animal Care and Use Committee at Institute of Genetics
   and Developmental Biology (IGDB), Chinese Academy of Sciences (Renewed
   as AP2020013), Beijing Institute of Microbiology and Epidemiology and
   the State Key Laboratory of Cognitive Neuroscience & Learning at Beijing
   Normal University (IACUC-BNU-NKLCNL-2016-02).
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen XJ, 2014, J NEUROSCI, V34, P2940, DOI 10.1523/JNEUROSCI.2640-13.2014
   Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009
   Gordon JA, 1996, J NEUROSCI, V16, P3274
   He LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6036
   Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787
   Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002
   Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006
   Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133
   Li C, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0042-1
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 29
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD SEP
PY 2020
VL 7
IS 18
AR 1901996
DI 10.1002/advs.201901996
EA AUG 2020
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA NW6HC
UT WOS:000554488300001
PM 32999822
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Martins, BMR
   Abreu, I
   Meio, MDB
   Moreira, MEL
AF Martins, Bianca M. R.
   Abreu, Isabel
   Meio, Maria Dalva B.
   Moreira, Maria Elisabeth L.
TI Gastroschisis in the neonatal period: A prospective case-series in a
   Brazilian referral center
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE Gastroschisis; Outcomes; Morbidity; Sutureless
ID HUMAN-MILK; INFECTIOUS COMPLICATIONS; RISK STRATIFICATION;
   NORTH-AMERICA; OUTCOMES; INFANTS; CLOSURE; SUTURELESS; STRATEGIES; TIME
AB Background/Purpose: Gastroschisis is increasing in incidence and has low mortality and high morbidity. We describe the clinical and surgical characteristics of gastroschisis patients in a Brazilian referral center.
   Methods: Single-center prospective case series of gastroschisis patients. The following two groups were formed depending on the intestinal characteristics: simple and complex patients.
   Results: In total, 79 patients were enrolled, 89% of whom were classified as simple and 11% as complex. The baseline characteristics were similar between the groups, with the exception of the illness severity score. The complex group had a significantly smaller defect size, more reoperations and worse clinical outcomes than the simple group, with the initiation of feeding taking 1.5 times longer, the duration of total parenteral nutrition taking twice as long, and the length of hospitalization being 2.5 times longer; the complex group also included all the deaths that occurred. Overall, the survival rate was 96%. Patients who underwent the sutureless technique had significantly fewer wound infections and a decreased duration of mechanical ventilation than sutured patients.
   Conclusions: This study provides a comprehensive picture of gastroschisis during the neonatal period in a Brazilian referral center, emphasizing the significantly higher risk for morbidity and mortality among complex patients than among simple patients and the few advantages of the sutureless technique over the sutured technique in terms of closing the defect. Type of study: Prognostic. (c) 2020 Elsevier Inc. All rights reserved.
C1 [Martins, Bianca M. R.; Abreu, Isabel] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Surg,Surg NICU, Rio De Janeiro, Brazil.
   [Meio, Maria Dalva B.; Moreira, Maria Elisabeth L.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Clin Res Unit, Rio De Janeiro, Brazil.
RP Martins, BMR (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bianca.martins@iff.fiocruz.br
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   fromRio de Janeiro BrazilCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E.26/202.979/2017]
FX This research received a grant from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ), fromRio de Janeiro Brazil
   (E.26/202.979/2017).
CR Albert A, 2001, PEDIATR SURG INT, V17, P116, DOI 10.1007/s003830000482
   Arnold MA, 2007, J PEDIATR SURG, V42, P1520, DOI 10.1016/j.jpedsurg.2007.04.032
   Baird R, 2012, PEDIATR SURG INT, V28, P399, DOI 10.1007/s00383-011-3038-6
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Barseghyan K, 2012, ARCH GYNECOL OBSTET, V286, P889, DOI 10.1007/s00404-012-2394-3
   Bergholz R, 2014, J PEDIATR SURG, V49, P1527, DOI 10.1016/j.jpedsurg.2014.08.001
   Bradnock TJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6749
   Bruzoni M, 2017, J AM COLL SURGEONS, V224, P1091, DOI 10.1016/j.jamcollsurg.2017.02.014
   Christison-Lagay ER, 2011, SEMIN FETAL NEONAT M, V16, P164, DOI 10.1016/j.siny.2011.02.003
   Emami CN, 2015, J PEDIATR SURG, V50, P102, DOI 10.1016/j.jpedsurg.2014.10.009
   Emil S, 2012, J PEDIATR SURG, V47, P1521, DOI 10.1016/j.jpedsurg.2011.12.023
   Fallon EM, 2012, J PEDIATR SURG, V47, P1529, DOI 10.1016/j.jpedsurg.2011.12.028
   Feldkamp M, ANN REPORT
   Fullerton BS, 2017, J PEDIATR-US, V188, P192, DOI 10.1016/j.jpeds.2017.06.013
   Giudici L, 2016, ACTA PAEDIATR, V105, pE275, DOI 10.1111/apa.13374
   Gulack BC, 2016, J PEDIATR-US, V170, P85, DOI 10.1016/j.jpeds.2015.11.046
   Kohler JA, 2013, J PERINATOL, V33, P627, DOI 10.1038/jp.2013.27
   Lap CCMM, 2016, EARLY HUM DEV, V103, P209, DOI 10.1016/j.earlhumdev.2016.10.002
   Lusk LA, 2014, J PEDIATR SURG, V49, P1782, DOI 10.1016/j.jpedsurg.2014.09.018
   Miranda ME, 2019, J PEDIATR SURG, V24, P30137
   Miyake H, 2019, PEDIATR SURG INT, V35, P107, DOI 10.1007/s00383-018-4381-7
   Molik KA, 2001, J PEDIATR SURG, V36, P51, DOI 10.1053/jpsu.2001.20004
   Nasr A, 2012, J PEDIATR SURG, V47, P2022, DOI 10.1016/j.jpedsurg.2012.07.037
   Neu J, 1999, JPEN-PARENTER ENTER, V23, pS13, DOI 10.1177/014860719902300504
   Owen A, 2010, J PEDIATR SURG, V45, P1808, DOI 10.1016/j.jpedsurg.2010.01.036
   Payne NR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-90
   Riboh J, 2009, J PEDIATR SURG, V44, P1947, DOI 10.1016/j.jpedsurg.2009.03.027
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Sandler A, 2004, J PEDIATR SURG, V39, P738, DOI 10.1016/j.jpedsurg.2004.01.040
   Savoie KB, 2014, J PEDIATR SURG, V49, P1771, DOI 10.1016/j.jpedsurg.2014.09.019
   Schlueter RK, 2015, J PEDIATR SURG, V50, P98, DOI 10.1016/j.jpedsurg.2014.10.001
   Skarsgard ED, 2008, J PEDIATR SURG, V43, P30, DOI 10.1016/j.jpedsurg.2007.09.011
   South AP, 2011, J PERINATOL, V31, P546, DOI 10.1038/jp.2010.206
   Stanger J, 2014, J PEDIATR SURG, V49, P720, DOI 10.1016/j.jpedsurg.2014.02.066
   Tannuri ACA, 2011, CLINICS, V66, P17, DOI 10.1590/S1807-59322011000100004
   van Manen M, 2013, J PEDIATR SURG, V48, P1682, DOI 10.1016/j.jpedsurg.2013.01.021
   Wissanji H, 2018, SEMIN PEDIATR SURG, V27, P300, DOI 10.1053/j.sempedsurg.2018.08.007
   Witt RG, 2019, JAMA SURG, V154, P33, DOI 10.1001/jamasurg.2018.3216
   Youssef F, 2016, J PEDIATR SURG, V51, P891, DOI 10.1016/j.jpedsurg.2016.02.046
NR 39
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0022-3468
EI 1531-5037
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PD AUG
PY 2020
VL 55
IS 8
BP 1546
EP 1551
DI 10.1016/j.jpedsurg.2020.04.011
PG 6
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA NF0MM
UT WOS:000562997700024
PM 32467036
DA 2020-12-17
ER

PT J
AU Brasil, P
   Vasconcelos, Z
   Kerin, T
   Gabaglia, CR
   Ribeiro, IP
   Bonaldo, MC
   Damasceno, L
   Pone, MV
   Pone, S
   Zin, A
   Tsui, I
   Adachi, K
   Pereira, JP
   Gaw, SL
   Carvalho, L
   Cunha, DC
   Guida, L
   Rocha, M
   Cherry, JD
   Wang, LL
   Aliyari, S
   Cheng, GH
   Foo, SS
   Chen, WQ
   Jung, J
   Brickley, E
   Moreira, MEL
   Nielsen-Saines, K
AF Brasil, Patricia
   Vasconcelos, Zilton
   Kerin, Tara
   Gabaglia, Claudia Raja
   Ribeiro, Ieda P.
   Bonaldo, Myrna C.
   Damasceno, Luana
   Pone, Marcos V.
   Pone, Sheila
   Zin, Andrea
   Tsui, Irena
   Adachi, Kristina
   Pereira, Jose Paulo, Jr.
   Gaw, Stephanie L.
   Carvalho, Liege
   Cunha, Denise C.
   Guida, Leticia
   Rocha, Mirza
   Cherry, James D.
   Wang, Lulan
   Aliyari, Saba
   Cheng, Genhong
   Foo, Suan-Sin
   Chen, Weiqiang
   Jung, Jae
   Brickley, Elizabeth
   Moreira, Maria Elisabeth L.
   Nielsen-Saines, Karin
TI Zika virus vertical transmission in children with confirmed antenatal
   exposure
SO NATURE COMMUNICATIONS
LA English
DT Article
ID INFECTION; INFANTS; DENGUE
AB We report Zika virus (ZIKV) vertical transmission in 130 infants born to PCR+ mothers at the time of the Rio de Janeiro epidemic of 2015-2016. Serum and urine collected from birth through the first year of life were tested by quantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA. Four hundred and seven specimens are evaluated; 161 sera tested by PCR and IgM assays, 85 urines by PCR. Sixty-five percent of children (N=84) are positive in at least one assay. Of 94 children tested within 3 months of age, 70% are positive. Positivity declines to 33% after 3 months. Five children are PCR+ beyond 200 days of life. Concordance between IgM and PCR results is 52%, sensitivity 65%, specificity 40% (positive PCR results as gold standard). IgM and serum PCR are 61% concordant; serum and urine PCR 55%. Most children (65%) are clinically normal. Equal numbers of children with abnormal findings (29 of 45, 64%) and normal findings (55 of 85, 65%) have positive results, p=0.98. Earlier maternal trimester of infection is associated with positive results (p=0.04) but not clinical disease (p=0.98). ZIKV vertical transmission is frequent but laboratory confirmed infection is not necessarily associated with infant abnormalities. Here, Brasil et al. investigate mother to child Zika virus (ZIKV) transmission rates in a large longitudinal cohort of pregnant ZIKV-positive women with their infants followed from the time of maternal infection through birth and onwards, finding high in utero transmission rates that do not predict clinical outcomes, suggesting follow-up of children with antenatal ZIKV exposure is necessary.
C1 [Brasil, Patricia; Vasconcelos, Zilton; Ribeiro, Ieda P.; Bonaldo, Myrna C.; Damasceno, Luana; Pone, Marcos V.; Pone, Sheila; Zin, Andrea; Pereira, Jose Paulo, Jr.; Carvalho, Liege; Cunha, Denise C.; Guida, Leticia; Rocha, Mirza; Moreira, Maria Elisabeth L.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Wang, Lulan; Aliyari, Saba; Cheng, Genhong; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA 92056 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Foo, Suan-Sin; Chen, Weiqiang; Jung, Jae] Univ Southern Calif, Los Angeles, CA 90007 USA.
   [Brickley, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
RP Brasil, P (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.; Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
EM patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu
RI ; Brickley, Elizabeth/U-3625-2017
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Bonaldo,
   Myrna/0000-0001-9899-3386; Brickley, Elizabeth/0000-0003-0280-2288
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-17]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [CAPES/88887.116627/2016-01, CAPES
   88881.130684/2016-01]; Brazilian National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq) [CNPq/441098/2016-9, CNPq307282/2017,
   CNPq440865/2016-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro [FAPERJ/E_18/2015TXB, FAPERJ/239224/E032018
   CNE, FAPERJ/E_26/202.862/2018 CNE]; Fondation Christophe and Rodolph
   Merieux; ZikAlliance [734548]; Thrasher Research Fund [20164370];
   National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534, AI140718,
   K08AI141728]; National Eye Institute (NEI) of the National Institutes of
   Health [AI129847]; United Kingdom's Department for International
   Development; Queenan Fellowship from the Foundation for the Society of
   Maternal-Fetal Medicine; ZikaPlan (Preparedness Latin American Network);
   Wellcome TrustWellcome Trust; UK's Department for International
   Development [205377/Z/16/Z]; European UnionEuropean Union (EU) [734584]
FX This study was supported by the Departamento de Ciencia e Tecnologia
   (DECIT/25000.072811/2016-17) do Ministerio da Saude do Brasil (P.B. and
   M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01; CAPES 88881.130684/2016-01); Brazilian
   National Council for Scientific and Technological Development
   CNPq/441098/2016-9; CNPq307282/2017; CNPq440865/2016-6) (P.B., M.E. M.,
   and M.C.B); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ/E_18/2015TXB (M.E.M.); FAPERJ/239224/E032018
   CNE (M.E.M.); FAPERJ/E_26/202.862/2018 CNE (P.B.); Fondation Christophe
   and Rodolph Merieux; ZikAlliance 734548 (P.B.); the Thrasher Research
   Fund (20164370) (K.N.S. and K.A.); the National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of Health AI28697
   (K.N.S.), AI1259534 (K.N.S. and P.B.), AI140718 (K.N.S., P.B., G.C., and
   J.J.), K08AI141728 (S.L.G.), the National Eye Institute (NEI) of the
   National Institutes of Health AI129847 (K.N.S., I.T., and P.B.) and the
   United Kingdom's Department for International Development (M.E.M.); the
   Queenan Fellowship from the Foundation for the Society of Maternal-Fetal
   Medicine (S.L.G.) and the ZikaPlan (Preparedness Latin American Network)
   (M.E.M.); Wellcome Trust & the UK's Department for International
   Development (205377/Z/16/Z; https://wellcome.ac.uk/) and the European
   Union's Horizon 2020 research and innovation program
   (https://ec.europa.eu/programmes/horizon2020/) under ZikaPLAN grant
   agreement No. 734584 (https://zikaplan.tghn.org/) (E.B.) We thank the
   women who enrolled in this study and the Fiocruz Zika Field Team who
   rendered our work possible.
CR Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cherry J. D. B. A, 2019, FEIGIN CHERRYS TXB P, P1601
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/aog.0000000000002737, 10.1097/AOG.0000000000002737]
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harrison G. J, 2019, FEIGIN CHERRYS TXB P, P1429
   Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira JP, 2019, CLIN INFECT DIS, V69, P713, DOI 10.1093/cid/ciz013
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
   Sanchez-Montalva A, 2019, NEW ENGL J MED, V380, P198, DOI 10.1056/NEJMc1814416
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01972-17, 10.1128/JCM.01972-17]
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Vasconcelos Z., 2018, ZIKV DIAGNOSTICS CUR
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Zin AA, 2018, J AAPOS, V22, P452, DOI 10.1016/j.jaapos.2018.07.352
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 32
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL 14
PY 2020
VL 11
IS 1
DI 10.1038/s41467-020-17331-0
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MM3LY
UT WOS:000550062200006
PM 32665616
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Cranston, JS
   Tiene, SF
   Nielsen-Saines, K
   Vasconcelos, Z
   Pone, MV
   Pone, S
   Zin, A
   Salles, TS
   Pereira, JP
   Orofino, D
   Brasil, P
   Kerin, T
   Adachi, K
   Soares, FM
   de Abranches, AD
   da Costa, ACC
   Moreira, MEL
AF Cranston, Jessica S.
   Tiene, Sophia Finn
   Nielsen-Saines, Karin
   Vasconcelos, Zilton
   Pone, Marcos V.
   Pone, Sheila
   Zin, Andrea
   Salles, Tania Saad
   Pereira, Jose Paulo, Jr.
   Orofino, Dulce
   Brasil, Patricia
   Kerin, Tara
   Adachi, Kristina
   Soares, Fernanda Mendes
   Dunshee de Abranches, Andrea
   da Costa, Ana Carolina C.
   Lopes Moreira, Maria Elisabeth
TI Association Between Antenatal Exposure to Zika Virus and Anatomical and
   Neurodevelopmental Abnormalities in Children
SO JAMA NETWORK OPEN
LA English
DT Article
ID BIRTH-DEFECTS; INFECTION; INFANTS; TRANSMISSION; BRAZIL; MANIFESTATIONS;
   EPIDEMIC; UPDATE; GROWTH; STATES
AB This cohort study characterizes the clinical features associated with antenatal exposure to the Zika virus in children and assesses whether an association exists between head circumference at birth and neurodevelopmental outcomes.
   Importance Zika virus (ZIKV) is a mosquito-borne flavivirus recognized as teratogenic since the 2015 to 2016 epidemic. Antenatal ZIKV exposure causes brain anomalies, yet the full spectrum has not been delineated. Objective To characterize the clinical features of ZIKV infection at a pediatric referral center in Rio de Janeiro, Brazil, among children with antenatal ZIKV exposure. Design, Setting, and Participants Retrospective cohort study conducted from May to July 2019 of a prospective cohort of 296 infants with antenatal ZIKV exposure followed up since December 2015 at a tertiary maternity-pediatric hospital. Exposures Zika virus infection during pregnancy. Main Outcomes and Measures Characterization of clinical features with anthropometric, neurologic, cardiologic, ophthalmologic, audiometric, and neuroimaging evaluations in infancy and neurodevelopmental assessments (Bayley Scales of Infant and Toddler Development, Third Edition) from 6 to 42 months of age, stratified by head circumference at birth (head circumference within the reference range, or normocephaly [NC] vs microcephaly [MC]). Results Antenatal exposure to ZIKV was confirmed for 219 of 296 children (74.0%) referred to Instituto Fernandes Figueira with suspected ZIKV infection through positive maternal or neonatal polymerase chain reaction analysis or IgM serology results. Of these children, 110 (50.2%) were boys, ages ranged from 0 to 4 years, and 53 (24.2%) had congenital microcephaly. The anomalies observed in ZIKV-exposed children with MC or NC were failure to thrive (MC: 38 of 53 [71.7%]; NC: 73 of 143 [51.0%]), cardiac malformations (MC: 19 of 46 [41.3%]; NC: 20 of 100 [20.0%]), excess nuchal skin (MC: 16 of 22 [72.7%]; NC: 35 of 93 [37.6%]), auditory abnormalities (MC: 13 of 50 [26.0%]; NC: 14 of 141 [9.9%]), and eye abnormalities (MC: 42 of 53 [79.2%]; NC: 28 of 158 [17.7%]). Although they experienced fewer neurologic abnormalities than children born with MC, those with NC also had frequent neurologic abnormalities (109 of 160 [68.1%]), including hyperreflexia (36 of 136 [26.5%]), abnormal tone (53 of 137 [38.7%]), congenital neuromotor signs (39 of 93 [41.9%]), feeding difficulties (15 of 143 [10.5%]), and abnormal brain imaging results (44 of 150 [29.3%]). Among 112 children with NC with Bayley-III evaluations, 72 (64.3%) had average or above-average scores; 30 (26.8%) scored 1 SD below average in at least 1 domain; and 10 (8.9%) scored 2 SD below average in at least 1 domain. Among 112 children with NC, a smaller head circumference at birth was significantly associated with subsequent below-average cognitive scores (U = 499.5; z = -2.833; P = .004) and language scores (U = 235.5; z = -2.491; P = .01). Conclusions and Relevance Children without MC who were exposed to ZIKV in utero had a high frequency of anatomical and neurodevelopmental abnormalities. The head circumference at birth for children with NC was associated with neurocognitive development. Recognition of the wide spectrum of clinical phenotypes is critical to ensure early referral to rehabilitative interventions.
   Question What is the spectrum of clinical findings associated with antenatal Zika virus exposure, and does an association exist between head circumference at birth and neurodevelopmental outcomes among Zika virus-exposed children with normocephaly? Findings This cohort study of 219 children found that antenatal Zika virus exposure was associated with a wide spectrum of clinical manifestations in normocephalic children beyond those previously described. The head circumference of normocephalic children was associated with neurodevelopmental outcomes. Meaning Recognition of the variety of clinical phenotypes following antenatal Zika virus exposure, including evaluation of head circumference as a continuous variable, may help ensure early intervention, appropriate cross-disciplinary evaluation, and comprehensive therapeutic care.
C1 [Cranston, Jessica S.; Tiene, Sophia Finn; Nielsen-Saines, Karin; Kerin, Tara; Adachi, Kristina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis, 10833 Le Conte Ave,MDCC 22-442, Los Angeles, CA 90095 USA.
   [Vasconcelos, Zilton; Pone, Marcos V.; Pone, Sheila; Zin, Andrea; Salles, Tania Saad; Pereira, Jose Paulo, Jr.; Orofino, Dulce; Brasil, Patricia; Soares, Fernanda Mendes; Dunshee de Abranches, Andrea; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Cranston, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Infect Dis, 10833 Le Conte Ave,MDCC 22-442, Los Angeles, CA 90095 USA.
EM jcranston@mednet.ucla.edu
RI de Abranches, Andrea Dunshee/ABA-8578-2020
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI28697, AI1259534, AI140718]; National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [AI129847]; Thrasher Foundation; CNPqNational Council for Scientific and
   Technological Development (CNPq) [441098/2016-9, 305090/2016-0];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E_18/2015TXB]
FX Drs Nielsen-Saines and Brasil were supported by grants AI28697,
   AI1259534, and AI140718 from NIAID, grant AI129847 from the National Eye
   Institute, and grants from the Thrasher Foundation; Dr Lopes Moreira was
   supported by awards 441098/2016-9 and 305090/2016-0 from CNPq and award
   E_18/2015TXB from FAPERJ.
CR Adachi K, 2020, CLIN INFECT DIS, V70, P2663, DOI 10.1093/cid/ciz704
   Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Macy K, 2013, ENCY AUTISM SPECTRUM, P399, DOI 10.1007/978-1-4419-1698-3_284
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pool KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8124
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Valdes V, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14061
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 52
TC 5
Z9 5
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL 7
PY 2020
VL 3
IS 7
DI 10.1001/jamanetworkopen.2020.9303
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA MP3GX
UT WOS:000552096400002
PM 32633763
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Amaral, Y
   Marano, D
   Abranches, A
   Silva, L
   Nehab, S
   Costa, AC
   Moreira, ME
AF Amaral, Yasmin
   Marano, Daniele
   Abranches, Andrea
   Silva, Leila
   Nehab, Sylvia
   Costa, Ana Carolina
   Moreira, Maria Elisabeth
TI Do chronic noncommunicable diseases modify the macronutrient composition
   of human milk?
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article; Early Access
DE Human milk; Excessive body weight; Hypertension; Diabetes Mellitus;
   Pre-gestational nutritional status; Nutrients
ID INSULIN; LACTOGENESIS; OVERWEIGHT; WOMEN; OBESITY; WEIGHT; PLASMA; FAT;
   AGE
AB This study aims to evaluate the impact of excess body weight, diabetes mellitus, and hypertension on the nutritional composition of human milk. This cohort study was conducted at a tertiary public health unit in the city of Rio de Janeiro from March 2016 to February 2018. The data were collected in two stages (96 hours and one month after delivery). The macronutrients (carbohydrate, protein, lipid) and total energy were determined using the MIRIS(R)equipment. The level of significance was 5%. Higher protein content was observed in the nutritional composition of colostrum in women with diabetes mellitus. A higher protein and energy content was observed in the milk of mothers with excessive body weight. The energy content was higher in the milk of mothers with excessive body weight. Increased protein content in the human milk of women with excessive body weight or diabetes.
C1 [Amaral, Yasmin; Marano, Daniele; Abranches, Andrea; Silva, Leila; Nehab, Sylvia; Costa, Ana Carolina; Moreira, Maria Elisabeth] Fiocruz MS, Natl Inst Womens Childrens & Adolescents Hlth Fer, Clin Res Dept, Rio De Janeiro, RJ, Brazil.
RP Amaral, Y (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Natl Inst Womens Childrens & Adolescents Hlth Fer, Clin Res Dept, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM yasminamaral@hotmail.com
RI de Abranches, Andrea Dunshee/ABA-8578-2020
OI Amaral, Yasmin/0000-0001-8159-0564; Carioca da Costa, Ana
   Carolina/0000-0002-9456-3319; /0000-0002-2034-0294; Dunshee de
   Abranches, Andrea/0000-0002-9323-3297; Nehab, Sylvia/0000-0003-0194-6060
CR Amaral Y, 2020, INT J FOOD SCI NUTR, V71, P186, DOI 10.1080/09637486.2019.1646713
   Bachour P, 2012, BREASTFEED MED, V7, P179, DOI 10.1089/bfm.2011.0038
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003
   Brazil Departamento de Acoes Programaticas Estrategicas, 2012, GEST ALT RISC MAN TE
   Brazil Departamento de Atencao Basica, 2012, AT AO PREN BAIX RISC
   BUTTE NF, 1987, J PEDIATR GASTR NUTR, V6, P936, DOI 10.1097/00005176-198711000-00020
   Correia LL, 2011, CIENC SAUDE COLETIVA, V16, P133, DOI 10.1590/S1413-81232011000100017
   de Morais Oliveira AM, 2008, ARQ BRAS ENDOCRINOL, V52, P473, DOI 10.1590/S0004-27302008000300007
   do Amaral YND, 2019, CIENC SAUDE COLETIVA, V24, P2491, DOI 10.1590/1413-81232018247.18972017
   Dritsakou K, 2017, J MATERN-FETAL NEO M, V30, P1302, DOI 10.1080/14767058.2016.1212329
   DUCLOS M, 1989, MOL CELL ENDOCRINOL, V65, P129, DOI 10.1016/0303-7207(89)90173-1
   Emmett PM, 1997, EARLY HUM DEV, V49, pS7, DOI 10.1016/S0378-3782(97)00051-0
   Freire Cláudia Maria Vilas, 2009, Arq. Bras. Cardiol., V93, P159, DOI 10.1590/S0066-782X2009001300017
   Fujimori M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0574-4
   Garcia-Ravelo S, 2018, BREASTFEED MED, V13, P702, DOI 10.1089/bfm.2017.0214
   Hahn WH, 2018, J MATERN-FETAL NEO M, V31, P1385, DOI 10.1080/14767058.2017.1315660
   Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P
   Jagiello KP, 2015, JOGNN-J OBST GYN NEO, V44, P500, DOI 10.1111/1552-6909.12658
   LAMMIKEEFE CJ, 1995, J PEDIATR GASTR NUTR, V20, P305, DOI 10.1097/00005176-199504000-00007
   Leghi GE, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040934
   Lovelady CA, 2005, NUTR REV, V63, P352, DOI 10.1111/j.1753-4887.2005.tb00113.x
   Mandel D, 2005, PEDIATRICS, V116, pE432, DOI 10.1542/peds.2005-0313
   MARANO D, 2014, BRAZIL REV BRAS EPID, V17, P45, DOI DOI 10.1590/1415-790X201400010005ENG
   Massmann PF, 2013, FRONT LIFE SCI, V7, P155, DOI 10.1080/21553769.2013.876451
   Nast M, 2013, REV BRAS GINECOL OBS, V35, P536, DOI 10.1590/S0100-72032013001200002
   National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC, VNG3
   NEUBAUER SH, 1993, AM J CLIN NUTR, V58, P54
   Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167
   Nommsen-Rivers LA, 2012, BREASTFEED MED, V7, P43, DOI 10.1089/bfm.2011.0007
   Peila C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010185
   Garcia-Lara NR, 2012, BREASTFEED MED, V7, P295, DOI 10.1089/bfm.2011.0079
   Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1
   Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Vieira RW, 2009, SAUDE AMB REV, V4, P1
   World Health Organisation (WHO)/United Nations Children's Fund (UNICEF), 1989, PROT PROM SUPP BREAS
   Young BE, 2017, EUR J CLIN NUTR, V71, P1094, DOI 10.1038/ejcn.2017.75
   Zhao FQ, 2004, BBA-GENE STRUCT EXPR, V1680, P103, DOI 10.1016/j.bbaexp.2004.09.001
NR 39
TC 0
Z9 0
U1 5
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
DI 10.1080/09637486.2020.1780568
EA JUL 2020
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA MI5DT
UT WOS:000547429100001
PM 32633176
DA 2020-12-17
ER

PT J
AU Marano, D
   de Oliveira, EC
   do Amaral, YND
   da Silva, LML
   Moreira, MEL
AF Marano, Daniele
   de Oliveira, Elissa Costa
   de Villarosa do Amaral, Yasmin Notarbartolo
   Lopes da Silva, Leila Maria
   Lopes Moreira, Maria Elisabeth
TI Evaluation of anthropometric equations developed to estimate neonates'
   body composition: a systematic review
SO CIENCIA & SAUDE COLETIVA
LA English
DT Review
DE Neonates; Fat-free mass; Fat mass; Plethysmography; Systematic review
ID BIOELECTRICAL-IMPEDANCE ANALYSIS; FAT-FREE MASS; SKINFOLD-THICKNESS;
   INFANTS; VALIDATION; CHILDREN; PREDICTION; PERCENTAGE
AB This article aims to evaluate the anthropometric equations developed by selected studies in order to estimate the body composition of neonates. The systematic review consisted in the research of published articles in the following databases: PubMed, Brazilian Virtual Health Library, Embase and ScienceDirect by utilizing the following descriptors: "fat mass, fat free mass, anthropometry, air displacement plethysmography, validation, neonate". For doing so, the PRISMA protocol has been utilized. The bibliographical research resulted in 181 articles. However, only eight were selected for the present review because repetition in different databases and having been performed in adults, during pregnancy, in athletes, in preterm and children. There was discrepancy in terms of study method, mainly over the variables of the anthropometric equations, age and ethnicity of the neonates. All studies used the plethysmography method as a reference apart from one study. Only four studies had their equations validated. The studies that developed anthropometric models for estimating the body composition of neonates are scarce, and the use of these equations needs to be conducted carefully in order to avoid errors in nutritional diagnosis.
C1 [Marano, Daniele; Lopes da Silva, Leila Maria; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz Fiocruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [de Oliveira, Elissa Costa] Fiocruz MS, Programa Inst Bolsa Iniciacao Cient PIBIC, Rio De Janeiro, RJ, Brazil.
   [de Villarosa do Amaral, Yasmin Notarbartolo] Fiocruz MS, IFF, Programa Posgrad Pesquisa Aplicada, Rio De Janeiro, RJ, Brazil.
RP Marano, D (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM danielemarano@yahoo.com.br
OI Amaral, Yasmin/0000-0001-8159-0564; /0000-0002-2034-0294; Oliveira,
   Elissa/0000-0002-7771-658X
CR [Anonymous], 2006, CHILD GROWTH STAND L
   Aris IM, 2013, EUR J CLIN NUTR, V67, P922, DOI 10.1038/ejcn.2013.69
   Catalano PM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.004
   CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3
   Cauble JS, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0844-6
   DAUNCEY MJ, 1977, ARCH DIS CHILD, V52, P223, DOI 10.1136/adc.52.3.223
   Deierlein AL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-21
   Deurenberg P, 2003, INT J BODY COMP RES, V1
   DEURENBERGYAP M, 2003, INT J BODY COMP RES, V1, P103
   Ellis KJ, 2007, SEMIN FETAL NEONAT M, V12, P87, DOI 10.1016/j.siny.2006.10.011
   Fields DA, 2002, AM J CLIN NUTR, V75, P453
   Gridneva Z, 2017, PEDIATR RES, V81, P423, DOI 10.1038/pr.2016.235
   Huvanandana J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195193
   Kulkarni B, 2014, EUR J CLIN NUTR, V68, P658, DOI 10.1038/ejcn.2014.37
   Lingwood BE, 2012, BRIT J NUTR, V107, P1545, DOI 10.1017/S0007114511004624
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Mello Marco Túlio de, 2005, Rev Bras Med Esporte, V11, P267, DOI 10.1590/S1517-86922005000500004
   Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Paley C, 2016, PEDIATR OBES, V11, P361, DOI 10.1111/ijpo.12072
   Schmelzle HR, 2002, AM J CLIN NUTR, V76, P1096
   Sletner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073058
   Strydom K, 2019, PEDIATR NEONATOL, V60, P121, DOI 10.1016/j.pedneo.2017.10.007
   Tint MT, 2016, BRIT J NUTR, V115, P1033, DOI 10.1017/S0007114515005486
   Villar J, 2017, PEDIATR RES, V82, P305, DOI 10.1038/pr.2017.52
   WESTSTRATE JA, 1989, AM J CLIN NUTR, V50, P1104
   WHO, 2007, CHILD GROWTH STAND L
   Wibaek R, 2015, EUR J CLIN NUTR, V69, P1099, DOI 10.1038/ejcn.2015.51
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2020
VL 25
IS 7
BP 2711
EP 2720
DI 10.1590/1413-81232020257.26982018
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MK9JI
UT WOS:000549095400019
PM 32667553
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Adachi, K
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Aibe, M
   de Aguiar, EB
   Sim, M
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Halai, UA
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Portari, E
   Cherry, JD
   Pone, M
   Moreira, ME
AF Adachi, Kristina
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Aibe, Mitsue
   de Aguiar, Elisa Barroso
   Sim, Myung
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Halai, Umme-Aiman
   Vasconcelos, Zilton
   Pereira, Jose Paulo
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Portari, Elyzabeth
   Cherry, James D.
   Pone, Marcos
   Moreira, Maria Elisabeth
TI Early Clinical Infancy Outcomes for Microcephaly and/or Small for
   Gestational Age Zika-Exposed Infants
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika; congenital Zika syndrome; microcephaly; proportional microcephaly;
   small for gestational age (SGA)
ID LINKED IMMUNOSORBENT ASSAYS; VIRUS-INFECTION; BRAZIL; CYTOMEGALOVIRUS;
   EPIDEMIC; GROWTH; STATE; IGM
AB Background. Zika-exposed infants with microcephaly (proportional or disproportional) and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.Antenatal Zika virus (ZIKV) exposure may lead to adverse infant outcomes including microcephaly and being small for gestational age (SGA). ZIKV-exposed infants with a diagnosis of microcephaly (proportional [PM] or disproportional [DM]) or SGA at birth were evaluated with anthropometric measurements and health outcomes.
   Methods. Infants had laboratory-confirmed ZIKV exposure in Brazil. PM, DM, or SGA classification was based on head circumference and weight. First-year growth parameters and clinical outcomes were recorded with analyses performed.
   Results. Among the 156 ZIKV-exposed infants, 14 (9.0%) were SGA, 13 (8.3%) PM, 13 (8.3%) DM, and 116 (74.4%) were neither SGA nor had microcephaly (NSNM). High rates of any neurologic, ophthalmologic, and hearing abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.001); odds ratio [OR], 3.4 (95% confidence interval [CI], 1.1-10.7) for SGA vs NSNM. Neuroimaging abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); OR 3.9 (95% CI, 1.2-12.8) for SGA vs NSNM. Growth rates by z score, particularly for microcephaly infants, were poor after birth but showed improvement beyond 4 months of life.
   Conclusions. ZIKV-exposed infants with microcephaly (PM and DM) had similarly high rates of adverse outcomes but showed improvement in growth measurements beyond 4 months of life. While SGA infants had fewer adverse outcomes compared with microcephaly infants, notable adverse outcomes were observed in some; their odds of having adverse outcomes were 3 to 4 times greater compared to NSNM infants.
C1 [Adachi, Kristina; Nielsen-Saines, Karin; Cherry, James D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
   [Romero, Tahmineh; Sim, Myung] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Aibe, Mitsue; de Aguiar, Elisa Barroso; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo; Salles, Tania Saad; Barbosa, Claudia Neves; Portari, Elyzabeth; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol, San Francisco, CA USA.
   [Halai, Umme-Aiman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
RP Moreira, ME (corresponding author), Inst Fernandes Figueira IFF, Ave Rui Barbosa 716, BR-22420040 Flamengo Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
OI Moura Pone, Sheila/0000-0002-6246-8915; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute [AI129847-01, UL1TR001881]; Thrasher Research Fund [20164370];
   UK Department for International Development; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K08AI141728,
   K08AI141728] Funding Source: NIH RePORTER
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01), the National Institute of Allergy and
   Infectious Diseases (AI28697, AI1259534-01) and the National Eye
   Institute (AI129847-01) of the National Institutes of Health
   (NIH)/National Center for Advancing Translational Science of the
   University of California-Los Angeles Clinical and Translational Science
   Institute (UL1TR001881), Thrasher Research Fund (20164370), and the UK
   Department for International Development.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, ZIK MAC ELISA, V2019
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   PAHO/WHO, 2017, ZIK CAS CONG SYNDR A
   PAHO WHO, 2016, REG ZIK EP UPD AM
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   PRIMHAK RA, 1982, CLIN PEDIATR, V21, P417, DOI 10.1177/000992288202100705
   Simonazzi G, 2014, PRENATAL DIAG, V34, P765, DOI 10.1002/pd.4362
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yamamoto R, 2013, J OBSTET GYNAECOL RE, V39, P653, DOI 10.1111/j.1447-0756.2012.02012.x
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 26
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2020
VL 70
IS 12
BP 2663
EP 2672
DI 10.1093/cid/ciz704
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA MO4RV
UT WOS:000551516200037
PM 31346616
OA Green Published
DA 2020-12-17
ER

PT J
AU Aguiar, RS
   Pohl, F
   Morais, GL
   Nogueira, FCS
   de Carvalho, JB
   Guida, L
   Arge, LWP
   Melo, A
   Moreira, MEL
   Cunha, DP
   Gomes, L
   Portari, EA
   Velasquez, E
   Melani, RD
   Pezzuto, P
   de Castro, FL
   Geddes, VEV
   Gerber, AL
   Azevedo, GS
   Schamber-Reis, BL
   Goncalves, AL
   Junqueira-de-Azevedo, I
   Nishiyama, MY
   Ho, P
   Schanoski, A
   Schuch, V
   Tanuri, A
   Chimelli, L
   Vasconcelos, ZFM
   Domont, GB
   Vasconcelos, ATR
   Nakaya, HI
AF Aguiar, Renato S.
   Pohl, Fabio
   Morais, Guilherme L.
   Nogueira, Fabio C. S.
   de Carvalho, Joseane B.
   Guida, Leticia
   Arge, Luis W. P.
   Melo, Adriana
   Moreira, Maria E. L.
   Cunha, Daniela P.
   Gomes, Leonardo
   Portari, Elyzabeth A.
   Velasquez, Erika
   Melani, Rafael D.
   Pezzuto, Paula
   de Castro, Fernanda L.
   Geddes, Victor E. V.
   Gerber, Alexandra L.
   Azevedo, Girlene S.
   Schamber-Reis, Bruno L.
   Goncalves, Alessandro L.
   Junqueira-de-Azevedo, Inacio
   Nishiyama Jr, Milton Y.
   Ho, Paulo
   Schanoski, Alessandra
   Schuch, Viviane
   Tanuri, Amilcar
   Chimelli, Leila
   Vasconcelos, Zilton F. M.
   Domont, Gilberto B.
   Vasconcelos, Ana T. R.
   Nakaya, Helder, I
TI Molecular alterations in the extracellular matrix in the brains of
   newborns with congenital Zika syndrome
SO SCIENCE SIGNALING
LA English
DT Article
ID VIRUS-INFECTION; RNA-SEQ; COLLAGEN; MUTATIONS; DATABASE; VISUALIZATION;
   POLYMORPHISM; DISRUPTION; PROTEINS; REGIONS
AB Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.
C1 [Aguiar, Renato S.; Pezzuto, Paula; de Castro, Fernanda L.; Geddes, Victor E. V.; Goncalves, Alessandro L.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Pohl, Fabio; Schuch, Viviane; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Morais, Guilherme L.; de Carvalho, Joseane B.; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.
   [Nogueira, Fabio C. S.; Velasquez, Erika; Melani, Rafael D.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.
   [Nogueira, Fabio C. S.] Univ Fed Rio de Janeiro, Inst Chem, LADETEC, Lab Prote, Rio De Janeiro, Brazil.
   [Guida, Leticia; Moreira, Maria E. L.; Cunha, Daniela P.; Gomes, Leonardo; Portari, Elyzabeth A.; Vasconcelos, Zilton F. M.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Melo, Adriana; Azevedo, Girlene S.] Inst Pesquisa Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Schamber-Reis, Bruno L.] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [Junqueira-de-Azevedo, Inacio; Nishiyama Jr, Milton Y.] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Ho, Paulo; Schanoski, Alessandra] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Vasconcelos, ATR (corresponding author), LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.; Domont, GB (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.; Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
EM chimelli@hucff.ufrj.br; zilton.vasconcelos@iff.fiocruz.br;
   gilbertodomont@gmail.com; atrv@lncc.br; hnakaya@usp.br
RI Junqueira-de-Azevedo, Inacio L. M./H-5239-2011; Nakaya, Helder
   I/A-1397-2010; NOGUEIRA, FABIO CESAR SOUSA/G-9580-2011; Center of
   Toxins, Immune-response/J-5731-2015; Junior, Milton Y
   Nishiyama/H-4002-2013; Nakaya, Helder/AAF-1738-2020; Aguiar,
   Renato/G-3542-2015
OI Junqueira-de-Azevedo, Inacio L. M./0000-0003-4491-0180; Nakaya, Helder
   I/0000-0001-5297-9108; NOGUEIRA, FABIO CESAR SOUSA/0000-0001-5507-7142;
   Junior, Milton Y Nishiyama/0000-0002-2410-0562; Nakaya,
   Helder/0000-0001-5297-9108; Pohl, Fabio/0000-0003-1695-4936;
   /0000-0002-2034-0294; Guida, Leticia/0000-0003-3543-1532; Geddes,
   Victor/0000-0002-0723-3873; Arge, Luis Willian
   Pacheco/0000-0002-0109-4809; Aguiar, Renato/0000-0001-5180-3717
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440900/2016-6, 313662/2017-7, 440613/2016-7, 303170/2017-4]; CAPESCAPES
   [88881.130757/2016-01, 001, 88887.130697]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [01.16.0078.00]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202.650/2018, 26/202.903/20]
FX This research was supported by CNPq (grant no. 440900/2016-6), CAPES
   (grant no. 88881.130757/2016-01), and FINEP (grant no. 01.16.0078.00).
   H.I.N. is supported by CNPq (313662/2017-7) and the Sao Paulo Research
   Foundation (FAPESP; grants 2017/50137-3, 2012/19278-6, 2018/14933-2,
   2018/21934-5, and 2013/08216-2). F.L.d.C., V.E.V.G., J.B.C., and
   L.W.P.A. are funded by CAPES (grant 001). G.B.D. has financial support
   from grants 88887.130697 (CAPES) and 440613/2016-7 (CNPq). F.C.S.N. is
   supported by FAPERJ (E-26/202.650/2018). A.T.R.V. is supported by CNPq
   (303170/2017-4) and FAPERJ (26/202.903/20).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954
   Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen Y, 2017, INT J CLIN EXP MED, V10, P14904
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653
   Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gorshkov V, 2015, ANAL CHEM, V87, P6319, DOI 10.1021/acs.analchem.5b01166
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HIPC-CHI Signatures Project Team; HIPC-I Consortium, 2017, SCI IMMUNOL, V2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797
   Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larroche J.-C., 1977, DEV PATHOLOGY NEONAT, Vxviii
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024
   Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026
   Maness PF, 2007, NAT NEUROSCI, V10, P263, DOI 10.1038/nn0207-263b
   Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007
   Plotkin Horacio, 2004, BMC Pediatr, V4, P16, DOI 10.1186/1471-2431-4-16
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004
   Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907
   Schiela B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02177
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Useche YM, 2019, J INFECT PUBLIC HEAL, V12, P43, DOI 10.1016/j.jiph.2018.08.009
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weng YC, 2012, ANN NEUROL, V71, P470, DOI 10.1002/ana.22682
   Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Zhu Zhe, 2017, J Exp Med, V214, P3145, DOI 10.1084/jem.2017109309122017c
   Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627
NR 86
TC 1
Z9 1
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 9
PY 2020
VL 13
IS 635
AR eaay6736
DI 10.1126/scisignal.aay6736
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LY4UD
UT WOS:000540523900001
PM 32518143
DA 2020-12-17
ER

PT J
AU Sobhani, NC
   Avvad-Portari, E
   Nascimento, ACM
   Machado, HN
   Lobato, DSS
   Pereira, JP
   Esquivel, MS
   Vasconcelos, ZC
   Zin, AA
   Tsui, I
   Adachi, K
   Brickley, EB
   Fisher, SJ
   Nielsen-Saines, K
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Sobhani, Nasim C.
   Avvad-Portari, Elyzabeth
   Nascimento, Aline C. M.
   Machado, Heloisa N.
   Lobato, Daniel S. S.
   Pereira, Jose Paulo
   Esquivel, Mikaela S.
   Vasconcelos, Zilton C.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Brickley, Elizabeth B.
   Fisher, Susan J.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Discordant Zika Virus Findings in Twin Pregnancies Complicated by
   Antenatal Zika Virus Exposure: A Prospective Cohort
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome; perinatal infection; TORCH infection; twin;
   vertical transmission
ID PLACENTAL PATHOLOGY; INFECTION; CELLS; INFANTS
AB Background. There are limited data on the natural history of antenatal Zika virus (ZIKV) exposure in twin pregnancies, especially regarding intertwin concordance of prenatal, placental, and infant outcomes.
   Methods. This prospective cohort study included twin pregnancies referred to a single institution from September 2015 to June 2016 with maternal ZIKV. Polymerase chain reaction (PCR) testing of maternal, placental, and neonatal samples was performed. Prenatal ultrasounds were completed for each twin, and histomorphologic analysis was performed for each placenta. Abnormal neonatal outcome was defined as abnormal exam and/or abnormal imaging. Two- to three-year follow-up of infants included physical exams, neuroimaging, and Bayley-III developmental assessment.
   Results. Among 244 pregnancies, 4 twin gestations without coinfection were identified. Zika virus infection occurred at 16-33 weeks gestation. Zika virus PCR testing revealed discordance between dichorionic twins, between placentas in a dichorionic pair, between portions of a monochorionic placenta, and between a neonate and its associated placenta. Of the 8 infants, 3 (38%) had an abnormal neonatal outcome. Of 6 infants with long-term follow-up, 3 (50%) have demonstrated ZIKV-related abnormalities.
   Conclusions. Neonatal PCR testing, placental findings, and infant outcomes can be discordant between co-twins with antenatal ZIKV exposure. These findings demonstrate that each twin should be evaluated independently for vertical transmission.
C1 [Sobhani, Nasim C.; Esquivel, Mikaela S.; Fisher, Susan J.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Avvad-Portari, Elyzabeth; Nascimento, Aline C. M.; Machado, Heloisa N.; Lobato, Daniel S. S.; Pereira, Jose Paulo; Vasconcelos, Zilton C.; Zin, Andrea A.; Brasil, Patricia; Moreira, Maria E.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556 16HSE, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Brickley, Elizabeth/U-3625-2017
OI Brickley, Elizabeth/0000-0003-0280-2288
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K08AI141728]; Foundation for the Society of
   MaternalFetal Medicine Queenan Fellowship for Global Health; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21AI28697,
   R21AI129534]; National Eye Institute (NEI)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318]; Brazilian Ministry of
   Health; Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department
   for International Development [205377/Z/16/Z]; European UnionEuropean
   Union (EU) [734584]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K08AI141728, K08AI141728] Funding Source: NIH RePORTER
FX This work was funded by the following: National Institute of Allergy and
   Infectious Diseases (NIAID) (K08AI141728) and the Foundation for the
   Society of Maternal Fetal Medicine Queenan Fellowship for Global Health
   (to S. L. G.); generous support from Marc and Lynne Benioff (to S. J.
   F.); National Institute of Allergy and Infectious Diseases (R21AI28697
   and R21AI129534) and National Eye Institute (NEI) (R21EY028318) (to K.
   N.-S.); the Brazilian Ministry of Health (to P. B. and M. E. M.);
   Wellcome Trust and the UK's Department for International Development
   (205377/Z/16/Z; to M. E. M. and E. B.); the European Union's Horizon
   2020 Research and Innovation Programme under ZikaPLAN grant agreement
   number 734584 and FAPERJ (to M. E. M.); and the Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ (EAP).
CR AHLFORS K, 1988, EARLY HUM DEV, V18, P125, DOI 10.1016/0378-3782(88)90049-7
   Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dickinson JE, 2006, TWIN RES HUM GENET, V9, P456, DOI 10.1375/twin.9.3.456
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010
   Higgins M, 2011, PEDIATR DEVEL PATHOL, V14, P273, DOI 10.2350/10-07-0872-OA.1
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pereira L, 2017, PLACENTA, V59, pS8, DOI 10.1016/j.placenta.2017.04.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056
   Reyes L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02628
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282X20170066, 10.1590/0004-282x20170066]
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 27
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2020
VL 221
IS 11
BP 1838
EP 1845
DI 10.1093/infdis/jiz629
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LU0MN
UT WOS:000537458000014
PM 31773163
DA 2020-12-17
ER

PT J
AU Duttine, A
   Smythe, T
   de Sa, MRC
   Ferrite, S
   Zuurmond, M
   Moreira, ME
   Collins, A
   Milner, K
   Kuper, H
AF Duttine, Antony
   Smythe, Tracey
   Calheiro de Sa, Miriam Ribiero
   Ferrite, Silvia
   Zuurmond, Maria
   Moreira, Maria Elisabeth
   Collins, Anna
   Milner, Kate
   Kuper, Hannah
TI Congenital Zika Syndrome-Assessing the Need for a Family Support
   Programme in Brazil
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE congenital zika syndrome; Zika; family support; Brazil; cerebral palsy;
   community programme
ID VIRUS-INFECTION; CEREBRAL-PALSY; CHILDREN; INFANTS
AB The Zika outbreak in Brazil caused congenital impairments and developmental delays, or Congenital Zika Syndrome (CZS). We sought to ascertain whether a family support programme was needed and, if so, could be adapted from the Getting to Know Cerebral Palsy programme (GTKCP) designed for children with cerebral palsy (CP). We conducted a systematic review of the needs of families of children with CZS or CP in low- and middle-income countries and reviewed the findings of the Social and Economic Impact of Zika study. We undertook a scoping visit to three facilities offering services to children with CZS in Brazil to understand potential utility and adaptability of GTKCP. The literature review showed that caregivers of children with CZS experience challenges in mental health, healthcare access, and quality of life, consistent with the CP literature. The scoping visits demonstrated that most support provided to families was medically orientated and while informal support networks were established, these lacked structure. Caregivers and practitioners expressed an eagerness for more structure community-based family support programmes. A support programme for families of children with CZS in Brazil appeared relevant and needed, and may fill an important gap in the Zika response.
C1 [Duttine, Antony; Smythe, Tracey; Zuurmond, Maria; Collins, Anna; Kuper, Hannah] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, Int Ctr Evidence Disabil, London WC1E 7HT, England.
   [Calheiro de Sa, Miriam Ribiero; Moreira, Maria Elisabeth] Inst Nacl Saude Mulher Crianca & Adolescente Fern, BR-22250020 Rio De Janeiro, Brazil.
   [Ferrite, Silvia] Univ Fed Bahia, Inst Hlth Sci, Dept Speech & Hearing Sci, BR-40110902 Salvador, BA, Brazil.
   [Milner, Kate] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
   [Milner, Kate] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.
RP Duttine, A (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, Int Ctr Evidence Disabil, London WC1E 7HT, England.
EM antony.duttine@lshtm.ac.uk; tracey.smythe@lshtm.ac.uk;
   calheirosa@uol.com.br; ferrite@ufba.br; maria.zuurmond@lshtm.ac.uk;
   bebethiff@gmail.com; annalucy0910@gmail.com; kate.m.milner@rch.org.au;
   hannah.kuper@lshtm.ac.uk
RI ; Ferrite, Silvia/I-2864-2013; Smythe, Tracey/N-7699-2017
OI Zuurmond, Maria/0000-0002-0347-0126; Ferrite,
   Silvia/0000-0001-5344-3751; Smythe, Tracey/0000-0003-3408-7362
FU Wellcome and DFID [206719/Z/17/Z.]
FX This research was funded by Wellcome and DFID, grant number
   206719/Z/17/Z.
CR Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   Alderdice F, 2016, J REPROD INFANT PSYC, V34, P429, DOI 10.1080/02646838.2016.1230369
   de Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-497420180002000014
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Cerebral Palsy Association (Eastern Cape), 2020, HAMB
   Collins A., 2017, CONGENITAL ZIKA SYND
   COLLUCCI C, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I6157
   de Carvalho AL, 2020, J CHILD NEUROL, V35, P202, DOI 10.1177/0883073819885724
   Donkor CM, 2019, FOOD SCI NUTR, V7, P35, DOI 10.1002/fsn3.788
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Hennigan T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1226
   Hohlfeld ASJ, 2018, AFR J DISABIL, V7, DOI 10.4102/ajod.v7i0.437
   International Centre for Evidence in Disability, 2011, WORK PAR GROUPS TRAI
   Karadag Saygi E, 2015, TURK FIZ TIP REHAB D, V61, P320, DOI 10.5152/tftrd.2015.70745
   Kuper H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007768
   Kuper Hannah, 2018, Wellcome Open Res, V3, P127, DOI 10.12688/wellcomeopenres.14838.1
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   MacLennan AH, 2019, J CHILD NEUROL, V34, P472, DOI 10.1177/0883073819840449
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Martin K., 2017, P PAS 2017 ANN M SAN
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Figueiredo LTM, 2018, REV SOC BRAS MED TRO, V51, P259, DOI 10.1590/0037-8682-0247-2018
   Pan American Health Organization, 2020, CAS ZIK VIR DIS COUN
   Pan American Health Organization, 2017, EP AL UPD
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Porter S, 2017, INFANT YOUNG CHILD, V30, P17, DOI 10.1097/IYC.0000000000000084
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Reilly M, 2017, J DEV BEHAV PEDIATR, V38, P65, DOI 10.1097/DBP.0000000000000382
   Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x
   Salomone E, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00769
   Vrabel M, 2015, ONCOL NURS FORUM, V42, P552, DOI 10.1188/15.ONF.552-554
   Zuurmond M, 2019, CHILD CARE HLTH DEV, V45, P45, DOI 10.1111/cch.12618
   Zuurmond M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202096
NR 37
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2020
VL 17
IS 10
AR 3559
DI 10.3390/ijerph17103559
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA LW7CK
UT WOS:000539300900216
PM 32438700
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Passos, MJ
   Matta, G
   Lyra, TM
   Moreira, MEL
   Kuper, H
   Penn-Kekana, L
   Mendonca, M
AF Passos, Maria Joana
   Matta, Gustavo
   Lyra, Tereza Maciel
   Lopes Moreira, Maria Elisabeth
   Kuper, Hannah
   Penn-Kekana, Loveday
   Mendonca, Mila
TI The promise and pitfalls of social science research in an emergency:
   lessons from studying the Zika epidemic in Brazil, 2015-2016
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID VIRUS-INFECTION; HUMAN-RIGHTS
AB Social science generates evidence necessary to control epidemics. It can help to craft appropriate public health responses, develop solutions to the epidemic impacts and improve understanding of why the epidemic occurred. Yet, there are practical constraints in undertaking this international research in a way that produces quality, ethical and appropriate data, and that values all voices and experiences, especially those of local researchers and research participants. In this paper, we reflected on the experience of undertaking social science research during the 2015/2016 Zika epidemic in Brazil. This experience was considered from the perspective of this paper's authors: three Brazilian academics, two UK academics and two mothers of children affected by congenital Zika syndrome. This group came together through the conduct of the Social and Economic Impact of Zika study, a mixed-methods social science study. The key findings highlight practical issues in the achievement of three goals: the conduct of high-quality social science in emergencies and efforts towards the decolonisation of global health in terms of levelling the power between Brazilian and UK researchers and optimising the role of patients within research. From our perspective, the information collected through social science was valuable, providing detailed insight into the programmatic needs of mothers and their affected children (eg, economic and social support and mental health services). Social science was considered a low priority within the Zika epidemic despite its potential importance. There were logistical challenges in conducting social science research, foremost of which are the difficulties in developing a trusting and balanced power relationship between the UK and Brazilian researchers in a short time frame. When these issues were overcome, each partner brought unique qualities, making the research stronger. The mothers of affected children expressed dissatisfaction with research, as they were involved in many studies which were not coordinated, and from which they did not see a benefit. In conclusion, the importance of social science in epidemics must continue to be promoted by funders. Funders can also set in place mechanisms to help equalise the power dynamics between foreign and local researchers, researchers and participants, both to promote justice and to create best quality data.
C1 [Passos, Maria Joana; Mendonca, Mila] Abraco Microcefalia, Salvador, BA, Brazil.
   [Matta, Gustavo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Lyra, Tereza Maciel] FIOCRUZ PE, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Univ Pernambuco, Fac Med, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Fernando Figueira Maternal & Childrens Inst, Rio De Janeiro, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.
   [Penn-Kekana, Loveday] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England.
RP Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.
EM Hannah.Kuper@lshtm.ac.uk
FU Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department for
   International Development [205377/Z/16/Z]; European Union's Horizon 2020
   research and innovation programme under ZikaPLAN grant [734584]
FX The Social and Economic Impact of Zika study was supported by the
   Wellcome Trust & the UK's Department for International Development
   (205377/Z/16/Z to LCR, https://wellcome.ac.uk/); the European Union's
   Horizon 2020 research and innovation programme
   (https://ec.europa.eu/programmes/horizon2020/) under ZikaPLAN grant
   agreement number 734584, https://zikaplan.tghn.org/).
CR Abimbola S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002068
   Abimbola S, 2017, LANCET GLOB HEALTH, V5, pE25, DOI 10.1016/S2214-109X(16)30302-3
   Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Cook N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026514
   Diniz D, 2019, INT J GYNECOL OBSTET, V147, P268, DOI 10.1002/ijgo.12924
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Gibb R, 2017, SOCIOL REV, V65, P134, DOI 10.1111/1467-954X.12389
   GloPID-R, 2020, GLOPID R GLOBAL RES
   Goodridge K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183134
   Hacking I, 2000, SOCIAL CONSTRUCTION
   HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066
   Hedt-Gauthier BL, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001853
   Janes CR, 2012, LANCET, V380, P1884, DOI 10.1016/S0140-6736(12)61725-5
   Keikelame MJ, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2018.1561175
   Kuper H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007768
   Kuper Hannah, 2018, Wellcome Open Res, V3, P127, DOI 10.12688/wellcomeopenres.14838.1
   Matta GC, 2019, FRAMING ANIMALS EPID, P211
   Mbaye R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001855
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Moreira MCN, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00075718
   Parker M, 2019, LANCET, V393, P2585, DOI 10.1016/S0140-6736(19)31364-9
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Reidpath DD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001719
   Saha S, 2019, C WORD TACKLING ENDU
   Stellmach D, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000534
   UNICEF and IDS, 2020, SOC SCI HUM ACT COMM
   Vargha D., 2016, SOMATSOPHERENET
   Wellcome Trust, 2016, STAT DAT SHAR PUBL H
   WHO, 2019, COMM ENG SOC MOB
   2018, LANCET GLOB HLTH, V6, pE59
NR 35
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD APR
PY 2020
VL 5
IS 4
AR e002307
DI 10.1136/bmjgh-2020-002307
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LV0PA
UT WOS:000538145000023
PM 32345582
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Pecanha, PM
   Gomes, SC
   Pone, SM
   Pone, MVD
   Vasconcelos, Z
   Zin, A
   Vilibor, RHH
   Costa, RP
   Meio, MDBB
   Nielsen-Saines, K
   Brasil, P
   Brickley, E
   Moreira, MEL
AF Pecanha, Pedro Massaroni
   Gomes Junior, Saint Clair
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
   Vasconcelos, Zilton
   Zin, Andrea
   Hasue Vilibor, Renata Hydee
   Costa, Roozemeria Pereira
   Barbosa Baker Meio, Maria Dalva
   Nielsen-Saines, Karin
   Brasil, Patricia
   Brickley, Elizabeth
   Lopes Moreira, Maria Elisabeth
TI Neurodevelopment of children exposed intra-uterus by Zika virus: A case
   series
SO PLOS ONE
LA English
DT Article
ID HEAD GROWTH; PRETERM INFANTS; INFECTION; BRAIN; STANDARDS; WEIGHT;
   BRAZIL; NEEDS
AB The main goal of this manuscript was to investigate the neurodevelopment of children exposed by Zika virus in the intrauterine period who are asymptomatic at birth. Newborns with documented Zika virus exposure during the intrauterine period who were asymptomatic at birth were followed in the first two years of life for neurodevelopment using Bayley III test. Children were classified as having normal or delayed neurodevelopment for age based on most recent Bayley III evaluation results. Eighty-four infants were included in the study. The first Bayley III evaluation was performed at a mean chronological age of 9.7 +/- 3.1 month; 13 children (15%) had a delay in one of the three domains, distributed as follow: 10 (12%) in the language domain and 3 (3.5%) in the motor domain. The most recent Bayley III evaluation was performed at a mean age 15.3 +/- 3.1 months; 42 children (50%) had a delay in one of the three domains: 4 (5%) in cognition, 31 (37%) in language, and 20 (24%) in motor performance. There were no statistical differences in Gender, Gestational Age, Birth Weight and Head Circurference at birth between children with normal and delayed neurodevelopment for age. A very high proportion of children exposed ZIKV during pregnancy who were asymptomatic at birth demonstrated a delay in neurodevelopment, mainly in the language domain, the first two years of life.
C1 [Pecanha, Pedro Massaroni; Gomes Junior, Saint Clair; Pone, Sheila Moura; da Silva Pone, Marcos Vinicius; Vasconcelos, Zilton; Zin, Andrea; Costa, Roozemeria Pereira; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
   [Hasue Vilibor, Renata Hydee] Univ Sao Paulo, Sao Paulo, Brazil.
   [Nielsen-Saines, Karin] UCLA, Los Angeles, CA USA.
   [Brasil, Patricia] Inst Nacl Infectol Fiocruz, Rio De Janeiro, Brazil.
   [Brickley, Elizabeth] London Sch Hyg & Trop Med, London, England.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
EM bebethiff@gmail.com
RI Hasue, Renata Hydee/B-2328-2013; Junior, Clair Gomes/F-7579-2012;
   Brickley, Elizabeth/U-3625-2017
OI Junior, Clair Gomes/0000-0002-1554-943X; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Massaroni Pecanha,
   Pedro/0000-0002-4151-5508; Brickley, Elizabeth/0000-0003-0280-2288
FU European UnionEuropean Union (EU) [734584]; Wellcome TrustWellcome Trust
   [205377/Z/16/Z]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPqNational Council for Scientific and Technological
   Development (CNPq) [441098/2016-9]; FaperjCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.979/2017]; PIP2/IFF/Fiocruz [IFF-002Fio1628]; NIH/NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [RO1-AI140718]
FX The author(s) received specific fundings for this work -European Union's
   Horizon 2020 Research and Innovation Programme under ZikaPLAN 734584
   Maria Elisabeth lopes Moreira - Wellcome Trust 205377/Z/16/Z Dr
   Elizabeth Brickley - Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPq 441098/2016-9 Maria Elisabeth lopes Moreira - Faperj
   E-26/202.979/2017 Maria Elisabeth lopes Moreira - PIP2/IFF/Fiocruz
   IFF-002Fio1628 Maria Elisabeth lopes Moreira - NIH/NIAID - RO1-AI140718.
CR Adu-Afarwuah S, 2017, ANN NY ACAD SCI, V1392, P18, DOI 10.1111/nyas.13328
   BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9
   Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atenc Saude, 2016, GUID EARL STIM INF 3
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438
   Coplan J., 1983, ELM SCALE EARLY LANG
   Countryeconomy.com, 2018, BRAZ NAT MIN WAG NMW
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   de Paiva GS, 2010, SAO PAULO MED J, V128, P276, DOI 10.1590/S1516-31802010000500007
   Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilberti LDP, 1999, AN 6 C GOIAN PED GOI
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Kuban KCK, 2009, J PEDIATR-US, V155, P344, DOI 10.1016/j.jpeds.2009.04.002
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Neubauer V, 2013, ACTA PAEDIATR, V102, P883, DOI 10.1111/apa.12319
   OECD, 2018, ED GLANC 2018
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Raghuram K, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0216
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Maria-Mengel MR, 2007, REV LAT-AM ENFERM, V15, P837, DOI 10.1590/S0104-11692007000700019
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Waldorf KMA, 2018, NAT MED
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Wu YH, 2018, CELL REP, V25, P1537, DOI 10.1016/j.celrep.2018.10.025
NR 41
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2020
VL 15
IS 2
AR e0229434
DI 10.1371/journal.pone.0229434
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ8HR
UT WOS:000535239800011
PM 32109947
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Magalhaes, ESD
   Meio, MDBB
   Peixoto, FM
   Gonzalez, S
   da Costa, ACC
   Moreira, MEL
AF da Silva Magalhaes, Elizabeth Soares
   Barbosa Baker Meio, Maria Dalva
   Peixoto-Filho, Fernando Maia
   Gonzalez, Sayonara
   Carioca da Costa, Ana Carolina
   Lopes Moreira, Maria Elisabeth
TI Pregnancy-induced hypertension, preterm birth, and cord blood adipokine
   levels
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE Preterm; Pregnancy-induced hypertension; Leptin; Ghrelin; Adiponectin;
   Intrauterine growth restriction
ID FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH; ADIPONECTIN LEVEL; LEPTIN
   LEVELS; GHRELIN; PREECLAMPSIA; PRESSURE
AB Maternal hypertension may alter physiological parameters, dysregulating the release of hormones such as adipokines, thus influencing the fetal growth course. This study investigated whether hypertensive disorders of pregnancy alter cord blood adipokine levels and correlate these with anthropometric parameters in preterm infants. This is a prospective cohort study with pregnant women < 37-week gestation with and without hypertension and their offspring. Cord blood leptin, adiponectin, and ghrelin were analyzed by LUMINEX (R). These adipokines were compared between the groups exposed or not to gestational hypertension using non-parametric statistical tests. The hypertensive pregnancies had significantly higher cord blood leptin (1.00 (IQR 0.67-1.20 ng/mL)) and adiponectin (18.52 (IQR 17.52-25.13 mu g/mL)) levels than those without hypertension (0.07 (IQR 0.06-0.08 ng/mL) and 8.13 (IQR 6.50-8.68 mu g/mL), respectively, p < 0.0001). The adipokine levels were higher in AGA and SGA infants in the exposed group for both moderate and late preterm. SGA had significantly higher ghrelin levels than the AGA infants. Ghrelin levels were negatively correlated with birth weight (r = - 0.613, p < 0.001), birth length (r = - 0.510, p < 0.001), head circumference (- 0.346, p < 0.002), and gestational age (r = - 0.612, p < 0.001). Conclusions: Our findings demonstrate an increase in adipokine levels in the cord blood of preterm newborn infants exposed to maternal hypertension.What is Known:center dot Clinical evidence suggests that concentration of the serum adipokines may be affected by risk of hypertension in both adults and pregnant women.center dot Maternal profile as hypertension alters intrauterine environment and could affect the function of fetal metabolism, impairing fetal growth.What is New:center dot Gestational hypertension modifies the adipokine profile, with higher rates already present at birth in cord blood samples.center dot Within the hypertensive group and stratifying for gestation age, ghrelin concentrations were higher in SGA newborns, both in the moderate and late preterm, compared with AGA newborns.
C1 [da Silva Magalhaes, Elizabeth Soares; Barbosa Baker Meio, Maria Dalva; Carioca da Costa, Ana Carolina; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Clin Res Unit, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Peixoto-Filho, Fernando Maia] Fundacao Oswaldo Cruz, Dept Obstet, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Gonzalez, Sayonara] Fundacao Oswaldo Cruz, Lab Genom Med, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Med Genet, Rio De Janeiro, RJ, Brazil.
RP Magalhaes, ESD (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Clin Res Unit, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM emagalhaesiff@gmail.com; mdbakermeio@gmail.com;
   fernandomaiapeixotofilho@gmail.com; sayonara.gonzalez@iff.fiocruz.br;
   carol.carioca@gmail.com; bebethiff@gmail.com
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior-CAPESCAPES
FX This study was financially supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro-FAPERJ, and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-CAPES.
CR Bell BB, 2016, CURR OBES REP, V5, P397, DOI 10.1007/s13679-016-0231-x
   Beltrand J, 2008, BEST PRACT RES CL EN, V22, P503, DOI 10.1016/j.beem.2008.01.015
   Bertagnolli M, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0637-6
   Dos Santos E, 2012, VITAM HORM, V90, P187, DOI 10.1016/B978-0-12-398313-8.00008-7
   Eleuterio NM, 2015, PREGNANCY HYPERTENS, V5, P205, DOI 10.1016/j.preghy.2015.03.001
   Espinoza J, 2019, OBSTET GYNECOL, V133, pE1, DOI 10.1097/AOG.0000000000003018
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3
   Gibas-Dorna M, 2015, J PHYSIOL PHARMACOL, V66, P367
   Girouard J, 2007, HYPERTENSION, V49, P1056, DOI 10.1161/HYPERTENSIONAHA.107.087528
   Hernandez MI, 2018, HORM RES PAEDIAT, V89, P233, DOI 10.1159/000487994
   Kesavan K, 2019, PEDIATR CLIN N AM, V66, P403, DOI 10.1016/j.pcl.2018.12.009
   Kintiraki E, 2015, HORM-INT J ENDOCRINO, V14, P211, DOI 10.14310/horm.2002.1582
   Mao YJ, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0622-5
   Martin CR, 2016, ARCH DIS CHILD-FETAL, V101, pF99, DOI 10.1136/archdischild-2015-308221
   Mendez-Ramirez F, 2009, CLIN ENDOCRINOL, V70, P41, DOI 10.1111/j.1365-2265.2008.03278.x
   Mierzynski R, 2016, CURR PHARM BIOTECHNO, V17, P587, DOI 10.2174/1389201017666160301104323
   Ogland B, 2010, HORM RES PAEDIAT, V74, P92, DOI 10.1159/000313376
   Perez-Perez A, 2018, J CELL MOL MED, V22, P716, DOI 10.1111/jcmm.13369
   Ren RX, 2010, WORLD J PEDIATR, V6, P311, DOI 10.1007/s12519-010-0216-x
   Sahin H, 2012, EUR J ENDOCRINOL, V166, P399, DOI 10.1530/EJE-11-0607
   Sferruzzi-Perri AN, 2013, CURR OPIN CLIN NUTR, V16, P298, DOI 10.1097/MCO.0b013e32835e3643
   Sindiani AM, 2019, J INT MED RES, V47, P2591, DOI 10.1177/0300060519848613
   Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443
   Stawerska R, 2016, J PEDIATR ENDOCR MET, V29, P939, DOI 10.1515/jpem-2015-0463
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Steinbrekera B, 2016, J ENDOCRINOL, V231, pR47, DOI 10.1530/JOE-16-0273
   Taylor BD, 2015, HYPERTENSION, V65, P594, DOI 10.1161/HYPERTENSIONAHA.114.03979
   Valuniene M, 2007, MEDICINA-LITHUANIA, V43, P784, DOI 10.3390/medicina43100100
   Warchol M, 2018, J PEDIATR ENDOCR MET, V31, P151, DOI 10.1515/jpem-2017-0285
   Wu F, 2019, CLIN EXP HYPERTENS, V41, P263, DOI 10.1080/10641963.2018.1469642
   Xu Q, 2017, EXP THER MED, V14, P4972, DOI 10.3892/etm.2017.5112
   Yeboah FA, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S134088
NR 33
TC 0
Z9 0
U1 2
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD AUG
PY 2020
VL 179
IS 8
BP 1239
EP 1246
DI 10.1007/s00431-020-03586-8
EA FEB 2020
PG 8
WC Pediatrics
SC Pediatrics
GA MH8DQ
UT WOS:000516146600002
PM 32062709
DA 2020-12-17
ER

PT J
AU Melo, RX
   Marano, D
   da Silva, DA
   Moreira, MEL
AF Melo, Raquel Ximenes
   Marano, Daniele
   da Silva, Danielle Aparecida
   Lopes Moreira, Maria Elisabeth
TI The influence of the gender of newborns on human milk composition
SO ACTA PAEDIATRICA
LA English
DT Editorial Material
ID ENERGY
C1 [Melo, Raquel Ximenes; Marano, Daniele; da Silva, Danielle Aparecida; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Natl Inst Womens Child & Adolescent Hlth Fernande, Ave Rui Barbosa 716,Flamengo, Rio De Janeiro, Brazil.
RP Melo, RX (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Womens Child & Adolescent Hlth Fernande, Ave Rui Barbosa 716,Flamengo, Rio De Janeiro, Brazil.
EM raquelximenesmelo@yahoo.com.br
OI /0000-0002-2034-0294; Ximenes Melo, Raquel/0000-0001-8494-3310
CR Fujita M, 2012, AM J PHYS ANTHROPOL, V149, P52, DOI 10.1002/ajpa.22092
   Hahn WH, 2017, J MATERN-FETAL NEO M, V30, P1608, DOI 10.1080/14767058.2016.1219989
   Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941
   Quinn EA, 2013, AM J PHYS ANTHROPOL, V152, P209, DOI 10.1002/ajpa.22346
   Thakkar Sagar K, 2013, Am J Hum Biol, V25, P770, DOI 10.1002/ajhb.22446
NR 5
TC 0
Z9 0
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD JUL
PY 2020
VL 109
IS 7
BP 1485
EP 1486
DI 10.1111/apa.15157
EA JAN 2020
PG 2
WC Pediatrics
SC Pediatrics
GA LZ4AN
UT WOS:000509883700001
PM 31899804
DA 2020-12-17
ER

PT J
AU Messias, CV
   Loss-Morais, G
   de Carvalho, JB
   Gonzalez, MN
   Cunha, DP
   Vasconcelos, Z
   Arge, LWP
   Farias-de-Oliveira, DA
   Gerber, AL
   Portari, EA
   Ferreira, N
   Raphael, LMS
   Bonaldo, MC
   Riederer, I
   Moreira, MEL
   Cotta-de-Almeida, V
   Vasconcelos, ATR
   Mendes-da-Cruz, DA
   Savino, W
AF Messias, Carolina V.
   Loss-Morais, Guilherme
   de Carvalho, Joseane Biso
   Gonzalez, Mariela N.
   Cunha, Daniela P.
   Vasconcelos, Zilton
   Arge, Luis W. P.
   Farias-de-Oliveira, Desio A.
   Gerber, Alexandra L.
   Portari, Elyzabeth A.
   Ferreira, Nilma
   Raphael, Lidiane M. S.
   Bonaldo, Myrna C.
   Riederer, Ingo
   Lopes Moreira, Maria E.
   Cotta-de-Almeida, Vinicius
   Vasconcelos, Ana T. R.
   Mendes-da-Cruz, Daniella A.
   Savino, Wilson
TI Zika virus targets the human thymic epithelium
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; NONCODING RNA; MEDIATED INTERACTIONS; CELLS;
   INFECTION; THYMOCYTES; MIGRATION; DIFFERENTIATION; EXPRESSION; MOLECULES
AB Previous work showed that the thymus can be infected by RNA viruses as HIV and HTLV-1. We thus hypothesized that the thymus might also be infected by the Zika virus (ZIKV). Herein we provide compelling evidence that ZIKV targets human thymic epithelial cells (TEC) in vivo and in vitro. ZIKV-infection enhances keratinization of TEC, with a decrease in proliferation and increase in cell death. Moreover, ZIKV modulates a high amount of coding RNAs with upregulation of genes related to cell adhesion and migration, as well as non-coding genes including miRNAs, circRNAs and lncRNAs. Moreover, we observed enhanced attachment of lymphoblastic T-cells to infected TEC, as well as virus transfer to those cells. Lastly, alterations in thymuses from babies congenitally infected were seen, with the presence of viral envelope protein in TEC. Taken together, our data reveals that the thymus, particularly the thymic epithelium, is a target for the ZIKV with changes in the expression of molecules that are relevant for interactions with developing thymocytes.
C1 [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.
   [Messias, Carolina V.; Gonzalez, Mariela N.; Farias-de-Oliveira, Desio A.; Riederer, Ingo; Cotta-de-Almeida, Vinicius; Mendes-da-Cruz, Daniella A.; Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Loss-Morais, Guilherme; de Carvalho, Joseane Biso; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
   [Raphael, Lidiane M. S.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol Flavivirus, Rio De Janeiro, Brazil.
   [Cunha, Daniela P.; Vasconcelos, Zilton; Portari, Elyzabeth A.; Ferreira, Nilma; Lopes Moreira, Maria E.] Fundacao Oswaldo Cruz, Lab High Complex, Fernandes Figueira Natl Inst Hlth Mother Child &, Rio De Janeiro, Brazil.
RP Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.; Mendes-da-Cruz, DA; Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Vasconcelos, ATR (corresponding author), Natl Lab Sci Comp, Bioinformat Lab, Rio De Janeiro, Brazil.
EM atrv@lncc.br; daniella@ioc.fiocruz.br; wilson.savino@fiocruz.br
RI ; Riederer, Ingo/O-1444-2017; Mendes-da-Cruz, Daniella/E-7875-2016
OI Cunha, Daniela/0000-0002-5954-6054; Riederer, Ingo/0000-0001-7171-9977;
   Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Arge, Luis Willian
   Pacheco/0000-0002-0109-4809
FU Brazilian Funding Agency for Studies and Projects (FINEP)
   [01.16.0078.00]; Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq) [303170/2017-4, 306699/2018-4,
   307720/2016-0]; Carlos Chagas Filho Foundation for Funding Research in
   the State of Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.826/2018]; Oswaldo Cruz Foundation (Fiocruz); National
   Laboratory for Scientific Computation; Coordination of Superior Level
   Staff Improvement (CAPES) -Brazil [001]; Mercosur Fund for Structural
   Convergence (FOCEM) [03/11]; Program of Preventing and Combating the
   Zika Virus, MCTIC/FNDCT -CNPq/MEC-CAPES/MS-Decit [426767/2018-7,
   88881.130684/2016-01];  [23038.010041/2013-13];  [465489/2014-1]
FX The human postnatal TEC line was kindly provided by Dr. Maria Luiza
   Toribio (Universidad Autonoma de Madrid, Madrid, Spain). The mouse
   monoclonal 4G2 antibody (anti-flavivirus) was gently provided by the
   Laboratory of Monoclonal Antibody Technology from Bio-Manguinhos
   (Oswaldo Cruz Foundation, Rio de Janeiro, Brazil). The authors thank
   Raquel de Souza Martins for confocal analysis assistance. This work was
   funded by Brazilian Funding Agency for Studies and Projects (FINEP)
   #01.16.0078.00; Brazilian National Council for Scientific and
   Technological Development (CNPq) ATRV supported by #303170/2017-4, WS by
   #306699/2018-4, DAMC by #307720/2016-0; Carlos Chagas Filho Foundation
   for Funding Research in the State of Rio de Janeiro (Faperj) ATRV
   supported by #E-26/202.826/2018; the Oswaldo Cruz Foundation (Fiocruz)
   and National Laboratory for Scientific Computation; Coordination of
   Superior Level Staff Improvement (CAPES) -Brazil -Finance Code 001 and
   GLM, JBC and LWPA supported #23038.010041/2013-13; Mercosur Fund for
   Structural Convergence (FOCEM, Mercosur #03/11) and the Program of
   Preventing and Combating the Zika Virus, MCTIC/FNDCT
   -CNPq/MEC-CAPES/MS-Decit (Grants 426767/2018-7 and 88881.130684/2016-01
   for MCB). This work was developed in the framework of the Brazilian
   National Institute of Science and Technology on Neuroimmunomodulation
   (INCT-NIM) WS supported by #465489/2014-1.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Azouz F, 2019, VIRUSES, V11, P1
   Bertoni A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020485
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Braun J, 1996, VIROLOGY, V225, P413, DOI 10.1006/viro.1996.0617
   Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14
   Cadena C, 2017, MOL CELL, V67, P163, DOI 10.1016/j.molcel.2017.07.005
   Carnero E, 2016, EMBO REP, V17, P1013, DOI 10.15252/embr.201541763
   Barros LRC, 2017, IMMUNOBIOLOGY, V222, P1053, DOI 10.1016/j.imbio.2017.08.001
   Cava C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020274
   Dairaghi DJ, 1998, BLOOD, V91, P2905, DOI 10.1182/blood.V91.8.2905.2905_2905_2913
   Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   FERNANDEZ E, 1994, BLOOD, V83, P3245
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LANNESVIEIRA J, 1993, INT IMMUNOL, V5, P1421, DOI 10.1093/intimm/5.11.1421
   LE PT, 1993, INT J CLIN LAB RES, V23, P56, DOI 10.1007/BF02592284
   Limonta D., 2018, VIRUSES, V10, P1
   Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2
   Liu L, 2019, CELL DEATH DIFFER, V26, P2607, DOI 10.1038/s41418-019-0324-7
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lyu Q, 2019, P NATL ACAD SCI USA, V116, P546, DOI 10.1073/pnas.1810729116
   MAGUERSATTA V, 1995, BLOOD, V86, P1444, DOI 10.1182/blood.V86.4.1444.bloodjournal8641444
   Manca N, 2002, J ACQ IMMUN DEF SYND, V29, P300, DOI 10.1097/00126334-200203010-00012
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Messias CV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4622-y
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Moreira-Ramos K, 2011, MEM I OSWALDO CRUZ, V106, P759, DOI 10.1590/S0074-02762011000600018
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nishitsuji H, 2016, P NATL ACAD SCI USA, V113, P10388, DOI 10.1073/pnas.1525022113
   Paessens LC, 2008, MOL IMMUNOL, V45, P42, DOI 10.1016/j.molimm.2007.05.016
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Ocampo JSP, 2008, CELL IMMUNOL, V254, P1, DOI 10.1016/j.cellimm.2008.06.005
   Ribeiro-Carvalho MM, 2007, SCAND J IMMUNOL, V66, P17, DOI 10.1111/j.1365-3083.2007.01928.x
   Ribeiro-Carvalho MM, 2002, NEUROIMMUNOMODULAT, V10, P142, DOI 10.1159/000067175
   Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X
   SAVINO W, 1988, ENDOCRINOLOGY, V123, P2557, DOI 10.1210/endo-123-5-2557
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Savino W, 2016, NAT REV ENDOCRINOL, V12, P77, DOI 10.1038/nrendo.2015.168
   Savino W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00579
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SINGER KH, 1990, J IMMUNOL, V144, P2931
   Singh P.K., 2018, SCI REP, V8, P1, DOI [10.1038/s41598-018-29329-2., DOI 10.1038/S41598-018-29329-2.]
   Strange DP, 2018, SCI REP, V8, P1
   Wang M, 2017, INT J BIOL SCI, V13, P1497, DOI 10.7150/ijbs.22531
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zamarchi R, 2002, CLIN EXP IMMUNOL, V127, P321, DOI 10.1046/j.1365-2249.2002.01775.x
   Zhang CL, 2018, AM J TRANSL RES, V10, P4193
   Zhao JM, 2018, NEOPLASMA, V65, P779, DOI 10.4149/neo_2018_171130N778
NR 66
TC 1
Z9 1
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 28
PY 2020
VL 10
IS 1
AR 1378
DI 10.1038/s41598-020-58135-y
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NE8OR
UT WOS:000562865600009
PM 31992777
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Baiao, AER
   de Carvalho, PRN
   Moreira, MEL
   de Sa, RAM
   Gome, SC
AF Baiao, Ana Elisa Rodrigues
   de Carvalho, Paulo Roberto Nassar
   Moreira, Maria Elisabeth Lopes
   de Sa, Renato Augusto Moreira
   Gomes Junior, Saint Clair
TI Predictors of perinatal outcome in early-onset fetal growth restriction:
   A study from an emerging economy country
SO PRENATAL DIAGNOSIS
LA English
DT Article
ID DUCTUS VENOSUS; BLOOD-FLOW; DOPPLER; WEIGHT; DEFINITION; GUIDELINES;
   MANAGEMENT; MORBIDITY; MORTALITY; INFANTS
AB Objective To identify antenatal predictors of adverse perinatal outcomes in a population of preterm fetuses with early placental insufficiency diagnosed by Doppler abnormalities. Method In this cross-sectional study of a cohort of singleton pregnant women diagnosed with early placental insufficiency, relationships between perinatal variables (arterial and venous Doppler, gestational age, birth weight, oligohydramnios, estimated fetal weight, and fetal weight z-scores) and major neonatal complications were analyzed by logistic regression. Results Two hundred sixty-five women were delivered, between 24 and 33 weeks gestation. The overall frequency of intact survival was 57.9% (n = 154). Gestational age thresholds for best prediction of survival was 27 + 6 weeks and for intact survival was 29 + 0 weeks gestation. Fetal weight and absent/reversed ductus venosus a-wave were the main predictors of survival in the regression model. When fetal weight was substituted for fetal weight z-score, ductus venosus abnormal Doppler predicted mortality and absent or reversed umbilical artery diastolic velocities predicted intact survival. Conclusions This study illustrates the impact of gestational age and fetal weight on perinatal outcomes in early placental insufficiency, with well-defined thresholds. Gestational age and fetal weight, or a combination of fetal weight z-scores and fetal Doppler parameters, were the best predictors of intact survival in our sample.
C1 [Baiao, Ana Elisa Rodrigues; de Carvalho, Paulo Roberto Nassar] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Obstet, Rio De Janeiro, Brazil.
   [Baiao, Ana Elisa Rodrigues; de Carvalho, Paulo Roberto Nassar] Perinatal Unidade Barra, Grp Perinatal, Dept Obstet, Rio De Janeiro, Brazil.
   [Moreira, Maria Elisabeth Lopes; de Sa, Renato Augusto Moreira; Gomes Junior, Saint Clair] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Clin Res, Rio De Janeiro, Brazil.
   [de Sa, Renato Augusto Moreira] Univ Fed Fluminense, Dept Obstet, Niteroi, RJ, Brazil.
RP Baiao, AER (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Obstet, Rio De Janeiro, Brazil.
EM anaelisa.baiao@gmail.com
RI de Sa, Renato Augusto Moreira/B-4778-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; MOREIRA DE SA,
   RENATO A/0000-0001-6357-7702; Baiao, Ana Elisa/0000-0002-5188-6134;
   Nassar de Carvalho, Paulo Roberto/0000-0002-7835-4656
FU Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz, Ministerio da Saude,
   Brasil
FX Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz, Ministerio da Saude,
   Brasil
CR [Anonymous], 1996, Eur J Obstet Gynecol Reprod Biol, V67, P121
   ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
   Baschat AA, 2003, ULTRASOUND OBST GYN, V22, P240, DOI 10.1002/uog.149
   Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P1, DOI 10.1002/uog.21
   Baschat AA, 2007, OBSTET GYNECOL, V109, P253, DOI 10.1097/01.AOG.0000253215.79121.75
   Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8
   Bilardo CM, 2017, ULTRASOUND OBST GYN, V50, P285, DOI 10.1002/uog.18815
   da Silva Fernanda C, 2007, Cardiovasc Ultrasound, V5, P15, DOI 10.1186/1476-7120-5-15
   Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249
   Fenton TR, 2003, BMC PEDIATR, V16, P3
   Figueras F, 2014, PRENATAL DIAG, V34, P655, DOI 10.1002/pd.4412
   Ghidini A, 2007, OBSTET GYNECOL, V109, P250, DOI 10.1097/01.AOG.0000254964.11691.af
   Giuliano N, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/620976
   HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4
   HECHER K, 1994, ULTRASOUND OBST GYN, V4, P381, DOI 10.1046/j.1469-0705.1994.04050381.x
   Lausman A, 2013, J OBSTET GYNAECOL CA, V35, P741, DOI 10.1016/S1701-2163(15)30865-3
   Lees C, 2013, ULTRASOUND OBST GYN, V42, P400, DOI 10.1002/uog.13190
   Leppanen M, 2010, ULTRASOUND OBST GYN, V36, P178, DOI 10.1002/uog.7694
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   PHELAN JP, 1987, J REPROD MED, V32, P540
   Rizzo G, 1996, ULTRASOUND OBST GYN, V7, P401, DOI 10.1046/j.1469-0705.1996.07060401.x
   Sa R AM, 2000, INT J GYNECOL OBSTET, V70, pA28, DOI 10. 1016/S0020-7292(00)82042-1
   Sankar MJ, 2016, J PERINATOL, V36, pS1, DOI 10.1038/jp.2016.27
   Savchev S, 2014, FETAL DIAGN THER, V36, P129, DOI 10.1159/000360419
   Savchev S, 2014, FETAL DIAGN THER, V36, P99, DOI 10.1159/000355525
   Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005
   Unterscheider J, 2015, AM J PERINAT, V32, P307, DOI 10.1055/s-0034-1387927
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963
   WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb07932.x
NR 30
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD FEB
PY 2020
VL 40
IS 3
BP 373
EP 379
DI 10.1002/pd.5596
EA JAN 2020
PG 7
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA KM5EA
UT WOS:000505305400001
PM 31674030
DA 2020-12-17
ER

PT J
AU Soares, F
   Abranches, AD
   Villela, L
   Lara, S
   Araujo, D
   Nehab, S
   Silva, L
   Amaral, Y
   Junior, SG
   Pone, S
   Lobkowicz, L
   Clemente, NS
   Brasil, P
   Nielsen-Saines, K
   Pone, M
   Brickley, E
   Moreira, ME
AF Soares, Fernanda
   Abranches, Andrea D.
   Villela, Leticia
   Lara, Sarah
   Araujo, Daniele
   Nehab, Sylvia
   Silva, Leila
   Amaral, Yasmin
   Junior, Saint Clair G.
   Pone, Sheila
   Lobkowicz, Ludmila
   Clemente, Nuria Sanchez
   Brasil, Patricia
   Nielsen-Saines, Karin
   Pone, Marcos
   Brickley, Elizabeth
   Moreira, Maria Elisabeth
TI Zika virus infection in pregnancy and infant growth, body composition in
   the first three months of life: a cohort study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AIR-DISPLACEMENT PLETHYSMOGRAPH; BIRTH; OUTBREAK; CHILDREN; WEIGHT;
   BRAZIL; BORN
AB The implications of Zika Virus exposure in pregnancy for early infant growth remains poorly described. The main goal of this study is to compare the growth, body composition, and feeding modality of infants in the first three months of life by prenatal Zika Virus exposure status. We selected an analytical cohort of 115 infants born without microcephaly, comprising 56 infants with qRT-PCR confirmed exposure to ZIKV during gestation and 59 infants born to women with presumptively no evidence of ZIKV in pregnancy. Infants were evaluated at birth, I and 3 months of age in terms of anthropometrics, body composition All the results were adjusted by maternal age, maternal BMI and gestational age. We observe no differences between anthropometric measurements at birth. Mothers in exposed group showed higher BMI. At 1 month and 3 months of age there were differences in mid arm circumference, arm muscle circumference and fat free mass. Weight and length was less in the ZIKV exposed in pregnancy infants and statistically different at 3 month of age. The findings of this investigation provide new evidence that ZIKV exposure in pregnancy may be associated with differences in body body composition.
C1 [Soares, Fernanda; Abranches, Andrea D.; Villela, Leticia; Lara, Sarah; Araujo, Daniele; Nehab, Sylvia; Silva, Leila; Amaral, Yasmin; Junior, Saint Clair G.; Pone, Sheila; Brasil, Patricia; Pone, Marcos; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Lobkowicz, Ludmila; Clemente, Nuria Sanchez; Brickley, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Clemente, Nuria Sanchez] Univ Sao Paulo, Dept Epidemiol, Sao Paulo, SP, Brazil.
   [Nielsen-Saines, Karin] UCLA, Univ Calif Pediat Infect Dis, Los Angeles, CA USA.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Lobkowicz, Ludmila/AAR-5878-2020; Lobkowicz, Ludmila/AAM-4279-2020; de
   Abranches, Andrea Dunshee/ABA-8578-2020; Clemente, Nuria
   Sanchez/AAL-4309-2020; Moreira, Maria Elisabeth Lopes/AAA-3775-2020;
   Brickley, Elizabeth/U-3625-2017
OI Lobkowicz, Ludmila/0000-0002-9915-0361; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915;
   Brickley, Elizabeth/0000-0003-0280-2288; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Amaral, Yasmin/0000-0001-8159-0564
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [441098/2016-9, 305090/2016-0]; FaperjCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [E_18/2015TXB];
   Wellcome TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's
   Department for International Development [205377/Z/16/Z]; European
   UnionEuropean Union (EU) [734584]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI140718, R21AI129534, R01AI140718] Funding Source:
   NIH RePORTER
FX CNPq 441098/2016-9 and 305090/2016-0; Faperj E_18/2015TXB; Wellcome
   Trust & the United Kingdom's Department for International Development
   (205377/Z/16/Z); European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN grant agreement no. 734584.
CR Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Beaudrap P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1135-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fields DA, 2011, OBESITY, V19, P1887, DOI 10.1038/oby.2011.11
   Frisancho A., 1991, CLIN NUTR, V10, P131, DOI DOI 10.1016/0261-5614(91)90103-J
   Fung EB, 2002, J AM DIET ASSOC, V102, P361, DOI 10.1016/S0002-8223(02)90084-2
   Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hortencio Taís Daiene Russo, 2015, Rev. paul. pediatr., V33, P3, DOI 10.1016/j.rpped.2014.11.004
   Kalanda BF, 2005, EARLY HUM DEV, V81, P841, DOI 10.1016/j.earlhumdev.2005.06.006
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Makasa M, 2007, TROP MED INT HEALTH, V12, P594, DOI 10.1111/j.1365-3156.2007.01836.x
   Mameli C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090838
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nicholson L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0386-8
   Organization W. H., 2017, WHO IHR EM COMM ZIK
   Perng W, 2017, AM J CLIN NUTR, V106, P559, DOI 10.3945/ajcn.116.149617
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Walther B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-16
   WHO, 2013, PHYS STAT UINT ANT
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   Yao M, 2003, ACTA DIABETOL, V40, pS55, DOI 10.1007/s00592-003-0027-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 4
Z9 4
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 16
PY 2019
VL 9
AR 19198
DI 10.1038/s41598-019-55598-6
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JW6WG
UT WOS:000503189100005
PM 31844129
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Tsui, I
   Neves, LM
   Adachi, K
   Gaw, SL
   Pereira, JP
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
   Zin, AA
AF Tsui, Irena
   Neves, Luiza M.
   Adachi, Kristina
   Gaw, Stephanie L.
   Pereira Jr, Jose Paulo
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria Elisabeth Lopes
   Zin, Andrea A.
TI Overlapping Spectrum of Retinochoroidal Scarring in Congenital Zika
   Virus and Toxoplasmosis Infections
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OCULAR TOXOPLASMOSIS; GENE POLYMORPHISM; MANIFESTATIONS; INFANTS
AB BACKGROUND AND OBJECTIVE: Antenatal Zika virus (ZIKV) or toxoplasmosis infections may present with isolated eye abnormalities with absence of other apparent birth defects. The purpose of this article is to discuss the overlapping spectrum of clinical presentation and retinochoroidal scarring in congenital ZIKV and toxoplasmosis infections.
   PATIENTS AND METHODS: Prenatal ultrasound abnormalities seen from antenatal ZIKV and toxoplasmosis infections overlap and may include intracranial calcifications, microcephaly, and intrauterine growth restriction. The clinical spectrum of both infections in less severely affected infants and children may include nonspecific neurological impairment such as developmental delay and seizures.
   RESULTS: Inherent limitations in serological testing pose additional barriers in establishing a diagnosis. Retinal pigment epithelium (RPE) mottling in ZIKV infection can occur in isolation or adjacent to retinochoroidal atrophy. In contrast, RPE mottling outside of the borders of retinochoroidal atrophy is not typically seen in toxoplasmosis. To date, postnatal reactivation of congenital eye lesions as seen in toxoplasmosis have not been reported with ZIKV infection.
   CONCLUSIONS: As children infected with congenital ZIKV grow older, subclinical eye abnormalities may be indistinguishable from toxoplasmosis. Brazil has had high prevalence of both diseases with long-term information available on toxoplasmosis only. Surveillance guidelines for asymptomatic eye abnormalities will likely evolve.
C1 [Tsui, Irena] Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
   [Neves, Luiza M.; Pereira Jr, Jose Paulo; Moreira, Maria Elisabeth Lopes; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescent Ferna, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Serv, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Tsui, I (corresponding author), Univ Calif Los Angeles, Dept Ophthalmol, Div Retina, 100 Stein Plaza, Los Angeles, CA 90095 USA.
EM itsui@jsei.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-02, R01 AI121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R21AI129534, R01AI121207,
   R21AI129534] Funding Source: NIH RePORTER
FX Funded by the Brazilian National Council for Scientific and
   Technological Development [441098/2016-9], National Eye Institute
   [R21EY028318-02 and [R01 AI121207], and National Institute of Allergy
   and Infectious Diseases [R21AI129534-02]. Dr. Tsui was supported in part
   by an unrestricted Research to Prevent Blindness grant given to the
   Stein Eye Institute. Funding sources had no involvement in design, data
   collection/interpretation, or manuscript preparation.
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Andrade GMQ, 2010, J PEDIAT-BRAZIL, V86, P85, DOI 10.2223/JPED.1948
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Cordeiro CA, 2008, BRIT J OPHTHALMOL, V92, P986, DOI 10.1136/bjo.2008.140590
   Cordeiro CA, 2008, INVEST OPHTH VIS SCI, V49, P1979, DOI 10.1167/iovs.07-1393
   Cordeiro CA, 2008, MOL VIS, V14, P1845
   de Albuquerque MC, 2009, MEM I OSWALDO CRUZ, V104, P451, DOI 10.1590/S0074-02762009000300009
   Fonseca ZC, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020026
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536
   Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Haddad Maria Aparecida Onuki, 2006, Clinics, V61, P239, DOI 10.1590/S1807-59322006000300009
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285
   Kimberlin DW, 2018, RED BOOK 2018 REPORT
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Melamed J, 2010, EYE, V24, P528, DOI 10.1038/eye.2009.140
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Montoya JG, 1999, OPHTHALMOLOGY, V106, P1554, DOI 10.1016/S0161-6420(99)90453-0
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Steele RW, 2016, CLIN PEDIATR, V55, P698, DOI 10.1177/0009922816638660
   de Paula CHT, 2015, J AAPOS, V19, P252, DOI 10.1016/j.jaapos.2015.03.011
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 40
TC 1
Z9 1
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD DEC
PY 2019
VL 50
IS 12
BP 779
EP 784
DI 10.3928/23258160-20191119-05
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA JZ0XL
UT WOS:000504829700005
PM 31877223
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Lucia Garces, Ana
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol (vol 19, 282, 2019)
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Correction
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Lucia Garces, Ana] Ctr Amer & Panama INCAP, Fdn Alimentac & Nutr, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Microcephaly Epidem Res Grp, PPGCS, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Ugarte-Gil, Cesar/E-6074-2013; Marques, Ernesto T. A/L-4967-2013
OI Ugarte-Gil, Cesar/0000-0002-2833-9087; Marques, Ernesto T.
   A/0000-0003-3826-9358; Galvao, Luiz Augusto/0000-0002-3918-0286;
   McClure, Elizabeth/0000-0001-8659-5444
FU NIMH NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R25 MH083617] Funding Source: Medline; NATIONAL INSTITUTE OF
   MENTAL HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R25MH083617, R25MH083617, R25MH083617] Funding Source: NIH
   RePORTER
CR Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
NR 1
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 19
PY 2019
VL 19
IS 1
AR 423
DI 10.1186/s12884-019-2589-8
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE3OE
UT WOS:000508467800004
PM 31744466
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Moreira, Maria Elisabeth
TI Reply to 'A critical analysis of neurodevelopmental and neurosensory
   outcomes after 2 years for children with in utero Zika virus exposure'
SO NATURE MEDICINE
LA English
DT Letter
C1 [Nielsen-Saines, Karin; Kerin, Tara] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI140718] Funding Source: Medline
CR Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Vouga M, 2019, NAT MED, V25, P1641, DOI 10.1038/s41591-019-0630-0
NR 6
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2019
VL 25
IS 11
BP 1642
EP 1643
DI 10.1038/s41591-019-0631-z
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA JT2KI
UT WOS:000500824300009
PM 31649351
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Monteiro, LMC
   Cruz, GND
   Fontes, JM
   de Araujo, GF
   Ventura, T
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, L. M.
   Cruz, G. N. de O.
   Fontes, J. M.
   de Araujo, G. F.
   Ventura, T.
   Monteiro, A. C.
   Moreira, M. E. L.
TI Neurogenic bladder in the settings of congenital Zika syndrome: a
   confirmed and unknown condition for urologists
SO JOURNAL OF PEDIATRIC UROLOGY
LA English
DT Article
DE Neurogenic bladder; Congenital Zika syndrome; Zika virus; Urinary tract
   infection; Microcephaly
AB Introduction
   Congenital Zika syndrome (CZS) is a recently discovered condition that affects central nervous system structures that control the lower urinary tract. The first cases of neurogenic bladder (NB) were recently reported as a sequalae of CZS in neurologically impaired children.
   Objective
   Our goal is to further evaluate NB in the setting of CZS, identifying urological risk indicators in hopes that early diagnosis will mitigate the impact of the disease.
   Study design
   Urological assessment was performed in all patients with CZS and neurological impairment who were referred to our urodynamic clinic between June 2016 and May 2018. Neurogenic bladder was confirmed by urodynamic evaluation, and urological risk was based on urodynamic results.
   Results
   Sixty-nine patients with CZS were tested. The majority (63 patients, 91.3%) presented with overactive bladder with increased pressures and reduced capacity for age (table 1). Different urodynamic patterns were observed, and the association of reduced bladder capacity for age, high bladderfilling pressure, and increased postvoid residual were frequently observed.
   Discussion
   NB continues to be consistently diagnosed in our cohort of CZS, mostly with high-risk indicators for renal impairment. When not intervened upon in a timely manner, NB can cause progressive damage to the urinary tract, but the lack of knowledge that CZS causes NB delays investigation and treatment. Parents and health professionals will need to be sensitized to the risks that ZIKV can pose to the urinary tract so that appropriate therapies are initiated to prevent irreversible renal damage.
   Conclusion
   NB is a common condition among our patients with CZS and microcephaly. This is a new cause of NB, unknown to urologists. While further investigation is necessary to understand long-term disease behavior and therapeutic response, increased knowledge among urologists may help to reduce morbidity related to untreated NB and to mitigate the disease burden for patients and families.
C1 [Costa Monteiro, L. M.; Cruz, G. N. de O.; Fontes, J. M.; de Araujo, G. F.; Ventura, T.; Moreira, M. E. L.] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, A. C.] UCLA, Div Pulm & Crit Care Med, Los Angeles, CA USA.
RP Monteiro, LMC (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM luciacostamonteiro@gmail.com
RI Monteiro, Lucia Maria Costa/O-7903-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Monteiro, Lucia Maria Costa/0000-0002-7612-7249; Moreira, Maria
   Elisabeth Lopes/0000-0002-2034-0294; Marin Fontes,
   Juliana/0000-0003-4098-7324
FU CAPES/MECCAPES; CNPq/MCTI; Decit/SCTIE/MS [440580/20161]
FX The research is funded by a research grant from the CAPES/MEC, CNPq/MCTI
   and Decit/SCTIE/MS (grant number 440580/20161). These are Brazilian
   Agencies that support research to Prevent and Fight the Zika virus.
CR Alcendor DJ, 2018, J MOL MED, V96, P1145, DOI 10.1007/s00109-018-1692-z
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Austin PF, 2016, NEUROUROL URODYNAM, V35, P471, DOI 10.1002/nau.22751
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783
   Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CDC report, 2018, PREGN WOM AN LAB EV
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Costa Monteiro LM, 2017, CRITERIA EVALUATE NE
   Monteiro LMC, 2017, J PEDIAT-BRAZIL, V93, P420, DOI 10.1016/j.jped.2016.11.010
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056
   Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Nogueira PCK, 2016, J PEDIAT-BRAZIL, V92, pS57, DOI 10.1016/j.jped.2016.01.006
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   (PAHO) Pan American Health Organization, 2018, ZIK CUM CAS
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
NR 24
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-5131
EI 1873-4898
J9 J PEDIATR UROL
JI J. Pediatr. Urol
PD OCT
PY 2019
VL 15
IS 5
DI 10.1016/j.jpurol.2019.04.018
PG 7
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA JQ4OT
UT WOS:000498927800007
PM 31142443
DA 2020-12-17
ER

PT J
AU Soares, FVM
   Abranches, AD
   Meio, MDBB
   Gomes, SC
   Villela, LD
   Moreira, MEL
AF Mendes Soares, Fernanda Valente
   Abranches, Andrea Dunshee
   Baker Meio, Maria Dalva Barbosa
   Gomes Junior, Saint-Clair
   Villela, Leticia Duarte
   Moreira, Maria Elisabeth L.
TI Differences in energy expenditure in human donor milk versus formula
   milk in preterm newborns: A crossover study
SO NUTRITION
LA English
DT Article
DE Preterm infant; Feeding; Human milk; Energy expenditure
ID INDIRECT CALORIMETRY; GROWTH; INFANTS; FORTIFICATION; BALANCE; NEEDS
AB Objective: The aim of this study was to compare the ratio between energy expenditure and caloric density in human donor milk versus formula milk in preterm newborn infants.
   Methods: This was a crossover, randomized clinical trial with 29 preterm newborn infants receiving full diet. The infants were randomly assigned to receive either human milk or formula milk alternating, after a 24-h period. Energy expenditure was evaluated by indirect calorimetry. Total calorie and macronutrient values in the human milk were calculated individually with infrared technique; energy expenditure/caloric density ratio was calculated.
   Results: Human donor milk energy expenditure/caloric density ratio was significantly greater than in formula milk at all time points. The total mean was 1.04 +/- 0.27 for the human milk and 0.81 +/- 0.11 for the formula. However, when we analyzed a subgroup of newborns that received human donor milk with >60 kcal/100 mL, there was no statistical difference (P = 0.36). The mean calorie values were 58.9 kcal/100 mL (human donor milk) and 81.4 kcal/100 mL (formula milk).
   Conclusion: Formula milk produced a better metabolic response than human donor milk. Human donor milk with higher caloric content showed no difference from formula, so the use of human donor milk with more caloric density should be reinforced. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Mendes Soares, Fernanda Valente; Abranches, Andrea Dunshee; Baker Meio, Maria Dalva Barbosa; Gomes Junior, Saint-Clair; Villela, Leticia Duarte; Moreira, Maria Elisabeth L.] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
RP Soares, FVM (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
EM fevalente@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; de Abranches, Andrea
   Dunshee/ABA-8578-2020; Gomes Junior, Saint Clair/V-5393-2018
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Dunshee de
   Abranches, Andrea/0000-0002-9323-3297; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091; Gomes Junior, Saint Clair/0000-0002-1554-943X
CR Arslanoglu S, 2010, J PERINAT MED, V38, P233, DOI [10.1515/JPM.2010.073, 10.1515/jpm.2010.073]
   Bauer K, 2003, J PEDIATR-US, V142, P390, DOI 10.1067/mpd.2003.143
   Ehrenkranz RA, 2014, WORLD REV NUTR DIET, V110, P11, DOI 10.1159/000358455
   Hay William W Jr, 2013, Curr Pediatr Rep, V1, DOI 10.1007/s40124-013-0026-4
   Hay WW, 2014, WORLD REV NUTR DIET, V110, P64, DOI 10.1159/000358459
   HEY EN, 1970, ARCH DIS CHILD, V45, P328, DOI 10.1136/adc.45.241.328
   Kashyap S, 2006, NEONATAL NUTRITION AND METABOLISM, 2ND EDITION, P134, DOI 10.1017/CBO9780511544712.013
   Lubetzky R, 2003, J PEDIATR-US, V143, P750, DOI 10.1067/S0022-3476(03)00532-8
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   MICHAELSEN KF, 1988, J PEDIATR GASTR NUTR, V7, P229, DOI 10.1097/00005176-198803000-00013
   Moreira MEL, 2007, J PERINAT MED, V35, P71, DOI 10.1515/JPM.2007.011
   Quigley MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub2
   Radmacher PG, 2017, SEMIN FETAL NEONAT M, V22, P30, DOI 10.1016/j.siny.2016.08.004
   Raiten DJ, 2016, AM J CLIN NUTR, V103, p648S, DOI 10.3945/ajcn.115.117309
   Romera G, 2004, J PEDIATR GASTR NUTR, V38, P407, DOI 10.1097/00005176-200404000-00008
   SHORTLAND GJ, 1992, ARCH DIS CHILD-FETAL, V67, P1207, DOI 10.1136/adc.67.10_Spec_No.1207
   Soares FVM, 2007, J PEDIAT-BRAZIL, V83, P567, DOI 10.1590/S0021-75572007000800015
   Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P22, DOI 10.1016/j.jped.2013.05.007
   Thureen PJ, 1998, J APPL PHYSIOL, V85, P223
   Uauy R, 2014, WORLD REV NUTR DIET, V110, P4, DOI 10.1159/000358453
   Ziegler EE, 2015, NESTLE NUTR WORKS SE, V81, P135, DOI 10.1159/000365902
   Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381
NR 23
TC 0
Z9 0
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT
PY 2019
VL 66
BP 1
EP 4
DI 10.1016/j.inut.2019.04.002
PG 4
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA IW6KV
UT WOS:000485087400001
PM 31177055
DA 2020-12-17
ER

PT J
AU Silva, FP
   Souza, RT
   Cecatti, JG
   Passini, R
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Oliveira, PF
   Silva, CM
   Costa, ML
   Pacagnella, RC
   Haddad, SM
   Zotarelli, V
   Gurgel, LT
   Maia, NL
   Mathias, JP
   Marba, ST
   Guinsburg, R
   Martinez, FE
   Quintana, SM
   Melli, PPS
   Feitosa, FE
   Chaves, GN
   Porto, AM
   Coutinho, IC
   Lima, ACB
   Melo, EF
   Leite, DF
   Amorim, MM
   Melo, ASO
   Melo, FO
   Martins, MG
   Nunes, MV
   Paiva, CS
   Lima, MD
   Freire, DM
   Tristao, EG
   Nascimento, DJ
   Menezes, CA
   Aquino, M
   Vettorazzi, J
   Senger, CE
   Assumpcao, AMB
   Guedes, MAF
   Moreira, MEL
   Borges, VT
   Souza, E
   Zamarian, ACP
   Lotufo, FA
   Uzilin, K
   Zanette, EA
   Andreucci, CB
   Oliveira, TA
   Oliveira, LR
   Santos, MAN
   Sass, N
   Silveira, MRF
   Coutinho, PR
   Siqueira, L
AF Silva, Fabia Pigatti
   Souza, Renato T.
   Cecatti, Jose G.
   Passini, Renato, Jr.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Oliveira, Paulo F.
   Silva, Cleide M.
   Costa, Maria L.
   Pacagnella, Rodolfo C.
   Haddad, Samira M.
   Zotarelli, Vilma
   Gurgel, Lucio T.
   Maia Filho, Nelson L.
   Mathias, Jacinta P.
   Marba, Sergio T.
   Guinsburg, Ruth
   Martinez, Francisco E.
   Quintana, Silvana M.
   Melli, Patricia P. S.
   Feitosa, Francisco E.
   Chaves, George N.
   Porto, Ana M.
   Coutinho, Isabela C.
   Barbosa Lima, Antonio C.
   Melo, Elias F.
   Leite, Debora F.
   Amorim, Melania M.
   Melo, Adriana S. O.
   Melo, Fabiana O.
   Martins, Marilia G.
   Nunes, Marinea V.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Tristao, Edson G.
   Nascimento, Denis J.
   Menezes, Carlos A.
   Aquino, Marcelo
   Vettorazzi, Janete
   Senger, Cintia E.
   Assumpcao, Augusta M. B.
   Guedes, Marcela A. F.
   Moreira, Maria E. L.
   Borges, Vera T.
   Souza, Eduardo
   Zamarian, Ana C. P.
   Lotufo, Fatima A.
   Uzilin, Kaliane
   Zanette, Elvira A.
   Andreucci, Carla B.
   Oliveira, Tenilson A.
   Oliveira, Laercio R.
   Santos, Marcos A. N.
   Sass, Nelson
   Silveira, Mirian R. F.
   Coutinho, Pedro R.
   Siqueira, Luciana
CA Brazilian Multictr Study Preterm
TI Role of Body Mass Index and gestational weight gain on preterm birth and
   adverse perinatal outcomes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MATERNAL NUTRITION; OBESITY; RISK; ASSOCIATION; PREGNANCY; EPIDEMIOLOGY;
   COUNTRIES; LABOR
AB The association of body mass index (BMI) and gestational weight gain (GWG) with preterm birth (PTB) remains controversial in the literature. To evaluate different maternal BMI and GWG categories, according to the initial BMI, in relation to different PTB subtypes and perinatal outcomes, we conducted a secondary analysis of a multicentre cross-sectional study, along with a nested case-control study including PTB from 20 centers in Brazil. Pre-pregnancy underweight was associated with a lower risk of provider-initiated PTB, while overweight and obesity were associated with a higher risk of provider-initiated PTB and a lower risk of spontaneous preterm birth. Insufficient gestational weight gain was associated with a higher prevalence of spontaneous PTB and preterm premature rupture of membranes. Excessive GWG correlated with a higher prevalence of provider-initiated PTB or preterm premature rupture of membranes. Irrespective of the initial BMI, the greater the rate of GWG, the higher the predicted probability of all PTB subtypes, except for spontaneous PTB in underweight women and those with normal BMI. On multivariate analysis, the initial BMI was shown to be the only factor associated with pi-PTB. Briefly, further studies evaluating the risk for PTB should consider that GWG may have a different role depending on the initial BMI and PTB subtype.
C1 [Silva, Fabia Pigatti; Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Costa, Maria L.; Pacagnella, Rodolfo C.; Haddad, Samira M.; Zotarelli, Vilma; Gurgel, Lucio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.; Maia Filho, Nelson L.; Mathias, Jacinta P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
   [Oliveira, Paulo F.; Silva, Cleide M.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Unit Stat, Campinas, Brazil.
   [Marba, Sergio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Pediat, Campinas, SP, Brazil.
   [Guinsburg, Ruth] Univ Fed Sao Paulo, UNIFESP, EPM, Div Neonatal Med, Sao Paulo, SP, Brazil.
   [Martinez, Francisco E.; Quintana, Silvana M.; Melli, Patricia P. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Feitosa, Francisco E.; Chaves, George N.] Matern Sch, Fortaleza, Ceara, Brazil.
   [Porto, Ana M.; Coutinho, Isabela C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Barbosa Lima, Antonio C.; Melo, Elias F.; Leite, Debora F.] Univ Fed Pernambuco, Sch Med, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Amorim, Melania M.; Melo, Adriana S. O.; Melo, Fabiana O.] Inst Saude Elpidio Almeida, Campina Grande, Paraiba, Brazil.
   [Martins, Marilia G.; Nunes, Marinea V.] Fed Univ Maranhao UFMA, Dept Gynecol & Obstet, Sao Luis, MA, Brazil.
   [Paiva, Claudio S.; Lima, Moises D.; Freire, Djacyr M.] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Tristao, Edson G.; Nascimento, Denis J.] Univ Fed Parana, Curitiba, Parana, Brazil.
   [Menezes, Carlos A.; Aquino, Marcelo] Univ Fed Bahia, Salvador, BA, Brazil.
   [Vettorazzi, Janete; Senger, Cintia E.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Assumpcao, Augusta M. B.; Guedes, Marcela A. F.; Moreira, Maria E. L.] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Borges, Vera T.] Sao Paulo State Univ, Dept Gynecol & Obstet, Botucatu, SP, Brazil.
   [Souza, Eduardo; Zamarian, Ana C. P.] Univ Fed Sao Paulo, EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Lotufo, Fatima A.; Uzilin, Kaliane] Santa Casa Limeira Hosp, Limeira, SP, Brazil.
   [Zanette, Elvira A.; Andreucci, Carla B.] Santa Casa Sao Carlos Hosp, Sao Carlos, SP, Brazil.
   [Oliveira, Tenilson A.; Oliveira, Laercio R.; Santos, Marcos A. N.] Matern Casa Maternal Leonor Mendes Barros, Sao Paulo, SP, Brazil.
   [Sass, Nelson; Silveira, Mirian R. F.] Matern Escola Vila Nova Cachoeirinha, Sao Paulo, SP, Brazil.
   [Coutinho, Pedro R.; Siqueira, Luciana] Hosp Estadual Sumare, Sumare, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Sass, Nelson/AAD-8259-2020; Souza, Renato Teixeira/G-4205-2017; Amorim,
   Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016; Moreira, Maria
   Elisabeth Lopes/AAA-3775-2020; feitosa, francisco e/H-8431-2014; BORGES,
   VERA T/B-7363-2014; Andreucci, Carla B/J-4845-2015
OI Sass, Nelson/0000-0001-7187-1004; Souza, Renato
   Teixeira/0000-0002-9075-9269; Amorim, Melania M/0000-0003-1047-2514;
   Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; BORGES, VERA
   T/0000-0002-9347-9641; Andreucci, Carla B/0000-0002-5590-108X; Cecatti,
   Jose Guilherme/0000-0003-1285-8445
FU FAPESP (Foundation for Research Support of the State of Sao Paulo)
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPq (Brazilian National Research Council) BrazilNational Council for
   Scientific and Technological Development (CNPq); Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation [401636/2013-5, 05/2013];
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [401636/2013-5, 05/2013]
FX Other members of the Brazilian Multicenter Study on Preterm Birth study
   group: Maria L. Costa, Rodolfo C. Pacagnella, Samira M. Haddad, Sergio
   T. Marba, Ruth Guinsburg, Francisco E. Martinez, Vilma Zotarelli, Lucio
   T. Gurgel, Francisco E. Feitosa, George N. Chaves, Ana M. Porto, Isabela
   C. Coutinho, Antonio C. Barbosa Lima, Elias F. Melo Jr, Debora F. Leite,
   Melania M. Amorim, Adriana S. O. Melo, Fabiana O. Melo, Marilia G.
   Martins, Marynea V. Nunes, Claudio S. Paiva, Moises D. Lima, Djacyr M.
   Freire, Edson G. Tristao, Denis J. Nascimento, Carlos A. Menezes,
   Marcelo Aquino, Janete Vettorazzi, Cintia E. Senger, Augusta M. B.
   Assumpcao, Marcela A. F. Guedes, Maria E. L. Moreira, Vera T. Borges,
   Nelson L. Maia Filho, Jacinta P. Mathias, Eduardo Souza, Ana C. P.
   Zamarian, Silvana M. Quintana, Patricia P. S. Melli, Fatima A. Lotufo,
   Kaliane Uzilin, Elvira A. Zanette, Carla B. Andreucci, Tenilson A.
   Oliveira, Laercio R. Oliveira, Marcos A. N. Santos, Nelson Sass, Mirian
   R. F. Silveira, Pedro R. Coutinho, Luciana Siqueira. This study was
   supported by a grant from FAPESP (Foundation for Research Support of the
   State of Sao Paulo), and by CNPq (Brazilian National Research Council)
   Brazil. Funders played no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript. The
   current secondary analyses of EMIP data was designed and developed by
   part of the Preterm SAMBA study Group (RTS, RPJ and JGC), a
   collaborative study group on Preterm Birth Research jointly issued by
   the Brazilian National Research Council (CNPq) and the Bill and Melinda
   Gates Foundation (Award 401636/2013-5 -Grand Challenges Brazil: Reducing
   the burden of preterm birth, number 05/2013). Current findings are
   therefore, part of the range of analyses of prematurity from the Preterm
   SAMBA study group.
CR AlSaif S, 2015, LIFE SCI, V125, P2, DOI 10.1016/j.lfs.2015.02.001
   Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Blevins JE, 2013, REV ENDOCR METAB DIS, V14, P311, DOI 10.1007/s11154-013-9260-x
   Bloomfield FH, 2011, ANNU REV NUTR, V31, P235, DOI 10.1146/annurev-nutr-072610-145141
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   Carlson NS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0129-6
   Carnero AM, 2012, BJOG-INT J OBSTET GY, V119, P924, DOI 10.1111/j.1471-0528.2012.03345.x
   Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6
   Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x
   Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a
   El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249
   Faucher MA, 2016, BJOG-INT J OBSTET GY, V123, P199, DOI 10.1111/1471-0528.13797
   Godoy AC, 2015, CLINICS, V70, P758, DOI 10.6061/clinics/2015(11)08
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201
   Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021
   Honest H, 2005, EUR J OBSTET GYN R B, V119, P11, DOI 10.1016/j.ejogrb.2004.07.041
   IOM (Institute of Medicine) NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC
   Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03
   Kominiarek MA, 2018, OBSTET GYNECOL, V132, P875, DOI 10.1097/AOG.0000000000002854
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Luke B, 2005, J PERINAT MED, V33, P500, DOI 10.1515/JPM.2005.088
   Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120
   Neggers Y, 2003, J NUTR, V133, p1737S, DOI 10.1093/jn/133.5.1737S
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x
   Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101
   Parker MG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-153
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293
   Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0
   Salihu HM, 2009, EUR J OBSTET GYN R B, V144, P119, DOI 10.1016/j.ejogrb.2009.02.047
   Salihu HM, 2010, ARCH GYNECOL OBSTET, V282, P127, DOI 10.1007/s00404-009-1213-y
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   Vahratian A, 2004, OBSTET GYNECOL, V104, P943, DOI 10.1097/01.AOG.0000142713.53197.91
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   World Health Organization, 2005, ANN NUMB DEATHS CAUS
NR 43
TC 5
Z9 5
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2019
VL 9
AR 13093
DI 10.1038/s41598-019-49704-x
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW8AR
UT WOS:000485215700003
PM 31511664
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Kuper, H
   Moreira, ME
   de Araujo, TVB
   Valongueiro, S
   Fernandes, S
   Pinto, M
   Lyra, TM
AF Kuper, Hannah
   Lopes Moreira, Maria Elisabeth
   Barreto de Araujo, Thalia Velho
   Valongueiro, Sandra
   Fernandes, Silke
   Pinto, Marcia
   Lyra, Tereza Maciel
TI The association of depression, anxiety, and stress with caring for a
   child with Congenital Zika Syndrome in Brazil; Results of a
   cross-sectional study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID QUALITY-OF-LIFE; CEREBRAL-PALSY; MOTHERS; NEWBORNS; HEALTH
AB Author summary The 2015 Zika epidemic in Brazil gained international attention with the birth of thousands of babies with severe adverse outcomes, collectively called "Congenital Zika Syndrome" (CZS). Parenting a child with disabilities can be extremely stressful, and in other settings is linked to depression, anxiety and other mental health conditions. However, these associations have not been fully explored in the context of CZS in Brazil. We conducted a cross-sectional study in Rio de Janeiro and Recife, two cities in Brazil. We identified 163 caregivers (mostly the mother) of a child with CZS, and 324 caregivers of children of similar ages, but without obvious disabilities. The caregivers were asked a series of questions to gauge whether they were experiencing depression, anxiety or stress. We found that a high proportion of the mothers reported experiencing severe or extremely severe levels of depression (18%), anxiety (27%) and stress (36%). Levels of depression and anxiety were even higher for mothers of children with CZS compared to mothers of unaffected children, especially for those mothers with low social support and those living in Rio de Janeiro.
   Background Zika virus (ZIKV) infection in pregnancy can cause microcephaly and a wide spectrum of severe adverse outcomes, collectively called "Congenital Zika Syndrome" (CZS). Parenting a child with disabilities can have adverse mental health impacts, but these associations have not been fully explored in the context of CZS in Brazil. Methodology/Principal findings A cross-sectional study was undertaken in Recife and Rio de Janeiro, including 163 caregivers of a child with CZS (cases) and 324 caregivers with an unaffected child (comparison subjects), identified from existing studies. The primary caregiver, almost always the mother, was interviewed using a structured questionnaire to collect information on: depression, anxiety, and stress (Depression, Anxiety, and Stress Scale-DASS-21), social support (Medical Outcomes Study Social Support Scale-MOS-SSS), and socio-demographic data. Data was collected May 2017-January 2018. Ethical standards were adhered to throughout the research. A high proportion of mothers reported experiencing severe or extremely severe levels of depression (18%), anxiety (27%) and stress (36%). Mothers of children with CZS were more likely to experience symptoms of depression, anxiety andstress, compared to mothers of comparison children. These associations were more apparent among mothers living in Rio de Janeiro. These differences were reduced after adjustment for socio-economic status and social support. Among mothers of children with CZS, low social support was linked to higher levels of depression, anxiety and stress, but there was no association with socio-economic status.
C1 [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Clin Res Dept, London, England.
   [Lopes Moreira, Maria Elisabeth; Pinto, Marcia] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Postgrad Programme Publ Hlth, Recife, PE, Brazil.
   [Fernandes, Silke] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.
   [Lyra, Tereza Maciel] FIOCRUZ PE, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Univ Pernambuco, Fac Med, Recife, PE, Brazil.
RP Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Clin Res Dept, London, England.
EM Hannah.kuper@lshtm.ac.uk
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Fernandes,
   Silke/0000-0001-7694-4233
FU Wellcome TrustWellcome Trust [MC_PC_15088]; UK's Department for
   International Development [205377/Z/16/Z]; Wellcome Trust's Enhancing
   Research Activity in Epidemic Situations programme [107779/Z/15/Z,
   ER1505, ER1601]; European Union's Horizon 2020 research and innovation
   program under ZikaPLAN grant [734584]; Medical Research Council on
   behalf of the Newton Fund; Secretaria de Vigilancia em Saude/Ministerio
   da Sau'de de Brasil Resposta a Emergencia em Saude Publica - Zika virus
   e Microcefalia [837058/2016]; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Departamento de Ciencia e Tecnologia
   [440839/2016-5]
FX This work was supported by the: Wellcome Trust & the UK's Department for
   International Development (205377/Z/16/Z to LCR;
   https://wellcome.ac.uk/); the Wellcome Trust's Enhancing Research
   Activity in Epidemic Situations programme (107779/Z/15/Z; with ER1505 &
   ER1601 to RAAX); the European Union's Horizon 2020 research and
   innovation program (https://ec.europa.eu/programmes/horizon2020/) under
   ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/); the
   Medical Research Council on behalf of the Newton Fund and the Wellcome
   Trust (MC_PC_15088 to LCR; https://mrc.ukri.org/); Secretaria de
   Vigilancia em Saude/Ministerio da Sau ' de de Brasil Resposta a
   Emergencia em Saude Publica - Zika virus e Microcefalia (837058/2016 to
   RAAX); the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br/); & the Departamento de Ciencia e
   Tecnologia (http://rebrats.saude.gov.br/noticias/59DECIT) for Prevencao
   e Combate ao virus Zika I (440839/2016-5 to RAAX). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Barcelos RS, 2019, INJURY PREV, V25, P222, DOI 10.1136/injuryprev-2017-042641
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Vignola RCB, 2014, J AFFECT DISORDERS, V155, P104, DOI 10.1016/j.jad.2013.10.031
   Brasil MdS., 2018, MONITORAMENTO INTEGR
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bromley J, 2004, AUTISM, V8, P409, DOI 10.1177/1362361304047224
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   DiGiacomo M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0668-3
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Eccleston C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009660.pub3
   Oliveira SJGD, 2017, ARCH WOMEN MENT HLTH, V20, P473, DOI 10.1007/s00737-017-0724-y
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   Kuper H, 2018, WELLCOME OPEN RES, V3
   Kupferberg A, 2016, NEUROSCI BIOBEHAV R, V69, P313, DOI 10.1016/j.neubiorev.2016.07.002
   Lindo EJ, 2016, FAM RELAT, V65, P207, DOI 10.1111/fare.12185
   Lovibond S.H., 1995, MANUAL DEPRESSION AN
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329
   Pesquisa ABdEd, CRIT CLASS EC BRAS 2
   Pinquart M, 2018, STRESS HEALTH, V34, P197, DOI 10.1002/smi.2780
   Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2
   Soares A, 2012, SUPPORT CARE CANCER, V20, P1895, DOI 10.1007/s00520-011-1292-8
   Stabile M, 2012, FUTURE CHILD, V22, P65
   Tilahun D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1383-9
   Unsal-Delialioglu S, 2009, INT J REHABIL RES, V32, P199, DOI 10.1097/MRR.0b013e32832607b6
   Yilmaz H, 2013, EUR J PHYS REHAB MED, V49, P823
NR 27
TC 4
Z9 4
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2019
VL 13
IS 9
AR e0007768
DI 10.1371/journal.pntd.0007768
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JE9CW
UT WOS:000490987100021
PM 31568478
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU Pereira, JP
   Maykin, MM
   Vasconcelos, Z
   Avvad-Portari, E
   Zin, AA
   Tsui, I
   Brasil, P
   Nielsen-Saines, K
   Moreira, ME
   Gaw, SL
AF Pereira, Jose Paulo, Jr.
   Maykin, Melanie M.
   Vasconcelos, Zilton
   Avvad-Portari, Elyzabeth
   Zin, Andrea A.
   Tsui, Irena
   Brasil, Patricia
   Nielsen-Saines, Karin
   Moreira, Maria E.
   Gaw, Stephanie L.
TI The Role of Amniocentesis in the Diagnosis of Congenital Zika Syndrome
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE ZIKV; TORCH infection; perinatal infection; pregnancy; vertical
   transmission
ID VIRUS-INFECTION; PREGNANCY; FETUSES; BLOOD
AB There are limited data on amniocentesis as a diagnostic tool for congenital Zika syndrome. Here we report on a prospective cohort of 16 women with suspected Zika virus infection in a highly endemic area, and discuss the role of amniocentesis in the prenatal diagnosis of fetal Zika infection.
C1 [Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Avvad-Portari, Elyzabeth; Zin, Andrea A.; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556,HSE16, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Gaw,
   Stephanie/0000-0003-0891-6964
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K12 HD000849,
   R21AI28697, R21AI129534, R21EY028318]; Queenan Fellowship for Global
   Health; Conselho Nacional de Pesquisa-Brazilian National Research
   Council of the Brazilian Ministry of Health (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Apoio a
   Pesquisa do Rio de Janeiro (Faperj)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); European Union
   European Horizon 2020 Research and Innovation Programme (Zika-PLAN)
   [734584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [K12HD000849, K12HD000849, K12HD000849, K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, K08AI141728, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER
FX This work was supported by the National Institutes of Health (grant
   numbers K12 HD000849 to S.L.G., R21AI28697, R21AI129534, and
   R21EY028318), the Queenan Fellowship for Global Health (to S. L. G.),
   the Conselho Nacional de Pesquisa-Brazilian National Research Council of
   the Brazilian Ministry of Health (CNPq, to M. E. M.); Fundacao de Apoio
   a Pesquisa do Rio de Janeiro (Faperj, to M. E. M); and the European
   Union European Horizon 2020 Research and Innovation Programme (Zika-PLAN
   grant number 734584).
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Besnard M, 2016, EUROSURVEILLANCE, V21, P302
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Herrera K, CASE REP PERINATAL M, V5, P374
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 12
TC 4
Z9 4
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2019
VL 69
IS 4
BP 713
EP 716
DI 10.1093/cid/ciz013
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IW7LJ
UT WOS:000485171100021
PM 30624579
OA Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Amaral, Y
   Marano, D
   Oliveira, E
   Moreira, ME
AF Amaral, Yasmin
   Marano, Daniele
   Oliveira, Elissa
   Moreira, Maria Elisabeth
TI Impact of pre-pregnancy excessive body weight on the composition of
   polyunsaturated fatty acids in breast milk: a systematic review
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Review
DE Pre-gestational nutritional status; overweight; excessive body weight;
   human milk; polyunsaturated fatty acid; systematic review
ID DOCOSAHEXAENOIC ACID; MOTHERS; OVERWEIGHT; WOMEN; DIETARY; LIPIDS; GAIN
AB This study aims to identify through a systematic review the possible effects of pre-gestational excessive body weight on the composition of polyunsaturated fatty acids in human milk. The papers were selected in the following databases: PubMed, Virtual Health Library, EMBASE, Web of Science and SCOPUS. The search strategy employed descriptors: 'Human Milk' AND 'Obesity' OR 'Overweight' OR 'Body Mass Index' AND 'Fatty acid' OR 'Omega3' OR 'Omega6'. According to the established strategy, six manuscripts were selected. Most of the selected studies concluded that mothers with excessive body weight presented a milk with a higher concentration of omega 6. In addition, all selected studies identified an increased Omega-6/Omega-3 ratio in the milk of pre-gestational excessive body weight mothers compared to the eutrophic ones. The milk of pre-gestational excessive body weight women had a higher Omega-6/Omega-3 ratio, which confirms the importance of starting pregnancy with adequate weight, thus minimising the possible influences that excessive body weight can cause infant health.
C1 [Amaral, Yasmin; Marano, Daniele; Oliveira, Elissa; Moreira, Maria Elisabeth] Natl Inst Womens Childrens & Adolescents Hlth Fer, Dept Clin Res, BR-22250020 Rio De Janeiro, RJ, Brazil.
RP Amaral, Y (corresponding author), Natl Inst Womens Childrens & Adolescents Hlth Fer, Dept Clin Res, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM yasminamaral@hotmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Amaral,
   Yasmin/0000-0001-8159-0564
CR Andreas NJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010778
   Armand M, 2018, CLIN NUTR, V37, P2127, DOI 10.1016/j.clnu.2017.10.007
   Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1
   Collado MC, 2012, PEDIATR RES, V72, P77, DOI 10.1038/pr.2012.42
   Cidade DG, 2011, COM CIENCIAS SAUDE, V22, P169
   Del Prado M, 2001, AM J CLIN NUTR, V74, P242
   Demmelmair H, 2018, BEST PRACT RES CL EN, V32, P57, DOI 10.1016/j.beem.2017.11.002
   Dritsakou K, 2016, J MATERN-FETAL NEO M, V2, P1
   Garcia-Ravelo S, 2018, BREASTFEED MED, V13, P702, DOI 10.1089/bfm.2017.0214
   Kim H, 2017, BRIT J NUTR, V117, P556, DOI [10.1017/S0007114517000253, 10.1017/s0007114517000253]
   Koletzko B, 2001, EARLY HUM DEV, V65, pS3, DOI 10.1016/S0378-3782(01)00204-3
   Linderborg KM, 2014, FOOD CHEM, V146, P583, DOI 10.1016/j.foodchem.2013.09.092
   Lindholm ES, 2013, PROSTAG LEUKOTR ESS, V88, P211, DOI 10.1016/j.plefa.2012.11.007
   Makela J, 2013, EUR J NUTR, V52, P727, DOI 10.1007/s00394-012-0378-5
   MARANO D, 2014, BRAZIL REV BRAS EPID, V17, P45, DOI DOI 10.1590/1415-790X201400010005ENG
   Marin MC, 2005, PROSTAG LEUKOTR ESS, V73, P355, DOI 10.1016/j.plefa.2005.07.005
   Masini JC, 2008, QUIM NOVA, V31, P704, DOI 10.1590/S0100-40422008000300040
   Massmann PF, 2013, FRONT LIFE SCI, V7, P155, DOI 10.1080/21553769.2013.876451
   Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050
   Nyuar KB, 2010, ACTA PAEDIATR, V99, P1824, DOI 10.1111/j.1651-2227.2010.01940.x
   Panagos PG, 2016, J PERINATOL, V36, P284, DOI 10.1038/jp.2015.199
   Seabra G, 2011, REV BRAS GINECOL OBS, V33, P348, DOI 10.1590/S0100-72032011001100005
   Sinanoglou VJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175817
   Stanke-Labesque F, 2008, BRIT J NUTR, V100, P829, DOI 10.1017/S0007114508923692
   Valentine CJ, 2010, J PEDIATR-US, V157, P906, DOI 10.1016/j.jpeds.2010.06.017
   Costa AGV, 2010, REV NUTR, V23, P445, DOI 10.1590/S1415-52732010000300012
NR 26
TC 4
Z9 4
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD FEB 17
PY 2020
VL 71
IS 2
BP 186
EP 192
DI 10.1080/09637486.2019.1646713
EA AUG 2019
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA KH2IT
UT WOS:000482167500001
PM 31423865
DA 2020-12-17
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Garces, Ana Lucia
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Zika virus; Pregnancy; Latin America; Microcephaly
ID VIRUS-INFECTION; BIRTH-DEFECTS; CLINICAL-MANIFESTATIONS; EMERGENCE;
   EXPOSURE; FETUSES; HISTORY; UPDATE; STATES; BRAZIL
AB Background Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood. With the unique opportunity to prospectively explore the full spectrum of issues related to ZIKV exposure during pregnancy, we undertook a multi-country, prospective cohort study to evaluate the association between ZIKV and pregnancy, neonatal, and infant outcomes. Methods At research sites in ZIKV endemic regions of Brazil (4 sites), Colombia, Guatemala, Nicaragua, Puerto Rico (2 sites), and Peru, up to 10,000 pregnant women will be recruited and consented in the first and early second trimesters of pregnancy and then followed through delivery up to 6 weeks post-partum; their infants will be followed until at least 1 year of age. Pregnant women with symptomatic ZIKV infection confirmed by presence of ZIKV RNA and/or IgM for ZIKV will also be enrolled, regardless of gestational age. Participants will be tested monthly for ZIKV infection; additional demographic, physical, laboratory and environmental data will be collected to assess the potential interaction of these variables with ZIKV infection. Delivery outcomes and detailed infant assessments, including physical and neurological outcomes, will be obtained. Discussion With the emergence of ZIKV in the Americas and its association with adverse pregnancy outcomes in this region, a much better understanding of the spectrum of clinical outcomes associated with exposure to ZIKV during pregnancy is needed. This cohort study will provide information about maternal, fetal, and infant outcomes related to ZIKV infection, including congenital ZIKV syndrome, and manifestations that are not detectable at birth but may appear during the first year of life. In addition, the flexibility of the study design has provided an opportunity to modify study parameters in real time to provide rigorous research data to answer the most critical questions about the impact of congenital ZIKV exposure.
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Garces, Ana Lucia] Fdn Alimentac & Nutr Cent Amer & Panama INCAP, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Programa Posgrad Ciencias Saude PPGCS, Microcephaly Epidem Res Grp, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Ugarte-Gil, Cesar/E-6074-2013; Marques, Ernesto T. A/L-4967-2013; Ko,
   Albert Icksang/P-2343-2015; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Ugarte-Gil, Cesar/0000-0002-2833-9087; Marques, Ernesto T.
   A/0000-0003-3826-9358; Ko, Albert Icksang/0000-0001-9023-2339; Moreira,
   Maria Elisabeth Lopes/0000-0002-2034-0294; McClure,
   Elizabeth/0000-0001-8659-5444; Martinez-Blanco, Alexander
   Maximiliano/0000-0001-5755-1776; Galvao, Luiz
   Augusto/0000-0002-3918-0286
FU U.S. National Institute of Child Health and Human Development
   (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   National Institute of Environmental Health Sciences (NIEHS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS);
   Fundacao Oswaldo Cruz-Fiocruz, Brazil; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [U01HD040636, U01HD040636, U01HD040636, U01HD040636]
   Funding Source: NIH RePORTER
FX This study is funded through grants from the U.S. National Institute of
   Child Health and Human Development (NICHD); National Institute of
   Allergy and Infectious Diseases (NIAID); National Institute of
   Environmental Health Sciences (NIEHS); and Fundacao Oswaldo
   Cruz-Fiocruz, Brazil. Representatives from each institution provided
   general support, scientific input, and peer review of the study design,
   protocol, consent forms, data collection forms, and analysis plan.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 33
TC 5
Z9 5
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 7
PY 2019
VL 19
IS 1
AR 282
DI 10.1186/s12884-019-2430-4
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IO2TY
UT WOS:000479235900001
PM 31391005
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Monteiro, LMC
   Cruz, GNO
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, L. M.
   Cruz, G. N. O.
   Monteiro, A. C.
   Moreira, M. E. L.
TI Comment on the 'Letter to the Editor' related to the article 'Neurogenic
   bladder in the settings of congenital Zika syndrome: a confirmed and
   unknown condition for urologists'
SO JOURNAL OF PEDIATRIC UROLOGY
LA English
DT Letter
C1 [Costa Monteiro, L. M.; Cruz, G. N. O.; Moreira, M. E. L.] Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, A. C.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA.
RP Monteiro, LMC (corresponding author), Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM luciacostamonteiro@gmail.com
RI Monteiro, Lucia Maria Costa/O-7903-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Monteiro, Lucia Maria Costa/0000-0002-7612-7249; Moreira, Maria
   Elisabeth Lopes/0000-0002-2034-0294
FU MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [440580/20161]
FX This work was supported by a grant from the
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit (grant number 440580/20161).
CR [Anonymous], 2017, LANCET, V389, P573, DOI 10.1016/S0140-6736(17)30325-2
   Monteiro LMC, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.04.018
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-5131
EI 1873-4898
J9 J PEDIATR UROL
JI J. Pediatr. Urol
PD AUG
PY 2019
VL 15
IS 4
BP 434
EP 435
DI 10.1016/j.jpurol.2019.06.021
PG 2
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA IY5PG
UT WOS:000486443900063
PM 31351948
DA 2020-12-17
ER

PT J
AU Nielsen-Saines, K
   Brasil, P
   Kerin, T
   Vasconcelos, Z
   Gabaglia, CR
   Damasceno, L
   Pone, M
   de Carvalho, LMA
   Pone, SM
   Zin, AA
   Tsui, I
   Salles, TRS
   da Cunha, DC
   Costa, RP
   Malacarne, J
   Reis, AB
   Hasue, RH
   Aizawa, CYP
   Genovesi, FF
   Einspieler, C
   Marschik, PB
   Pereira, JP
   Gaw, SL
   Adachi, K
   Cherry, JD
   Xu, ZH
   Cheng, GH
   Moreira, ME
AF Nielsen-Saines, Karin
   Brasil, Patricia
   Kerin, Tara
   Vasconcelos, Zilton
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Pone, Marcos
   Abreu de Carvalho, Liege M.
   Pone, Sheila M.
   Zin, Andrea A.
   Tsui, Irena
   Salles, Tania Regina S.
   da Cunha, Denise Cotrim
   Costa, Roozemerie Pereira
   Malacarne, Jociele
   Reis, Ana Beatriz
   Hasue, Renata Hydee
   Aizawa, Carolina Y. P.
   Genovesi, Fernanda F.
   Einspieler, Christa
   Marschik, Peter B.
   Pereira, Jose Paulo
   Gaw, Stephanie L.
   Adachi, Kristina
   Cherry, James D.
   Xu, Zhiheng
   Cheng, Genhong
   Moreira, Maria Elisabeth
TI Delayed childhood neurodevelopment and neurosensory alterations in the
   second year of life in a prospective cohort of ZIKV-exposed children
SO NATURE MEDICINE
LA English
DT Article
ID INFANT NEUROLOGICAL EXAMINATION; VIRUS-INFECTION; OPHTHALMIC
   MANIFESTATIONS; CEREBRAL-PALSY; BIRTH-DEFECTS; BAYLEY-III; EPIDEMIC;
   OUTCOMES; SEX
AB We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. (1,2)). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children. Complete eye exams (n = 137) and hearing assessments (n = 114) were also performed. Below-average neurodevelopment and/or abnormal eye or hearing assessments were noted in 31.5% of children between 7 and 32 months of age. Among children assessed by Bayley-III, 12% scored below -2 s.d. (score < 70; a score of 100 +/- 2 s.d. is the range) in at least one domain; and 28% scored between -1 and -2 s.d. in any domain (scores < 85-70). Language function was most affected, with 35% of 146 children below average. Improved neurodevelopmental outcomes were noted in female children, term babies, children with normal eye exams and maternal infection later in pregnancy (P = 0.01). We noted resolution of microcephaly with normal neurodevelopment in two of eight children, development of secondary microcephaly in two other children and autism spectrum disorder in three previously healthy children in the second year of life.
C1 [Nielsen-Saines, Karin; Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Cheng, Genhong] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.
   [Brasil, Patricia; Vasconcelos, Zilton; Damasceno, Luana; Pone, Marcos; Abreu de Carvalho, Liege M.; Pone, Sheila M.; Zin, Andrea A.; Salles, Tania Regina S.; da Cunha, Denise Cotrim; Costa, Roozemerie Pereira; Malacarne, Jociele; Reis, Ana Beatriz; Pereira, Jose Paulo; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, Renata Hydee; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria.
   [Marschik, Peter B.] Univ Med Ctr, Gottingen, Germany.
   [Gaw, Stephanie L.] UCSF Sch Med, San Francisco, CA USA.
   [Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China.
RP Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.; Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM knielsen@mednet.ucla.edu; bebethiff@gmail.com
RI Hasue, Renata Hydee/B-2328-2013; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Reis,
   AlessanRSS/0000-0001-8486-7469; Moura Pone, Sheila/0000-0002-6246-8915;
   Vasconcelos, Zilton/0000-0002-2193-2224; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil
   [DECIT/25000.072811/2016-19]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES [001/88887.116627/2016-01]; Brazilian
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq/441098/2016-9, CNPq307282/2017-1]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-18/2015TXB, 239224/E-032018, E-26/202.862/2018]; Fondation
   Christophe e Rodolphe Merieux [734548]; Thrasher Research Fund
   [20164370]; Bill and Melinda gates Foundation Grand Challenges
   ExplorationsBill & Melinda Gates Foundation [OPP112887]; National
   Institute of Allergy and Infectious Diseases (NIAID) of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01,
   AI140718-01]; National Eye Institute (NEI) of the National Institutes of
   Health [AI129847-01]; United Kingdom's Department for International
   Development; ZikaPlan (Preparedness Latin American Network); NATIONAL
   EYE INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI140718, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R21AI129534, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, K08AI141728, R01AI140718] Funding
   Source: NIH RePORTER
FX This study was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil (DECIT/25000.072811/2016-19, to P.B. and
   M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES 001/88887.116627/2016-01 to PB); Brazilian National Council for
   Scientific and Technological Development (CNPq/441098/2016-9 to M.E.M.
   and CNPq307282/2017-1 to P.B.); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, No. E-18/2015TXB to
   M.E.M., No. 239224/E-032018 to M.E.M. and No. E-26/202.862/2018 to
   P.B.); Fondation Christophe e Rodolphe Merieux to P.B.; ZikAlliance,
   734548 to P.B.; the Thrasher Research Fund (No. 20164370 to K.N.S. and
   K.A.); the Bill and Melinda gates Foundation Grand Challenges
   Explorations (No. OPP112887 to P.B.M.); the National Institute of
   Allergy and Infectious Diseases (NIAID) of the National Institutes of
   Health (No. AI28697 to K.N.S., No. AI1259534-01 to K.N.S. and G.C., No.
   AI140718-01 to K.N.S. and P.B.); the National Eye Institute (NEI) of the
   National Institutes of Health (No. AI129847-01 to K.N.S., I.T. and
   P.B.); the United Kingdom's Department for International Development (to
   M.E.M.); and the ZikaPlan (Preparedness Latin American Network, to
   M.E.M.). We thank the women who enrolled in this study, the Fiocruz Zika
   Field Team who rendered our work possible, and P.F. Augusto and C.B. de
   Souza (Federal University of Sao Paulo), who assisted with
   neurodevelopmental assessments.
CR Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20
   Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.1111/j.1467-8624.1965.tb05304.x
   Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cherry JD, 2018, FEIGIN CHERRYS TXB P
   da Cunha RDES, 2016, J PEDIAT-BRAZIL, V92, P136, DOI 10.1016/j.jped.2015.04.004
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037
   Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006
   Rossetto J. D., 2018, J AAPOS, V22, pe60
   Souza CT, 2010, BRAZ J PHYS THER, V14, P309
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura C. V, 2016, ARQ BRAS OFTALMOL, V79
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vianna P, 2018, NEUROIMMUNOMODULAT, V25, P320, DOI 10.1159/000495660
   Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 39
TC 45
Z9 45
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2019
VL 25
IS 8
BP 1213
EP +
DI 10.1038/s41591-019-0496-1
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA IQ0BI
UT WOS:000480414600018
PM 31285631
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Pool, KL
   Adachi, K
   Karnezis, S
   Salamon, N
   Romero, T
   Nielsen-Saines, K
   Pone, S
   Boechat, M
   Aibe, M
   da Silva, TG
   Ribeiro, CTM
   Boechat, I
   Brasil, P
   Zin, A
   Tsui, I
   Gaw, SL
   Daltro, P
   Ribeiro, BG
   Fazecas, T
   da Cruz, LCH
   Nogueira, R
   Vasconcelos, Z
   Pereira, JP
   Salles, TS
   Barbosa, CN
   Chen, WQ
   Foo, SS
   Jung, J
   Moreira, ME
   Pone, M
AF Pool, Kara-Lee
   Adachi, Kristina
   Karnezis, Stellios
   Salamon, Noriko
   Romero, Tahmineh
   Nielsen-Saines, Karin
   Pone, Sheila
   Boechat, Marcia
   Aibe, Mitsue
   da Silva, Tallita Gomes
   Martins Ribeiro, Carla Trevisan
   Boechat, Ines
   Brasil, Patricia
   Zin, Andrea
   Tsui, Irena
   Gaw, Stephanie L.
   Daltro, Pedro
   Ribeiro, Bianca Guedes
   Fazecas, Tatiana
   Celso Hygino da Cruz, L.
   Nogueira, Renata
   Vasconcelos, Zilton
   Pereira, Jose Paulo, Jr.
   Salles, Tania Saad
   Barbosa, Claudia Neves
   Chen, Weiqiang
   Foo, Suan-Sin
   Jung, Jae
   Moreira, Maria Elisabeth
   Pone, Marcos
TI Association Between Neonatal Neuroimaging and Clinical Outcomes in
   Zika-Exposed Infants From Rio de Janeiro, Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES
AB IMPORTANCE Congenital Zika virus (ZIKV) infection may present with a spectrum of clinical and neuroradiographic findings.
   OBJECTIVE To determine whether neuroimaging findings for infants with a history of ZIKV exposure are associated with infant clinical outcomes and gestational age at antenatal ZIKV infection.
   DESIGN, SETTING, AND PARTICIPANTS This cohort study retrospectively reviewed neuroimaging results (computed tomography and/or magnetic resonance imaging scans) of 110 ZIKV-exposed infants from a maternity and children's hospital in Rio de Janeiro, Brazil, following the 2015 to 2016 ZIKV epidemic. Neuroimaging from March 1, 2016, to June 30, 2017, was evaluated to determine whether findings were associated with clinical outcomes and the timing of maternal ZIKV infection. Data were analyzed from July 1, 2017, to August 30, 2018.
   EXPOSURES Neuroimaging (computed tomography and/or magnetic resonance imaging) was performed on ZIKV-exposed infants after birth. Blood and/or urine specimens from mothers and infants were tested for ZIKV by polymerase chain reaction assay.
   MAIN OUTCOMES AND MEASURES Neuroimaging studies were evaluated for structural abnormalities and other forms of brain injury.
   RESULTS A total of 110 infants with a mean (SD) gestational age of 38.4 (2.1) weeks had neuroimaging and clinical outcome data reviewed. Of these, 71 (65%) had abnormal neuroimaging findings, with the majority (96%) classified as having severe ZIKV infection at birth. The most common neuroimaging abnormalities were structural abnormalities including brain calcifications, especially at the cortico-subcortical white matter junction, cortex malformations, ventriculomegaly, and reduced brain volumes, followed by brainstem hypoplasia, cerebellar hypoplasia, and corpus callosum abnormalities. Frequency of abnormal imaging was higher in infants with specific clinical findings as opposed to those without them; these findings included fetal brain disruption sequence (100% vs 35%), microcephaly (100% vs 30%), congenital contractures (100% vs 58%), ophthalmologic abnormalities (95% vs 44%), hearing abnormalities (100% vs 58%), and neurologic symptoms (94% vs 10%). Four of 39 infants (10%) without initial evidence of severe ZIKV infection and normal findings on neurologic evaluation at birth had abnormal neuroimaging findings. Neuroimaging abnormalities differed by trimester of maternal ZIKV infection, with 63% of infants born to mothers infected in the first trimester, 13% of infants born to mothers infected in the second trimester, and 1% of infants born to mothers infected in the third trimester exhibiting neuroimaging abnormalities. The odds of abnormal neuroimaging were 7.9 times greater for infants with first trimester ZIKV exposure compared with other trimesters combined (odds ratio, 7.9; 95% CI, 3.0-20.4; P < .001).
   CONCLUSIONS AND RELEVANCE Neuroimaging abnormalities of computed tomography and/or magnetic resonance imaging scans were common in ZIKV-exposed infants. While neuroimaging abnormalities were seen in 10% of infants without clinically severe ZIKV, most occurred almost exclusively among those with clinically severe ZIKV, especially among those with a history of ZIKV exposure in the first trimester.
C1 [Pool, Kara-Lee; Adachi, Kristina; Karnezis, Stellios; Salamon, Noriko; Romero, Tahmineh; Nielsen-Saines, Karin; Boechat, Marcia; Tsui, Irena] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Pone, Sheila; Boechat, Marcia; Aibe, Mitsue; da Silva, Tallita Gomes; Martins Ribeiro, Carla Trevisan; Brasil, Patricia; Zin, Andrea; Vasconcelos, Zilton; Pereira, Jose Paulo, Jr.; Salles, Tania Saad; Barbosa, Claudia Neves; Moreira, Maria Elisabeth; Pone, Marcos] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Daltro, Pedro; Ribeiro, Bianca Guedes; Fazecas, Tatiana; Celso Hygino da Cruz, L.; Nogueira, Renata] Clin Diagnost Imagem CDPI, Rio De Janeiro, Brazil.
   [Chen, Weiqiang; Foo, Suan-Sin; Jung, Jae] Univ Southern Calif, Sch Med, Los Angeles, CA 90007 USA.
RP Adachi, K (corresponding author), David Geffen UCLA Sch Med, Dept Pediat, Div Infect Dis, MDCC 22-442,10833 Le Conte Ave, Los Angeles, CA 90049 USA.
EM kadachi@mednet.ucla.edu
OI Moura Pone, Sheila/0000-0002-6246-8915; Martins Ribeiro, Carla
   Trevisan/0000-0002-2478-9144; Vasconcelos, Zilton/0000-0002-2193-2224;
   da Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [CAPES/88887.116627/2016-01]; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01,
   AI140718-01]; National Eye Institute of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [AI129847-01]; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute [UL1TR001881]; Thrasher Research Fund [20164370]; United
   Kingdom's Department for International Development; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [441098/2016-9]; Fundo de amparo a
   pesquisa estado do Rio de Janeiro [E_18/2015TXB]; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318, R21EY028318] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI140718, R01AI140718] Funding Source: NIH RePORTER
FX The work was supported by the Departamento de Ciencia e Tecnologia do
   Ministerio da Saude do Brasil and grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   CAPES/88887.116627/2016-01); the National Institute of Allergy and
   Infectious Diseases (grants AI28697, AI1259534-01, AI140718-01) and the
   National Eye Institute (grant AI129847-01) of the National Institutes of
   Health; NIH/National Center for Advancing Translational Science
   University of California, Los Angeles Clinical and Translational Science
   Institute (grant UL1TR001881); Thrasher Research Fund (grant 20164370);
   and the United Kingdom's Department for International Development. The
   work was also supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 441098/2016-9) and Fundo de amparo a
   pesquisa estado do Rio de Janeiro (grant E_18/2015TXB).
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baskin HJ, 2007, PEDIATR RADIOL, V37, P949, DOI 10.1007/s00247-007-0506-1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chan SRLL, 1992, J OBSTET GYNAECOL, V12, P25, DOI [10.3109/01443619209029914, DOI 10.3109/01443619209029914]
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raymond A, 2018, PEDIATR INFECT DIS J, V37, pE112, DOI 10.1097/INF.0000000000001832
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Uggetti C, 2009, AM J NEURORADIOL, V30, P1971, DOI 10.3174/ajnr.A1694
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
NR 27
TC 8
Z9 8
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JUL
PY 2019
VL 2
IS 7
AR e198124
DI 10.1001/jamanetworkopen.2019.8124
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA KL0VM
UT WOS:000513150700009
PM 31365112
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Haefeli, LD
   Neves, LM
   Malacarne, J
   Moreira, MEL
   Zin, AA
   Pinto, MT
AF Haefeli, Lorena de Melo
   Neves, Luiza Maceira
   Malacarne, Jocieli
   Lopes Moreira, Maria Elizabeth
   Zin, Andrea Araujo
   Pinto, Marcia Teixeira
TI Universal digital imaging screening cost of neonatal visual impairment
   causes
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 28-MAY 02, 2019
CL Vancouver, CANADA
SP Assoc Res Vis & Ophthalmol
C1 [Haefeli, Lorena de Melo; Neves, Luiza Maceira; Malacarne, Jocieli; Lopes Moreira, Maria Elizabeth; Zin, Andrea Araujo; Pinto, Marcia Teixeira] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2019
VL 60
IS 9
MA 3141
PG 2
WC Ophthalmology
SC Ophthalmology
GA JB5TF
UT WOS:000488628107264
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU do Amaral, YND
   Rocha, DM
   da Silva, LML
   Soares, FVM
   Moreira, MEL
AF di Villarosa do Amaral, Yasmin Notarbartolo
   Rocha, Daniele Marano
   Lopes da Silva, Leila Maria
   Mendes Soares, Fernanda Valente
   Lopes Moreira, Maria Elisabeth
TI Do maternal morbidities change the nutritional composition of human
   milk? A systematic review
SO CIENCIA & SAUDE COLETIVA
LA English
DT Review
DE Chronic disease; Human milk; Macronutrients
ID GESTATIONAL DIABETES-MELLITUS; FATTY-ACID-COMPOSITION; WOMEN;
   LACTOGENESIS; GLUCOSE; HYPERTENSION; COLOSTRUM
AB This paper aims to identify the effects of maternal morbidities on the nutritional composition of human milk. This systematic review of the literature employed a PRISMA's protocol for searching, selecting, and extracting data. The flowchart proposed for bibliographic search resulted in 1,582 papers, of which 14 were selected for this work. The papers selected for this review were published between 1987 and 2016. Nine studies found significant differences in the nutritional composition of the milk of mothers with diabetes mellitus, arterial hypertension, or overweight compared to the control group. Most studies have shown that the presence of chronic diseases leads to changes in the nutritional composition of human milk. The main results showed a lower concentration of lactose and fat in the milk of women with diabetes mellitus. Concerning hypertension, higher levels of total protein were found in colostrum and mature milk. A higher fat and energy content was observed in overweight mothers. It is imperative that these women have continuous nutritional monitoring to minimize the impact of these morbidities on the nutritional composition of breast milk.
C1 [di Villarosa do Amaral, Yasmin Notarbartolo; Rocha, Daniele Marano; Lopes da Silva, Leila Maria; Mendes Soares, Fernanda Valente; Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Nacl Saude Mulher Criaca & Adolescente Ferna, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
RP do Amaral, YND (corresponding author), Fiocruz MS, Inst Nacl Saude Mulher Criaca & Adolescente Ferna, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM yasminamaral@hotmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Amaral,
   Yasmin/0000-0001-8159-0564
CR ARTHUR PG, 1989, J PEDIATR GASTR NUTR, V9, P488, DOI 10.1097/00005176-198911000-00016
   Bachour P, 2012, BREASTFEED MED, V7, P179, DOI 10.1089/bfm.2011.0038
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Barros Denise Cavalcante de, 2008, Rev. Bras. Saude Mater. Infant., V8, P363, DOI 10.1590/S1519-38292008000400002
   Bertoldi Nucci L, 2001, Cad Saude Publica, V17, P1367, DOI 10.1590/S0102-311X2001000600020
   BITMAN J, 1989, AM J CLIN NUTR, V50, P1364
   Brasil. Ministerio da Saude (MS), 2012, CAD AT BAS AT PREN B
   BUTTE NF, 1987, J PEDIATR GASTR NUTR, V6, P936, DOI 10.1097/00005176-198711000-00020
   de Morais Oliveira AM, 2008, ARQ BRAS ENDOCRINOL, V52, P473, DOI 10.1590/S0004-27302008000300007
   Sirio MAD, 2007, CAD SAUDE PUBLICA, V23, P2205, DOI 10.1590/S0102-311X2007000900028
   Dritsakou K, 2017, J MATERN-FETAL NEO M, V30, P1302, DOI 10.1080/14767058.2016.1212329
   Freire Cláudia Maria Vilas, 2009, Arq. Bras. Cardiol., V93, P159, DOI 10.1590/S0066-782X2009001300017
   Fujimori M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0574-4
   JACKSON MB, 1994, AM J CLIN NUTR, V60, P353
   LAMMIKEEFE CJ, 1995, J PEDIATR GASTR NUTR, V20, P305, DOI 10.1097/00005176-199504000-00007
   Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.7326/0003-4819-151-4-200908180-00136, 10.1371/journal.pmed.1000100]
   Makela J, 2013, EUR J NUTR, V52, P727, DOI 10.1007/s00394-012-0378-5
   Massmann PF, 2013, FRONT LIFE SCI, V7, P155, DOI 10.1080/21553769.2013.876451
   Morceli G, 2011, ACTA PAEDIATR, V100, P550, DOI 10.1111/j.1651-2227.2010.02070.x
   NEUBAUER SH, 1993, AM J CLIN NUTR, V58, P54
   Schmidt MI, 2001, DIABETES CARE, V24, P1151, DOI 10.2337/diacare.24.7.1151
   [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001
   VANBEUSEKOM CM, 1993, AM J CLIN NUTR, V57, P938
NR 24
TC 4
Z9 4
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2019
VL 24
IS 7
BP 2491
EP 2498
DI 10.1590/1413-81232018247.18972017
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IK5VS
UT WOS:000476654000013
PM 31340268
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Castro, FL
   Geddes, VEV
   Monteiro, FLL
   Goncalves, RMDT
   Campanati, L
   Pezzuto, P
   Paquin-Proulx, D
   Schamber-Reis, BL
   Azevedo, GS
   Goncalves, AL
   Cunha, DP
   Moreira, MEL
   Vasconcelos, ZFM
   Chimeli, L
   Melo, A
   Tanuri, A
   Nixon, DF
   Ribeiro-Alves, M
   Aguiar, RS
AF Castro, Fernanda L.
   Geddes, Victor E. V.
   Monteiro, Fabio L. L.
   Goncalves, Raphael M. D. T.
   Campanati, Loraine
   Pezzuto, Paula
   Paquin-Proulx, Dominic
   Schamber-Reis, Bruno L.
   Azevedo, Girlene S.
   Goncalves, Alessandro L.
   Cunha, Daniela P.
   Moreira, Maria Elisabeth L.
   Vasconcelos, Zilton F. M.
   Chimeli, Leila
   Melo, Adriana
   Tanuri, Amilcar
   Nixon, Douglas F.
   Ribeiro-Alves, Marcelo
   Aguiar, Renato S.
TI MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus
   Infection
SO ASN NEURO
LA English
DT Article
DE miRNAs; microcephaly; neuroblastoma; postmortem brain autopsies; Zika
ID INVASION; BRAIN; CELLS; MIGRATION; PATHOLOGY; MIR-148A; REVEALS;
   MITOSIS; GROWTH; MODEL
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) member of the Flaviviridae family, which has been associated with the development of the congenital Zika syndrome (CZS). RNA viruses, such as flaviviruses, have been reported to exert a profound impact on host microRNAs (miRNAs). Cellular miRNAs modulated by ZIKV may help identify cellular pathways of relevance to pathogenesis. Here, we screened 754 human cellular miRNAs modulated by ZIKV infection (Brazilian PE strain) in a neuroblastoma cell line. Seven miRNAs (miR-99a*, miR-126*, miR-190b, miR-361-3p, miR-522-3p, miR-299-5p, and miR-1267) were downregulated during ZIKV infection, while miR-145 was upregulated. Furthermore, 11 miRNAs were exclusively expressed in ZIKV-infected (miR-148a, miR-342-5p, miR-598, and miR-708-3p) or mock cells (miR-208, miR-329, miR-432-5p, miR-488, miR-518b, miR-520g, and miR-767-5p). Furthermore, in silico analysis indicated that some central nervous system, cellular migration, and adhesion function-related biological processes were overrepresented in the list of target genes of the miRNAs regulated in ZIKV-infected cells, especially for miR-145 and miR-148a. The induction of miR-145 and miR-148a was confirmed in postmortem brain samples from stillborn with severe CZS. Finally, we determined the expression regulation of microcephaly related genes through RNA interference pathway caused by ZIKV directly on neuron cells.
C1 [Castro, Fernanda L.; Geddes, Victor E. V.; Monteiro, Fabio L. L.; Goncalves, Raphael M. D. T.; Pezzuto, Paula; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Paquin-Proulx, Dominic] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [Schamber-Reis, Bruno L.; Melo, Adriana] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
   [Azevedo, Girlene S.; Melo, Adriana] Inst Pesquisa Prof Amor Neto, Campina Grande, Brazil.
   [Goncalves, Alessandro L.] Hosp Vera Cruz, Serv Neurol, Belo Horizonte, MG, Brazil.
   [Cunha, Daniela P.; Moreira, Maria Elisabeth L.; Vasconcelos, Zilton F. M.] Inst Fernandes Figueira FIOCRUZ, Rio De Janeiro, Brazil.
   [Chimeli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nixon, Douglas F.] Weill Cornell Med, Div Infect Dis, New York, NY USA.
   [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
RP Aguiar, RS (corresponding author), Lab Virol Mol, Av Carlos Chagas Filho 373,Predio CCS,Bloco A2, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM santanarnt@gmail.com
RI Melo, Adriana S O/H-5650-2016; Vasconcelos, Zilton/AAD-5784-2019;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Aguiar, Renato
   S/G-3542-2015; Nixon, Douglas/AAU-5734-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Aguiar, Renato S/0000-0001-5180-3717; Nixon,
   Douglas/0000-0002-2801-1786; Lima Monteiro, Fabio
   Luis/0000-0002-9107-6865; Paquin Proulx, Dominic/0000-0003-1407-3414;
   Geddes, Victor/0000-0002-0723-3873; Cunha, Daniela/0000-0002-5954-6054;
   Ribeiro-Alves, Marcelo/0000-0002-8663-3364
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440900/2016-6]; council for the Improvement of Higher Education
   (CAPES) [88881.130757/2016-01]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-18/2015]; CAPESCAPES
   [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by National Council for Scientific and Technological
   Development (CNPq) grant 440900/2016-6, council for the Improvement of
   Higher Education (CAPES) grant 88881.130757/2016-01 and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant E-18/2015.
   F.L.C. and V. E. V. G. are funded by CAPES (grant 001).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140
   [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Brasil P, 2016, OBSTET GYNECOL SURV, V71, P331, DOI 10.1097/01.ogx.0000483239.08585.8d
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034
   Chen ZT, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.572.6270
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Donzelli S, 2015, ONCOTARGET, V6, P35183, DOI 10.18632/oncotarget.5930
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ferreira RN, 2018, VIRAL IMMUNOL, V31, P583, DOI 10.1089/vim.2017.0186
   Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hu CW, 2013, J PROTEOME RES, V12, P3993, DOI 10.1021/pr400302w
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kakumani PK, 2016, GENE, V586, P7, DOI 10.1016/j.gene.2016.03.053
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652
   Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Muti P, 2014, CANCER EPIDEM BIOMAR, V23, P2471, DOI 10.1158/1055-9965.EPI-14-0398
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Romero DM, 2018, SEMIN CELL DEV BIOL, V76, P33, DOI 10.1016/j.semcdb.2017.09.031
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sachdeva M, 2010, AM J TRANSL RES, V2, P170
   Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511
   Shalev SA, 2014, PEDIATR DIABETES, V15, P252, DOI 10.1111/pedi.12086
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Zhang HJ, 2019, MOL NEUROBIOL, V56, P4072, DOI 10.1007/s12035-018-1358-4
   Zhang L, 2017, INT J CLIN EXP PATHO, V10, P8361
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
NR 62
TC 2
Z9 2
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1759-0914
J9 ASN NEURO
JI ASN Neuro
PD JUN
PY 2019
VL 11
AR 1759091419850983
DI 10.1177/1759091419850983
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA IE1TZ
UT WOS:000472170000001
PM 31213064
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Wilder-Smith, A
   Wei, YH
   de Araujo, TVB
   VanKerkhove, M
   Martelli, CMT
   Turchi, MD
   Teixeira, M
   Tami, A
   Souza, J
   Sousa, P
   Soriano-Arandes, A
   Soria-Segarra, C
   Clemente, NS
   Rosenberger, KD
   Reveiz, L
   Prata-Barbosa, A
   Pomar, L
   Rosado, LEP
   Perez, F
   Passos, SD
   Nogueira, M
   Noel, TP
   da Silva, AM
   Moreira, ME
   Morales, I
   Montoya, MCM
   Miranda, DD
   Maxwell, L
   Macpherson, CNL
   Low, N
   Lan, ZY
   LaBeaud, AD
   Koopmans, M
   Kim, C
   Joao, E
   Jaenisch, T
   Hofer, CB
   Gustafson, P
   Gerardin, P
   Ganz, JS
   Dias, ACF
   Elias, V
   Duarte, G
   Debray, TPA
   Cafferata, ML
   Buekens, P
   Broutet, N
   Brickley, EB
   Brasil, P
   Brant, F
   Bethencourt, S
   Benedetti, A
   Avelino-Silva, VL
   Ximenes, RAD
   da Cunha, AA
   Alger, J
AF Wilder-Smith, Annelies
   Wei, Yinghui
   Barreto de Araujo, Thalia Velho
   VanKerkhove, Maria
   Turchi Martelli, Celina Maria
   Turchi, Marilia Dalva
   Teixeira, Mauro
   Tami, Adriana
   Souza, Joao
   Sousa, Patricia
   Soriano-Arandes, Antoni
   Soria-Segarra, Carmen
   Clemente, Nuria Sanchez
   Rosenberger, Kerstin Daniela
   Reveiz, Ludovic
   Prata-Barbosa, Arnaldo
   Pomar, Leo
   Rosado, Luiza Emylce Pela
   Perez, Freddy
   Passos, Saulo D.
   Nogueira, Mauricio
   Noel, Trevor P.
   da Silva, Antonio Moura
   Moreira, Maria Elisabeth
   Morales, Ivonne
   Miranda Montoya, Maria Consuelo
   Miranda-Filho, Democrito de Barros
   Maxwell, Lauren
   Macpherson, Calum N. L.
   Low, Nicola
   Lan, Zhiyi
   LaBeaud, Angelle Desiree
   Koopmans, Marion
   Kim, Caron
   Joao, Esau
   Jaenisch, Thomas
   Hofer, Cristina Barroso
   Gustafson, Paul
   Gerardin, Patrick
   Ganz, Jucelia S.
   Fialho Dias, Ana Carolina
   Elias, Vanessa
   Duarte, Geraldo
   Alfons Debray, Thomas Paul
   Cafferata, Maria Luisa
   Buekens, Pierre
   Broutet, Nathalie
   Brickley, Elizabeth B.
   Brasil, Patricia
   Brant, Fatima
   Bethencourt, Sarah
   Benedetti, Andrea
   Avelino-Silva, Vivian Lida
   de Alencar Ximenes, Ricardo Arraes
   da Cunha, Antonio Alves
   Alger, Jackeline
CA Zika Virus Individual Participant
TI Understanding the relation between Zika virus infection during pregnancy
   and adverse fetal, infant and child outcomes: a protocol for a
   systematic review and individual participant data meta-analysis of
   longitudinal studies of pregnant women and their infants and children
SO BMJ OPEN
LA English
DT Review
ID MULTIVARIATE METAANALYSIS; PREDICTION MODELS; PATIENT DATA; REGRESSION;
   FRAMEWORK; DENGUE; ENHANCEMENT; PERFORMANCE; DIAGNOSIS; SELECTION
AB Introduction Zika virus (ZIKV) infection during pregnancy is a known cause of microcephaly and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or prophylactics, principal investigators (PIs) and international leaders in ZIKV research have formed the ZIKV Individual Participant Data (IPD) Consortium to identify, collect and synthesise IPD from longitudinal studies of pregnant women that measure ZIKV infection during pregnancy and fetal, infant or child outcomes.
   Methods and analysis We will identify eligible studies through the ZIKV IPD Consortium membership and a systematic review and invite study Pls to participate in the IPD meta-analysis (IPD-MA). We will use the combined dataset to estimate the relative and absolute risk of congenital Zika syndrome (CZS), including microcephaly and late symptomatic congenital infections; identify and explore sources of heterogeneity in those estimates and develop and validate a risk prediction model to identify the pregnancies at the highest risk of CZS or adverse developmental outcomes. The variable accuracy of diagnostic assays and differences in exposure and outcome definitions means that included studies will have a higher level of systematic variability, a component of measurement error, than an IPD-MA of studies of an established pathogen. We will use expert testimony, existing internal and external diagnostic accuracy validation studies and laboratory external quality assessments to inform the distribution of measurement error in our models. We will apply both Bayesian and frequentist methods to directly account for these and other sources of uncertainty.
   Ethics and dissemination The IPD-MA was deemed exempt from ethical review. We will convene a group of patient advocates to evaluate the ethical implications and utility of the risk stratification tool. Findings from these analyses will be shared via national and international conferences and through publication in open access, peer-reviewed journals.
C1 [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wei, Yinghui] Univ Plymouth, Ctr Math Sci, Plymouth, Devon, England.
   [Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [VanKerkhove, Maria] WHO, Hlth Emergencies Programme, Geneva, Switzerland.
   [Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes CPqAM, Dept Collect Hlth, Recife, PE, Brazil.
   [Turchi, Marilia Dalva] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [Teixeira, Mauro; Fialho Dias, Ana Carolina; Brant, Fatima] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Tami, Adriana] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Souza, Joao] Univ Sao Paulo, Dept Social Med, Sao Paulo, Brazil.
   [Sousa, Patricia] Reference Ctr Neurodev Assistance & Rehabil Child, State Dept Hlth Maranhao, Sao Luis, Maranhao, Brazil.
   [Soriano-Arandes, Antoni] Univ Hosp Vall dHebron, Dept Pediat, Barcelona, Spain.
   [Soria-Segarra, Carmen] SOSECALI C Ltda, Guayaquil, Ecuador.
   [Clemente, Nuria Sanchez] Univ Sao Paulo, Dept Epidemiol, Sao Paulo, Brazil.
   [Rosenberger, Kerstin Daniela; Morales, Ivonne; Jaenisch, Thomas] Univ Klinikum Heidelberg, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Reveiz, Ludovic] Pan Amer Hlth Org, Evidence & Intelligence Act Hlth, Washington, DC USA.
   [Prata-Barbosa, Arnaldo] DOr Inst Res & Educ, Dept Pediat, Rio De Janeiro, Brazil.
   [Pomar, Leo] Ctr Hosp Ouest Guyanais, Dept Obstet & Gynecol, St Laurent Du Maroni, French Guiana.
   [Rosado, Luiza Emylce Pela] Goiania State Hlth Secretary, Hosp Materno Infantil Goiania, Goiania, Go, Brazil.
   [Perez, Freddy] Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth Dep, Washington, DC USA.
   [Passos, Saulo D.] FMJ, Dept Pediat, Sao Paulo, Brazil.
   [Nogueira, Mauricio] Fac Med Sao Jose do Rio Preto, Dept Dermatol Dis, Sao Jose Do Rio Preto, Brazil.
   [Noel, Trevor P.; Macpherson, Calum N. L.] St Georges Univ, Windward Isl Res & Educ Fdn, True Blue Point, Grenada.
   [da Silva, Antonio Moura] Univ Fed Maranhao Sao Luis, Dept Publ Hlth, Sao Luis, Maranhao, Brazil.
   [Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Dept Neonatol, Rio De Janeiro, Brazil.
   [Miranda Montoya, Maria Consuelo] Univ Ind Santander, Fac Salud, Bucaramanga, Colombia.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Maxwell, Lauren] WHO, Reprod Hlth & Res, Geneva, Switzerland.
   [Maxwell, Lauren] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Lan, Zhiyi] McGill Univ, Hlth Ctr, Montreal, PQ, Canada.
   [LaBeaud, Angelle Desiree] Stanford Hosp, Pediat Infect Dis, Palo Alto, CA USA.
   [Koopmans, Marion] Erasmus MC, Dept Virol, Rotterdam, Netherlands.
   [Kim, Caron; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Joao, Esau] Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, Brazil.
   [Hofer, Cristina Barroso] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil.
   [Gustafson, Paul] Univ British Columbia, Stat, Vancouver, BC, Canada.
   [Gerardin, Patrick] CHU La Reunion, INSERM, CIC1410, Clin Epidemiol, St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ la Reunion, UM PIMIT 134, CNRS 9192, INSERM U1187,IRD 249, St Clotilde, Reunion, France.
   [Ganz, Jucelia S.] Childrens Hosp Juvencio Matos, Sao Luis, Maranhao, Brazil.
   [Elias, Vanessa] Pan Amer Hlth Org, Sustainable Dev & Environm Hlth, Washington, DC USA.
   [Duarte, Geraldo] Univ Sao Paulo, Dept Gynecol & Obstet, Sao Paulo, Brazil.
   [Alfons Debray, Thomas Paul] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Cafferata, Maria Luisa] Inst Efectividad Clin & Sanitaria, Mother & Children Hlth Res Dept, Buenos Aires, DF, Argentina.
   [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.
   [Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Benedetti, Andrea] McGill Univ, Dept Med, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Biostat, Montreal, PQ, Canada.
   [Benedetti, Andrea] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada.
   [Avelino-Silva, Vivian Lida] Univ Sao Paulo, Dept Infect & Parasit Dis, Fac Med, Sao Paulo, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [da Cunha, Antonio Alves] Univ Fed Rio de Janeiro, Dept Pediat, Rio De Janeiro, Brazil.
   [Alger, Jackeline] Univ Nacl Autonoma Honduras, Fac Ciencias Med, Tegucigalpa, Honduras.
RP Maxwell, L (corresponding author), WHO, Reprod Hlth & Res, Geneva, Switzerland.; Maxwell, L (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
EM lauren.maxwell.us@gmail.com
RI Prata-Barbosa, Arnaldo/B-2212-2009; Debray, Thomas/J-7413-2012;
   Teixeira, Mauro M/A-4587-2008; Nogueira, Mauricio L/B-7599-2012;
   Arandes, Antonio Soriano/Q-3348-2016; Avelino-Silva, Vivian/L-2640-2013;
   Passos, Saulo/C-5166-2012; Brickley, Elizabeth/U-3625-2017
OI Prata-Barbosa, Arnaldo/0000-0002-4726-9782; Debray,
   Thomas/0000-0002-1790-2719; Teixeira, Mauro M/0000-0002-6944-3008;
   Nogueira, Mauricio L/0000-0003-1102-2419; Arandes, Antonio
   Soriano/0000-0001-9613-7228; Avelino-Silva, Vivian/0000-0002-6660-3088;
   Perez, Freddy/0000-0003-2001-0057; Passos, Saulo/0000-0002-0908-2677;
   Brickley, Elizabeth/0000-0003-0280-2288; Koopmans,
   Marion/0000-0002-5204-2312; Wei, Yinghui/0000-0002-7873-0009; Joao,
   Esau/0000-0002-2412-0627; Sulleiro, Elena/0000-0002-9783-6060
FU Wellcome TrustWellcome Trust; WHO Department of Reproductive Health and
   Research Human Reproduction Programme [206532/Z/17/]; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI140718,
   R01AI140718, R01AI140718] Funding Source: NIH RePORTER
FX The development of the IPD-MA protocol was supported by a Wellcome Trust
   grant to the WHO Department of Reproductive Health and Research Human
   Reproduction Programme, grant number 206532/Z/17/
CR Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Andrade PE, 2017, J IMMUNOL, V198
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2016, NATURE, V530, P5, DOI 10.1038/530005a
   [Anonymous], 2016, ZIK VIR INF CLIN
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Audigier V, 2017, MULTIPLE IMPUTATION
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Barchfield J., 2016, BOSTON GLOBE
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayley N., 1993, BAYLEY SCALES INFANT, V2nd ed.
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brodzinsky Sibylla, 2016, GUARDIAN
   Burgess S, 2013, STAT MED, V32, P4499, DOI 10.1002/sim.5844
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheng YKY, 2016, BJOG-INT J OBSTET GY, V123, P48, DOI 10.1111/1471-0528.14008
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Counotte M, 2018, ZIKA VIRUS INFECT CA
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cruz MM, 2017, J IMMUNOL, V198
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2018, LANCET INFECT DIS, V18
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Debray TPA, 2018, STAT METHODS MED RES, V27, P1351, DOI 10.1177/0962280216660741
   Debray TPA, 2015, RES SYNTH METHODS, V6, P293, DOI 10.1002/jrsm.1160
   Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886
   Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732
   Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durbin AP, 2017, J INFECT DIS, V216, pS971, DOI 10.1093/infdis/jix491
   Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533
   ELPUB, 2016, JUP NOT A PUBL FORM
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fernandes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113360
   Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gelman A., 2014, BAYESIAN DATA ANAL
   Gerardin P, 2016, BMJ-BRIT MED J, V354, P4850
   Gomez G, 2003, STAT MED, V22, P409, DOI 10.1002/sim.1326
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Groll A, 2016, PACKAGE GLMMLASSO
   Groll A, 2014, STAT COMPUT, V24, P137, DOI 10.1007/s11222-012-9359-z
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Hansen BB, 2008, BIOMETRIKA, V95, P481, DOI 10.1093/biomet/asn004
   Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43
   Higgins J. P., 2008, COCHRANE HDB SYSTEMA, P481, DOI DOI 10.1002/9780470712184.CH16
   Higgins J. P. T., 2016, COCHRANE DATABASE S1, V10, P29, DOI DOI 10.1002/14651858.CD201601
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   Jackson D, 2017, STAT METHODS MED RES, V26, P2853, DOI 10.1177/0962280215611702
   Jaenisch T, 2016, B WHO
   Jarde A, 2013, INT J CLIN HLTH PSYC, V13, P138, DOI 10.1016/S1697-2600(13)70017-6
   Joseph KS, 2018, ACTA OBSTET GYN SCAN, V97, P454, DOI 10.1111/aogs.13194
   Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002
   Kiserud T, 2016, PLOS MED, P1
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   Koopman L, 2008, INT J TECHNOL ASSESS, V24, P358, DOI 10.1017/S0266462308080471
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Lash TL, 2011, APPL QUANTITATIVE BI
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587
   Marx A, 2003, EVID BASED MED, V8, P36
   Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x
   Menikoff J., 2017, COMMUNICATION
   Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935
   Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2
   Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Pacheco O, 2016, N ENGL J MED OVERSEA
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO, P1
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Popay J, 2014, PUBLIC INVOLVEMENT I
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Richardson DB, 2015, INT J EPIDEMIOL, V44, P1660, DOI 10.1093/ije/dyv137
   Riley RD, 2015, RES SYNTH METHODS, V6, P157, DOI 10.1002/jrsm.1129
   Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165
   Riley RD, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3932
   Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221
   Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691
   Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.ijsu.2011.09.004, 10.1016/j.jclinepi.2010.02.005]
   Silverman JG, 2006, AM J OBSTET GYNECOL, V195, P140, DOI 10.1016/j.ajog.2005.12.052
   Sorvillo FJ, 2001, EPIDEMIOLOGIC METHOD, P249
   Squires J., 2009, AGES STAGES QUESTION
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tierney JF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001855
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vander Weele TJ, 2014, EPIDEMIOLOGY, V25, P711, DOI 10.1097/EDE.0000000000000096
   VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei YH, 2013, STAT MED, V32, P2911, DOI 10.1002/sim.5745
   Wellcome Trust, 2016, SHAR DAT ZIK OTH GLO
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x
   World Health Organization, 2016, SCREEN ASS MAN NEON
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183
   Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x
NR 128
TC 6
Z9 6
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD JUN
PY 2019
VL 9
IS 6
AR e026092
DI 10.1136/bmjopen-2018-026092
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA ND7XT
UT WOS:000562117100061
PM 31217315
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Magalhaes, ESD
   Meio, MDBB
   Moreira, MEL
AF da Silva Magalhaes, Elizabeth Soares
   Barbosa Baker Meio, Maria Dalva
   Lopes Moreira, Maria Elisabeth
TI Hormonal Biomarkers for Evaluating the Impact of Fetal Growth
   Restriction on the Development of Chronic Adult Disease
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Review
DE fetal growth restriction; developmental origins of health and disease;
   growth; development; biomarkers
ID FOR-GESTATIONAL-AGE; CATCH-UP GROWTH; CORONARY-HEART-DISEASE;
   INTRAUTERINE GROWTH; FACTOR-I; NEUROENDOCRINE FUNCTION; BINDING
   PROTEIN-3; FAMINE EXPOSURE; POSTNATAL LIFE; BIRTH-WEIGHT
AB The hypothesis of fetal origins to adult diseases proposes that metabolic chronic disorders, including cardiovascular diseases, diabetes, and hypertension originate in the developmental plasticity due to intrauterine insults. These processes involve an adaptative response by the fetus to changes in the environmental signals, which can promote the reset of hormones and of the metabolism to establish a "thrifty phenotype". Metabolic alterations during intrauterine growth restriction can modify the fetal programming. The present nonsystematic review intended to summarize historical and current references that indicated that developmental origins of health and disease (DOHaD) occur as a consequence of altered maternal and fetal metabolic pathways. The purpose is to highlight the potential implications of growth factors and adipokines in "developmental programming", which could interfere in the development by controlling fetal growth patterns. These changes affect the structure and the functional capacity of various organs, including the brain, the kidneys, and the pancreas. These investigations may improve the approach to optimizing antenatal as well as perinatal care aimed to protect newborns against long-term chronic diseases.
C1 [da Silva Magalhaes, Elizabeth Soares; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Clin Res Unit, Rio De Janeiro, RJ, Brazil.
RP Meio, MDBB (corresponding author), Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM mdbakermeio@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; BARBOSA BAKER MEIO,
   MARIA DALVA/0000-0002-7290-9091
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (Capes)CAPES; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The authors wish to thank the sources of funding from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes, in the Portuguese
   acronym) and from the National Council for Scientific and Technological
   Development (CNPq, in the Portuguese acronym).
CR Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112
   Meio MDBB, 2009, J PERINAT MED, V37, P689, DOI 10.1515/JPM.2009.122
   Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca
   Barker DJP, 2012, ANN HUM BIOL, V39, P335, DOI 10.3109/03014460.2012.712717
   BARKER DJP, 1989, LANCET, V2, P577
   Baumann MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106037
   Berglund SK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2809-3
   Beukers F, 2013, ARCH DIS CHILD, V98, P30, DOI 10.1136/archdischild-2012-302510
   Briffa JF, 2015, AM J PHYSIOL-ENDOC M, V308, pE335, DOI 10.1152/ajpendo.00312.2014
   Bronsky J, 2011, J PEDIATR GASTR NUTR, V52, P474, DOI 10.1097/MPG.0b013e3182062fcc
   Cheong JN, 2016, J PHYSIOL-LONDON, V594, P4727, DOI 10.1113/JP271745
   Chiesa C, 2008, CLIN CHEM, V54, P550, DOI 10.1373/clinchem.2007.095299
   Claris O, 2010, SEMIN PERINATOL, V34, P207, DOI 10.1053/j.semperi.2010.02.005
   Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470
   Davidson S, 2006, CLIN ENDOCRINOL, V65, P586, DOI 10.1111/j.1365-2265.2006.02632.x
   Devaskar SU, 2016, PHYSIOLOGY, V31, P131, DOI 10.1152/physiol.00033.2015
   Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001
   Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056
   Eriksson JG, 2011, AM J CLIN NUTR, V94, p1799S, DOI 10.3945/ajcn.110.000638
   Forhead AJ, 2009, J PHYSIOL-LONDON, V587, P1145, DOI 10.1113/jphysiol.2008.167072
   Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225
   Galjaard S, 2013, J PERINAT MED, V41, P101, DOI 10.1515/jpm-2012-0020
   Gatford KL, 2013, CLIN OBSTET GYNECOL, V56, P520, DOI 10.1097/GRF.0b013e31829e5b29
   Giapros VI, 2012, HORM METAB RES, V44, P845, DOI 10.1055/s-0032-1321759
   Gohlke BC, 2010, J CLIN ENDOCR METAB, V95, P5375, DOI 10.1210/jc.2010-0271
   Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133
   Hawkes CP, 2015, PEDIATR ENDOCR REV P, V13, P499
   Hellstrom A, 2016, AM J PERINAT, V33, P1067, DOI 10.1055/s-0036-1586109
   Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4
   Josefson JL, 2014, HORM RES PAEDIAT, V81, P13, DOI 10.1159/000355387
   Kaar JL, 2014, J DEV ORIG HLTH DIS, V5, P214, DOI 10.1017/S204017441400021X
   Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048
   Kajantie E, 2003, J CLIN ENDOCR METAB, V88, P1059, DOI 10.1210/jc.2002-021380
   Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012
   Kamenicky P, 2014, ENDOCR REV, V35, P234, DOI 10.1210/er.2013-1071
   Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P4498, DOI 10.1210/jc.2012-1716
   Kermack AJ, 2015, J DEV ORIG HLTH DIS, V6, P415, DOI 10.1017/S2040174415001324
   Law CM, 1996, J HYPERTENS, V14, P935
   Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253
   Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126
   Lumey LH, 2009, AM J CLIN NUTR, V89, P1737, DOI 10.3945/ajcn.2008.27038
   Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9
   Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x
   Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025
   Mathew H, 2018, METABOLISM, V86, P18, DOI 10.1016/j.metabol.2017.11.006
   McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448
   Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0
   Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402
   Milsom SR, 2008, HORM RES, V69, P307, DOI 10.1159/000114863
   Miras M, 2010, J PEDIATR ENDOCR MET, V23, P463, DOI 10.1515/jpem.2010.077
   Mitanchez D, 2015, BEST PRACT RES CL OB, V29, P256, DOI 10.1016/j.bpobgyn.2014.08.004
   Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d
   Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456
   Okada T, 2015, PEDIATR RES, V77, P136, DOI 10.1038/pr.2014.164
   Pandit R, 2017, AM J PHYSIOL-REG I, V312, pR938, DOI 10.1152/ajpregu.00045.2016
   Paneni F, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0419-z
   Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004
   Perez-Perez A, 2018, J CELL MOL MED, V22, P716, DOI 10.1111/jcmm.13369
   RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701
   Roseboom TJ, 2012, PLACENTA, V33, pE40, DOI 10.1016/j.placenta.2012.07.018
   Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017
   Ross MG, 2008, SEMIN PERINATOL, V32, P213, DOI 10.1053/j.semperi.2007.11.005
   Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002
   Sarr O, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/134758
   Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001
   Schneider HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033084
   Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307
   Sehgal A, 2016, J DEV ORIG HLTH DIS, V7, P626, DOI 10.1017/S2040174416000337
   Seoane-Collazo P, 2015, ENDOCRINE, V50, P276, DOI 10.1007/s12020-015-0658-y
   Sferruzzi-Perri AN, 2017, J PHYSIOL-LONDON, V595, P5057, DOI 10.1113/JP273330
   Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070
   Singh RR, 2015, CURR OPIN PHARMACOL, V21, P53, DOI 10.1016/j.coph.2014.12.010
   Stawerska R, 2016, J PEDIATR ENDOCR MET, V29, P939, DOI 10.1515/jpem-2015-0463
   Stevens A, 2014, PHARMACOGENOMICS J, V14, P376, DOI 10.1038/tpj.2014.4
   Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516
   Valleau JC, 2014, J CHEM NEUROANAT, V61-62, P221, DOI 10.1016/j.jchemneu.2014.05.001
   Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215
   Velegrakis A, 2017, BIOMED REP, V7, P115, DOI 10.3892/br.2017.930
   von Ehr J, 2016, ARCH GYNECOL OBSTET, V294, P673, DOI 10.1007/s00404-016-4178-7
   Wang KCW, 2012, CLIN EXP PHARMACOL P, V39, P958, DOI 10.1111/j.1440-1681.2012.05743.x
   Watanabe S, 2010, EUR J HEART FAIL, V12, P1214, DOI 10.1093/eurjhf/hfq166
   Wells JCK, 2014, INT J OBESITY, V38, P930, DOI 10.1038/ijo.2014.24
   Wolfe A, 2014, FRONT NEUROENDOCRIN, V35, P558, DOI 10.1016/j.yfrne.2014.05.007
   World Health Organization, 2015, GLOB GLOB HLTH OBS G
   Yigiter AB, 2011, J PERINAT MED, V39, P137, DOI 10.1515/jpm.2010.136
   Yousefzadeh G, 2013, J CARDIOVASC MED, V14, P416, DOI 10.2459/JCM.0b013e328358c7c7
NR 86
TC 3
Z9 3
U1 0
U2 1
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD APR
PY 2019
VL 41
IS 4
BP 256
EP 263
DI 10.1055/s-0039-1683904
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HW7SL
UT WOS:000466889900008
PM 30939608
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU dos Santos, SFM
   Soares, FVM
   de Abranches, AD
   da Costa, ACC
   Moreira, MEL
   Fonseca, VD
AF Morais dos Santos, Samira Fernandes
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Carioca da Costa, Ana Carolina
   Lopes Moreira, Maria Elisabeth
   Fonseca, Vania de Matos
TI Infants with microcephaly due to ZIKA virus exposure: nutritional status
   and food practices
SO NUTRITION JOURNAL
LA English
DT Article
DE Zika virus; Microcephaly; Nutritional status; Infant nutrition
ID FEEDING PRACTICES; CHILDREN; BRAZIL; AGE
AB BackgroundChildren with microcephaly due to vertical exposure to Zika virus are an interesting population for investigation. Highlighted among their unique aspects are those related to nutrition due to its impact on child growth and development. Knowledge about the nutrition of microcephalic infants can help mothers and caregivers provide better care. Thus, this study aimed to describe the nutritional status and feeding practices of infants with microcephaly due to Zika virus exposure at birth and 12-23months of age.MethodsThis is a descriptive study developed from a cohort of patients attending a public institution of reference. A total of 65 infants attended outpatient nutrition clinics. The food practices were described using the 24-h food recall and food consumption indicators. Anthropometric measurements and consultations were made using the Child Health Handbook to obtain information on the nutritional status (weight, height and head circumference) at the time of consultation and birth.ResultsThere was a significant decrease in z-scores for weight, height and head circumference (HC) from birth to the time of the consultation. However, most infants did not show weight-for-height deficits. Additionally, HC was correlated with the anthropometric indices weight-for-age, height-for-age, body mass index-for-age and weight-for-height.ConclusionInfants exhibited a worsening of their nutritional status between birth and the time of their consultation, notably when we evaluated the indices of height and head circumference for age. The main inadequacies regarding dietary practices were low food diversity, use of ultra-processed products and low lipid intake.
C1 [Morais dos Santos, Samira Fernandes; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Carioca da Costa, Ana Carolina; Lopes Moreira, Maria Elisabeth; Fonseca, Vania de Matos] Fiocruz MS, Fundacao Oswaldo Cruz, IFF, Inst Inst Nacl Saude Mulher Crianca & Adolescente, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
RP dos Santos, SFM (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, IFF, Inst Inst Nacl Saude Mulher Crianca & Adolescente, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM samira_fernandes13@hotmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Santos,
   Samira/0000-0002-1745-7678
FU Wellcome TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's
   Department for International Development; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441098/2016-9];
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E_18/2015TXB]; European Union's Horizon 2020 research
   and innovation programme under Zika-PLAN grant [734584]
FX This study was supported by the Wellcome Trust (205377/Z/16/Z) and the
   United Kingdom's Department for International Development; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (441098/2016-9); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)(E_18/2015TXB) and European Union's Horizon 2020
   research and innovation programme under Zika-PLAN grant agreement no.
   734584.
CR [Anonymous], 2015, DEZ PASS AL SAUD GUI
   [Anonymous], 2017, OR INT VIG AT SAUD A
   [Anonymous], 2002, DIET REF INT EN CARB
   [Anonymous], 2015, OR AV MARC CONS AL A
   Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2011, OR COL AN DAD ANTR S
   Claro RM, 2015, EPIDEMIOL SERV SAUDE, V24, P257, DOI 10.5123/S1679-49742015000200008
   Cozzolino SMF, 2013, BASES BIOQUIMICAS FI, P1257
   CULLEY WJ, 1969, J PEDIATR-US, V75, P380, DOI 10.1016/S0022-3476(69)80262-3
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Marinho LMF, 2016, CIENC SAUDE COLETIVA, V21, P977, DOI 10.1590/1413-81232015213.06532015
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude. Sistema de Vigilancia Alimentar e Nutricional, 2006, SIST VIG AL NUTR
   Monteiro C, 2010, WORLD NUTR, V1, P237
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mozetic RM, 2016, REAS REV ELETRONICA, V8
   Oliveira JM, 2015, CAD SAUDE PUBLICA, V31, P377, DOI 10.1590/0102-311X00209513
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102
   Saldan PC, 2015, REV NUTR, V28, P409, DOI 10.1590/1415-52732015000400007
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   White JM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12505
   WHO (World Health Organization), 2011, WHO ANTHR VERS 3 2 2
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 30
TC 5
Z9 5
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD JAN 11
PY 2019
VL 18
AR 4
DI 10.1186/s12937-019-0429-3
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HH2LR
UT WOS:000455550600002
PM 30634976
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zin, OA
   Soares, FVM
   de Abranches, AD
   da Costa, ACC
   Villela, LD
   Moreira, MEL
AF Zin, Olivia Araujo
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Carioca da Costa, Ana Carolina
   Villela, Leticia Duarte
   Lopes Moreira, Maria Elisabeth
TI Analysis of the differences between the prescribed and the administered
   diet to preterm infants using an electronic too
SO REVISTA PAULISTA DE PEDIATRIA
LA Portuguese
DT Article
DE Nutrition therapy; Premature newborn; Electronic health records
ID BIRTH-WEIGHT INFANTS; BODY-COMPOSITION; NUTRITION; GROWTH; CHILD;
   PROGRAM
AB Objective: To create an electronic instrument in order to analyze the adequacy of the preterm infants' nutritional therapy, checking the difference between the prescribed and the administered diet.
   Methods: A prospective and observational study on newborns with birthweight <= 1,500g and/or gestational age <= 32 weeks, without congenital malformations. The electronic instrument was developed based on Microsoft Excel 2010 spreadsheets and aimed at automatically calculating body weight gain, calories and macronutrients received daily by each patient from parenteral nutrition, intravenous hydration and enteral feedings. The weekly means of each nutrient were used to compare the prescribed and administered diets.
   Results: To evaluate the instrument, 60 newborns with a birth weight of 1,289 +/- 305 g and a gestational age of 30 +/- 2 weeks were included. Of them, 9.6% had restricted growth at birth and 55% at discharge. The median length of stay was 45 +/- 17 days. There were significant differences between prescribed and administered diet for all of the macronutrients and for total calories in the first three weeks. The lipid was the macronutrient with the greatest percentage error in the first week of life.
   Conclusions: The use of a computational routine was important to verify differences between the prescribed and the administered diet. This analysis is necessary to minimize calculation errors and to speed up health providers' decisions about the nutritional approach, which can contribute to patients' safety and to good nutritional practice. Very low birth weight infants are extremely vulnerable to nutritional deficiencies and any reduction in macronutrients they receive may be harmful to achieve satisfactory growth.
C1 [Zin, Olivia Araujo; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Carioca da Costa, Ana Carolina; Villela, Leticia Duarte; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernando Figueira, Rio De Janeiro, Brazil.
RP Soares, FVM (corresponding author), Fundacao Oswaldo Cruz, Inst Fernando Figueira, Rio De Janeiro, Brazil.
EM fevalente@gmail.com
RI de Abranches, Andrea Dunshee/ABA-8578-2020
OI Carioca da Costa, Ana Carolina/0000-0002-9456-3319; Dunshee de
   Abranches, Andrea/0000-0002-9323-3297; Zin, Olivia/0000-0002-7704-3450;
   /0000-0002-2034-0294
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   Assis Michelli Cristina Silva de, 2010, Rev. bras. ter. intensiva, V22, P346, DOI 10.1590/S0103-507X2010000400006
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Cade A, 1997, CLIN NUTR, V16, P19, DOI 10.1016/S0261-5614(97)80254-3
   Cazacu Andreea C., 2001, Pediatric Research, V49, p343A
   Cole TJ, 2014, ARCH DIS CHILD-FETAL, V99, pF34, DOI 10.1136/archdischild-2012-303536
   Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Gnigler M, 2014, PEDIATR NEONATOL, V55, P41, DOI 10.1016/j.pedneo.2013.05.010
   Johnson MJ, 2012, PEDIATRICS, V130, pE640, DOI 10.1542/peds.2011-3379
   Lapillonne A, 2013, J PEDIATR-US, V162, pS90, DOI 10.1016/j.jpeds.2012.11.058
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   PICART D, 1989, INTENS CARE MED, V15, P279, DOI 10.1007/BF00271068
   Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038
   Puangco MA, 1997, J AM DIET ASSOC, V97, P258, DOI 10.1016/S0002-8223(97)00067-9
   Ramel Sara E, 2014, Curr Pediatr Rep, V2, P248
   Roggero P, 2008, EARLY HUM DEV, V84, P555, DOI 10.1016/j.earlhumdev.2008.01.012
   Sjostrom ES, 2016, ARCH DIS CHILD-FETAL, V101, pF108, DOI 10.1136/archdischild-2014-306816
   Souza FIS, 2008, REV PAUL PEDIATR, V26, P278
   Symonds ME, 2013, ANN NUTR METAB, V62, P137, DOI 10.1159/000345598
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P22, DOI 10.1016/j.jped.2013.05.007
   Uauy R, 2014, WORLD REV NUTR DIET, V110, P4, DOI 10.1159/000358453
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SOC PEDIATRIA SAO PAULO
PI SAO PAULO SP
PA ALAMEDA SANTOS 211, 5O ANDAR, SAO PAULO SP, 01419-000, BRAZIL
SN 0103-0582
EI 1984-0462
J9 REV PAUL PEDIATR
JI Rev. Paul. Pediatr.
PY 2019
VL 37
IS 4
BP 472
EP 478
DI 10.1590/1984-0462/;2019;37;4;00008
PG 7
WC Pediatrics
SC Pediatrics
GA NR7VB
UT WOS:000571767300012
PM 31340244
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Sa, MRC
   Vieira, ACD
   Castro, BSM
   Agostini, O
   Smythe, T
   Kuper, H
   Moreira, MEL
   Moreira, MCN
AF Calheiros de Sa, Miriam Ribeiro
   Dias Vieira, Ana Carolina
   Madeira Castro, Barbara S.
   Agostini, Olivia
   Smythe, Tracey
   Kuper, Hannah
   Lopes Moreira, Maria Elisabeth
   Nunes Moreira, Martha Cristina
TI The need to act together in every way possible: inter-sector action in
   health and education for children living with the congenital Zika
   syndrome
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Child; Zika Virus; Disabled Persons; Intersectorial Collaboration
ID CHALLENGES; CARE
AB The experience with an intervention program conducted in an educational institution and targeted to families of children with congenital Zika syndrome, which includes multiple disabilities, revealed the challenges and strides with the entry of these families in the school system. This article aimed to explore the findings from a study conducted after the conclusion of an intervention program, using semi-open interviews with professional staff at the institution and the possible contributions towards establishing inter-sector relations aimed at school inclusion of children with disabilities. A change was seen, as a result of the program, in the relationship between the families and the professionals at the educational institution, whereby the families had room to voice their fears and discuss the school's role in the lives of their children with disabilities. The professionals thus came to see the families taking a more active stance. This experience can favor other services and municipalities that seek school inclusion for children and adolescents with disabilities, as well as their social inclusion and that of their families.
C1 [Calheiros de Sa, Miriam Ribeiro; Dias Vieira, Ana Carolina; Madeira Castro, Barbara S.; Agostini, Olivia; Lopes Moreira, Maria Elisabeth; Nunes Moreira, Martha Cristina] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Smythe, Tracey; Kuper, Hannah] London Sch Hyg & Trop Med, London, England.
RP de Sa, MRC (corresponding author), Rua Marechal Raul Albuquerque 273,Apto 705, BR-24370025 Niteroi, RJ, Brazil.
EM calheirosa@uol.com.br
RI Moreira, Martha Cristina Nunes/AAQ-5567-2020; Smythe, Tracey/N-7699-2017
OI moreira, martha cristina nunes/0000-0002-7199-3797;
   /0000-0002-2034-0294; Sa, Miriam/0000-0002-3972-0377; Smythe,
   Tracey/0000-0003-3408-7362
CR Alves RLC, 2018, REV ANTHR, V29, P6
   de Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-497420180002000014
   Baglieri S, 2011, REM SPEC EDUC, V32, P267, DOI 10.1177/0741932510362200
   BORKMAN T, 1976, SOC SERV REV, V50, P445, DOI 10.1086/643401
   Bourdieu P., RAZOES PRATICAS TEOR
   BOURDIEU Pierre, 1994, P BOURDIEU, P46
   Camargos Ana Cristina Resende, 2012, Fisioter. mov., V25, P83, DOI 10.1590/S0103-51502012000100009
   Diniz D., 2017, CORREIO BRAZILIENSE
   do Carmo ME, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00101417, 10.1590/0102-311x00101417]
   Hirata Helena, 2007, Cad. Pesqui., V37, P595, DOI 10.1590/S0100-15742007000300005
   Hirata HS, 2012, REV POLIT PUBLICAS U, V16, P283
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR GE
   JURDI A. P. S., 2017, REV TER OCUP U SAO P, V28, P281
   KAFROUNI R, 2001, REV INTERACAO CURITI, V5, P31
   London School of Hygiene & Tropical Medicine; International Center for Evidence in Disability, 2014, GETT KNOW CER PALS
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   Mattos RA, 2001, SENTIDOS INTEGRALIDA, P39
   MAUSS Marcel, 2003, SOCIOLOGIA ANTROPOLO
   Moreira Martha Cristina Nunes, 2005, Ciênc. saúde coletiva, V10, P780, DOI 10.1590/S1413-81232005000300034
   Moreira MCN, 2018, INTERFACE-BOTUCATU, V22, P697, DOI 10.1590/1807-57622017.0930
   Moreira MCN, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00189516, 10.1590/0102-311x00189516]
   PAULA Kelly Andressa, 2004, INTERFACE-BOTUCATU, V8, P331
   Ryan JM, 2018, DEV MED CHILD NEUROL, V60, P753, DOI 10.1111/dmcn.13737
   Sa MRC, 2015, CADERNOS EDUCACAO SA, V2, P67
   Santos B., 2007, RENOVAR TEORIA CRITI
   SANTOS Boaventura de Sousas, 2010, EPISTEMOLOGIAS
   Scott RP, 2018, INTERFACE-BOTUCATU, V22, P673, DOI 10.1590/1807-57622017.0425
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EP, V49
   Silva KL, 2010, REV BRAS ENFERM, V63, P762, DOI 10.1590/S0034-71672010000500011
   Souza JM, 2018, REV BRAS PROMOC SAUD, V31, P1
   Valle JW, 2014, RESSIGNIFICANDO DEFI
NR 31
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2019
VL 35
IS 12
AR e00233718
DI 10.1590/0102-311X00233718
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JT4NF
UT WOS:000500967300001
PM 31800795
OA DOAJ Gold, Green Accepted
DA 2020-12-17
ER

PT J
AU dos Santos, SFM
   Soares, FVM
   de Abranches, AD
   da Costa, ACC
   Gomes, SD
   Fonseca, VD
   Moreira, MEL
AF Morais dos Santos, Samira Fernandes
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Carioca da Costa, Ana Carolina
   Dos Santos Gomes-Junior, Saint Clair
   Fonseca, Vania de Matos
   Lopes Moreira, Maria Elisabeth
TI Nutritional profile of newborns with microcephaly and factors associated
   with worse outcomes
SO CLINICS
LA English
DT Article
DE Zika Virus; Microcephaly; Nutritional Status; Newborn
ID ZIKA VIRUS-INFECTION; CHILDREN; INFANTS; BRAZIL
AB OBJECTIVE: To describe the nutritional profile of newborns with microcephaly and factors associated with worse outcomes during the first 14 days of life.
   METHODS: This investigation is a longitudinal, descriptive study carried out in 21 full-term neonates exposed vertically to the Zika virus and hospitalized in a neonatal intensive care unit from February to September 2016. Patients receiving parenteral nutrition were excluded. Data analysis was performed using a generalized estimating equation model and Student's t-test to evaluate the association between worsening weight-for-age z-scores and independent clinical, sociodemographic and nutritional variables during hospitalization, with p < 0.05 indicating significance.
   RESULTS: During hospitalization, there was a decrease in the mean values of the weight-for-age z-scores. The factors associated with worse nutritional outcomes were symptomatic exposure to the Zika virus, low maternal schooling, absence of maternal income and consumption of infant formula (p <0.05). Calcification and severe microcephaly were also associated with poor nutritional outcomes. Energy and macronutrient consumption remained below the recommendations and had an upward trend during hospitalization.
   CONCLUSION: The presence of cerebral calcification, the severity of microcephaly and symptomatic maternal exposure to Zika virus affected the nutritional status of newborns. In terms of nutritional factors, human milk intake had a positive impact, reducing weight loss in the first days of life. Other known factors, such as income and maternal schooling, were still associated with a poor nutritional status.
C1 [Morais dos Santos, Samira Fernandes; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Carioca da Costa, Ana Carolina; Dos Santos Gomes-Junior, Saint Clair; Fonseca, Vania de Matos; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz IFF Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz IFF Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; de Abranches, Andrea
   Dunshee/ABA-8578-2020; Gomes Junior, Saint Clair/V-5393-2018
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Gomes Junior, Saint
   Clair/0000-0002-1554-943X
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   441098/2016-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [FAPERJ -E_18/2015TXB]; Wellcome
   TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's Department for
   International Development; European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN grant [734584]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   441098/2016-9. Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   - FAPERJ -E_18/2015TXB. Wellcome Trust (205377/Z/16/Z) and the United
   Kingdom's Department for International Development. European Union's
   Horizon 2020 research and innovation programme under Zika-PLAN grant
   agreement no. 734584.
CR Caram ALA, 2010, REV NUTR, V23, P211, DOI 10.1590/S1415-52732010000200004
   Bell KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-179
   Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7
   Botelho AC, 2016, REV BRAS SAUDE MA S1, V16, pS45
   Brasil. Ministerio da Saude, 2012, SAUDE CRIANCA CRESCI
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Davanzo R, 2013, J HUM LACT, V29, P45, DOI 10.1177/0890334412444005
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Institute of Medicine, 2002, DIET REF INT EN CARB
   Kehinde O, 2013, NIGER J PAEDIAT, V40, P299
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Lopes Patrícia Ayrosa C., 2013, Rev. paul. pediatr., V31, P344, DOI 10.1590/S0103-05822013000300011
   Ministerio da Saude (BR), 2015, SAUD CRIANC AL MAT A
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude Brazil, 2009, ALEITAMENTO MATERNO, V123
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   National Institute of Neurological Disorders and Stroke, HYDR FACT SHEET
   Oliveira FLC, 2013, MANUAL TERAPIA NUTR
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares FVM, 2017, PED AC SOC M SAN FRA
   Souza Alex Sandro Rolland, 2016, Rev. Bras. Saude Mater. Infant., V16, P467, DOI 10.1590/1806-93042016000400007
   Vieira AA, 2011, EARLY HUM DEV, V87, P577, DOI 10.1016/j.earlhumdev.2011.04.016
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization ( WHO), 2011, CHILD GROWTH STAND W
   World Health Organization (WHO), 2016, WHO CHILD GROWTH STA
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 36
TC 2
Z9 2
U1 0
U2 1
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2019
VL 74
AR e798
DI 10.6061/clinics/2019/e798
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA JH5QK
UT WOS:000492823100001
PM 31644665
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Wilder-Smith, A
   Preet, R
   Brickley, EB
   Ximenes, RAD
   Miranda, DD
   Martelli, CMT
   de Araujo, TVB
   Montarroyos, UR
   Moreira, ME
   Turchi, MD
   Solomon, T
   Jacobs, BC
   Villamizar, CP
   Osorio, L
   de Filipps, AMB
   Neyts, J
   Kaptein, S
   Huits, R
   Arien, KK
   Willison, HJ
   Edgar, JM
   Barnett, SC
   Peeling, R
   Boeras, D
   Guzman, MG
   de Silva, AM
   Falconar, AK
   Romero-Vivas, C
   Gaunt, MW
   Sette, A
   Weiskopf, D
   Lambrechts, L
   Dolk, H
   Morris, JK
   Orioli, IM
   O'Reilly, KM
   Yakob, L
   Rocklov, J
   Soares, C
   Ferreira, MLB
   Franca, RFD
   Precioso, AR
   Logan, J
   Lang, T
   Jamieson, N
   Massad, E
AF Wilder-Smith, Annelies
   Preet, Raman
   Brickley, Elizabeth B.
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Turchi Martelli, Celina Maria
   Barreto de Araujo, Thalia Velho
   Montarroyos, Ulisses Ramos
   Moreira, Maria Elisabeth
   Turchi, Marilia Dalva
   Solomon, Tom
   Jacobs, Bart C.
   Pardo Villamizar, Carlos
   Osorio, Lyda
   de Filipps, Ana Maria Bispo
   Neyts, Johan
   Kaptein, Suzanne
   Huits, Ralph
   Arien, Kevin K.
   Willison, Hugh J.
   Edgar, Julia M.
   Barnett, Susan C.
   Peeling, Rosanna
   Boeras, Debi
   Guzman, Maria G.
   de Silva, Aravinda M.
   Falconar, Andrew K.
   Romero-Vivas, Claudia
   Gaunt, Michael W.
   Sette, Alessandro
   Weiskopf, Daniela
   Lambrechts, Louis
   Dolk, Helen
   Morris, Joan K.
   Orioli, Ieda M.
   O'Reilly, Kathleen M.
   Yakob, Laith
   Rocklov, Joacim
   Soares, Cristiane
   Ferreira, Maria Lucia Brito
   Franca, Rafael Freitas de Oliveira
   Precioso, Alexander R.
   Logan, James
   Lang, Trudie
   Jamieson, Nina
   Massad, Eduardo
TI ZikaPLAN: addressing the knowledge gaps and working towards a research
   preparedness network in the Americas
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika; congenital Zika syndrome; birth defect; epidemic preparedness;
   research capacity building; European Commission; microcephaly;
   Guillain-Barr? syndrome; encephalitis; sustainability
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; TRAVELERS; BRAZIL;
   EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; DIAGNOSIS; OUTBREAK; HISTORY
AB Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network.
C1 [Wilder-Smith, Annelies; Preet, Raman; Rocklov, Joacim] Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
   [Brickley, Elizabeth B.; Peeling, Rosanna; Boeras, Debi; Falconar, Andrew K.; Gaunt, Michael W.; O'Reilly, Kathleen M.; Yakob, Laith; Logan, James] London Sch Hyg & Trop Med, London, England.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Turchi, Marilia Dalva] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Pardo Villamizar, Carlos] Johns Hopkins Univ, Baltimore, MD USA.
   [Pardo Villamizar, Carlos; Osorio, Lyda] Univ Valle, Cali, Colombia.
   [de Filipps, Ana Maria Bispo] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Neyts, Johan; Kaptein, Suzanne] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
   [Huits, Ralph; Arien, Kevin K.] Inst Trop Med, Antwerp, Belgium.
   [Willison, Hugh J.; Edgar, Julia M.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Guzman, Maria G.] Inst Med Trop, Pedro Kouri, Cuba.
   [de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Falconar, Andrew K.; Romero-Vivas, Claudia] Fdn Univ Norte, Dept Med, Barranquilla, Colombia.
   [Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Lambrechts, Louis] Inst Pasteur, CNRS, Insect Virus Interact Unit, UMR2000, Paris, France.
   [Dolk, Helen] Ulster Univ, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland.
   [Morris, Joan K.] St Georges Univ London, Populat Hlth Res Inst, London, England.
   [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Inst Biol, Assoc Tecn Cient Estudo Colaborat Latino Amer Mal, Dept Genet, Rio De Janeiro, Brazil.
   [Soares, Cristiane] Hosp Fed Serv Estado, Rio De Janeiro, Brazil.
   [Ferreira, Maria Lucia Brito] Hosp Restauracao, Recife, PE, Brazil.
   [Franca, Rafael Freitas de Oliveira] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Precioso, Alexander R.] Inst Butantan, Sao Paulo, Brazil.
   [Precioso, Alexander R.] Univ Sao Paulo, Sch Med, Pediat Dept, Sao Paulo, Brazil.
   [Lang, Trudie; Jamieson, Nina] Univ Oxford, Global Hlth Network Masters & Scholars, Oxford, England.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
EM anneliesws@gmail.com
RI Precioso, Alexander Roberto/A-9712-2013; Montarroyos,
   Ulisses/AAJ-7527-2020; Kaptein, Suzanne JF/O-4714-2019; Moreira, Maria
   Elisabeth Lopes/AAA-3775-2020; O'Reilly, Kathleen/H-9170-2019; Huits,
   Ralph/I-8361-2019; Lambrechts, Louis/ABF-2520-2020; Brickley,
   Elizabeth/U-3625-2017; NEYTS, Johan/U-8267-2017
OI Precioso, Alexander Roberto/0000-0001-8657-9292; Kaptein, Suzanne
   JF/0000-0002-7935-0219; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; O'Reilly, Kathleen/0000-0002-4892-8022;
   Huits, Ralph/0000-0001-8803-9468; Lambrechts, Louis/0000-0001-5958-2138;
   Solomon, Tom/0000-0001-7266-6547; Brickley,
   Elizabeth/0000-0003-0280-2288; Rocklov, Joacim/0000-0003-4030-0449;
   Wilder-Smith, Annelies/0000-0003-0362-5375; Preet, Raman
   Kaur/0000-0002-4371-5941; NEYTS, Johan/0000-0002-0033-7514
FU European UnionEuropean Union (EU) [734584]; National Institute for
   Health Research (NIHR), Health Protection Research Unit in Emerging and
   Zoonotic Infections [IS-HPU-1112-10117]; NIHR Global Health Research
   Group on Brain Infections [17/63/110]; Wellcome Trust UKWellcome Trust;
   Department for International Development UK; Medical Research Council
   UKMedical Research Council UK (MRC); CNPqNational Council for Scientific
   and Technological Development (CNPq); Secretaria de Vigilancia de Saude
   (SVS); Fundacao do Amparo a Ciencia e Tecnologia (FACEPE)
FX This project, ZikaPLAN is funded by the European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584. Some
   authors have received additional research funding. For example, TS is
   supported by the National Institute for Health Research (NIHR), Health
   Protection Research Unit in Emerging and Zoonotic Infections (Grant No.
   IS-HPU-1112-10117), and NIHR Global Health Research Group on Brain
   Infections (No. 17/63/110). MERG as a group has received funding from
   Wellcome Trust UK, Department for International Development UK, Medical
   Research Council UK, the Brazilian funding through CNPq, Secretaria de
   Vigilancia de Saude (SVS), and Fundacao do Amparo a Ciencia e Tecnologia
   (FACEPE).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Albuquerque MSV, 2019, HLTH POLICY PLAN
   Angelo KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay074
   Awadh A, 2017, PLOS CURR, V9
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beran D, 2017, LANCET GLOB HEALTH, V5, pE567, DOI 10.1016/S2214-109X(17)30180-8
   Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004
   Boggild AK, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay117
   Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay095
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tax097
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fischer C, 2019, LANCET INFECT DIS, V19, P240, DOI 10.1016/S1473-3099(19)30049-0
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097
   Hamer DH, 2019, J TRAVEL MED, V26
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huits R, 2019, INT J INFECT DIS, V78, P39, DOI 10.1016/j.ijid.2018.10.010
   Huits R, 2019, TRAVEL MED INFECT DI, V27, P107, DOI 10.1016/j.tmaid.2018.08.007
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Massad E, 2017, EPIDEMIOL INFECT, P1
   Massad E, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000712, 10.1017/s0950268819000712]
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Michal Stevens A, 2017, J TRAVEL MED, V24
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   dos Santos SFM, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0429-3
   Msall ME, 2010, ARCH PEDIAT ADOL MED, V164, P391, DOI 10.1001/archpediatrics.2010.25
   Neumayr A, 2017, EURO SURVEILL, V22
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Salzer HJF, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay055
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Shanks GD, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz003
   Sheldrick RC, 2013, ACAD PEDIATR, V13, P577, DOI 10.1016/j.acap.2013.07.001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Watts AG, 2018, J TRAVEL MED, V25
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026092
   Wilder-Smith A, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay157
   Wilder-Smith A, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1549930
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay139
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Xu X, 2016, PLOS CURR, V8
   Yakob L, 2017, PLOS CURR, V9
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 96
TC 4
Z9 4
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD JAN 1
PY 2019
VL 12
IS 1
AR 1666566
DI 10.1080/16549716.2019.1666566
PG 16
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JF7EZ
UT WOS:000491550400001
PM 31640505
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Einspieler, C
   Utsch, F
   Brasil, P
   Aizawa, CYP
   Peyton, C
   Hasue, RH
   Genovesi, FF
   Damasceno, L
   Moreira, ME
   Adachi, K
   Marschik, PB
   Nielsen-Saines, K
   Bartl-Pokorny, KD
   Krieber-Tomantschger, I
   Krieber-Tomantschger, M
   Langmann, L
   Peharz, R
   Pokorny, FB
   Zhang, DJ
   Ramos, C
   Silva, D
   Reis, A
   Alves, E
   Passos, SA
   Velloso, R
   Dobaja, F
   Pansy, J
   Scheuchenegger, A
AF Einspieler, Christa
   Utsch, Fabiana
   Brasil, Patricia
   Aizawa, Carolina Y. Panvequio
   Peyton, Colleen
   Hasue, Renata Hydee
   Genovesi, Fernanda Francoso
   Damasceno, Luana
   Moreira, Maria Elisabeth
   Adachi, Kristina
   Marschik, Peter B.
   Nielsen-Saines, Karin
   Bartl-Pokorny, Katrin D.
   Krieber-Tomantschger, Iris
   Krieber-Tomantschger, Magdalena
   Langmann, Laura
   Peharz, Robert
   Pokorny, Florian B.
   Zhang, Dajie
   Ramos, Cinthia
   Silva, Diniz
   Reis, Alberto
   Alves, Elaine
   Passos, Sandra Alvarenga
   Velloso Filho, Roberto
   Dobaja, Felicitas
   Pansy, Jasmin
   Scheuchenegger, Anna
CA GM Zika Working Grp
TI Association of Infants Exposed to Prenatal Zika Virus Infection With
   Their Clinical, Neurologic, and Developmental Status Evaluated via the
   General Movement Assessment Tool
SO JAMA NETWORK OPEN
LA English
DT Article
ID CEREBRAL-PALSY; BIRTH
AB IMPORTANCE There is an urgent need to assess neurodevelopment in Zika virus (ZIKV)-exposed infants
   OBJECTIVES To perform general movement assessment (GMA) at 9 to 20 weeks' postterm age and to evaluate whether the findings are associated with neurodevelopmental outcomes at age 12 months in infants prenatally exposed to acute maternal illness with rash in Brazil during the ZIKV outbreak and in age-matched controls.
   DESIGN, SETTING, AND PARTICIPANTS In this cohort study, infants prenatally exposed to acute maternal illness with rash were recruited at medical institutions in Rio de Janeiro and Belo Horizonte, Brazil, from February 1, 2016, to April 30, 2017, while infants without any exposure to maternal illness originated from the Graz University Audiovisual Research Database for the Interdisciplinary Analysis of Neurodevelopment. Participants were 444 infants, including 76 infants without congenital microcephaly, 35 infants with microcephaly, and 333 neurotypical children matched for sex, gestational age at birth, and age at GMA.
   MAIN OUTCOMES AND MEASURES General movement assessment performed at 9 to 20 weeks' postterm age, with negative predictive value, positive predictive value, sensitivity, and specificity generated, as well as clinical, neurologic, and developmental status (Bayley Scales of Infant and Toddler Development, Third Edition [Bayley-III] scores) at age 12 months. Motor Optimality Scores were generated based on the overall quality of the motor repertoire. Adverse outcomes were defined as a Bayley-III score less than 2 SD in at least 1 domain, a score less than 1 SD in at least 2 domains, and/or atypical neurologic findings.
   RESULTS A total of 444 infants were enrolled, including 111 children prenatally exposed to a maternal illness with rash and 333 children without any prenatal exposure to maternal illness (57.7% male and mean [SD] age, 14 [2] weeks for both groups); 82.1%(46 of 56) of ZIKV-exposed infants without congenital microcephaly were healthy at age 12 months. Forty-four of 46 infants were correctly identified by GMA at 3 months, with a negative predictive value of 94%(95% CI, 85%-97%). Seven of 10 ZIKV-exposed children without microcephaly with adverse neurodevelopmental outcomes were identified by GMA. The GMA positive predictive value was 78% (95% CI, 46%-94%), sensitivity was 70%(95% CI, 35%-93%), specificity was 96%(95% CI, 85%-99%), and accuracy was 91%(95% CI, 80%-97%). Children with microcephaly had bilateral spastic cerebral palsy; none had normal movements. The Motor Optimality Score differentiated outcomes: the median Motor Optimality Score was 23 (interquartile range [IQR], 21-26) in children with normal development, 12 (IQR, 8-19) in children with adverse outcomes, and 5 (IQR, 5-6) in children with microcephaly, a significant difference (P=.001).
   CONCLUSIONS AND RELEVANCE This study suggests that although a large proportion of ZIKV-exposed infants without microcephaly develop normally, many do not. The GMA should be incorporated into routine infant assessments to enable early entry into targeted treatment programs.
C1 [Einspieler, Christa; Marschik, Peter B.; Bartl-Pokorny, Katrin D.; Krieber-Tomantschger, Iris; Krieber-Tomantschger, Magdalena; Langmann, Laura; Peharz, Robert; Pokorny, Florian B.; Zhang, Dajie] Med Univ Graz, Interdisciplinary Dev Neurosci iDN, Graz, Austria.
   [Utsch, Fabiana; Ramos, Cinthia; Silva, Diniz; Reis, Alberto; Alves, Elaine; Passos, Sandra Alvarenga; Velloso Filho, Roberto] Rede SARAH Hosp Reabil, Reabil Infantil, Belo Horizonte, MG, Brazil.
   [Brasil, Patricia; Damasceno, Luana] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas INI, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Aizawa, Carolina Y. Panvequio; Hasue, Renata Hydee; Genovesi, Fernanda Francoso] Univ Sao Paulo, Fac Med, Dept Phys Therapy Commun Sci & Disorders & Occupa, Sao Paulo, Brazil.
   [Peyton, Colleen] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Peyton, Colleen] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.
   [Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Dept Pediat, Rio De Janeiro, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
   [Marschik, Peter B.] Univ Med Ctr Gottingen, Dept Child & Adolescent Psychiat & Psychotherapy, Interdisciplinary Dev Neurosci iDN, Gottingen, Germany.
   [Marschik, Peter B.] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders KIND, Stockholm, Sweden.
   [Dobaja, Felicitas; Pansy, Jasmin; Scheuchenegger, Anna] Med Univ Graz, Dept Pediat, Graz, Austria.
RP Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Infect,Marion Davies Childrens Clin, Room 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM knielsen@mednet.ucla.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Hasue, Renata
   Hydee/B-2328-2013; Bartl-Pokorny, Katrin/C-5396-2014; Marschik, Peter
   B/F-8195-2011
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Marschik, Peter
   B/0000-0001-8932-0980
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI28697, AI1259534-01];
   National Eye Institute of the NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [AI129847-01]; Thrasher Foundation; Bill and Melinda
   Gates Foundation Grand Challenges ExplorationsBill & Melinda Gates
   Foundation [OPP 1128871]; NATIONAL EYE INSTITUTEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI140718, R21AI129534, R21AI129534, R01AI140718] Funding Source: NIH
   RePORTER
FX Drs Brasil, Moreira, and Nielsen-Saines were supported by grants AI28697
   and AI1259534-01 from the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (NIH), by grant
   AI129847-01 from the National Eye Institute of the NIH, and by the
   Thrasher Foundation. Dr Marschik was supported by the Bill and Melinda
   Gates Foundation Grand Challenges Explorations (grant OPP 1128871).
CR Adde L, 2016, EUR J PAEDIATR NEURO, V20, P918, DOI 10.1016/j.ejpn.2016.07.019
   Bayley N, 2006, BAYLEY SCALES INFANT
   Bosanquet M, 2013, DEV MED CHILD NEUROL, V55, P418, DOI 10.1111/dmcn.12140
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burger M, 2009, EUR J PAEDIATR NEURO, V13, P408, DOI 10.1016/j.ejpn.2008.09.004
   Cardoso Jr TF, ARCH DIS CHILD
   Crowle C, 2018, EARLY HUM DEV, V118, P42, DOI 10.1016/j.earlhumdev.2018.02.001
   Einspieler C, 2004, SERIES CLIN DEV MED
   Einspieler C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00406
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palchik AB, 2013, EARLY HUM DEV, V89, P229, DOI 10.1016/j.earlhumdev.2013.02.004
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricci E, 2018, PHYS OCCUP THER PEDI, V38, P269, DOI 10.1080/01942638.2017.1395380
   Soares-Marangoni DA, DEV NEUROREHABIL
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wu SS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00227
   2017, ARCH PATHOL LAB MED, V141, P26, DOI DOI 10.5858/ARPA.2016-0382-RA
   2018, CURR OPIN PEDIATR, V30, P105, DOI DOI 10.1097/MOP.0000000000000582
   2008, EMERG INFECT DIS, V14, P1232, DOI DOI 10.3201/EID1408.080287
   2011, DEV MED CHILD NEUROL, V53, P896, DOI DOI 10.1111/J.1469-8749.2011.04017.X
   2016, LANCET, V388, P891, DOI DOI 10.1016/S0140-6736(16)30902-3
   2008, DEV MED CHILD NEUROL, V50, P744, DOI DOI 10.1111/J.1469-8749.2008.03089.X
   2016, J PAEDIATR CHILD H, V52, P54, DOI DOI 10.1111/JPC.12995
   2018, MMWR-MORBID MORTAL W, V67, P858, DOI DOI 10.15585/MMWR.MM6731E1
   2016, EARLY HUM DEV, V100, P27, DOI DOI 10.1016/J.EARLHUMDEV.2016.03.010
   2015, EARLY HUM DEV, V91, P479, DOI DOI 10.1016/J.EARLHUMDEV.2015.05.007
NR 30
TC 21
Z9 21
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD JAN
PY 2019
VL 2
IS 1
AR e187235
DI 10.1001/jamanetworkopen.2018.7235
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA HU6WO
UT WOS:000465422700020
PM 30657537
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-17
ER

PT J
AU Pereira, JP
   Nielsen-Saines, K
   Sperling, J
   Maykin, MM
   Damasceno, L
   Cardozo, RF
   Valle, HA
   Dutra, BRT
   Gama, HD
   Adachi, K
   Zin, AA
   Tsui, I
   Vasconcelos, Z
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Pereira Jr, Jose Paulo
   Nielsen-Saines, Kann
   Sperling, Jeffrey
   Maykin, Melanie M.
   Damasceno, Luana
   Cardozo, Renan Fonseca
   Valle, Helena Abreu
   Torres Dutra, Beatriz Ribeiro
   Gama, Helder Dona
   Adachi, Kristina
   Zin, Andrea A.
   Tsui, Irena
   Vasconcelos, Zilton
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Association of Prenatal Ultrasonographic Findings With Adverse Neonatal
   Outcomes Among Pregnant Women With Zika Virus Infection in Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID INTERIM GUIDANCE; BIRTH-DEFECTS; INFANTS; DIAGNOSIS; REGISTRY; FETUSES;
   WEIGHT; UPDATE; HEAD
AB IMPORTANCE Congenital Zika virus infection causes a spectrum of adverse birth outcomes, including severe birth defects of the central nervous system. The association of prenatal ultrasonographic findings with adverse neonatal outcomes, beyond structural anomalies such as microcephaly, has not been described to date.
   OBJECTIVE To determine whether prenatal ultrasonographic examination results are associated with abnormal neonatal outcomes in Zika virus-affected pregnancies.
   DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study conducted at a single regional referral center in Rio de Janeiro, Brazil, from September 1, 2015, to May 31, 2016, among 92 pregnant women diagnosed during pregnancy with Zika virus infection by reverse-transcription polymerase chain reaction, who underwent subsequent prenatal ultrasonographic and neonatal evaluation.
   EXPOSURES Prenatal ultrasonography.
   MAIN OUTCOMES AND MEASURES The primary outcome measure was composite adverse neonatal outcome (perinatal death, abnormal finding on neonatal examination, or abnormal finding on postnatal neuroimaging). Secondary outcomes include association of specific findings with neonatal outcomes.
   RESULTS Of 92 mother-neonate dyads (mean [SD] maternal age, 29.4 [6.3] years), 55 (60%) had normal results and 37 (40%) had abnormal results on prenatal ultrasonographic examinations. The median gestational age at delivery was 38.6 weeks (interquartile range, 37.9-39.3). Of the 45 neonates with composite adverse outcome, 23 (51%) had normal results on prenatal ultrasonography. Eleven pregnant women (12%) had a Zika virus-associated finding that was associated with an abnormal result on neonatal examination (adjusted odds ratio [aOR], 11.6; 95% CI, 1.8-72.8), abnormal result on postnatal neuroimaging (aOR, 6.7; 95% CI, 1.1-38.9), and composite adverse neonatal outcome (aOR, 27.2; 95% CI, 2.5-296.6). Abnormal results on middle cerebral artery Doppler ultrasonography were associated with neonatal examination abnormalities (aOR, 12.8; 95% CI, 2.6-63.2), postnatal neuroimaging abnormalities (aOR, 8.8; 95% CI, 1.7-45.9), and composite adverse neonatal outcome (aOR, 20.5; 95% CI, 3.2-132.6). There were 2 perinatal deaths. Abnormal findings on prenatal ultrasonography had a sensitivity of 48.9% (95% CI, 33.7%-64.2%) and a specificity of 68.1% (95% CI, 52.9%-80.1%) for association with composite adverse neonatal outcomes. For a Zika virus-associated abnormal result on prenatal ultrasonography, the sensitivity was lower (22.2%; 95% CI, 11.2%-37.1%) but the specificity was higher (97.9%; 95% CI, 88.7%-99.9%).
   CONCLUSIONS AND RELEVANCE Abnormal results on prenatal ultrasonography were associated with adverse outcomes in congenital Zika infection. The absence of abnormal findings on prenatal ultrasonography was not associated with a normal neonatal outcome. Comprehensive evaluation is recommended for all neonates with prenatal Zika virus exposure.
C1 [Pereira Jr, Jose Paulo; Cardozo, Renan Fonseca; Valle, Helena Abreu; Torres Dutra, Beatriz Ribeiro; Gama, Helder Dona; Zin, Andrea A.; Vasconcelos, Zilton; Moreira, Maria E.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Kann; Adachi, Kristina] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Sperling, Jeffrey; Maykin, Melanie M.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA 94143 USA.
   [Damasceno, Luana; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,16HSE Box 0556, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224
FU Reproductive Scientist Development Program of the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development of the National
   Institutes of Health [K12 HD000849]; Departamento de Ciencia e
   Tecnologia do Ministerio da Saude do Brasil [441098/2016-9]; Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015TXB]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI28697, R21AI29534-01]; National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R21EY028318]; Wellcome TrustWellcome Trust [205377/Z/16/Z]; European
   Union's Horizon 2020 Research and Innovation Programme [734584];
   Burroughs Wellcome Fund for the Reproductive Scientist Development
   Program; Queenan Fellowship from the Foundation for the Society of
   Maternal-Fetal Medicine; UK Department for International Development;
   University of California, San Francisco National Center of Excellence in
   Women's HealthUniversity of California System; EUNICE KENNEDY SHRIVER
   NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [K12HD000849, K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318,
   R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, R21AI129534,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, R21AI129534, P30AI028697, P30AI028697] Funding Source: NIH
   RePORTER
FX This work was supported by grants K12 HD000849 from the Reproductive
   Scientist Development Program of the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development of the National
   Institutes of Health (Dr Gaw), 441098/2016-9 from the Departamento de
   Ciencia e Tecnologia do Ministerio da Saude do Brasil (Dr Moreira),
   E_18/2015TXB from Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (Dr Moreira), R21AI28697 and R21AI29534-01 from the National
   Institute of Allergy and Infectious Diseases (Dr Nielsen-Saines),
   R21EY028318 from the National Eye Institute (Drs Nielsen-Saines and
   Tsui), 205377/Z/16/Z from Wellcome Trust (Dr Moreira), and 734584 from
   European Union's Horizon 2020 Research and Innovation Programme (Dr
   Moreira); the Burroughs Wellcome Fund for the Reproductive Scientist
   Development Program (Dr Gaw), the Queenan Fellowship from the Foundation
   for the Society of Maternal-Fetal Medicine (Dr Gaw), UK Department for
   International Development, and the University of California, San
   Francisco National Center of Excellence in Women's Health.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Azam AZ, 2001, OBSTET GYNECOL, V97, P443, DOI 10.1016/S0029-7844(00)01140-6
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Hobbins JC, 2018, OBSTET GYNECOL, V131, P661, DOI 10.1097/AOG.0000000000002538
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 27
TC 5
Z9 5
U1 1
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD DEC
PY 2018
VL 1
IS 8
AR e186529
DI 10.1001/jamanetworkopen.2018.6529
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HI2SJ
UT WOS:000456295400050
PM 30646333
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, JD
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Adachi, K
   Pone, MVD
   Pone, SM
   Molleri, N
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Vasconcelos, Z
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia D.
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Molleri, Natalia
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Vasconcelos, Zilton
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Visual function in infants with antenatal Zika virus exposure
SO JOURNAL OF AAPOS
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; MACULAR ATROPHY; BIRTH; IMPAIRMENT;
   PREGNANCY; CHILDREN; IMPACT
AB PURPOSE To report the findings of a cross-sectional study of visual function in infants with confirmed or suspected antenatal Zika virus (ZIKV) infection seen at a single referral center in Rio de Janeiro.
   METHODS Infants were examined following the ZIKV outbreak period at Instituto Fernandes Figueira/FIOCRUZ. Visual function was considered abnormal if an infant could not fix and follow a standardized high-contrast target (10 cm) by 3-6 months of age. Visual function and associations with structural eye abnormalities, central nervous system (CNS) abnormalities, microcephaly, and nystagmus were assessed. Sensitivity and specificity of screening criteria for structural eye abnormalities was assessed.
   RESULTS A total of 173 infants met inclusion criteria. Abnormal visual function was found in 52 infants (30.0%) and was significantly associated with eye abnormalities (40/52; OR = 44.2; 95% CI, 16.6-117.6), CNS abnormalities (50/52; OR = 64.0; 95% CI, 14.7-277.6), microcephaly (44/52; OR = 31.5; 95% CI, 12.7-77.8), and nystagmus (26/52; OR = 120.0; 95% CI, 15.6-924.5). Using microcephaly as screening criteria for the detection of eye abnormalities provided a sensitivity of 88.9% (95% CI, 76.0-96.3) and specificity of 82.8% (95% CI, 75.1-88.9). Using both abnormal visual function and microcephaly increased sensitivity to 100% (95% CI, 92.1-100.0) and decreased specificity to 80.5% (95% CI, 72.5-86.9).
   CONCLUSIONS Infants with suspected antenatal ZIKV infection and reduced visual function should be referred to an ophthalmologist. Visual function assessments are helpful in screening for antenatal ZIKV exposure in resource-limited settings and can identify infants who may benefit from visual habilitation.
C1 [Zin, Andrea A.; Rossetto, Julia D.; Neves, Luiza M.; Haefeli, Lorena; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Molleri, Natalia; Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Tsui, Irena; Adachi, Kristina; Arumugaswami, Vaithilingaraja; Nielsen-Saines, Karin] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Pesquisa Clin, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM andreazin@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Vasconcelos,
   Zilton/AAD-5784-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-01, R01AI1121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); Queenan Fellowship in Global Health from the Foundation
   for the Society of Maternal Fetal Medicine; UCSF National Center of
   Excellence in Women's Health; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534, R01AI140718,
   R01AI140718] Funding Source: NIH RePORTER
FX Brazilian National Council for Scientific and Technological Development
   (441098/2016-9), National Eye Institute [R21EY028318-01 and
   R01AI1121207], and National Institute of Allergy and Infectious Diseases
   (R21AI129534-02). Dr. Tsui was supported in part by an unrestricted
   Research to Prevent Blindness grant given to the Stein Eye Institute.
   Dr. Gaw was supported in part by the Queenan Fellowship in Global Health
   from the Foundation for the Society of Maternal Fetal Medicine, and the
   UCSF National Center of Excellence in Women's Health. Funding sources
   had no involvement in design, data collection/interpretation, or
   manuscript preparation.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Diretrizes de Atencao a Sande Ocular na Infancia, 2013, DIRETRIZES ATENCAO S
   Donahue SP, 2016, PEDIATRICS, V137
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Freitas BP, 2016, JAMA OPHTHALMOL
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harvey EM, 1999, INVEST OPHTH VIS SCI, V40, P1565
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Sherrell H, 2018, EUR J OBSTET GYN R B, V225, P26, DOI 10.1016/j.ejogrb.2018.03.059
   Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782
   Sonnander K, 2000, ACTA PAEDIATR, V89, P17, DOI 10.1080/080352500750027358
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 31
TC 2
Z9 3
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2018
VL 22
IS 6
BP 452
EP 456
DI 10.1016/j.jaapos.2018.07.352
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA HE7RQ
UT WOS:000453638000012
PM 30359768
OA Other Gold, Green Accepted
DA 2020-12-17
ER

PT J
AU de Abranches, AD
   Soares, FVM
   Villela, LD
   Meio, MDBB
   Zin, OA
   Gomes, SC
   Moreira, MEL
AF de Abranches, Andrea Dunshee
   Mendes Soares, Fernanda Valente
   Villela, Leticia Duarte
   Barbosa Baker Meio, Maria Dalva
   Zin, Olivia Araujo
   Gomes Junior, Saint-Clair
   Lopes Moreira, Maria Elisabeth
TI Energy expenditure, growth, and nutritional therapy in appropriate and
   small for gestational age preterm infants
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Resting energy expenditure; Preterm infants; Nutritional therapy;
   Nutritional status
ID BIRTH-WEIGHT; RESTRICTION
AB Objective: To evaluate the resting energy expenditure, growth, and quantity of energy and macronutrients intake in a group of preterm newborns.
   Methods: The cohort study was performed with appropriate and small for gestational age preterm infants (birth weight lower than 1500 g or gestational age < 32 weeks). Resting energy expenditure was measured using indirect calorimetry on the 7th, 14th, 21st, and 28th days of life, and at discharge. Length, head circumference and body weight were assessed weekly. Nutritional therapy was calculated during the hospital stay and the information for each type of food was recorded in software that calculates the total amount of energy and macronutrients.
   Results: 61 preterm infants were followed; 43 appropriate and 18 small for gestational age infants. There was no statistical difference for resting energy expenditure between the groups, and it increased from the first to the fourth week of life (appropriate: 26.3% and small: 21.8%). Energy intake in the first two weeks of life was well below the energy requirement.
   Conclusion: Considering that the results demonstrate high energy expenditure during the first weeks of life, there is an evident need to provide the best quality of nutrition for each child in the first weeks of life so that preterm infants with or without intrauterine growth restriction can achieve their maximum potential for growth and development. (C) 2017 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [de Abranches, Andrea Dunshee; Villela, Leticia Duarte] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Neonatol, Rio De Janeiro, RJ, Brazil.
   [Mendes Soares, Fernanda Valente; Barbosa Baker Meio, Maria Dalva; Zin, Olivia Araujo; Gomes Junior, Saint-Clair; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Unidade Pesquisa Clin, Rio De Janeiro, RJ, Brazil.
RP de Abranches, AD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Neonatol, Rio De Janeiro, RJ, Brazil.
EM andreadunshee@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Junior, Clair
   Gomes/F-7579-2012; de Abranches, Andrea Dunshee/ABA-8578-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Junior, Clair
   Gomes/0000-0002-1554-943X; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX CNPq.
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295
   Bauer J, 2003, BRIT J NUTR, V89, P533, DOI 10.1079/BJN2002816
   Bauer J, 2011, HORM RES PAEDIAT, V76, P202, DOI 10.1159/000329049
   Bauer J, 2009, AM J CLIN NUTR, V90, P1517, DOI 10.3945/ajcn.2009.28304
   Cai W, 2003, NUTRITION, V19, P133, DOI 10.1016/S0899-9007(02)00929-2
   CAUDERAY M, 1988, EUR J CLIN NUTR, V42, P125
   Cooke RJ, 2016, ARCH DIS CHILD-FETAL, V101, pF366, DOI 10.1136/archdischild-2015-310097
   Critical Care Medicine Department, DELT 2 MET MON OP CA
   Ditzenberger Georgia, 2009, Crit Care Nurs Clin North Am, V21, P181, DOI 10.1016/j.ccell.2009.01.005
   Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270
   Embteton ND, 2014, WORLD REV NUTR DIET, P177
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Kleinman R, 2009, PEDIAT NUTR HDB, P79
   Koletzko B, 2014, WORLD REV NUTR DIET, V110, P297, DOI 10.1159/000360195
   Moreira MEL, 2007, J PERINAT MED, V35, P71, DOI 10.1515/JPM.2007.011
   Okada T, 2015, PEDIATR RES, V77, P136, DOI 10.1038/pr.2014.164
   Sepulveda C, 2013, HORM RES PAEDIAT, V79, P347, DOI 10.1159/000351466
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P22, DOI 10.1016/j.jped.2013.05.007
   Uauy R, 2014, WORLD REV NUTR DIET, V110, P4, DOI 10.1159/000358453
   Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215
   Vitteta LD, 2015, REV NUTR, V28, P619
   Weintraub V, 2009, AM J PERINAT, V26, P173, DOI 10.1055/s-0028-1103023
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
NR 27
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD NOV-DEC
PY 2018
VL 94
IS 6
BP 652
EP 657
DI 10.1016/j.jped.2017.09.005
PG 6
WC Pediatrics
SC Pediatrics
GA HC2NA
UT WOS:000451637600011
PM 29121495
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Martins, AD
   Meio, MDBB
   Gomes, SS
   Lima, PAT
   Milanesi, BG
   Moreira, MEL
AF Martins, Amanda da Silva
   Barbosa Baker Meio, Maria Dalva
   Gomes, Saint Clair S., Jr.
   Tabicas Lima, Paola Azara
   Milanesi, Brunna Grazziotti
   Lopes Moreira, Maria Elisabeth
TI Growth and body composition in preterm newborns with bronchopulmonary
   dysplasia: a cohort study
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE Body composition; bronchopulmonary dysplasia; growth; plethysmography
ID LOW-BIRTH-WEIGHT; AIR-DISPLACEMENT PLETHYSMOGRAPH; NEONATAL OUTCOMES;
   INFANTS; NUTRITION
AB Objective: To compare growth and body composition of preterm infants (gestational age <32 weeks) with and without bronchopulmonary dysplasia (BPD).
   Methods: A prospective cohort involving three neonatal units in the public health system of the Brazilian city of Rio de Janeiro. Inclusion: newborns with gestational age <32 weeks. Exposure: BPD. Anthropometric measurements were performed at birth and at 1 month of infant corrected age. Body composition was measured using an air displacement plethysmography (ADP) (PEA POD (R)) at 1 month of infant corrected age.
   Results: Ninety-five newborns were eligible, of which 67 were included, 32.8% of them with BPD. Newborns with BPD presented lower gestational age at birth, greater need for resuscitation in the delivery room, received parenteral nutrition (PN) for a longer period of time, achieved lower weights during hospital stay and required more time to reach a full enteral diet. No statistically significant differences were observed in relation to anthropometric measurements and body composition at 1 month of infant corrected age between the groups with and without BPD.
   Conclusion: This study, unlike previous ones, has shown that children who developed BPD were able to regain growth, as measured by anthropometric measures, with no change in body composition at 1 month of infant corrected age.
C1 [Martins, Amanda da Silva; Tabicas Lima, Paola Azara; Milanesi, Brunna Grazziotti] Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Rio De Janeiro, Brazil.
   [Barbosa Baker Meio, Maria Dalva; Gomes, Saint Clair S., Jr.; Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Pos Grad Pesquisa Aplicada, Rio De Janeiro, Brazil.
RP Martins, AD (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Rio De Janeiro, Brazil.
EM amandadasmartins@yahoo.com.br
RI Junior, Clair Gomes/F-7579-2012; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; DA SILVA MARTINS, AMANDA/0000-0002-0981-8939;
   BARBOSA BAKER MEIO, MARIA DALVA/0000-0002-7290-9091
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   Demerath EW, 2014, AM J HUM BIOL, V26, P291, DOI 10.1002/ajhb.22500
   Denne SC, 2001, J NUTR, V131, p935S
   deRegnier RAO, 1996, J NUTR, V126, P168
   Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280
   Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fernandez R, 2014, ARCH ARGENT PEDIATR, V112, P405, DOI [10.1590/S0325-00752014000500004, 10.5546/aap.2014.405]
   Ghanta S, 2013, SEMIN PERINATOL, V37, P115, DOI 10.1053/j.semperi.2013.01.008
   Hay WW, 1999, PEDIATRICS, V104, P1360, DOI 10.1542/peds.104.6.1360
   Huysman WA, 2003, ARCH DIS CHILD-FETAL, V88, P46
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Kugelman A, 2011, PEDIATR PULM, V46, P1153, DOI 10.1002/ppul.21508
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Rice MS, 2015, NUTR CLIN PRACT, V30, P625, DOI 10.1177/0884533615578917
   Roggero P, 2012, PEDIATR RES, V72, P316, DOI 10.1038/pr.2012.75
   Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198
   Shah PS, 2016, J PEDIATR-US, V177, P144, DOI 10.1016/j.jpeds.2016.04.083
   Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959
   Urlando A, 2003, PEDIATR RES, V53, P486, DOI 10.1203/01.PDR.0000049669.74793.E3
   Wemhoner A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-7
NR 22
TC 0
Z9 0
U1 0
U2 5
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD NOV
PY 2018
VL 46
IS 8
BP 913
EP 918
DI 10.1515/jpm-2018-0005
PG 6
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GW1ZB
UT WOS:000446680300016
PM 29949515
DA 2020-12-17
ER

PT J
AU Tsui, I
   Moreira, MEL
   Rossetto, JD
   Vasconcelos, Z
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Gomes, SC
   Adachi, K
   Pone, MVD
   Pone, SM
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Brasil, P
   Nielsen-Saines, K
   Zin, AA
AF Tsui, Irena
   Lopes Moreira, Maria Elisabeth
   Rossetto, Julia D.
   Vasconcelos, Zilton
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Gomes, Saint Clair, Jr.
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Brasil, Patricia
   Nielsen-Saines, Karin
   Zin, Andrea A.
TI Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus
   Exposure
SO PEDIATRICS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; OPHTHALMIC MANIFESTATIONS; MACULAR
   ATROPHY; INFECTION; STATES
AB OBJECTIVES:To characterize ophthalmic manifestations of confirmed or suspected antenatal Zika virus (ZIKV) exposure.METHODS:Infants with antenatal ZIKV exposure were referred for evaluation during the 2015-2016 Rio de Janeiro outbreak. Mothers with symptomatic ZIKV infection during pregnancy and/or infants with microcephaly or other findings that were suggestive of suspected antenatal exposure were tested with reverse transcriptase polymerase chain reaction (RT-PCR). Complete eye examinations were performed by pediatric ophthalmologists between January 2016 and February 2017. The main outcome measure was eye abnormalities in RT-PCR-positive and suspected (ie, not tested or RT-PCR-negative) antenatal ZIKV cases.RESULTS:Of 224 infants, 189 had RT-PCR testing performed. Of 189 patients, 156 had positive RT-PCR results in their blood, urine, and/or placenta. Of 224 infants, 90 had central nervous system (CNS) abnormalities, including microcephaly (62 infants). Eye abnormalities were present in 57 of 224 (25.4%) infants. Optic nerve (44 of 57; 77.2%) and retina abnormalities (37 of 57; 64.9%) were the most common. The group with suspected ZIKV infection (68 infants) had proportionally more eye (36.8% vs 20.5%; P = .022) and CNS abnormalities (68.3% vs 28.1%; P = .008), likely because of referral patterns. Eye abnormalities consistent with ZIKV infection were clinically comparable in both RT-PCR-positive and unconfirmed groups, including 4 RT-PCR-positive infants of 5 without any CNS abnormalities.CONCLUSIONS:Similar eye manifestations were identified regardless of laboratory confirmation. Well-appearing infants were also found to have eye abnormalities. Therefore, all infants born after ZIKV outbreaks should be universally screened for eye abnormalities.
C1 [Tsui, Irena; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Opthalmol, Retina Div, Los Angeles, CA USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Lopes Moreira, Maria Elisabeth; Rossetto, Julia D.; Vasconcelos, Zilton; Neves, Luiza M.; Haefeli, Lorena; Gomes, Saint Clair, Jr.; da Silva Pone, Marcos Vinicius; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; Pereira, Jose Paulo, Jr.; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Ophthalmol, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Vasconcelos, Zilton/AAD-5784-2019; Junior, Clair Gomes/F-7579-2012;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020; da Silva Pone, Marcos
   Vinicius/N-1285-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224; Junior, Clair
   Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI128697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent BlindnessResearch to Prevent Blindness (RPB);
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318,
   R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI129534, R21AI129534]
   Funding Source: NIH RePORTER
FX Supported by the Brazilian National Council for Scientific and
   Technological Development (grant 441098/2016-9), the National Institute
   of Allergy and Infectious Diseases (grant AI AI128697), and the National
   Eye Institute (grant R21EY028318-01). Dr Tsui was supported in part by a
   Research to Prevent Blindness unrestricted grant given to the Jules
   Stein Eye Institute. Funded by the National Institutes of Health (NIH).
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, PREV COMB DENG CHIUN
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Rifkin LM, 2016, JAMA OPHTHALMOL, V134, P1427, DOI 10.1001/jamaophthalmol.2016.4299
   Secretaria Municipal de Saude, PREF RIO DE JAN
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 7
Z9 7
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD OCT
PY 2018
VL 142
IS 4
AR e20181104
DI 10.1542/peds.2018-1104
PG 8
WC Pediatrics
SC Pediatrics
GA GZ0EU
UT WOS:000449034300029
PM 30213843
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Villela, LD
   Meio, MDBB
   Gomes, SCS
   de Abranches, AD
   Soares, FVM
   Moreira, MEL
AF Villela, Leticia Duarte
   Barbosa Baker Meio, Maria Dalva
   Gomes Junior, Saint Clair S.
   de Abranches, Andrea Dunshee
   Mendes Soares, Fernanda Valente
   Lopes Moreira, Maria Elisabeth
TI Body composition in preterm infants with intrauterine growth
   restriction: a cohort study
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE Body composition; growth; preterm infants
ID POSTNATAL-GROWTH; LEAN MASS; NUTRITION; ADIPOSITY; STANDARDS; WEIGHT;
   BIRTH; AGE
AB Aims: The comparison of body composition parameters between the small for gestational age (SGA) and appropriate for gestational age (AGA) at term, 1, 3 and 5 months corrected ages in very preterm infants.
   Methods: This cohort study included 92 preterm infants at term age, younger than 32 weeks or <1500 g, classified in two groups: SGA and AGA. Anthropometry and body composition, estimated by air displacement plethysmography, were evaluated at the corrected ages: term and 1, 3, and 5 months. We used the lean mass/fat mass index (LM/FM) at each time point and the weight, length and head circumference SDS gain between the time points.
   Results: At term age, the SGA preterm infants had less lean mass (g), fat mass (g) and percent fat mass but a greater LM/FM index than AGA infants (P < 0.001). At 1 month corrected age the LM/FM index and percent fat mass between the groups became similar. Lower lean mass persisted up to 3 months in the SGA group [4004 g (3256-4595) vs. 4432 g (3190-6246), P < 0.001]. During the first month corrected age, the weight SDS gain was higher in SGA preterm infants when compared to AGA preterm infants. However, the SGA preterm infants remained lighter, shorter and with smaller head circumferences than the AGA preterm infants until 3 months of corrected age.
   Conclusions: The greater lean tissue deficits and an earlier "catch-up" in fat in the SGA group can reflect growth patterns variability since the early life.
C1 [Villela, Leticia Duarte] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Unidade Pesquisa Clin,Dept Neonatol, Ave Rui Barbosa 716,Bloco 2, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Barbosa Baker Meio, Maria Dalva] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Posgrad Pesquisa Aplicada Saude Crianca, Rio De Janeiro, Brazil.
   [Gomes Junior, Saint Clair S.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [de Abranches, Andrea Dunshee; Mendes Soares, Fernanda Valente; Lopes Moreira, Maria Elisabeth] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Unidade Pesquisa Clin, Rio De Janeiro, Brazil.
RP Villela, LD (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Unidade Pesquisa Clin,Dept Neonatol, Ave Rui Barbosa 716,Bloco 2, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM lelevillela@globo.com
RI Junior, Clair Gomes/F-7579-2012; de Abranches, Andrea
   Dunshee/ABA-8578-2020; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091
CR BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001
   de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005
   Demerath EW, 2017, AM J CLIN NUTR, V105, P70, DOI 10.3945/ajcn.116.138248
   Demerath EW, 2014, AM J HUM BIOL, V26, P291, DOI 10.1002/ajhb.22500
   Embleton ND, 2014, WORLD REV NUTR DIET, V110, P177, DOI 10.1159/000358466
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Griffin IJ, 2012, EARLY HUM DEV, V88, pS19, DOI 10.1016/j.earlhumdev.2011.12.023
   HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248
   Horbar JD, 2015, PEDIATRICS, V136, pE84, DOI 10.1542/peds.2015-0129
   Johnson MJ, 2012, PEDIATRICS, V130, pE640, DOI 10.1542/peds.2011-3379
   Ma G, 2003, PEDIATR RES, V53, P486
   Modi N, 2006, PEDIATR RES, V60, P345, DOI 10.1203/01.pdr.0000232732.93000.52
   Okada T, 2015, PEDIATR RES, V77, P136, DOI 10.1038/pr.2014.164
   Raiten DJ, 2016, AM J CLIN NUTR, V103, p648S, DOI 10.3945/ajcn.115.117309
   Rice MS, 2015, NUTR CLIN PRACT, V30, P625, DOI 10.1177/0884533615578917
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Roggero P, 2012, PEDIATR RES, V72, P316, DOI 10.1038/pr.2012.75
   Roggero P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014489
   Senterre T, 2014, WORLD REV NUTR DIET, V110, P201, DOI 10.1159/000358468
   SHENNAN AT, 1988, PEDIATRICS, V82, P527
   Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P427, DOI 10.1016/j.jped.2014.04.004
   Urlando A, 2003, PEDIATR RES, V53, P486, DOI 10.1203/01.PDR.0000049669.74793.E3
   van de Lagemaat M, 2014, EUR J CLIN NUTR, V68, P1261, DOI 10.1038/ejcn.2014.182
   Villar J, 2010, ARCH DIS CHILD, V95, P1034, DOI 10.1136/adc.2009.175067
   Wells JCK, 2012, REV ENDOCR METAB DIS, V13, P93, DOI 10.1007/s11154-012-9213-9
NR 26
TC 1
Z9 1
U1 1
U2 6
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD OCT
PY 2018
VL 46
IS 7
BP 804
EP 810
DI 10.1515/jpm-2017-0175
PG 7
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GT1LJ
UT WOS:000444231300017
PM 29408800
DA 2020-12-17
ER

PT J
AU Lessa, CCR
   Lamy, F
   Lamy, ZC
   da Silva, AAM
   Moreira, MEL
   Gomes, MADM
AF Rios Lessa, Ceane Cunha
   Lamy Filho, Fernando
   Lamy, Zeni Carvalho
   Moura da Silva, Antonio Augusto
   Lopes Moreira, Maria Elizabeth
   de Souza Mendes Gomes, Maria Atailiadora
TI Prevalence and factors associated with surfactant use in Brazilian
   Neonatal Intensive Care Units: A multilevel analysis
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Newborn infant; Pulmonary surfactants; Multilevel analysis
ID PATIENT VOLUME; INFANTS BORN; MORTALITY; PRETERM; BIRTH
AB The treatment with exogenous surfactant reduces mortality and the risk of complications in preterm newborns with Respiratory Distress Syndrome. Higher usage levels have been associated with individual and institutional factors. The study aimed to identify these factors associated with use of this technology in 16 public Brazilian Neonatal Units using logistic multilevel analysis. In a sample of 630 newborns the use at some time was 82.6%. Only 24.7% made use of this technology up to two hours after birth. An intraclass correlation of 0.30 showed that 30% of the variance in the use of exogenous surfactant could be assigned to the contextual level. In the final model, a greater severity score (SNAPPE-II) was associated with increased surfactant use (OR = 2.64), whereas being small for gestational age (SGA) (OR = 0.59) was associated with lower use of this technology. At the contextual level the number of beds in the unit >15 (OR 5.86), units with higher complexity (OR = 1.73) or units with implemented Kangaroo Mother Care (OR = 2.91), especially units in Rio de Janeiro state (OR = 16.17) were associated with greater surfactant use. Although individual clinical features explained most of the variation in the use of this technology, factors linked to the institution were also of utmost importance.
C1 [Rios Lessa, Ceane Cunha; Lamy Filho, Fernando; Lamy, Zeni Carvalho; Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Saude Publ, Ctr Ciencias Saude, R Barao Itapary 155, BR-65020070 Sao Luis, MA, Brazil.
   [Lopes Moreira, Maria Elizabeth; de Souza Mendes Gomes, Maria Atailiadora] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
RP Lessa, CCR (corresponding author), Univ Fed Maranhao, Dept Saude Publ, Ctr Ciencias Saude, R Barao Itapary 155, BR-65020070 Sao Luis, MA, Brazil.
EM ceanecrios@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; FILHO, FERNANDO
   LAMY/I-3633-2013; Silva, Antonio A M/B-5410-2009; Lamy, Zeni
   Carvalho/AAP-6494-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Silva, Antonio A
   M/0000-0003-4968-5138; 
CR Bahadue FL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001456.pub2
   BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0
   de Almeida MFB, 2008, J PEDIAT-BRAZIL, V84, P300, DOI 10.2223/JPED.1787
   Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Acoes Programaticas Estrategicas, 2011, AT HUM REC NASC BAIX
   da Silva CF, 2014, CAD SAUDE PUBLICA, V30, P355, DOI 10.1590/0102-311X00050013
   Fioretto JR, 2012, CONSENSO BRASILEIRO
   Fiori HH., 2003, J PEDIAT S2, V79, P205
   Giapros V, 2012, J MATERN-FETAL NEO M, V25, P153, DOI 10.3109/14767058.2011.565837
   HORBAR JD, 2002, VERMONT OXFORD NETWO
   Howell EA, 2010, J PERINATOL, V30, P590, DOI 10.1038/jp.2010.6
   Kaplan HC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-22
   Menezes Maria Alexsandra da S., 2014, Rev. paul. pediatr., V32, P171, DOI 10.1590/0103-0582201432213113
   Neves Valéria Cabral, 2009, Rev. bras. ter. intensiva, V21, P453, DOI 10.1590/S0103-507X2009000400017
   Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054
   Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, VI
   Rebello CM, 2010, EINSTEIN-SAO PAULO, V8, P320, DOI 10.1590/S1679-45082010AO1758
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Seger N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007836
   Soll RF, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000510
   Speer Christian P, 2013, Early Hum Dev, V89 Suppl 1, pS22, DOI 10.1016/S0378-3782(13)70008-2
   Tucker J, 2002, LANCET, V359, P99
   Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2
NR 22
TC 0
Z9 0
U1 0
U2 1
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD SEP
PY 2018
VL 23
IS 9
BP 3067
EP 3076
DI 10.1590/1413-81232018239.22192016
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GU4QE
UT WOS:000445267900028
PM 30281743
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Meio, MDBB
   Villela, LD
   Gomes, SCD
   Tovar, CM
   Moreira, MEL
AF Baker Meio, Maria Dalva Barbosa
   Villela, Leticia Duarte
   dos Santos Gomes Junio, Saint Clair
   Tovar, Camilla Morcelli
   Lopes Moreira, Maria Elisabeth
TI Breastfeeding of preterm newborn infants following hospital discharge:
   follow-up during the first year of life
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Breastfeeding; Newborn; Premature
ID FATHER INVOLVEMENT; MILK VOLUME; INITIATION; MOTHERS; BIRTH; IMPACT;
   WOMEN; CARE
AB This paper aims to evaluate the prevalence of breastfeeding among premature infants following hospital discharge. Cohort (< 33 gestation weeks) followed up to 12 months (adjusted age). Variables: breastfeeding, anthropometric measurements, social and family information. The proportion of breastfeeding during follow-up was calculated. Survival analysis was conducted to estimate breastfeeding duration. In total, 242 of the 258 infants (93.7%) returned to follow-up; 170 (69.9%) at 6 months and 139 (57.2%) at 12 months (adjusted age). A history of miscarriages (27.5%), stillbirths (11.7%), neonatal deaths (9.5%) and preterm births (21.1%) was noted in 65.5% of women. At hospital discharge: 5.5% received exclusive breastfeeding, 65.8% breastfeeding and formula, 28.6% formula. At month 1, 81.3% received breastfeeding, decreasing to 68.5% at month 2, 62.4% at month 3, 48.1% at month 4 and 22.4% at month 6 (adjusted age). The median of breastfeeding duration was 4 months. Breastfeeding occurred up to four months adjusted age in almost half of the population. Despite the need to improve these rates, the results could reflect the profile of the Child-Friendly Hospital Initiative Unit. Maintaining breastfeeding amongst preterm infants following hospital discharge is still a challenge, for both mothers and health professionals.
C1 [Baker Meio, Maria Dalva Barbosa; Villela, Leticia Duarte; dos Santos Gomes Junio, Saint Clair; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Fiocruz Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Tovar, Camilla Morcelli] Univ Fed Fluminense, Hosp Antonio Pedro, Niteroi, RJ, Brazil.
RP Meio, MDBB (corresponding author), Inst Fernandes Figueira Fiocruz, Fiocruz Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM mdbakermeio@gmail.com
RI Junior, Clair Gomes/F-7579-2012; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091
FU CNPq - PAPES / FiocruzNational Council for Scientific and Technological
   Development (CNPq)
FX To the nursing techniques Rosanea S dos Santos, Catisa Silene da S
   Brandao and Maria Aparecida da S Pereira for the implementation of the
   anthropometric measurements throughout the study period. And to CNPq -
   PAPES / Fiocruz for the financing.
CR Alves Anna Maria Lages, 2007, Rev. soc. bras. fonoaudiol., V12, P23, DOI 10.1590/S1516-80342007000100006
   Brown A, 2014, MATERN CHILD NUTR, V10, P510, DOI 10.1111/mcn.12129
   Brusco Thaísa Rodrigues, 2014, Rev. CEFAC, V16, P917, DOI 10.1590/1982-021620145313
   Callen Jennifer, 2005, Adv Neonatal Care, V5, P93, DOI 10.1016/j.adnc.2004.12.005
   Cregan MD, 2002, ACTA OBSTET GYN SCAN, V81, P870, DOI 10.1034/j.1600-0412.2002.810913.x
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Freitas Brunnella Alcantara Chagas de, 2016, Rev. paul. pediatr., V34, P189, DOI [10.1016/j.rpped.2015.10.005, 10.1016/j.rppede.2016.02.010]
   Goes FV, 2015, REV BRAS SAUDE MATER, V15, P45
   Groleau D, 2009, MATERN CHILD NUTR, V5, P10, DOI 10.1111/j.1740-8709.2008.00151.x
   Hunter T, 2014, HEALTH PROMOT PERSPE, V4, P132, DOI 10.5681/hpp.2014.017
   Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da
   Jedrychowski W, 2012, EUR J PEDIATR, V171, P151, DOI 10.1007/s00431-011-1507-5
   Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005
   Lapillonne A., 2014, NUTR CARE PRETERM IN
   Makrides M, 2011, MATERN CHILD NUTR, V7, P80, DOI 10.1111/j.1740-8709.2011.00304.x
   Menezes Maria Alexsandra da S., 2014, Rev. paul. pediatr., V32, P171, DOI 10.1590/0103-0582201432213113
   Morag I, 2016, BREASTFEED MED, V11, P138, DOI 10.1089/bfm.2015.0161
   Murase M, 2014, J HUM LACT, V30, P425, DOI 10.1177/0890334414543951
   O'Connor DL, 2013, SEMIN FETAL NEONAT M, V18, P124, DOI 10.1016/j.siny.2013.05.001
   Oras P, 2016, ACTA PAEDIAT
   Parker LA, 2015, BREASTFEED MED, V10, P84, DOI 10.1089/bfm.2014.0089
   Regan J, 2013, BREASTFEED MED, V8, P181, DOI 10.1089/bfm.2012.0049
   Roussel C, 2012, ARCH PEDIATRIE, V19, P663, DOI 10.1016/j.arcped.2012.03.003
   Santoro W, 2007, J PEDIAT-BRAZIL, V83, P541, DOI 10.2223/JPED.1724
   Tessier R, 2009, ACTA PAEDIATR, V98, P1444, DOI 10.1111/j.1651-2227.2009.01370.x
   Vieira GO, 2015, J PEDIAT-BRAZIL, V91, P270, DOI 10.1016/j.jped.2014.08.012
   Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760
   von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147
   World Health Organization, 2009, INF YOUNG CHILD FEED
NR 30
TC 1
Z9 3
U1 0
U2 1
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2018
VL 23
IS 7
BP 2403
EP 2412
DI 10.1590/1413-81232018237.15742016
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GN3OX
UT WOS:000438917100029
PM 30020392
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Chimelli, L
   Wiley, CA
   Vasconcelos, ZFM
   Moreira, MEL
   Pone, SM
   Pone, MVD
AF Chimelli, Leila
   Wiley, Clayton A.
   Meira Vasconcelos, Zilton Farias
   Lopes Moreira, Maria Elisabeth
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth Response
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Letter
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbyterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
   [Meira Vasconcelos, Zilton Farias; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Clin Res Unit, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Pediat Infect Dis Unit, Rio De Janeiro, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
EM chimelli@hucff.ufrj.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Moura Pone,
   Sheila/0000-0002-6246-8915; Vasconcelos, Zilton/0000-0002-2193-2224; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
NR 7
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUL
PY 2018
VL 77
IS 7
BP 656
EP 657
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GO1KC
UT WOS:000439709000012
DA 2020-12-17
ER

PT J
AU Nico, D
   Conde, L
   Rivera-Correa, JL
   Vasconcelos-dos-Santos, A
   Mesentier-Louro, L
   Freire-de-Lima, L
   Arruda, MB
   Freire-de-Lima, CG
   Ferreira, OD
   Moreira, MEL
   Zin, AA
   Vasconcelos, ZFM
   Otero, RM
   Palatnik-de-Sousa, CB
   Tanuri, A
   Todeschini, AR
   Savino, W
   Rodriguez, A
   Morrot, A
AF Nico, Dirlei
   Conde, Luciana
   Rivera-Correa, Juan L.
   Vasconcelos-dos-Santos, Andreia
   Mesentier-Louro, Louise
   Freire-de-Lima, Leonardo
   Arruda, Monica Barcellos
   Freire-de-Lima, Celio Geraldo
   Ferreira, Orlando da Costa, Jr.
   Lopes Moreira, Maria Elisabeth
   Zin, Andrea Araujo
   Meira Vasconcelos, Zilton Farias
   Otero, Rosalia Mendez
   Palatnik-de-Sousa, Clarisa Beatriz
   Tanuri, Amilcar
   Todeschini, Adriane Regina
   Savino, Wilson
   Rodriguez, Ana
   Morrot, Alexandre
TI Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika
   Virus Infection
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE Zika virus; gangliosides; autoimmunity; autoantibody; infectious
   diseases
ID NEURAL STEM-CELLS; ANTIBODY-RESPONSE; EXPRESSION; RETINA; BRAIN
AB Zika virus (ZIKV) disease has become a global health emergency with devastating effects on public health. Recent evidences implicate the virus as an emergent neuropathological agent promoting serious pathologies of the human nervous system, that include destructive and malformation consequences such as development of ocular and fetal brain lesions, microcephaly in neonates, and Guillain-Barre syndrome (GBS) in adults. These neurological disorders of both central and peripheral nervous systems are thought to be associated to the neurotropic properties of the virus that has ability to infect neural stem cells as well as peripheral neurons, a hallmark of its pathogenicity. The presence of autoantibodies against gangliosides plays a pivotal role in the etiogenesis of GBS and a variety of neurological disorders. Gangliosides are a class of galactose -containing cerebrosides mainly expressed in nervous system tissues playing a critical role in the physiology of neural cells and neurogenesis. Herein, our findings indicate that patients at acute phase of ZIKV infection without any neurological signs show increased levels of IgG autoantibody against GD3 gangliosides, a class of glycolipid found to be highly expressed in neural stem cell acting in the maintenance of their self -renewal cellular capacity. It is possible that a pathological threshold of these antibodies is only acquired in secondary or subsequent infections. In the light of these evidences, we propose that the target of GD3 by autoimmune responses may possibly has an effect in the neuropathy and neurogenesis disorder seen during ZIKV infection.
C1 [Nico, Dirlei; Conde, Luciana; Palatnik-de-Sousa, Clarisa Beatriz] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Rivera-Correa, Juan L.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
   [Vasconcelos-dos-Santos, Andreia; Mesentier-Louro, Louise; Freire-de-Lima, Leonardo; Freire-de-Lima, Celio Geraldo; Otero, Rosalia Mendez; Todeschini, Adriane Regina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Arruda, Monica Barcellos; Ferreira, Orlando da Costa, Jr.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Lopes Moreira, Maria Elisabeth; Zin, Andrea Araujo; Meira Vasconcelos, Zilton Farias] Fiocruz MS, Inst Oswaldo Cruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Savino, Wilson] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Savino, Wilson] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro, Brazil.
   [Morrot, Alexandre] Univ Fed Rio de Janeiro, Ctr Pesquisas TB, Fac Med, Rio De Janeiro, Brazil.
   [Morrot, Alexandre] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunopatol, Rio De Janeiro, Brazil.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.; Morrot, A (corresponding author), Univ Fed Rio de Janeiro, Ctr Pesquisas TB, Fac Med, Rio De Janeiro, Brazil.; Morrot, A (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunopatol, Rio De Janeiro, Brazil.
EM Ana.Rodriguez@nyumc.org; alexandre.lima@ioc.fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Todeschini,
   Adriane/AAG-8128-2020; de Lima, Celio Geraldo Freire/A-9057-2012;
   Todeschini, Adriane Regina/ABC-9165-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Todeschini, Adriane
   Regina/0000-0002-6049-2751; Rivera-Correa, Juan/0000-0003-4822-0005;
   Mendez-Otero, Rosalia/0000-0002-1798-9930; Freire-de-Lima,
   Leonardo/0000-0003-3013-3173; Rodriguez, Ana/0000-0002-0060-3405;
   Vasconcelos, Zilton/0000-0002-2193-2224; Palatnik-de-Sousa, Clarisa
   B./0000-0002-6231-0608
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)
   fellowshipNational Council for Scientific and Technological Development
   (CNPq) [310977/2014-2, 404400/2012-4]; Focem/Mercosur; Fundacao Carlos
   Chagas de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26-201.583/2014]; FaperjCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   [E-26/ 201747/2015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32AI100853, T32AI100853, T32AI100853,
   T32AI100853, T32AI100853] Funding Source: NIH RePORTER
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPQ) fellowship 310977/2014-2 and grant
   404400/2012-4 (to CP-d-S); Focem/Mercosur (WS); and by Fundacao Carlos
   Chagas de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) grants
   E-26-201.583/2014 (to CP-d-S), Zika-related networks funded by Faperj
   (AT and WS) and fellowships E-26/ 201747/2015 (to DN).
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ang CW, 2002, INFECT IMMUN, V70, P5081, DOI 10.1128/IAI.70.9.5081-5085.2002
   Bowes T, 2002, INFECT IMMUN, V70, P5008, DOI 10.1128/IAI.70.9.5008-5018.2002
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DANIOTTI JL, 1990, J NEUROSCI RES, V26, P436, DOI 10.1002/jnr.490260406
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Fujio K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00028
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldman JE, 1996, GLIA, V16, P291, DOI 10.1002/(SICI)1098-1136(199604)16:4<291::AID-GLIA1>3.0.CO;2-3
   Gomez-Nicola D, 2006, J NEUROSCI RES, V83, P754, DOI 10.1002/jnr.20777
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Horwacik I, 2015, APOPTOSIS, V20, P679, DOI 10.1007/s10495-015-1103-7
   Huijbers MG, 2015, EUR J NEUROL, V22, P1151, DOI 10.1111/ene.12758
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Ilyas AA, 2001, RES COMMUN MOL PATH, V109, P115
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179
   Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6
   Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149
   Pan QJ, 2017, DISCOV MED, V23, P169
   Park JE, 2008, CYTOTHERAPY, V10, P38, DOI 10.1080/14653240701762380
   Pisetsky DS, 2009, LUPUS, V18, P1176, DOI 10.1177/0961203309106492
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01740
   Ryu JS, 2009, BIOCHEM BIOPH RES CO, V387, P266, DOI 10.1016/j.bbrc.2009.07.005
   Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020
   Schwerer B, 1999, INFECT IMMUN, V67, P2414, DOI 10.1128/IAI.67.5.2414-2420.1999
   SPARROW JR, 1988, J NEUROSCI RES, V21, P398, DOI 10.1002/jnr.490210231
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Wang J, 2014, J NEUROSCI, V34, P13790, DOI 10.1523/JNEUROSCI.2275-14.2014
   Wang J, 2013, P NATL ACAD SCI USA, V110, P19137, DOI 10.1073/pnas.1307224110
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537
NR 45
TC 7
Z9 7
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD MAR 9
PY 2018
VL 5
DI 10.3389/fmed2018.00025
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY7SZ
UT WOS:000427064700001
PM 29594116
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Orofino, DHG
   Passos, SRL
   de Oliveira, RVC
   Farias, CVB
   Leite, MDMP
   Pone, SM
   Pone, MVD
   Mendes, HART
   Moreira, MEL
   Nielsen-Saines, K
AF Orofino, Dulce H. G.
   Passos, Sonia R. L.
   de Oliveira, Raquel V. C.
   Farias, Carla Verona B.
   Leite, Maria de Fatima M. P.
   Pone, Sheila M.
   Pone, Marcos V. da S.
   Teixeira Mendes, Helena A. R.
   Moreira, Maria Elizabeth L.
   Nielsen-Saines, Karin
TI Cardiac findings in infants with in utero exposure to Zika virus- a
   cross sectional study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CONGENITAL HEART-DISEASE; INFECTION; BRAZIL
AB Background
   Antenatal exposure to Zika virus (ZIKV) is related to severe neurological manifestations. A previous study in Brazil reported an increased incidence of non-severe congenital heart defects in infants with diagnosis of congenital Zika syndrome but without laboratory confirmation of ZIKV infection in the mother or infant. The objective of this study is to report echocardiographic (ECHO) findings in infants with laboratory confirmed antenatal exposure to ZIKV.
   Methodology
   Cross sectional study of cardiologic assessments of infants born between November 2015 and January 2017 with confirmed vertical exposure to ZIKV in Rio de Janeiro, Brazil.
   Results
   The study enrolled 120 children with a median age of 97 days (1 to 376 days). In utero exposure to ZIKV was confirmed in 97 children (80,8%) through positive maternal polymerase chain reaction (PCR) results during pregnancy or a positive PCR result at birth; 23 additional children (19.2%) had maternal positive PCR results during pregnancy and postnatally. Forty-eight infants (40%) had cardiac defects noted on ECHO. Thirteen infants (10.8%) had major cardiac defects (atrial septal defect, ventricular septal defect, patent ductus arteriosus). None of the defects were severe. The frequency of major defects was higher in infants whose mothers had a rash in the 2nd trimester of pregnancy, or who had altered Central Nervous System (CNS) imaging postnatally or were preterm.
   Conclusions
   Infants with in utero ZIKV exposure have a higher prevalence of major cardiac defects, however none were severe enough to require immediate intervention. For this reason, guidelines for performance of postnatal ECHO in this population should follow general newborn screening guidelines, which significantly reduces the burden of performing emergent fetal or neonatal ECHOs in a setting where resources are not available, such as most Brazilian municipalities.
C1 [Orofino, Dulce H. G.; Farias, Carla Verona B.; Leite, Maria de Fatima M. P.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Pediat, Rio De Janeiro, Brazil.
   [Orofino, Dulce H. G.; Teixeira Mendes, Helena A. R.] Souza Marques Sch Med, Rio De Janeiro, Brazil.
   [Passos, Sonia R. L.; de Oliveira, Raquel V. C.; Teixeira Mendes, Helena A. R.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infectol, Lab Clin Epidemiol, Rio De Janeiro, Brazil.
   [Pone, Sheila M.; Pone, Marcos V. da S.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Infect Dis, Rio De Janeiro, Brazil.
   [Moreira, Maria Elizabeth L.] Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Clin Res, Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
RP Orofino, DHG (corresponding author), Fundacao Oswaldo Cruz, Fernandes Figueira Inst, Dept Pediat, Rio De Janeiro, Brazil.; Orofino, DHG (corresponding author), Souza Marques Sch Med, Rio De Janeiro, Brazil.
EM dulceorofino@yahoo.com.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; DE FATIMA MONTEIRO PEREIRA
   LEITE, MARIA/AAO-9985-2020; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Oliveira, Raquel de V C de/S-7443-2016
OI DE FATIMA MONTEIRO PEREIRA LEITE, MARIA/0000-0001-6244-3593; Moreira,
   Maria Elisabeth Lopes/0000-0002-2034-0294; Passos,
   Sonia/0000-0001-9947-2291; Oliveira, Raquel de V C
   de/0000-0001-9387-8645; orofino, dulce/0000-0002-0953-1831; da Silva
   Pone, Marcos Vinicius/0000-0002-5152-2242; Moura Pone,
   Sheila/0000-0002-6246-8915
FU MCTI Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440846/2016-1, 310765/2016-1]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES [88881130793/2016-01,
   88887130789/2016-00]; Universidade Estacio de Sa-Bolsa Produtividade
FX Sonia Regina Lambert Passos was supported by MCTI Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 440846/2016-1 and
   310765/2016-1; supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) Grant 88881130793/2016-01 and by Universidade
   Estacio de Sa-Bolsa Produtividade. Helena Alencar Rosa Teixeira Mendes
   was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) Grant 88887130789/2016-00. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdulkadir M, 2016, AFR HEALTH SCI, V16, P367, DOI 10.4314/ahs.v16i2.5
   Brasil. Ministerio da SaCrde (MS), 2009, DIR MET EST AV LOG S
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caneo LF, 2012, ARQ BRAS CARDIOL, V98, P390, DOI 10.1590/S0066-782X2012005000030
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pedra CAC, 2009, HEART, V95, P1385, DOI 10.1136/hrt.2008.152017
   Pinto VC, 2015, REV BRAS CIR CARDIOV, V30, P219, DOI 10.5935/1678-9741.20150018
   Qu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159257
   Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 19
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006362
DI 10.1371/journal.pntd.0006362
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900078
PM 29579059
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Chimelli, L
   Pone, SM
   Avvad-Portari, E
   Vasconcelos, ZFM
   Zin, AA
   Cunha, DP
   Thompson, NR
   Moreira, MEL
   Wiley, CA
   Pone, MVD
AF Chimelli, Leila
   Pone, Sheila Moura
   Avvad-Portari, Elyzabeth
   Meira Vasconcelos, Zilton Farias
   Zin, Andrea Araujo
   Cunha, Daniela Prado
   Thompson, Nathalia Raposo
   Lopes Moreira, Maria Elisabeth
   Wiley, Clayton A.
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth: Clinical, Virological,
   Neuroimaging, and Neuropathological Documentation in a 5-Month Infant
   With Congenital Zika Syndrome
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Arthrogryposis; Calcification; Hydrocephalus; Microcephaly;
   Neuropathology; RT-qPCR; Zika virus
ID INFECTION; POSTMORTEM; BRAIN
AB During the Zika epidemic in Brazil, a baby was born at term with microcephaly and arthrogryposis. The mother had Zika symptoms at 10 weeks of gestation. At 17 weeks, ultrasound showed cerebral malformation and ventriculomegaly. At 24 weeks, the amniotic fluid contained ZIKV RNA and at birth, placenta and maternal blood were also positive using RT-qPCR. At birth the baby urine contained ZIKV RNA, whereas CSF at birth and urine at 17 days did not. Seizures started at 6 days. EEG was abnormal and CT scan showed cerebral atrophy, calcifications, lissencephaly, ventriculomegaly, and cerebellar hypoplasia. Bacterial sepsis at 2 months was treated. A sudden increase in head circumference occurred at 4 months necessitating ventricle-peritoneal shunt placement. At 5 months, the infant died with sepsis due to bacterial meningitis. Neuropathological findings were as severe as some of those found in neonates who died soon after birth, including hydrocephalus, destructive lesions/calcification, gliosis, abnormal neuronal migration, dysmaturation of nerve cells, hypomyelination, loss of descending axons, and spinal motor neurons. ZIKV RNA was detected only in frozen brain tissue using RT-qPCR, but infected cells were not detected by in situ hybridization. Progressive gliosis and microgliosis in the midbrain may have contributed to aqueduct compression and subsequent hydrocephalus. The etiology of progressive disease after in utero infection is not clear and requires investigation.
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Pone, Sheila Moura; Thompson, Nathalia Raposo; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pediat Infect Dis, Rio De Janeiro, Brazil.
   [Avvad-Portari, Elyzabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Pathol, Rio De Janeiro, Brazil.
   [Meira Vasconcelos, Zilton Farias; Zin, Andrea Araujo; Cunha, Daniela Prado; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Vasconcelos,
   Zilton/AAD-5784-2019; da Silva Pone, Marcos Vinicius/N-1285-2019
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224; Moura Pone, Sheila/0000-0002-6246-8915;
   Cunha, Daniela/0000-0002-5954-6054; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Ochieng' N, 2015, J NEUROSURG-PEDIATR, V15, P150, DOI 10.3171/2014.10.PEDS14178
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Siebert JR, 2007, POTTERS PATHOLOGY FE, P695
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
NR 16
TC 19
Z9 19
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAR
PY 2018
VL 77
IS 3
BP 193
EP 198
DI 10.1093/jnen/nlx116
PG 6
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GB3IH
UT WOS:000428949800002
PM 29346650
DA 2020-12-17
ER

PT J
AU Monteiro, LMC
   Cruz, GND
   Fontes, JM
   Salles, TRDS
   Boechat, MCB
   Monteiro, AC
   Moreira, MEL
AF Costa Monteiro, Lucia Maria
   de Oliveira Cruz, Glaura Nisya
   Fontes, Juliana Marin
   Dias Saad Salles, Tania Regina
   Bastos Boechat, Marcia Cristina
   Monteiro, Ana Carolina
   Lopes Moreira, Maria Elizabeth
TI Neurogenic bladder findings in patients with Congenital Zika Syndrome: A
   novel condition
SO PLOS ONE
LA English
DT Article
ID VIRUS-INFECTION; NEUROPATHIC BLADDER; MEDICAL-TREATMENT; URINARY-TRACT;
   CHILDREN; BRAZIL; COUNTRIES; INFANTS
AB Introduction
   Congenital Zika Syndrome ( CZS) has been associated with microcephaly and other central nervous system abnormalities including areas that have been implicated in the control of the lower urinary tract. As such, this descriptive case series has aimed to investigate whether CZS is linked with neurogenic bladder. Identifying such an association is paramount in the effort to recognize CZS complications that have putative treatment options that could mitigate the impact of CZS in infected children.
   Methods
   Following IRB approval, urological assessment was performed in all patients referred to our clinic between June 2016 and May 2017 who presented with confirmed CZS-associated microcephaly. The research protocol consisted of obtaining clinical history, laboratory tests, lower and upper urinary tract ultrasounds, as well as a diagnostic urodynamic evaluation. ZIKA virus infection was previously confirmed by maternal history and positive PCR in babies and mothers. Microcephaly and other central nervous system abnormalities were established based on neurological assessment and associated imaging of the central nervous system ( CT head and/or Brain MRI).
   Results
   Twenty-two consecutive CZS patients were tested and confirmed to have neurogenic bladder. Of the 22 patients assessed, 21 presented with an overactive bladder combined with reduced bladder capacity and elevated detrusor filling pressures. Clinically significant increases in postvoid residual ( PVR) were confirmed in 40% of cases while a urinary tract infection ( UTI) was identified in 23% of cases.
   Conclusion
   Neurogenic bladder, a known treatable health condition, was confirmed in 100% of patients tested in this study, most presenting with high-risk urodynamic patterns known to lead to renal damage when left untreated. Follow up studies are necessary to provide further insight onto long-term disease progression and to investigate the response to standard therapies for neurogenic bladder. Nonetheless, we emphasize the importance of proactive management of neurogenic bladder and prompt referral so as to help mitigate CZS disease burden for patients and their families.
C1 [Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin] Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Dias Saad Salles, Tania Regina] Fiocruz MS, Dept Pediat Neurol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Bastos Boechat, Marcia Cristina] Fiocruz MS, Dept Pediat Radiol & Imagining, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
   [Monteiro, Ana Carolina] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA.
   [Lopes Moreira, Maria Elizabeth] Fiocruz MS, Dept Neonatol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
RP Monteiro, LMC (corresponding author), Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM lucia@iff.fiocruz.br
RI Monteiro, Lucia Maria Costa/O-7903-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Monteiro, Lucia Maria Costa/0000-0002-7612-7249; Moreira, Maria
   Elisabeth Lopes/0000-0002-2034-0294; Costa Monteiro, Ana
   Carolina/0000-0002-1501-4435; Marin Fontes, Juliana/0000-0003-4098-7324;
   Dobon, Begona/0000-0002-5608-6021
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPES (Brazil)CAPES [440580/2016-1]; National Plan to Prevent
   and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS) [14/2016];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX The research is funded by a grant from CNPq and CAPES (Brazil), process
   number 440580/2016-1, from the National Plan to Prevent and Combat ZIKA
   (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Com
   bate ao virus Zika). Lucia M Costa Monteiro is the grant coordinator.
   Maria Elizabeth Lopes Moreira is funded by FAPERJ.
CR Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783
   Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Costa Monteiro LM, 2017, CRITERIA EVALUATE NE
   Costa Monteiro LM, 2017, J PEDIAT RIO J
   de Groat W. C., 2014, COMPREHENSIVE PHYSL, P327
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056
   Drzewiecki BA, 2011, J UROLOGY, V186, P1190, DOI 10.1016/j.juro.2011.02.2692
   Filler G, 2012, INT UROL NEPHROL, V44, P817, DOI 10.1007/s11255-010-9894-5
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Kari JA, 2006, PEDIATR NEPHROL, V21, P517, DOI 10.1007/s00467-006-0034-5
   Lehnert T, 2012, INT UROL NEPHROL, V44, P335, DOI 10.1007/s11255-011-0030-y
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3
   McKibben MJ, 2015, UROL CLIN N AM, V42, P527, DOI 10.1016/j.ucl.2015.05.006
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodriguez-Ruiz M, 2016, ACTAS UROL ESP, V40, P37, DOI [10.1016/j.acuro.2015.06.002, 10.1016/j.acuroe.2015.11.005]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STEINHARDT GF, 1988, J UROLOGY, V140, P1293, DOI 10.1016/S0022-5347(17)42028-3
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Verpoorten C, 2008, PEDIATR NEPHROL, V23, P717, DOI 10.1007/s00467-007-0691-z
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 30
TC 9
Z9 9
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 1
PY 2018
VL 13
IS 3
AR e0193514
DI 10.1371/journal.pone.0193514
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX8RR
UT WOS:000426363200059
PM 29494684
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Abramov, DM
   Saad, T
   Gomes, SC
   Silva, DDE
   Araujo, I
   Moreira, MEL
   Lazarev, VV
AF Abramov, Dimitri Marques
   Saad, Tania
   Gomes-Junior, Saint-Clair
   de Souza e Silva, Daniel
   Araujo, Izabel
   Lopes Moreira, Maria Elizabeth
   Lazarev, Vladimir V.
TI Auditory brainstem function in microcephaly related to Zika virus
   infection
SO NEUROLOGY
LA English
DT Article
ID SENSORINEURAL HEARING-LOSS; HYPOPLASIA; CEREBELLUM; CHILDREN; FETUSES;
   INFANTS
AB ObjectiveTo study the effect of prenatal Zika virus (ZV) infection on brainstem function reflected in brainstem auditory evoked potentials (BAEPs).MethodsIn a cross-sectional study in 19 children (12 girls) with microcephaly related to ZV infection, aged between 12 and 62 weeks, the brainstem function was examined through BAEPs. The latencies of wave peaks I, III, and V of the left and right ears (n = 37) were standardized according to normative data, and compared between them by 2-tailed t test. The confounding variables (cephalic perimeter at the born and chronological age) were correlated with the normalized latencies using Pearson test.ResultsAll patients showed, in general, clear waveforms, with latencies within 3 SDs of the normative values. However, statistically increased latencies of waves I and III (I > III, p = 0.031) were observed, relative to wave V (p < 0.001), the latter being closer to respective normative value. The latency of wave I was observed to increase with age (r = 0.45, p = 0.005). The waves, in turn, did not depend on cephalic perimeter.ConclusionsThese results are consistent with the functional normality of the brainstem structure and its lack of correlation with microcephaly, suggesting that the disruption produced by the ZV infection does not act in the cell proliferation phase, but mostly in the processes of neuronal migration and differentiation in the telencephalon.
C1 [Abramov, Dimitri Marques; Saad, Tania; de Souza e Silva, Daniel; Araujo, Izabel; Lazarev, Vladimir V.] Minist Hlth, Lab Neurobiol & Clin Neurophysiol, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
   [Gomes-Junior, Saint-Clair; Lopes Moreira, Maria Elizabeth] Minist Hlth, Unit Clin Res, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
RP Lazarev, VV (corresponding author), Minist Hlth, Lab Neurobiol & Clin Neurophysiol, Natl Inst Women Children & Adolescents, Hlth Fernandes Figueira,Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil.
EM vlad.v@iname.com
RI Junior, Clair Gomes/F-7579-2012; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico)National Council
   for Scientific and Technological Development (CNPq)
FX Study funded by the National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico).
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   [Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1
   Basel-Vanagaite L, 2010, PEDIATR NEUROL, V43, P7, DOI 10.1016/j.pediatrneurol.2010.02.015
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Celesia GG, 2011, NIEDERMEYERS ELECTRO, P976
   Chiappa Keith H., 1997, P199
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   da Cunha AJLA, 2016, PEDIATR INFECT DIS J, V36, P1
   Das Piyali, 2010, Indian J Physiol Pharmacol, V54, P376
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guha R, 2017, PEDIATR NEUROL, V70, P81, DOI 10.1016/j.pediatrneurol.2017.01.012
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Kenna MA, 2015, OTOLARYNG CLIN N AM, V48, P933, DOI 10.1016/j.otc.2015.07.011
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Legatt AD, 2012, AMINOFFS ELECTRODIAG, P519
   Levy SR, 1997, EVOKED POTENTIALS CL, P271
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Marrs GS, 2012, J PHYSIOL-LONDON, V590, P2391, DOI 10.1113/jphysiol.2011.226886
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Morzaria S, 2004, INT J PEDIATR OTORHI, V68, P1193, DOI 10.1016/j.ijporl.2004.04.013
   Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194
   Nakamura K, 2012, J CHILD NEUROL, V27, P218, DOI 10.1177/0883073811416239
   Olusanya BO, 2013, ANN AFR MED, V12, P98, DOI 10.4103/1596-3519.112399
   Pan American Health Organization, 2016, GUID SURV ZIK VIR DI
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001
   Rajab A, 2007, AM J MED GENET A, V143A, P2761, DOI 10.1002/ajmg.a.31955
   Ramalho Rocha YR, 2016, PLOS CURR OUTBREAKS
   Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   World Health Organization Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA
NR 40
TC 5
Z9 6
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD FEB 13
PY 2018
VL 90
IS 7
BP E606
EP E614
DI 10.1212/WNL.0000000000004974
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA FZ7VS
UT WOS:000427813200009
PM 29352094
DA 2020-12-17
ER

PT J
AU Villela, LD
   Meio, MDBB
   Fonseca, VD
   de Abranches, AD
   Gomes, S
   da Costa, ACC
   Murta, MM
   Nehab, SRG
   Soares, FVM
   Moreira, MEL
AF Villela, Leticia Duarte
   Barbosa Baker Meio, Maria Dalva
   Fonseca, Vania de Matos
   de Abranches, Andrea Dunshee
   Gomes Junior, Saint-Clair
   Carioca da Costa, Ana Carolina
   Murta, Maria M.
   Goncalves Nehab, Sylvia Reis
   Mendes Soares, Fernanda Valente
   Lopes Moreira, Maria Elisabeth
TI Growth and body composition of preterm infants less than or equal to 32
   weeks: Cohort study
SO EARLY HUMAN DEVELOPMENT
LA English
DT Article
ID AIR-DISPLACEMENT PLETHYSMOGRAPH; POSTNATAL-GROWTH; BIRTH-WEIGHT; LEAN
   MASS; NUTRITION; AGE; ADIPOSITY; STANDARDS; VELOCITY; WATER
AB Background: Extremely preterm infants with weights less than the 10th percentile at discharge have a fat-free mass deficit.
   Aim To analyze the relationship of weight Z-scores less than-2SD at term age with fat-free mass and fat mass at term age and at 1 and 3 months of corrected age in very preterm infants.
   Study design: cohort study: Subjects: Sixty-six preterm infants born before or at 32 weeks gestation with birth weight equal or greater than the 10th percentile for age were included at term age. They were classified according to weight Z-score as either: "term (-)" (n = 18) if weight Z-scores were less-2SD or "term (+)" (n = 48) if the weight Z-scores were equal or greater than-2SD at term age.
   Outcome measures: Growth and body composition by an air displacement plethysmography system and bioimpedance were assessed at term age and 1 and 3 months of corrected age.
   Results: Lower fat-free mass persisted up to 3 months in the "term (-)" group [4137 g (645) vs 4592 g (707), p <.01]. Fat mass was lower in the "term (-)" group at term and at 1 month but was similar at 3 months of corrected age [1295 g (774) vs 1477 g (782), p =.109]. Weight, length and head circumference Z-scores were lower in the "term (-)" group compared to those in the "term ( +)" group.
   Conclusions: The lean tissue deficits were maintained in the "term (-)" group while the differences in body fat percentage were not.
C1 [Villela, Leticia Duarte; Barbosa Baker Meio, Maria Dalva; Fonseca, Vania de Matos; de Abranches, Andrea Dunshee; Gomes Junior, Saint-Clair; Carioca da Costa, Ana Carolina; Murta, Maria M.; Goncalves Nehab, Sylvia Reis; Mendes Soares, Fernanda Valente; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira IFF Fiocruz, Ave Rui Barbosa,716 Flamengo, BR-22250020 Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira IFF Fiocruz, Ave Rui Barbosa,716 Flamengo, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM mdmeio@centroin.com.br; scgomes@iff.fiocruz.br;
   ana.costa@iff.ftocruz.br; mariamurta@id.uff.br; bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; de Abranches, Andrea Dunshee/ABA-8578-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; 
FU CNPq - Conselho Nacional de Pesquisa -BrazilNational Council for
   Scientific and Technological Development (CNPq)
FX CNPq - Conselho Nacional de Pesquisa -Brazil
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   Meio MDBB, 2008, J PERINAT MED, V36, P354, DOI 10.1515/JPM.2008.058
   Belfort MB, 2013, J PEDIATR-US, V163, P1564, DOI 10.1016/j.jpeds.2013.06.032
   BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001
   Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044
   de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005
   Demerath EW, 2017, AM J CLIN NUTR, V105, P70, DOI 10.3945/ajcn.116.138248
   Demerath EW, 2014, AM J HUM BIOL, V26, P291, DOI 10.1002/ajhb.22500
   Embleton ND, 2014, WORLD REV NUTR DIET, V110, P177, DOI 10.1159/000358466
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Gianni ML, 2015, ACTA PAEDIATR, V104, pE119, DOI 10.1111/apa.12856
   Gianni ML, 2012, EARLY HUM DEV, V88, pS13, DOI 10.1016/j.earlhumdev.2011.12.022
   Griffin IJ, 2012, EARLY HUM DEV, V88, pS19, DOI 10.1016/j.earlhumdev.2011.12.023
   Hay WW, 2008, NEONATOLOGY, V94, P245, DOI 10.1159/000151643
   Higgins RD, 2012, J PEDIATR-US, V160, P511, DOI 10.1016/j.jpeds.2011.12.024
   Horbar JD, 2015, PEDIATRICS, V136, pE84, DOI 10.1542/peds.2015-0129
   Huke V, 2013, J PEDIATR-US, V163, P1301, DOI 10.1016/j.jpeds.2013.06.035
   Johnson MJ, 2012, PEDIATRICS, V130, pE640, DOI 10.1542/peds.2011-3379
   Kensara OA, 2005, AM J CLIN NUTR, V82, P980
   Lapillonne A, 2013, J PEDIATR-US, V162, pS7, DOI 10.1016/j.jpeds.2012.11.048
   Ma GS, 2004, AM J CLIN NUTR, V79, P653
   Mamelle N, 2006, EUR J PEDIATR, V165, P717, DOI 10.1007/s00431-005-0045-4
   Martin CR, 2009, PEDIATRICS, V124, P649, DOI 10.1542/peds.2008-3258
   Okada T, 2015, PEDIATR RES, V77, P136, DOI 10.1038/pr.2014.164
   Ong KK, 2015, ACTA PAEDIATR, V104, P974, DOI 10.1111/apa.13128
   Quintal Virginia S., 2014, J. Pediatr. (Rio J.), V90, P556, DOI 10.1016/j.jped.2014.03.001
   Raiten DJ, 2016, AM J CLIN NUTR, V103, p648S, DOI 10.3945/ajcn.115.117309
   Ramel SE, 2011, J PEDIATR GASTR NUTR, V53, P333, DOI 10.1097/MPG.0b013e3182243aa7
   Rice MS, 2015, NUTR CLIN PRACT, V30, P625, DOI 10.1177/0884533615578917
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Rochow N, 2016, PEDIATR RES, V79, P870, DOI 10.1038/pr.2016.15
   Roggero P., 2014, ITAL J PEDIAT S2, V40, pA27
   Roggero P, 2012, PEDIATR RES, V72, P316, DOI 10.1038/pr.2012.75
   Roggero P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014489
   Roggero P, 2009, EARLY HUM DEV, V85, P349, DOI 10.1016/j.earlhumdev.2008.12.011
   Senterre T, 2014, WORLD REV NUTR DIET, V110, P201, DOI 10.1159/000358468
   SHENNAN AT, 1988, PEDIATRICS, V82, P527
   Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P427, DOI 10.1016/j.jped.2014.04.004
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   Tudehope D, 2013, J PEDIATR-US, V162, pS72, DOI 10.1016/j.jpeds.2012.11.056
   Urlando A, 2003, PEDIATR RES, V53, P486, DOI 10.1203/01.PDR.0000049669.74793.E3
   van de Lagemaat M, 2014, EUR J CLIN NUTR, V68, P1261, DOI 10.1038/ejcn.2014.182
   Villar J, 2010, ARCH DIS CHILD, V95, P1034, DOI 10.1136/adc.2009.175067
NR 44
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-3782
EI 1872-6232
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD FEB
PY 2018
VL 117
BP 90
EP 95
DI 10.1016/j.earlhumdev.2018.01.007
PG 6
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GB9KF
UT WOS:000429392000015
PM 29360048
DA 2020-12-17
ER

PT J
AU Freire, IM
   Pone, SM
   Ribeiro, MD
   Aibe, MS
   Pone, MVD
   Moreira, MEL
   Dupret, L
AF Freire, Imara Moreira
   Pone, Sheila Moura
   Ribeiro, Milena da Cunha
   Aibe, Mitsue Senra
   da Silva Pone, Marcos Vinicius
   Lopes Moreira, Maria Elisabeth
   Dupret, Leila
TI Congenital Zika virus syndrome in infants: repercussions for the
   promotion of families' mental health
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus; Mental Health; Infant; Family Relations
AB This article aims to discuss the impacts of the promotion of families' mental health following the diagnosis of Zika virus infection in the pregnant woman and/or congenital Zika virus syndrome (CZVS) in the infant. The study also aims to foster reflection on mother-infant bonding in this context. The study is relevant not only because there is still so much to learn about CZVS, with its enormous capacity for dispersion and many doubts as to the physical consequences and psychological impacts, but also due to the urgent need to provide families and/or caregivers with guidelines for care and alternatives for dealing with the illness. The study was conducted in an outpatient clinic specifically providing care to children with CZVS at the Unit for Infectious Diseases in Pediatrics in a tertiary hospital of the Brazilian Unified National Health System (SUS) in Rio de Janeiro, Brazil. The team is multidisciplinary, and each member conducts an assessment based on their specific field of knowledge. This qualitative study drew on participant observation, and the data analysis showed that the use of virtual social networks, which function (independently of the medicine approaches) as channels for communication and collective discussion of the different experiences, in order to share strategies to overcome the diagnosed impossibilities.
C1 [Freire, Imara Moreira; Pone, Sheila Moura; Ribeiro, Milena da Cunha; Aibe, Mitsue Senra; da Silva Pone, Marcos Vinicius; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Dupret, Leila] Univ Fed Rural Rio de Janeiro, Nova Iguacu, Brazil.
RP Freire, IM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM imara.freire@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019
OI da Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Moura Pone,
   Sheila/0000-0002-6246-8915
CR BARSAGLINI R.A, 2013, ADOECIMENTOS SOFRIME, P70
   Bezerra Junior B, 1992, CIDADANIA LOUCURA PO, P134
   Dimenstein MDB, 1998, ESTUDOS PSICOLOGIA, V3, P53, DOI DOI 10.1590/S1413-294X1998000100004
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   GONZALEZ REY F. L., 2005, PESQUISA QUALITATIVA
   Haguette TMF, 1995, METODOLOGIAS QUALITA
   Ministerio da Saude, 2017, AP PSIC MULH GEST FA
NR 7
TC 4
Z9 4
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 9
AR e00176217
DI 10.1590/0102-311X00176217
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GT4KD
UT WOS:000444471900001
PM 30208181
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Moreira, MCN
   Nascimento, M
   Mendes, CHF
   Pinto, M
   Valongueiro, S
   Moreira, MEL
   Lyra, TM
   Kuper, H
AF Nunes Moreira, Martha Cristina
   Nascimento, Marcos
   Figueira Mendes, Corina Helena
   Pinto, Marcia
   Valongueiro, Sandra
   Lopes Moreira, Maria Elisabeth
   Lyra, Tereza Maciel
   Kuper, Hannah
CA SEIZ Res Grp
TI Emergency and permanence of the Zika virus epidemic: an agenda
   connecting research and policy
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Nunes Moreira, Martha Cristina; Nascimento, Marcos; Figueira Mendes, Corina Helena; Pinto, Marcia; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716,2o Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Valongueiro, Sandra] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, London, England.
RP Moreira, MCN (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716,2o Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM moreira@iff.fiocruz.br
RI Moreira, Martha Cristina Nunes/AAQ-5567-2020
OI Nascimento, Marcos/0000-0002-3363-4232; Fernandes,
   Silke/0000-0001-7694-4233
FU Horizon 2020, the European Union's Framework Programme for Research and
   Innovation, under the Zika Preparedness Latin American Network
   (ZikaPLAN) of the United Kingdom's Department for International
   Development (DFID) [734584]; Wellcome TrustWellcome Trust
   [206016/Z/16/A]; Brazilian National Research Council (CNPq)National
   Council for Scientific and Technological Development (CNPq); Rio de
   Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Our funding was provided by the Horizon 2020, the European Union's
   Framework Programme for Research and Innovation, under the Zika
   Preparedness Latin American Network (ZikaPLAN) grant agreement n. 734584
   of the United Kingdom's Department for International Development (DFID)
   and Wellcome Trust (206016/Z/16/A). We thank the Brazilian National
   Research Council (CNPq) and the Rio de Janeiro State Research Foundation
   (FAPERJ) for the funding of research productivity for the students M. C.
   N. Moreira and M. E. L. Moreira.
CR Aquino EML, 2014, CAD SAUDE PUBLICA, V30, P2005, DOI 10.1590/0102-311X00009214
   Vignola RCB, 2014, J AFFECT DISORDERS, V155, P104, DOI 10.1016/j.jad.2013.10.031
   da Silva A. C. R., 2017, REV ANTHR, V28, P223
   Diniz D, 2016, RECIIS ONLINE, V10, P1
   do Brasil Governo, GOV AC AC EM DIANT A
   FLEISCHER S., 2017, CADERNOS GENERO DIVE, V3, P93
   Governo do Brasil, MIN SAUD DECL FIM EM
   LATOUR Bruno, 2012, REAGREGANDO SOCIAL I
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Mauss Marcel, 2003, SOCIOLOGIA ANTROPOLO, P183
   Nacoes Unidas no Brasil, OMS DECL VIR ZIK MIC
   Moreira MCN, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00189516, 10.1590/0102-311x00189516]
   Organizacao Pan-Americana da Saude; Orga-nizacao Mundial da Saude, OMS DECL FIM EM SAUD
   Scarpelli AC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-35
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Secretaria de Atencao a Saude Ministerio da Saude, 2016, PROT AT SAUD RESP OC
   SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B
NR 17
TC 4
Z9 4
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 8
AR e00075718
DI 10.1590/0102-311X00075718
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GR2PF
UT WOS:000442418000001
PM 30133655
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU de Vasconcelos, ZFM
   Azevedo, RC
   Thompson, N
   Gomes, L
   Guida, L
   Moreira, MEL
AF Meira de Vasconcelos, Zilton Farias
   Azevedo, Renata Campos
   Thompson, Nathalia
   Gomes, Leonardo
   Guida, Leticia
   Lopes Moreira, Maria Elisabeth
TI Challenges for molecular and serological ZIKV infection confirmation
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE ZIKV; Arboviruses; RT-PCR; Serology; PRNT; Vertical transmission;
   Microcephaly
ID FEMALE GENITAL-TRACT; SEXUAL TRANSMISSION; VIRUS-INFECTION; DENGUE;
   BRAZIL; ASSOCIATION; CHIKUNGUNYA; OUTBREAK; SALIVA
AB Zika Virus (ZIKV), member of Flaviviridae family and Flavivirus genus, has recently emerged as international public health emergency after its association with neonatal microcephaly cases. Clinical diagnosis hindrance involves symptom similarities produced by other arbovirus infections, therefore laboratory confirmation is of paramount importance.
   The most reliable test available is based on ZIKV RNA detection from body fluid samples. However, short viremia window periods and asymptomatic infections diminish the success rate for RT-PCR positivity. Beyond molecular detection, all serology tests in areas where other Flavivirus circulates proved to be a difficult task due to the broad range of cross-reactivity, especially with dengue pre-exposed individuals.
   Altogether, lack of serological diagnostic tools brings limitations to any retrospective evaluation. Those studies are central in the context of congenital infection that could occur asymptomatically and mask prevalence and risk rates.
C1 [Meira de Vasconcelos, Zilton Farias; Thompson, Nathalia; Gomes, Leonardo; Guida, Leticia; Lopes Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Avenida Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Azevedo, Renata Campos] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
RP de Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Avenida Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM zvasconcelos@iff.fiocruz.br
RI Azevedo, Renata/V-3130-2019; Vasconcelos, Zilton/AAD-5784-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224
FU Fernandes Figueira Institute Research Program (Programa de Incentivo a
   Pesquisa II); Rio de Janeiro State Research Grant (Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro) [E-26/201.840/2017]; National
   Research Grant (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico) [441098/2016-9]; CAPES/FIOCRUZ fellowship (Plano Brasil sem
   Miseria)
FX This work was supported by Fernandes Figueira Institute Research Program
   (Programa de Incentivo a Pesquisa II), Rio de Janeiro State Research
   Grant (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-grant
   E-26/201.840/2017), National Research Grant (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-grant 441098/2016-9), and
   CAPES/FIOCRUZ fellowship (Plano Brasil sem Miseria).
CR Alcon-LePoder S, 2006, Novartis Found Symp, V277, P233, DOI 10.1002/0470058005.ch17
   Alcon- LePoder S, 2006, NOVART FDN SYMP, V277, P247
   Ambrose JH, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8072491
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   deMFreire CC, 2015, BIORXIV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oom AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05980-z
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658089, 10.1590/s1678-9946201658089]
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weltman JK, 2016, J MED MICROB DIAGN
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 11
Z9 11
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JAN
PY 2018
VL 34
IS 1
BP 79
EP 84
DI 10.1007/s00381-017-3641-5
PG 6
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA FS7GQ
UT WOS:000419966300016
PM 29110196
DA 2020-12-17
ER

PT J
AU Leal, MD
   Esteves-Pereira, AP
   Nakamura-Pereira, M
   Domingues, RMSM
   Dias, MAB
   Moreira, ME
   Theme, M
   da Gama, SGN
AF Leal, Maria Do Carmo
   Esteves-Pereira, Ana Paula
   Nakamura-Pereira, Marcos
   Soares Madeira Domingues, Rosa Maria
   Bastos Dias, Marcos Augusto
   Moreira, Maria Elisabeth
   Theme-Filha, Mariza
   Nogueira da Gama, Silvana Granado
TI Burden of early-term birth on adverse infant outcomes: a
   population-based cohort study in Brazil
SO BMJ OPEN
LA English
DT Article
ID LATE-PRETERM; NEONATAL MORBIDITY; CESAREAN-SECTIONS; GESTATIONAL-AGE;
   DELIVERY; RISK
AB Objectives To estimate the national rate of early-term live births in Brazil and to evaluate the effect of birth at 37 and 38 weeks' gestation, as compared with 39 and 40 weeks' gestation on infant outcomes according to precursors of birth and the existence of maternal/fetal medical conditions.
   Design National perinatal population-based cohort study.
   Setting 266 maternity services located in the five Brazilian macroregions.
   Participants 18 652 singleton live newborns from 37 0/7 to 40 6/7 weeks of gestation.
   Main outcome measures Resuscitation in delivery room, oxygen therapy, transient tachypnoea, admission to neonatal intensive care unit (NICU), hypoglycaemia, use of antibiotics, phototherapy, phototherapy after hospital discharge, neonatal death and breastfeeding.
   Results Early terms accounted for 35% (95% CI 33.4% to 36.7%) of all live births. Among provider-initiated births in women without medical conditions, infants of 37 and 38 weeks' gestation had higher odds of oxygen therapy (adjusted OR (AOR) 2.93, 95% CI 1.72 to 4.98 and AOR 1.92 95% CI 1.18 to 3.13), along with admission to NICU (AOR 2.01, 95% CI 1.18 to 3.41 and AOR 1.56, 95% CI 1.02 to 2.60), neonatal death (AOR 14.40, 95% CI 1.94 to 106.69 and AOR 13.76,95% CI 2.84 to 66.75), hypoglycaemia in the first 48 hours of life (AOR 7.86, 95% CI 1.95 to 31.71 and AOR 5.76, 95% CI 1.63 to 20.32), transient tachypnoea (AOR 2.98, 95% CI 1.57 to 5.65 and AOR 2.12, 95% CI 1.00 to 4.48) and the need for phototherapy within the first 72 hours of life (AOR 3.59, 95% CI 1.95 to 6.60 and AOR 2.29, 95% CI 1.49 to 3.53), yet lower odds of breastfeeding up to 1 hour after birth (AOR 0.67, 95% CI 0.53 to 0.86 and AOR 0.87, 95% CI 0.76 to 0.99) and exclusive breastfeeding during hospital stay (AOR 0.68, 95% CI 0.51 to 0.89 and AOR 0.84, 95% CI 0.71 to 0.99).
   Conclusion Birth at 37 and 38 weeks' gestation increased the risk of most adverse infant outcomes analysed, especially among provider-initiated births and should be avoided before 39 weeks' gestation in healthy pregnancies.
C1 [Leal, Maria Do Carmo; Esteves-Pereira, Ana Paula; Theme-Filha, Mariza; Nogueira da Gama, Silvana Granado] Fundacao Oswaldo Cruz, Dept Epidemiol & Quantitat Methods Hlth, Womens Childrens & Adolescents Res Grp, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Nakamura-Pereira, Marcos; Bastos Dias, Marcos Augusto; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Figueira Natl Inst Womens Childrens & Adolescent, Rio De Janeiro, Brazil.
   [Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Res Lab STI Aids, Natl Inst Infect Dis, Rio De Janeiro, Brazil.
RP Domingues, RMSM (corresponding author), Fundacao Oswaldo Cruz, Res Lab STI Aids, Natl Inst Infect Dis, Rio De Janeiro, Brazil.
EM rosa.domingues@ini.fiocruz.br
RI Domingues, Rosa/AAS-3606-2020; Nakamura-Pereira, Marcos/X-1107-2019
OI Domingues, Rosa/0000-0001-5722-8127; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205
FU Ministerio da Ciencia, Tecnologia e Inovacao - Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz
FX This work was supported by the Ministerio da Ciencia, Tecnologia e
   Inovacao - Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro and Fundacao Oswaldo Cruz. The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P904, DOI 10.1097/01.AOG.0000428647.67925.d3
   Bailey BA, 2014, SOUTH MED J, V107, P624, DOI 10.14423/SMJ.0000000000000176
   Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI 10.1590/s0034-89102011005000039
   Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896
   Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251
   Chiossi G, 2013, OBSTET GYNECOL, V121, P561, DOI 10.1097/AOG.0b013e3182822193
   Clark SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.036
   Dietz PM, 2012, J PEDIATR-US, V161, P234, DOI 10.1016/j.jpeds.2012.02.005
   Edwards MO, 2015, J ALLERGY CLIN IMMUN, V136, P581, DOI 10.1016/j.jaci.2015.05.005
   Engle WA, 2008, CLIN PERINATOL, V35, P325, DOI 10.1016/j.clp.2008.03.003
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Ganchimeg T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149091
   Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE
   Leal MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155511
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Nakamura-Pereira M, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0228-7
   NICE, 2011, CAES SECT CLIN GUID
   Parikh L, 2014, J MATERN-FETAL NEO M, V27, P1158, DOI 10.3109/14767058.2013.851190
   Parikh LI, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.021
   Potter JE, 2008, BIRTH-ISS PERINAT C, V35, P33, DOI 10.1111/j.1523-536X.2007.00209.x
   Prefumo F, 2016, J MATERN-FETAL NEO M, V29, P1334, DOI 10.3109/14767058.2015.1047758
   Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232
   Richards JL, 2016, JAMA-J AM MED ASSOC, V316, P410, DOI 10.1001/jama.2016.9635
   Rubin D.B., 1987, MULTIPLE IMPUTATION
   Schonhaut L, 2015, PEDIATRICS, V135, pE835, DOI 10.1542/peds.2014-1957
   Sengupta S, 2013, JAMA PEDIATR, V167, P1053, DOI 10.1001/jamapediatrics.2013.2581
   Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113
   Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999
   Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267
   White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067
NR 30
TC 14
Z9 14
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD DEC
PY 2017
VL 7
IS 12
AR e017789
DI 10.1136/bmjopen-2017-017789
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA FU4MH
UT WOS:000423826700079
PM 29284716
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, J
   Vasconcelos, Z
   Adachi, K
   Valderramos, S
   Halai, UA
   Pone, MVD
   Pone, SM
   Silveira, JCB
   Aibe, MS
   da Costa, ACC
   Zin, OA
   Belfort, R
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia
   Vasconcelos, Zilton
   Adachi, Kristina
   Valderramos, Stephanie
   Halai, Umme-Aiman
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Barros Silveira Filho, Joel Carlos
   Aibe, Mitsue S.
   da Costa, Ana Carolina C.
   Zin, Olivia A.
   Belfort, Rubens, Jr.
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Screening Criteria for Ophthalmic Manifestations of Congenital Zika
   Virus Infection
SO JAMA PEDIATRICS
LA English
DT Article
ID INFANTS; VIREMIA
AB IMPORTANCE Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero.
   OBJECTIVE To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy.
   DESIGN, SETTING, AND PARTICIPANTS In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil.
   PARTICIPANTS Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus.
   MAIN OUTCOMES AND MEASURES Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection.
   RESULTS Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2).
   CONCLUSIONS AND RELEVANCE Eye abnormalitiesmay be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
C1 [Zin, Andrea A.; Rossetto, Julia; Vasconcelos, Zilton; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Tsui, Irena; Halai, Umme-Aiman] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Rossetto, Julia; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Valderramos, Stephanie] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Aibe, Mitsue S.] Fundacao Oswaldo Cruz, Dept Doencas Infecciosas, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Zin, Olivia A.] Hosp Fed Servidores Estado, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Vasconcelos,
   Zilton/AAD-5784-2019; Gaw, Stephanie/K-4592-2019
OI Vasconcelos, Zilton/0000-0002-2193-2224; Gaw,
   Stephanie/0000-0003-0891-6964; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI28697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent Blindness grantResearch to Prevent Blindness (RPB);
   Thrasher Research Fund [20164370]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source:
   NIH RePORTER
FX This study was supported by grant 441098/2016-9 from the Brazilian
   National Council for Scientific and Technological Development, grant AI
   AI28697 from the National Institute of Allergy and Infectious Diseases,
   and grant R21EY028318-01 from the National Eye Institute. Dr Tsui was
   supported in part by an unrestricted Research to Prevent Blindness grant
   given to the Stein Eye Institute. Dr Adachi was supported in part by
   grant 20164370 from the Thrasher Research Fund.
CR [Anonymous], 2016, MMWR MORB MORTA 0819
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maa AY, 2017, TELEMED E-HEALTH, V23, P42, DOI 10.1089/tmj.2016.0039
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pasquel Francisco J, 2015, J Diabetes Sci Technol, V10, P301, DOI 10.1177/1932296815624109
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Sadler T.W., 2015, LANGMANS MED EMBRYOL
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vinekar A, 2015, SEMIN FETAL NEONAT M, V20, P335, DOI 10.1016/j.siny.2015.05.002
NR 26
TC 37
Z9 38
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD SEP
PY 2017
VL 171
IS 9
BP 847
EP 854
DI 10.1001/jamapediatrics.2017.1474
PG 8
WC Pediatrics
SC Pediatrics
GA FG3XL
UT WOS:000410140700011
PM 28715527
OA Green Published
DA 2020-12-17
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Ferreira, Thales Araujo/AAA-6252-2019;
   Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016; Moll,
   Fernanda Tovar/N-3320-2018; Rehen, Stevens K/J-5874-2012; ANDRADE,
   CECILIA/B-5916-2017
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Moll, Fernanda Tovar/0000-0002-0292-5985; Rehen,
   Stevens K/0000-0003-4216-9501; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182; FERREIRA, THALES/0000-0002-6699-5886;
   ANDRADE, CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI111598, U01AI111598, U01AI111598,
   U01AI111598, U01AI111598, U01AI111598] Funding Source: NIH RePORTER;
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: researchfish
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220, DOI DOI 10.4172/2314-7326.1000220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 74
Z9 77
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-12-17
ER

PT J
AU Zin, A
   Rosseto, J
   Tsui, I
   Zin, O
   Silveira, J
   Vasconcelos, Z
   Moreira, MEL
AF Zin, Andrea
   Rosseto, Julia
   Tsui, Irena
   Zin, Olivia
   Silveira, Joel
   Vasconcelos, Zilton
   Lopes Moreira, Maria Elisabeth
TI Prescription of overplus of+3.00 D to Infants with Severe Visual
   Impairment due to Congenital Zika Virus Syndrome
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Zin, Andrea; Rosseto, Julia; Silveira, Joel; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fernandes Figueira Inst, Clin Res Unit, Rio De Janeiro, RJ, Brazil.
   [Tsui, Irena] Jules Stein Eye Inst, Ophthalmol, Los Angeles, CA 90024 USA.
   [Zin, Olivia] Hosp Fed Servidores Estado, Ophthalmol, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 4673
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176303417
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU do Amaral, YND
   Marano, D
   da Silva, LML
   Guimaraes, ACLD
   Moreira, MEL
AF di Villarosa do Amaral, Yasmin Notarbartolo
   Marano, Daniele
   Lopes da Silva, Leila Maria
   Lia Dias Guimaraes, Aline Carnevale
   Lopes Moreira, Maria Elisabeth
TI Are There Changes in the Fatty Acid Profile of Breast Milk with
   Supplementation of Omega-3 Sources? A Systematic Review
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Review
DE pregnant women; breastfeeding; human milk; omega-3 fatty acids;
   systematic review
ID RANDOMIZED CONTROLLED-TRIAL; FISH-OIL SUPPLEMENTATION; DOCOSAHEXAENOIC
   ACID; ARACHIDONIC-ACID; LACTATING WOMEN; DHA SUPPLEMENTATION; LATE
   PREGNANCY; CHAIN; N-3; LIPIDS
AB Purpose To evaluate the effect of supplementation with omega-3 sources on the fatty acid composition of human milk.
   Methods The review consisted of the search for articles published in PubMed, Biblioteca Virtual de Saude (Virtual Health Library[VHL]) and Web of Science databases using the following keywords: fatty acids, omega-3, human milk and supplementation; for this purpose, we have used the program of research to integrate the services for the maintenance of autonomy (PRISMA) checklist. The following selection criteria were used: articles in English, Portuguese, Spanish or Italian, published between 2000 and 2015, and about studies performed in humans. We found 710 articles that met the established criteria; however, only 22 of them were selected to be part of this study.
   Results All studies found a positive relationship between the consumption of omega-3 sources and their concentration in human milk. The differences in the findings are due to the distinct methods used, such as the specific time of the omega-3 supplementation, the type of omega-3 source offered, as well as the sample size.
   Conclusion Although the studies were different in several methodological aspects, it was possible to observe the importance of omega-3 supplementation during gestation and/or the puerperium.
C1 [di Villarosa do Amaral, Yasmin Notarbartolo; Marano, Daniele; Lopes da Silva, Leila Maria; Lia Dias Guimaraes, Aline Carnevale; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Clin Res Unit, Rio De Janeiro, RJ, Brazil.
RP do Amaral, YND (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Unidade Pesquisa Clin, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM yasminamaral@hotmail.com
CR Agostoni C, 2008, J PEDIATR GASTR NUTR, V47, pS41, DOI 10.1097/01.mpg.0000338811.52062.b2
   Atalah E, 2009, ARCH LATINOAM NUTR, V59, P271
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Bergmann RL, 2008, ANN NUTR METAB, V52, P157, DOI 10.1159/000129651
   Bonham MP, 2008, PROSTAG LEUKOTR ESS, V78, P343, DOI 10.1016/j.plefa.2008.04.005
   Boris J, 2004, LIPIDS, V39, P1191, DOI 10.1007/s11745-004-1347-7
   Brenna JT, 2007, AM J CLIN NUTR, V85, P1457
   Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013
   Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021
   Denomme J, 2005, J NUTR, V135, P206
   Dunstan JA, 2007, PEDIATR RES, V62, P689, DOI 10.1203/PDR.0b013e318159a93a
   Bortolozo EAFQ, 2013, REV NUTR, V26, P27, DOI 10.1590/S1415-52732013000100003
   Fidler N, 2000, J LIPID RES, V41, P1376
   Francois CA, 2003, AM J CLIN NUTR, V77, P226
   Gaete G. Marcela, 2003, Rev. chil. pediatr., V74, P158, DOI 10.4067/S0370-41062003000200003
   Gaete G. Marcela, 2002, Rev. chil. pediatr., V73, P239, DOI 10.4067/S0370-41062002000300004
   HARRIS WS, 1984, AM J CLIN NUTR, V40, P780
   Hawkes JS, 2001, LIPIDS, V36, P1179, DOI 10.1007/s11745-001-0830-5
   HENDERSON RA, 1992, LIPIDS, V27, P863, DOI 10.1007/BF02535865
   Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S
   Holub BJ, 2002, CAN MED ASSOC J, V166, P608
   Imhoff-Kunsch B, 2011, PEDIATRICS, V128, pE505, DOI 10.1542/peds.2010-1386
   Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666
   Jensen CL, 2000, AM J CLIN NUTR, V71, p292S, DOI 10.1093/ajcn/71.1.292s
   Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001
   Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747
   Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S
   KUS MM, 2010, ACIDOS GRAXOS EICOSA, DOI DOI 10.1016/J.PLEFA.2006.05.013
   Makrides M, 2000, AM J CLIN NUTR, V71, p307S, DOI 10.1093/ajcn/71.1.307S
   Makrides M, 2008, J AM DIET ASSOC, V108, P1622, DOI 10.1016/j.jada.2008.07.003
   Marc I, 2011, J NUTR, V141, P231, DOI 10.3945/jn.110.125880
   MOHER D, 2009, LOS MED, V6
   Nishimura RY, 2014, NUTRITION, V30, P685, DOI 10.1016/j.nut.2013.11.002
   Olafsdottir AS, 2006, ANN NUTR METAB, V50, P270, DOI 10.1159/000091685
   Patin Rose V., 2006, J. Pediatr. (Rio J.), V82, P63, DOI [10.1590/S0021-75572006000100013, 10.2223/JPED.1439]
   Ribeiro P, 2012, INT J FOOD SCI NUTR, V63, P36, DOI 10.3109/09637486.2011.593714
   Rogers LK, 2013, PHARMACOL RES, V70, P13, DOI 10.1016/j.phrs.2012.12.003
   Sherry CL, 2015, PROSTAG LEUKOTR ESS, V95, P63, DOI 10.1016/j.plefa.2015.01.005
   Smit EN, 2000, PROSTAG LEUKOTR ESS, V62, P335, DOI 10.1054/plef.2000.0163
   Smithers LG, 2010, PROSTAG LEUKOTR ESS, V83, P9, DOI 10.1016/j.plefa.2010.02.034
   Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893
   Valentine CJ, 2013, BREASTFEED MED, V8, P86, DOI 10.1089/bfm.2011.0126
   van Goor SA, 2009, PROSTAG LEUKOTR ESS, V80, P65, DOI 10.1016/j.plefa.2008.11.002
   Weseler AR, 2008, J NUTR, V138, P2190, DOI 10.3945/jn.108.089318
   Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473
NR 45
TC 7
Z9 7
U1 0
U2 11
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAR
PY 2017
VL 39
IS 3
BP 128
EP 141
DI 10.1055/s-0037-1599094.ISSN0100-7203
PG 14
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4QZ
UT WOS:000410251800007
PM 28315281
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Amaral, Y
   Marano, D
   Silva, L
   Guimaraes, A
   Moreira, ME
AF Amaral, Yasmin
   Marano, Daniele
   Silva, Leila
   Guimaraes, Aline
   Moreira, Maria Elisabeth
TI ARE THERE CHANGES IN THE FATTY ACID PROFILE IN BREAST MILK WITH
   SUPPLEMENTATION OF OMEGA 3 SOURCES? A SYSTEMATIC REVIEW
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Meeting Abstract
DE Pregnant women; Breastfeeding; Human milk; Omega-3 Fatty Acids;
   Systematic review
C1 [Amaral, Yasmin; Marano, Daniele; Silva, Leila; Guimaraes, Aline; Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 71
SU 2
MA 144/2319
BP 599
EP 599
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FM9QD
UT WOS:000415605301349
DA 2020-12-17
ER

PT J
AU Ferreira, INA
   Soares, FVS
   da Costa, ACC
   Novak, FR
   Moreira, MEL
AF Nascimento Alves Ferreira, Isabella
   Valente Mendes Soares, Fernanda
   Carioca da Costa, Ana Carolina
   Reis Novak, Franz
   Lopes Moreira, Maria Elisabeth
TI SUPPLEMENTATION OF HUMAN MILK AND ITS OSMOLALITY
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Meeting Abstract
DE Human milk; Osmolality; Newborns; Fortifiers; Food Safety
C1 [Nascimento Alves Ferreira, Isabella] Fernandes Figueira Inst FIOCRUZ, Rio De Janeiro, Brazil.
   [Valente Mendes Soares, Fernanda; Carioca da Costa, Ana Carolina; Reis Novak, Franz; Lopes Moreira, Maria Elisabeth] Fernandes Figueira Inst, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 71
SU 2
MA 144/2225
BP 816
EP 816
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FM9QD
UT WOS:000415605302001
DA 2020-12-17
ER

PT J
AU Amaral, Y
   Marano, D
   Costa, AC
   Moreira, ME
AF Amaral, Yasmin
   Marano, Daniele
   Costa, Ana Carolina
   Moreira, Maria Elisabeth
TI FACTORS ASSOCIATED WITH MATERNAL PROFILE AND NEWBORNS WITH GASTROSCHISIS
   TREATED AT A REFERENCE CENTER IN THE CITY OF RIO DE JANEIRO
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Meeting Abstract
DE Gastroschisis; Epidemiology; Child Health
C1 [Amaral, Yasmin; Marano, Daniele; Costa, Ana Carolina; Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 71
SU 2
MA 144/2314
BP 827
EP 827
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FM9QD
UT WOS:000415605302023
DA 2020-12-17
ER

PT J
AU Brasil, P
   Pereira, JP
   Moreira, ME
   Nogueira, RMR
   Damasceno, L
   Wakimoto, M
   Rabello, RS
   Valderramos, SG
   Halai, UA
   Salles, TS
   Zin, AA
   Horovitz, D
   Daltro, P
   Boechat, M
   Gabaglia, CR
   de Sequeira, PC
   Pilotto, JH
   Medialdea-Carrera, R
   da Cunha, DC
   de Carvalho, LMA
   Pone, M
   Siqueira, AM
   Calvet, GA
   Baiao, AER
   Neves, ES
   de Carvalho, PRN
   Hasue, RH
   Marschik, PB
   Einspieler, C
   Janzen, C
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, P.
   Pereira, J. P., Jr.
   Moreira, M. E.
   Ribeiro Nogueira, R. M.
   Damasceno, L.
   Wakimoto, M.
   Rabello, R. S.
   Valderramos, S. G.
   Halai, U. -A.
   Salles, T. S.
   Zin, A. A.
   Horovitz, D.
   Daltro, P.
   Boechat, M.
   Gabaglia, C. Raja
   Carvalho de Sequeira, P.
   Pilotto, J. H.
   Medialdea-Carrera, R.
   Cotrim da Cunha, D.
   Abreu de Carvalho, L. M.
   Pone, M.
   Machado Siqueira, A.
   Calvet, G. A.
   Rodrigues Baiao, A. E.
   Neves, E. S.
   Nassar de Carvalho, P. R.
   Hasue, R. H.
   Marschik, P. B.
   Einspieler, C.
   Janzen, C.
   Cherry, J. D.
   Bispo de Filippis, A. M.
   Nielsen-Saines, K.
TI Zika Virus Infection in Pregnant Women in Rio de Janeiro
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID BRAZIL; TRANSMISSION; RUBELLA
AB BACKGROUND
   Zika virus (ZIKV) has been linked to central nervous system malformations in fetuses. To characterize the spectrum of ZIKV disease in pregnant women and infants, we followed patients in Rio de Janeiro to describe clinical manifestations in mothers and repercussions of acute ZIKV infection in infants.
   METHODS
   We enrolled pregnant women in whom a rash had developed within the previous 5 days and tested blood and urine specimens for ZIKV by reverse-transcriptase-polymerase-chain-reaction assays. We followed women prospectively to obtain data on pregnancy and infant outcomes.
   RESULTS
   A total of 345 women were enrolled from September 2015 through May 2016; of these, 182 women (53%) tested positive for ZIKV in blood, urine, or both. The timing of acute ZIKV infection ranged from 6 to 39 weeks of gestation. Predominant maternal clinical features included a pruritic descending macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (short-term and low-grade). By July 2016, a total of 134 ZIKV-affected pregnancies and 73 ZIKV-unaffected pregnancies had reached completion, with outcomes known for 125 ZIKV-affected and 61 ZIKV-unaffected pregnancies. Infection with chikungunya virus was identified in 42% of women without ZIKV infection versus 3% of women with ZIKV infection (P<0.001). Rates of fetal death were 7% in both groups; overall adverse outcomes were 46% among offspring of ZIKV-positive women versus 11.5% among offspring of ZIKV-negative women (P<0.001). Among 117 live infants born to 116 ZIKV-positive women, 42% were found to have grossly abnormal clinical or brain imaging findings or both, including 4 infants with microcephaly. Adverse outcomes were noted regardless of the trimester during which the women were infected with ZIKV (55% of pregnancies had adverse outcomes after maternal infection in the first trimester, 52% after infection in the second trimester, and 29% after infection in the third trimester).
   CONCLUSIONS
   Despite mild clinical symptoms in the mother, ZIKV infection during pregnancy is deleterious to the fetus and is associated with fetal death, fetal growth restriction, and a spectrum of central nervous system abnormalities. (Funded by Ministerio da Saude do Brasil and others.)
C1 [Brasil, P.; Pereira, J. P., Jr.; Moreira, M. E.; Ribeiro Nogueira, R. M.; Damasceno, L.; Wakimoto, M.; Rabello, R. S.; Salles, T. S.; Zin, A. A.; Horovitz, D.; Boechat, M.; Carvalho de Sequeira, P.; Pilotto, J. H.; Medialdea-Carrera, R.; Cotrim da Cunha, D.; Abreu de Carvalho, L. M.; Pone, M.; Machado Siqueira, A.; Calvet, G. A.; Rodrigues Baiao, A. E.; Neves, E. S.; Nassar de Carvalho, P. R.; Bispo de Filippis, A. M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Daltro, P.] Clin Diagnost Imagem, Rio De Janeiro, Brazil.
   [Valderramos, S. G.; Halai, U. -A.; Janzen, C.; Cherry, J. D.; Nielsen-Saines, K.] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Gabaglia, C. Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, R. H.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Marschik, P. B.; Einspieler, C.] Med Univ Graz, Graz, Austria.
   [Marschik, P. B.] Karolinska Inst, Stockholm, Sweden.
RP Brasil, P (corresponding author), Fiocruz MS, INI, Lab Doencas Febris Agudas, 4365 Av Brasil, BR-21040900 Rio De Janeiro, RJ, Brazil.; Nielsen-Saines, K (corresponding author), UCLA, David Geffen Sch Med, Div Pediat Infectious Dis, MDCC 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Hasue, Renata
   Hydee/B-2328-2013; Siqueira, Andre M/G-1340-2010; Gaw,
   Stephanie/K-4592-2019; Calvet, GA/G-6959-2013; Pilotto, Jose
   Henrique/AAD-9773-2019; Marschik, Peter B/F-8195-2011
OI Siqueira, Andre M/0000-0003-2208-0294; Gaw,
   Stephanie/0000-0003-0891-6964; Calvet, GA/0000-0002-3545-5238; Pilotto,
   Jose Henrique/0000-0003-0521-8597; Marschik, Peter
   B/0000-0001-8932-0980; Medialdea-Carrera, Raquel/0000-0002-0371-5138; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Ministerio da Saude do Brasil; Medical Research CouncilMedical Research
   Council UK (MRC) [MC_PC_15101] Funding Source: researchfish; Bill &
   Melinda Gates Foundation � Grand Challenges Explorations Initiative
   [OPP1128871] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R21AI129534, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   R21AI129534, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697,
   P30AI028697, P30AI028697, P30AI028697, P30AI028697, P30AI028697] Funding
   Source: NIH RePORTER
FX Funded by Ministerio da Saude do Brasil and others.
CR [Anonymous], 2015, EP AL NEUR SYNDR CON
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cherry JD, 2014, FEIGIN CHERRYS TXB P, P741
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088
   GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NAEYE RL, 1965, J AMER MED ASSOC, V194, P1277, DOI 10.1001/jama.194.12.1277
   Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037
   PLOTKIN SA, 1965, AM J EPIDEMIOL, V81, P71, DOI 10.1093/oxfordjournals.aje.a120499
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1964, OBSTET GYNECOL, V23, P153
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 857
Z9 883
U1 9
U2 209
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 15
PY 2016
VL 375
IS 24
BP 2321
EP 2334
DI 10.1056/NEJMoa1602412
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF0SO
UT WOS:000390036500004
PM 26943629
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Leal, MD
   Esteves-Pereira, AP
   Nakamura-Pereira, M
   Torres, JA
   Theme-Filha, M
   Domingues, RMSM
   Dias, MAB
   Moreira, ME
   Gama, SG
AF Leal, Maria Do Carmo
   Esteves-Pereira, Ana Paula
   Nakamura-Pereira, Marcos
   Torres, Jacqueline Alves
   Theme-Filha, Mariza
   Soares Madeira Domingues, Rosa Maria
   Bastos Dias, Marcos Augusto
   Moreira, Maria Elizabeth
   Gama, Silvana Granado
TI Prevalence and risk factors related to preterm birth in Brazil
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Spontaneous preterm birth; pPROM; Provider-initiated preterm birth; Risk
   factors; Brazil
ID PRENATAL-CARE; CHILD-HEALTH; EPIDEMIOLOGY; DELIVERY; ADEQUACY; MODERATE;
   INFANTS; INDEX
AB Background: The rate of preterm birth has been increasing worldwide, including in Brazil. This constitutes a significant public health challenge because of the higher levels of morbidity and mortality and long-term health effects associated with preterm birth. This study describes and quantifies factors affecting spontaneous and provider-initiated preterm birth in Brazil.
   Methods: Data are from the 2011-2012 "Birth in Brazil" study, which used a national population-based sample of 23,940 women. We analyzed the variables following a three-level hierarchical methodology. For each level, we performed non-conditional multiple logistic regression for both spontaneous and provider-initiated preterm birth.
   Results: The rate of preterm birth was 11.5 %, (95 % confidence 10.3 % to 12.9 %) 60.7 % spontaneous with spontaneous onset of labor or premature preterm rupture of membranes - and 39.3 % provider-initiated, with more than 90 % of the last group being pre-labor cesarean deliveries. Socio-demographic factors associated with spontaneous preterm birth were adolescent pregnancy, low total years of schooling, and inadequate prenatal care. Other risk factors were previous preterm birth (OR 3.74; 95 % CI 2.92-4.79), multiple pregnancy (OR 16.42; 95 % CI 10.56-25.53), abruptio placentae (OR 2.38; 95 % CI 1.27-4.47) and infections (OR 4.89; 95 % CI 1.72-13.88). In contrast, provider-initiated preterm birth was associated with private childbirth healthcare (OR 1.47; 95 % CI 1.09-1.97), advanced-age pregnancy (OR 1.27; 95 % CI 1.01-1.59), two or more prior cesarean deliveries (OR 1.64; 95 % CI 1.19-2.26), multiple pregnancy (OR 20.29; 95 % CI 12.58-32.72) and any maternal or fetal pathology (OR 6.84; 95 % CI 5.56-8.42).
   Conclusion: The high proportion of provider-initiated preterm birth and its association with prior cesarean deliveries and all of the studied maternal/fetal pathologies suggest that a reduction of this type of prematurity may be possible. The association of spontaneous preterm birth with socially-disadvantaged groups reaffirms that the reduction of social and health inequalities should continue to be a national priority.
C1 [Leal, Maria Do Carmo; Esteves-Pereira, Ana Paula; Theme-Filha, Mariza; Gama, Silvana Granado] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rua Leopoldo Bulhoes 1480,Sala 809, BR-21041210 Rio De Janeiro, Brazil.
   [Nakamura-Pereira, Marcos; Bastos Dias, Marcos Augusto; Moreira, Maria Elizabeth] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Ave Rui Barbosa 716 Flamengo, Rio De Janeiro, RJ, Brazil.
   [Torres, Jacqueline Alves] Minist Hlth, Natl Hlth Agcy, Av Augusto Severo 84 Gloria, BR-20021040 Rio De Janeiro, RJ, Brazil.
   [Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Natl Inst Infect Dis, Ave Brasil 4-365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Leal, MD (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rua Leopoldo Bulhoes 1480,Sala 809, BR-21041210 Rio De Janeiro, Brazil.
EM ducaleal@gmail.com
RI Domingues, Rosa/AAS-3606-2020; Nakamura-Pereira, Marcos/O-4496-2014;
   Nakamura-Pereira, Marcos/X-1107-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Domingues, Rosa/0000-0001-5722-8127; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Miranda Theme Filha,
   Mariza/0000-0002-7075-9819
FU National Council of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); National School of Public Health, Oswaldo Cruz Foundation (INOVA
   Project); Research Funding Agency of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX This work was supported by the funding from the National Council of
   Technological and Scientific Development (CNPq); the National School of
   Public Health, Oswaldo Cruz Foundation (INOVA Project); and the Research
   Funding Agency of the State of Rio de Janeiro (FAPERJ).
CR Adams-Chapman I, 2006, CLIN PERINATOL, V33, P947, DOI 10.1016/j.clp.2006.09.004
   Bannerman CG, 2011, AM J OBSTET GYNECOL, V204, P459, DOI [10.1016/j.ajog.2011.02.075, 10.1016/j.ajog.2011.02.004]
   BRASIL. Ministerio da Saude (BR), 2006, 5 BRASIL MIN SAUD A
   Brown HK, 2015, BJOG-INT J OBSTET GY, V122, P491, DOI 10.1111/1471-0528.13191
   Bittencourt SDD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176913
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Fuchs K, 2008, CLIN PERINATOL, V35, P343, DOI 10.1016/j.clp.2008.03.004
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007
   Gyamfi-Bannerman C, 2014, OBSTET GYNECOL, V124, P1069, DOI 10.1097/AOG.0000000000000546
   Holland MG, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.066
   Khan KA, 2015, BJOG-INT J OBSTET GY, V122, P1495, DOI 10.1111/1471-0528.13515
   KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414
   Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   Leal MC, 2004, CAD SAUDE PUBLICA S1, V20, P63, DOI DOI 10.1590/S0102-311X2004000700007
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Lisonkova S, 2012, BJOG-INT J OBSTET GY, V119, P1630, DOI 10.1111/j.1471-0528.2012.03403.x
   Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10
   Machado LC, 2014, J PEDIAT-BRAZIL, V90, P221, DOI 10.1016/j.jped.2013.08.012
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60
   Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009
   Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018
   Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007
   Silveira MF, 2013, BJOG-INT J OBSTET GY, V120, P81, DOI 10.1111/1471-0528.12046
   Domingues RMSM, 2015, REV PANAM SALUD PUBL, V37, P140
   Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
NR 33
TC 24
Z9 26
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD OCT 17
PY 2016
VL 13
SU 3
AR 127
DI 10.1186/s12978-016-0230-0
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH1RW
UT WOS:000410918100001
PM 27766978
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Moreira, ME
   Pereira, APE
   Gomesr, SC
   Guinsburg, R
   de Almeida, MFB
   Gama, SG
   Leal, MD
AF Moreira, Maria Elisabeth
   Esteves Pereira, Ana Paula
   Gomes Junior, Saint Clair
   Guinsburg, Ruth
   Branco de Almeida, Maria Fernanda
   Gama, Silvana Granado
   Leal, Maria do Carmo
TI Factors associated with the use of supplemental oxygen or positive
   pressure ventilation in the delivery room, in infants born with a
   gestational age >= 34 weeks
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE C-section; Late preterm; Early term; Positive pressure ventilation
ID CARDIOVASCULAR CARE SCIENCE; ELECTIVE CESAREAN-SECTION; LATE-PRETERM;
   CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL CONSENSUS; OUTCOMES; TERM;
   POPULATION; MORTALITY; IMPACT
AB Background: Approximately 5-10 % of newborns require some form of resuscitationupon delivery; several factors, such as maternal abnormal conditions, gestational age and type of delivery could be responsible for this trend. This study aimed to describe the factors associated with the need for positive pressure ventilation (PPV) via a mask or endotracheal tube and the use of supplemental O2 in newborns with a gestational age greater than 34 weeks in Brazil.
   Methods: We performed a cross-sectional study and obtained data from the Birth in Brazil Survey. The inclusion criterion was a gestational age >= 34 weeks. Exclusion criteria were newborns with congenital malformations, and cases with undetermined gestational age or type of delivery (vaginal, pre labor cesarean section and cesarean section during labor). The primary outcomes were need of PPV via a mask or endotracheal tube and the use of supplemental oxygen without PPV. Confounding variables, including maternal age, source of birth payment, years of maternal schooling, previous birth, newborn presentation, multiple pregnancy, and maternal obstetric risk, were analyzed.
   Results: We included 22,720 newborns. Of these, 2974 (13.1 %) required supplementary oxygen. PPV with a bag and mask was used for 727 (3.2 %) newborns and tracheal intubation for 192 (0.8 %) newborns. Chest compression was necessary for 136 (0.6 %) newborns and drugs administered in 114 (0.5 %). 51.3 % of newborns were delivered by cesarean section, with the majority of cesarean sections (88.7 %) being performed prior to labor. Gestational age (late preterm infants: (Relative Risk-(RR) 2.46; 95 % (Confidence interval-CI 1.79-3.39), maternal obstetric risk (RR 1.59; 95 % CI1.30-1.94), and maternal age of 12-19 years old (RR 1.36; 95 % CI1.06-1.74) contributed to rates of PPV in the logistic regression analysis. Newborns aged between 37-38 weeks of gestaional age weren't less likely to require PPV compared with those aged 39-41 weeks of gestational age.
   Conclusions: Late preterm infants, previous maternal obstetric risks and maternal age contributed to the higher needs of PPV and use of O2 in the delivery room. These variables need to be considered in planning care in the delivery room.
C1 [Moreira, Maria Elisabeth; Gomes Junior, Saint Clair] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22520020 Rio De Janeiro, RJ, Brazil.
   [Esteves Pereira, Ana Paula; Gama, Silvana Granado; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, R Leopoldo Bulhoes 1480, BR-20911300 Rio De Janeiro, RJ, Brazil.
   [Guinsburg, Ruth; Branco de Almeida, Maria Fernanda] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22520020 Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Guinsburg, Ruth/F-1984-2013; Junior, Clair Gomes/F-7579-2012
OI Guinsburg, Ruth/0000-0003-1967-9861; Junior, Clair
   Gomes/0000-0002-1554-943X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Departamento de Ciencia e Tecnologia, Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos, Ministerio da Saude; Escola Nacional
   de Saude Publica Sergio Arouca, Fundacao Oswaldo Cruz (Projeto INOVA);
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq); Departamento de Ciencia e Tecnologia,
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Ministerio da
   Saude; Escola Nacional de Saude Publica Sergio Arouca, Fundacao Oswaldo
   Cruz (Projeto INOVA); and Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (Faperj).
CR Auger N, 2016, EARLY HUM DEV, V100, P43, DOI 10.1016/j.earlhumdev.2016.04.006
   Boyle EM, 2015, ARCH DIS CHILD-FETAL, V100, pF479, DOI 10.1136/archdischild-2014-307347
   de Almeida MFB, 2010, ARCH DIS CHILD-FETAL, V95, pF326, DOI 10.1136/adc.2009.174532
   Do Carmo Leal M, 2012, REPROD HLTH, V22, P9
   Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952
   Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005
   Fuchs K, 2006, CLIN PERINATOL, V33, P793, DOI 10.1016/j.clp.2006.09.010
   Glavind J, 2013, BJOG-INT J OBSTET GY, V120, P1123, DOI 10.1111/1471-0528.12278
   Glavind J, 2015, CURR OPIN OBSTET GYN, V27, P121, DOI 10.1097/GCO.0000000000000158
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Moreira MEL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00145213
   Malta DC, 2007, EPIDEMIOL SERV SAUDE, V16, P233
   Mann C, 2012, RESUSCITATION, V83, P607, DOI 10.1016/j.resuscitation.2012.01.002
   McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73
   Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276
   Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127
   Saugstad OD, 1998, CLIN PERINATOL, V25, P741
NR 18
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD OCT 17
PY 2016
VL 13
AR 116
DI 10.1186/s12978-016-0235-8
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ6NZ
UT WOS:000385980500003
PM 27766977
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nakamura-Pereira, M
   Leal, MD
   Esteves-Pereira, AP
   Domingues, RMSM
   Torres, JA
   Dias, MAB
   Moreira, ME
AF Nakamura-Pereira, Marcos
   Leal, Maria do Carmo
   Esteves-Pereira, Ana Paula
   Soares Madeira Domingues, Rosa Maria
   Torres, Jacqueline Alves
   Bastos Dias, Marcos Augusto
   Moreira, Maria Elisabeth
TI Use of Robson classification to assess cesarean section rate in Brazil:
   the role of source of payment for childbirth
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Cesarean section; Brazil; Robson classification; Health systems
ID MATERNAL MORTALITY; DELIVERY; BIRTH; WOMEN; OUTCOMES; HEALTH; LABOR;
   RISK; TERM
AB Background: Cesarean section (CS) rates are increasing worldwide but there is some concern with this trend because of potential maternal and perinatal risks. The Robson classification is the standard method to monitor and compare CS rates. Our objective was to analyze CS rates in Brazil according to source of payment for childbirth (public or private) using the Robson classification.
   Methods: Data are from the 2011-2012 "Birth in Brazil" study, which used a national hospital-based sample of 23,940 women. We categorized all women into Robson groups and reported the relative size of each Robson group, the CS rate in each group and the absolute and relative contributions made by each to the overall CS rate. Differences were analyzed through chi-square and Z-test with a significance level of < 0.05.
   Results: The overall CS rate in Brazil was 51.9 % (42.9 % in the public and 87.9 % in the private health sector). The Robson groups with the highest impact on Brazil's CS rate in both public and private sectors were group 2 (nulliparous, term, cephalic with induced or cesarean delivery before labor), group 5 (multiparous, term, cephalic presentation and previous cesarean section) and group 10 (cephalic preterm pregnancies), which accounted for more than 70 % of CS carried out in the country. High-risk women had significantly greater CS rates compared with low-risk women in almost all Robson groups in the public sector only.
   Conclusions: Public policies should be directed at reducing CS in nulliparous women, particularly by reducing the number of elective CS in these women, and encouraging vaginal birth after cesarean to reduce repeat CS in multiparous women.
C1 [Nakamura-Pereira, Marcos; Bastos Dias, Marcos Augusto; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Ave Rui Barbosa 716 Flamengo, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Nakamura-Pereira, Marcos; Leal, Maria do Carmo; Esteves-Pereira, Ana Paula] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rua Leopoldo Bulhoes 1480,Sala 809, BR-21041210 Rio De Janeiro, Brazil.
   [Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Natl Inst Infectol, Ave Brasil 4-365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Torres, Jacqueline Alves] Minist Hlth, Natl Hlth Agcy, Av Augusto Severo 84 Gloria, BR-20021040 Rio De Janeiro, RJ, Brazil.
RP Nakamura-Pereira, M (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Ave Rui Barbosa 716 Flamengo, BR-22250020 Rio De Janeiro, RJ, Brazil.; Nakamura-Pereira, M (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rua Leopoldo Bulhoes 1480,Sala 809, BR-21041210 Rio De Janeiro, Brazil.
EM marcosnakamura@globo.com
RI Domingues, Rosa/AAS-3606-2020; Nakamura-Pereira, Marcos/X-1107-2019;
   Nakamura-Pereira, Marcos/O-4496-2014
OI Domingues, Rosa/0000-0001-5722-8127; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Nakamura-Pereira, Marcos/0000-0002-4231-0205
FU National Council of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); National School of Public Health, Oswaldo Cruz Foundation (INOVA
   Project); Research Funding Agency of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX This work was supported by the funding from the National Council of
   Technological and Scientific Development (CNPq); the National School of
   Public Health, Oswaldo Cruz Foundation (INOVA Project); and the Research
   Funding Agency of the State of Rio de Janeiro (FAPERJ).
CR [Anonymous], 2016, SIST INF NASC VIV
   Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI 10.1590/s0034-89102011005000039
   Dias MAB, 2008, CIENC SAUDE COLETIVA, V13, P1521, DOI 10.1590/S1413-81232008000500017
   Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18
   Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769
   Brennan DJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.021
   Bittencourt SDD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176913
   Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Guerra GV, 2009, BJOG-INT J OBSTET GY, V116, P1762, DOI 10.1111/j.1471-0528.2009.02348.x
   Guise Jeanne-Marie, 2010, Evid Rep Technol Assess (Full Rep), P1
   Hellerstein S, 2015, BJOG-INT J OBSTET GY, V122, P160, DOI 10.1111/1471-0528.12971
   Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3
   Hopkins K, 2014, BIRTH-ISS PERINAT C, V41, P169, DOI 10.1111/birt.12106
   Kelly S, 2013, J OBSTET GYNAECOL CA, V35, P206, DOI 10.1016/S1701-2163(15)30992-0
   Le Ray C, 2015, BJOG-INT J OBSTET GY, V122, P690, DOI 10.1111/1471-0528.13199
   Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870
   Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155
   de Jesus GR, 2015, BJOG-INT J OBSTET GY, V122, P606, DOI 10.1111/1471-0528.13119
   Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044
   Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156
   Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84
   Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113
   Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71
   Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267
   Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55
   Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X
   World Health Organization, 2015, GLOB HLTH OBS DAT RE
   Zhang J, 2016, BJOG-INT J OBSTET GY, V123, P754, DOI 10.1111/1471-0528.13520
NR 34
TC 35
Z9 37
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD OCT 17
PY 2016
VL 13
SU 3
AR 128
DI 10.1186/s12978-016-0228-7
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FH1RW
UT WOS:000410918100009
PM 27766941
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Comym, VC
   Macedu, YS
   Neves, EKPB
   Bueno, AC
   Fernandez, HC
   Moreira, MEL
   Vieira, AA
AF Comym, Viviane C.
   Macedu, Yuri S.
   Neves, Eduardo K. P. B.
   Bueno, Arnaldo C.
   Fernandez, Herminia C.
   Moreira, Maria E. L.
   Vieira, Alan A.
TI Interference of heart and transcutaneous oxygen monitoring in the
   measurement of bioelectrical impedance analysis in preterm newborns
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Electrical impedance; Neonate; Body composition
ID PHASE-ANGLE; PRINCIPLES
AB Objective: To verify if the connection of electrodes for heart and transcutaneous oxygen monitoring interfere with the measurement of electrical bioimpedance in preterm newborns.
   Methods: This was a prospective, blinded, controlled, cross-sectional, crossover study that assessed and compared paired measures of resistance (R) and reactance (Xc) by BIA, obtained with and without monitoring wires attached to the preterm newborn. The measurements were performed in immediate sequence, after randomization to the presence or absence of electrodes. The sample size calculated was 114 measurements or tests with monitoring wires and 114 without monitoring wires, considering for a difference between the averages of 0.1 ohms, with an alpha error of 10% and beta error of 20%, with significance <0.05.
   Results: No differences were observed between the R (677.37 +/- 196.07 vs. 677.46 +/- 194.86) and Xc (31.15 +/- 9.36 vs. 31.01 +/- 9.56) values obtained with and without monitoring wires, respectively, with good correlation between them (R: 0.997 and Xc: 0.968).
   Conclusion: The presence of heart and/or transcutaneous oxygen monitoring wires connected to the preterm newborn did not affect the values of R or Xc measured by BIA, allowing them to be carried out in this population without risks. (C) 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
C1 [Comym, Viviane C.; Macedu, Yuri S.; Neves, Eduardo K. P. B.; Fernandez, Herminia C.] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Bueno, Arnaldo C.; Vieira, Alan A.] Univ Fed Fluminense, Dept Materno Infantil, Niteroi, RJ, Brazil.
   [Moreira, Maria E. L.] Fundacao Oswaldo Cruz Fiocruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
RP Comym, VC (corresponding author), Univ Fed Fluminense, Niteroi, RJ, Brazil.
EM viviane.comym@gmail.com
CR Barbosa-Silva MCG, 2005, AM J CLIN NUTR, V82, P49
   Eickemberg M, 2011, REV NUTR, V24, P883, DOI 10.1590/S1415-52732011000600009
   Foster KR, 1996, AM J CLIN NUTR, V64, P388
   Hui D, 2014, CANCER-AM CANCER SOC, V120, P2207, DOI 10.1002/cncr.28624
   KUSHNER RF, 1992, J AM COLL NUTR, V11, P199
   Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
   Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004
   Lee SY, 2014, KOREAN J FAM MED, V35, P251, DOI 10.4082/kjfm.2014.35.5.251
   Lingwood BE, 2013, EUR J CLIN NUTR, V67, pS28, DOI 10.1038/ejcn.2012.162
   Lingwood BE, 2005, PHYSIOL MEAS, V26, pS235, DOI 10.1088/0967-3334/26/2/022
   Lingwood BE, 2000, PHYSIOL MEAS, V21, P251, DOI 10.1088/0967-3334/21/2/305
   Moreira ME, 2004, RECEM NASCIDO ALTO R
   Seoane F, 2012, PHYSIOL MEAS, V33, P1363, DOI 10.1088/0967-3334/33/8/1363
   Tanabe RF., 2010, THESIS
NR 14
TC 4
Z9 4
U1 0
U2 1
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2016
VL 92
IS 5
BP 528
EP 531
DI 10.1016/j.jped.2016.01.009
PG 4
WC Pediatrics
SC Pediatrics
GA EA3VN
UT WOS:000386537500014
PM 27237088
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Brasil, P
   Pereira, JP
   Gabaglia, CR
   Damasceno, L
   Wakimoto, M
   Nogueira, RMR
   de Sequeira, PC
   Siqueira, AM
   de Carvalho, LMA
   da Cunha, DC
   Calvet, GA
   Neves, ES
   Moreira, ME
   Baiao, AER
   de Carvalho, PRN
   Janzen, C
   Valderramos, SG
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, Patricia
   Pereira, Jose P., Jr.
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita M.
   de Sequeira, Patricia Carvalho
   Siqueira, Andre Machado
   Abreu de Carvalho, Liege M.
   da Cunha, Denise Cotrim
   Calvet, Guilherme A.
   Neves, Elizabeth S.
   Moreira, Maria E.
   Rodrigues Baiao, Ana E.
   Nassar de Carvalho, Paulo R.
   Janzen, Carla
   Valderramos, Stephanie G.
   Cherry, James D.
   Bispo de Filippis, Ana M.
   Nielsen-Saines, Karin
TI Zika Virus Infection in Pregnant Women in Rio de JaneiroPreliminary
   Report
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Meeting Abstract
C1 [Brasil, Patricia; Pereira, Jose P., Jr.; Damasceno, Luana; Wakimoto, Mayumi; Ribeiro Nogueira, Rita M.; de Sequeira, Patricia Carvalho; Siqueira, Andre Machado; Abreu de Carvalho, Liege M.; da Cunha, Denise Cotrim; Calvet, Guilherme A.; Neves, Elizabeth S.; Moreira, Maria E.; Rodrigues Baiao, Ana E.; Nassar de Carvalho, Paulo R.; Bispo de Filippis, Ana M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Janzen, Carla; Valderramos, Stephanie G.; Cherry, James D.; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
RI Calvet, GA/G-6959-2013; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Calvet, GA/0000-0002-3545-5238; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Siqueira, Andre/0000-0003-2208-0294
NR 0
TC 4
Z9 4
U1 0
U2 56
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD JUN
PY 2016
VL 71
IS 6
BP 331
EP 333
DI 10.1097/01.ogx.0000483239.08585.8d
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP3XL
UT WOS:000378429200006
OA Green Published
DA 2020-12-17
ER

PT J
AU Sadeck, LSR
   Leone, CR
   Procianoy, RS
   Guinsburg, R
   Marba, STM
   Martinez, FE
   Rugolo, LMSS
   Moreira, MEL
   Fiori, RM
   Ferrari, LL
   Menezes, JA
   Venzon, PS
   Abdallah, VQS
   Duarte, JLMB
   Nunes, MV
   Anchieta, LM
   Alves, N
AF Sadeck, Lilian S. R.
   Leone, Clea R.
   Procianoy, Renato S.
   Guinsburg, Ruth
   Marba, Sergio T. M.
   Martinez, Francisco E.
   Rugolo, Ligia M. S. S.
   Moreira, M. Elisabeth L.
   Fiori, Renato M.
   Ferrari, Ligia L.
   Menezes, Jucille A.
   Venzon, Paulyne S.
   Abdallah, Vania Q. S.
   Duarte, Jose Luiz M. B.
   Nunes, Marynea V.
   Anchieta, Leni M.
   Alves Filho, Navantino
TI Effects of therapeutic approach on the neonatal evolution of very low
   birth weight infants with patent ductus arteriosus
SO REVISTA CHILENA DE PEDIATRIA-CHILE
LA English
DT Article
DE Preterm; Very low birth weight; Ligation; Patent ductus arteriosus
   managem
AB Objective: To analyze the effects of treatment approach on the outcomes of newborns (birthweight [ BW] <1000 g) with patent ductus arteriosus (PDA), from the Brazilian Neonatal Research Network (BNRN) on: death, bronchopulmonary dysplasia (BPD), severe intraventricular hemorrhage (IVH III/IV), retinopathy of prematurity requiring surgical (ROPsur), necrotizing enterocolitis requiring surgery (NECsur), and death/BPD.
   Methods: This was a multicentric, cohort study, retrospective data collection, including newborns (BW <1000 g) with gestational age (GA) <33 weeks and echocardiographic diagnosis of PDA, from 16 neonatal units of the BNRN from January 1, 2010 to December 31, 2011. Newborns who died or were transferred until the third day of life, and those with presence of congenital mal-formation or infection were excluded. Groups: G1 - conservative approach (without treatment), G2 - pharmacologic (indomethacin or ibuprofen), G3 - surgical ligation (independent of previous treatment).
   Factors analyzed: antenatal corticosteroid, cesarean section, BW, GA, 5 min. Apgar score <4, male gender, Score for Neonatal Acute Physiology Perinatal Extension (SNAPPEII), respiratory distress syndrome (RDS), late sepsis (LS), mechanical ventilation (MV), surfactant (<2 h of life), and time of MV.
   Outcomes: death, O-2 dependence at 36 weeks (BPD36wks), IVH III/IV, ROPsur, NECsur, and death/BPD36wks.
   Statistics: Student's t-test, Chi-squared test, or Fisher's exact test; Odds ratio (95% CI); logistic binary regression and backward stepwise multiple regression.
   Software: MedCalc (Medical Calculator) software, version 12.1.4.0. p values <0.05 were considered statistically significant.
   Results: 1097 newborns were selected and 494 newborns were included: G1 - 187 (37.8%), G2 - 205 (41.5%), and G3 102 (20.6%). The highest mortality was observed in G1 (51.3%) and the lowest in G3 (14.7%). The highest frequencies of BPD36wks (70.6%) and ROPsur were observed in G3 (23.5%). The lowest occurrence of death/BPD36wks occurred in G2 (58.0%). Pharmacological (OR 0.29; 95% CI: 0.14 - 0.62) and conservative (OR 0.34; 95% CI: 0.140.79) treatments were protective for the outcome death/BPD36wks.
   Conclusion: The conservative approach of PDA was associated to high mortality, the surgical approach to the occurrence of BPD36wks and ROPsur, and the pharmacological treatment was protective for the outcome death/BPD36wks.
C1 [Sadeck, Lilian S. R.] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Leone, Clea R.; Guinsburg, Ruth] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, SP, Brazil.
   [Procianoy, Renato S.] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Child Care, Porto Alegre, RS, Brazil.
   [Marba, Sergio T. M.] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Pediat, Campinas, SP, Brazil.
   [Martinez, Francisco E.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pediat, Ribeirao Preto, SP, Brazil.
   [Rugolo, Ligia M. S. S.] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Pediat, Botucatu, SP, Brazil.
   [Moreira, M. Elisabeth L.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Fernandes Figueira, Dept Neonatol, Rio De Janeiro, RJ, Brazil.
   [Fiori, Renato M.] Pontificia Univ Catolica Rio Grande do Sul PUC RS, Fac Med, Dept Pediat, Porto Alegre, RS, Brazil.
   [Ferrari, Ligia L.] Univ Estadual Londrina, Fac Med, Londrina, PR, Brazil.
   [Menezes, Jucille A.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Venzon, Paulyne S.] Univ Fed Parana UFPR, Dept Pediat, Curitiba, PR, Brazil.
   [Abdallah, Vania Q. S.] Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   [Duarte, Jose Luiz M. B.] Univ Estadual Rio de Janeiro UERJ, Rio De Janeiro, RJ, Brazil.
   [Nunes, Marynea V.] Univ Fed Maranhao UFMA, Sao Luis, MA, Brazil.
   [Anchieta, Leni M.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Alves Filho, Navantino] Fac Ciencias Med Minas Gerais CMMG, Belo Horizonte, MG, Brazil.
RP Sadeck, LSR (corresponding author), Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
EM liliansadeck@uol.com.br
RI Guinsburg, Ruth/F-1984-2013; Leone, Clea/ABA-6374-2020
OI Guinsburg, Ruth/0000-0003-1967-9861; 
NR 0
TC 0
Z9 0
U1 0
U2 5
PU SOC CHILENA PEDIATRIA
PI SANTIAGO
PA ALCALDE EDUARDO CASTILLO VELASCO 1838, NUNOA, CASILLA 593-11, SANTIAGO,
   00000, CHILE
SN 0370-4106
EI 0717-6228
J9 REV CHIL PEDIATR-CHI
JI Rev. Chil. Pediatr.-Chile
PD JUN
PY 2016
VL 87
IS 3
BP 233
EP 234
DI 10.1016/j.rchipe.2014.04.001
PG 2
WC Pediatrics
SC Pediatrics
GA FJ8IN
UT WOS:000413008900015
OA Green Published, Other Gold
DA 2020-12-17
ER

PT J
AU Leal, MD
   Esteves-Pereira, AP
   Nakamura-Pereira, M
   Torres, JA
   Domingues, RMSM
   Dias, MAB
   Moreira, ME
   Theme-Filha, M
   da Gama, SGN
AF Leal, Maria do Carmo
   Esteves-Pereira, Ana Paula
   Nakamura-Pereira, Marcos
   Torres, Jacqueline Alves
   Soares Madeira Domingues, Rosa Maria
   Bastos Dias, Marcos Augusto
   Moreira, Maria Elizabeth
   Theme-Filha, Mariza
   Nogueira da Gama, Silvana Granado
TI Provider-Initiated Late Preterm Births in Brazil: Differences between
   Public and Private Health Services
SO PLOS ONE
LA English
DT Article
ID CESAREAN-SECTION; DELIVERY; MORBIDITY; MORTALITY; INFANTS; EPIDEMIOLOGY;
   METAANALYSIS; COUNTRIES; RATES; LABOR
AB Background
   A large proportion of the rise in prematurity worldwide is owing to late preterm births, which may be due to the expansion of obstetric interventions, especially pre-labour caesarean section. Late preterm births pose similar risks to overall prematurity, making this trend a concern. In this study, we describe factors associated with provider-initiated late preterm birth and verify differences in provider-initiated late preterm birth rates between public and private health services according to obstetric risk.
   Methods
   This is a sub-analysis of a national population-based survey of postpartum women entitled " Birth in Brazil", performed between 2011 and 2012. We included 23,472 singleton live births. We performed non-conditional multiple logistic regressions assessing associated factors and analysing differences between public and private health services.
   Results
   Provider-initiated births accounted for 38% of late preterm births; 32% in public health services and 61% in private health services. They were associated with previous preterm birth (s) and maternal pathologies for women receiving both public and private services and with maternal age >= 35 years for women receiving public services. Women receiving private health services had higher rates of provider-initiated late preterm birth (rate of 4.8%) when compared to the ones receiving public services (rate of 2.4%), regardless of obstetric riskadjusted OR of 2.3 (CI 1.5-3.6) for women of low obstetric risk and adjusted OR of 1.6 (CI 1.1-2.3) for women of high obstetric risk.
   Conclusion
   The high rates of provider-initiated late preterm birth suggests a considerable potential for reduction, as such prematurity can be avoided, especially in women of low obstetric risk. To promote healthy births, we advise introducing policies with incentives for the adoption of new models of birth care.
C1 [Leal, Maria do Carmo; Esteves-Pereira, Ana Paula; Nakamura-Pereira, Marcos; Theme-Filha, Mariza; Nogueira da Gama, Silvana Granado] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil.
   [Nakamura-Pereira, Marcos; Bastos Dias, Marcos Augusto; Moreira, Maria Elizabeth] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
   [Torres, Jacqueline Alves] Minist Hlth, Natl Hlth Agcy, Rio De Janeiro, Brazil.
   [Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Natl Inst Infect Dis, Rio De Janeiro, Brazil.
RP Esteves-Pereira, AP (corresponding author), Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil.
EM ana.pep@gmail.com
RI Domingues, Rosa/AAS-3606-2020; Nakamura-Pereira, Marcos/X-1107-2019;
   Nakamura-Pereira, Marcos/O-4496-2014; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Domingues, Rosa/0000-0001-5722-8127; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Miranda Theme Filha,
   Mariza/0000-0002-7075-9819
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); National School of Public Health; Oswaldo Cruz Foundation (INOVA
   Project); Foundation for supporting Research in the State of Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX The Birth in Brazil Study was funded by the National Council for
   Scientific and Technological Development (CNPq); National School of
   Public Health, Oswaldo Cruz Foundation (INOVA Project); and Foundation
   for supporting Research in the State of Rio de Janeiro (FAPERJ). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Al-Zirqi I, 2016, BJOG-INT J OBSTET GY, V123, P780, DOI 10.1111/1471-0528.13394
   American College of Obstetricians and Gynecologists, 2002, OBSTET GYNECOL, V100, P617
   Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213
   Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2
   Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z
   Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X
   Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381
   d'Orsi E, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00087813
   Dahlen HG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001723
   Declercq E, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311XCO05S114
   Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24
   Engle WA, 2011, CLIN PERINATOL, V38, P493, DOI 10.1016/j.clp.2011.06.009
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865
   Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007
   Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f
   Horta BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074301
   Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   Leal MC, 2016, PREVALENCE IN PRESS
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   Lipkind HS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.007
   Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10
   Moreira MEL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00145213
   Mahoney AD, 2013, CLIN PERINATOL, V40, P665, DOI 10.1016/j.clp.2013.07.004
   Martin J, 2015, NATL VITAL STA REP, P1
   McCabe ERB, 2014, PEDIATRICS, V134, P1193, DOI 10.1542/peds.2014-2541
   Mesquita DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066827
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Nakamura-Pereira M, 2016, REPROD HLTH IN PRESS
   Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009
   Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018
   de Jesus GR, 2015, BJOG-INT J OBSTET GY, V122, P606, DOI 10.1111/1471-0528.13119
   Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232
   Scott JR, 2014, BJOG-INT J OBSTET GY, V121, P157, DOI 10.1111/1471-0528.12449
   Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007
   Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84
   Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113
   Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999
   Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015
   Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x
   Torres J. M., 2014, THESIS
   Torres JA, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00129813
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
NR 45
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2016
VL 11
IS 5
AR e0155511
DI 10.1371/journal.pone.0155511
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM4BR
UT WOS:000376291100052
PM 27196102
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Azevedo, CTD
   do Brasil, PEAA
   Guida, L
   Moreira, MEL
AF de Oliveira Azevedo, Christianne Terra
   do Brasil, Pedro Emmanuel A. A.
   Guida, Leticia
   Lopes Moreira, Maria Elizabeth
TI Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid
   of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID PRENATAL-DIAGNOSIS; MOLECULAR DIAGNOSIS; GONDII; INFECTION; PCR;
   TRANSMISSION; TIME; AGE; MULTICENTER; PROGRAMS
AB Introduction
   Congenital infection caused by Toxoplasma gondii can cause serious damage that can be diagnosed in utero or at birth, although most infants are asymptomatic at birth. Prenatal diagnosis of congenital toxoplasmosis considerably improves the prognosis and outcome for infected infants. For this reason, an assay for the quick, sensitive, and safe diagnosis of fetal toxoplasmosis is desirable.
   Goal
   To systematically review the performance of polymerase chain reaction (PCR) analysis of the amniotic fluid of pregnant women with recent serological toxoplasmosis diagnoses for the diagnosis of fetal toxoplasmosis.
   Method
   A systematic literature review was conducted via a search of electronic databases; the literature included primary studies of the diagnostic accuracy of PCR analysis of amniotic fluid from pregnant women who seroconverted during pregnancy. The PCR test was compared to a gold standard for diagnosis.
   Results
   A total of 1.269 summaries were obtained from the electronic database and reviewed, and 20 studies, comprising 4.171 samples, met the established inclusion criteria and were included in the review. The following results were obtained: studies about PCR assays for fetal toxoplasmosis are generally susceptible to bias; reports of the tests' use lack critical information; the protocols varied among studies; the heterogeneity among studies was concentrated in the tests' sensitivity; there was evidence that the sensitivity of the tests increases with time, as represented by the trimester; and there was more heterogeneity among studies in which there was more time between maternal diagnosis and fetal testing. The sensitivity of the method, if performed up to five weeks after maternal diagnosis, was 87% and specificity was 99%.
   Conclusion
   The global sensitivity heterogeneity of the PCR test in this review was 66.5%(I-2). The tests show low evidence of heterogeneity with a sensitivity of 87% and specificity of 99% when performed up to five weeks after maternal diagnosis. The test has a known performance and could be recommended for use up to five weeks after maternal diagnosis, when there is suspicion of fetal toxoplasmosis.
C1 [de Oliveira Azevedo, Christianne Terra; Guida, Leticia; Lopes Moreira, Maria Elizabeth] Fiocruz MS, IFF, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Recife, PE, Brazil.
   [do Brasil, Pedro Emmanuel A. A.] Fiocruz MS, Ipec, Inst Nacl Infectol Evandro Chagas, Recife, PE, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, IFF, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Recife, PE, Brazil.
EM bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Brasil, Pedro
   Emmanuel/B-4357-2008
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Brasil, Pedro
   Emmanuel/0000-0002-6700-2268
CR Andrade GMQ, 2001, REV MED MINAS GERAIS, V11, P202
   Antsaklis A, 2002, PRENATAL DIAG, V22, P1107, DOI 10.1002/pd.476
   Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33
   Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007
   Baquero-Artigao F, 2013, AN PEDIATR, V79, P116, DOI 10.1016/j.anpedi.2012.12.001
   Bastien P, 2008, J CLIN MICROBIOL, V46, P1897, DOI 10.1128/JCM.02258-07
   Bastien Patrick, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS205, DOI 10.1016/S0035-9203(02)90078-7
   Bessieres M, 2002, IMMUNO-ANAL BIOL SPE, V17, P358
   Bessieres MH, 2009, MEM I OSWALDO CRUZ, V104, P389, DOI 10.1590/S0074-02762009000200038
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010
   BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989
   Cao Y, 1999, Zhonghua Fu Chan Ke Za Zhi, V34, P517
   Castro FC, 2001, REV BRAS GINECOL OBS, V23, P277
   CAZENAVE J, 1992, PRENATAL DIAG, V12, P119, DOI 10.1002/pd.1970120207
   Cermakova Z, 2003, ACTA MED HRADEC KRAL, V47, P71
   Czuba B, 2000, WIAD PARAZYTOL, V47, P91
   Dupouy-Camet J, 1991, COMP VALUE POLYM CHA, P315
   Eida Omima M., 2009, Journal of the Egyptian Society of Parasitology, V39, P541
   Favero A, 1997, DIAGN LAB 2 LIVELLO, V12, P459
   Figueiro EA, 2005, REV BRAS GINECOL OBS, V27, P442, DOI 10.1590/S0100-72032005000800002
   Foulon W, 1999, AM J OBSTET GYNECOL, V181, P843, DOI 10.1016/S0002-9378(99)70311-X
   Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3
   Geerts I, 2008, TIJDSCHR GENEESKD, V64, P920
   Gola J, 2000, Ginekol Pol, V71, P954
   Golab E., 1996, Medycyna Doswiadczalna i Mikrobiologia, V48, P189
   Golab E, 2001, WIAD PARAZYTOL, V48, P311
   Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x
   Jenum PA, 1998, APMIS, V106, P680, DOI 10.1111/j.1699-0463.1998.tb00211.x
   Kieffer F, 2008, PEDIATR INFECT DIS J, V27, P27, DOI 10.1097/INF.0b013e318134286d
   Kieffer F, 2013, HAND CLINIC, V112, P1099, DOI 10.1016/B978-0-444-52910-7.00028-3
   KNERER B, 1995, WIEN KLIN WOCHENSCHR, V107, P137
   Kompalic-Cristo A, 2004, T ROY SOC TROP MED H, V98, P92, DOI 10.1016/S0035-9203(03)00012-9
   Li S, 1995, Zhonghua Fu Chan Ke Za Zhi, V30, P200
   Ma Yu-yan, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P8
   McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029
   Nagaty Ibraheim M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P625
   Nagy B, 2005, MAGY NOORV L, V68, P95
   Ordinaire I, 2004, REAL TIME QUANTITATI, P67
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Perez P, 2006, PERFORMANCES TESTS I
   Prasil P, 2010, CZECH SLOVAK PEDIAT, V65, P432
   Prusa AR, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.018
   Rabilloud M, 2010, PEDIATR INFECT DIS J, V29, P421, DOI 10.1097/INF.0b013e3181c80493
   Robert-Gangneux F, 1999, J CLIN MICROBIOL, V37, P2893, DOI 10.1128/JCM.37.9.2893-2898.1999
   Romand S, 2001, OBSTET GYNECOL, V97, P296, DOI 10.1016/S0029-7844(00)01118-2
   Lopes-Mori FMR, 2011, REV ASSOC MED BRAS, V57, P594, DOI 10.1590/S0104-42302011000500021
   Slawska H, 2000, WIAD PARAZYTOL, V47, P99
   Slawska Helena, 2005, Ginekol Pol, V76, P536
   Sterkers Y, 2010, CLIN MICROBIOL INFEC, V16, P1594, DOI [10.1111/j.1469-0691.2010.03101.x, 10.1111/j.1469-0691.2009.03101.x]
   Sterkers Y, 2012, J CLIN MICROBIOL, V50, P3944, DOI 10.1128/JCM.00918-12
   Szenborn L, 2009, PRZEGL LEK, V67, P54
   Teixeira LE, 2013, REV SOC BRAS MED TRO, V46, P584, DOI 10.1590/0037-8682-0095-2013
   Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x
   Thiebaut R, 2007, LANCET, V369, P115
   Tomasoni LR, 2014, NEW MICROBIOL, V37, P347
   Tuma W, 1994, LAB MED, V18, P512
   Vidigal Paula Vieira Teixeira, 2002, Rev. Soc. Bras. Med. Trop., V35, P1, DOI 10.1590/S0037-86822002000100001
   Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032
   Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Xia A, 1991, ZHONGGUO JI SHENG CH, V10, P171
NR 61
TC 13
Z9 14
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2016
VL 11
IS 4
AR e0149938
DI 10.1371/journal.pone.0149938
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6KO
UT WOS:000373608000002
PM 27055272
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Guinsburg, R
   de Almeida, MFB
   de Castro, JS
   Silveira, RC
   Caldas, JPD
   Fiori, HH
   do Vale, MS
   Abdallah, VOS
   Cardoso, LEMB
   Alves, N
   Moreira, ME
   Acquesta, AL
   Ferrari, LSL
   Bentlin, MR
   Venzon, PS
   Ferri, WAG
   Meneses, JD
   Diniz, EMD
   Zanardi, DMT
   Dos Santos, CN
   Duarte, JLB
   Rego, MAS
AF Guinsburg, Ruth
   Branco de Almeida, Maria Fernanda
   de Castro, Junia Sampel
   Silveira, Rita C.
   de Siqueira Caldas, Jamil Pedro
   Fiori, Humberto Holmer
   do Vale, Marynea Silva
   Steffen Abdallah, Vania Olivetti
   Monteiro Bigelli Cardoso, Laura Emilia
   Alves Filho, Navantino
   Moreira, Maria Elisabeth
   Acquesta, Ana Lucia
   Lopes Ferrari, Ligia S.
   Bentlin, Maria Regina
   Venzon, Paulyne Stadler
   Goncalves Ferri, Walusa Assad
   Meneses, Jucille do Amaral
   De Albuquerque Diniz, Edna Maria
   Toledo Zanardi, Dulce Maria
   Dos Santos, Cristina Nunes
   Bandeira Duarte, Jose Luiz
   Santiago Rego, Maria Albertina
TI Death or survival with major morbidity in VLBW infants born at Brazilian
   neonatal research network centers
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Bronchopulmonary dysplasia; intraventricular hemorrhage; neonatal
   mortality; periventricular leukomalacia; preterm newborn infant;
   retinopathy of prematurity; very low birth weight newborn infant
ID LOW-BIRTH-WEIGHT; PRETERM INFANTS; UNITED-STATES; MORTALITY; OUTCOMES;
   RETINOPATHY; HEMORRHAGE; TRENDS; IMPACT; JAPAN
AB Objective: To analyze unfavorable outcomes at hospital discharge of preterm infants born at Brazilian public university centers.Methods: Prospective cohort of 2646 inborn infants with gestational age 23-33 weeks and birth weight 400-1499g, without malformations, born at 20 centers in 2012-2013. Unfavorable outcome was defined as in-hospital death or survival at hospital discharge with 1 major morbidities: bronchopulmonary dysplasia (BPD) at 36 corrected weeks, intraventricular hemorrhage (IVH) grades 3-4, periventricular leukomalacia (PVL) or surgically treated retinopathy of prematurity (ROP).Results: Among 2646 infants, 1390 (53%) either died or survived with major morbidities: 793 (30%) died; 497 (19%) had BPD; 358 (13%) had IVH 3-4 or PVL; and 84 (3%) had ROP. Logistic regression adjusted by center showed association of unfavorable outcome with: antenatal steroids (OR 0.70; 95%CI 0.55-0.88), C-section (0.72; 0.58-0.90), gestational age <30 (4.00; 3.16-5.07), being male (1.44; 1.19-1.75), small for gestational age (2.19; 1.72-2.78), 5th-min Apgar <7 (3.89; 2.88-5.26), temperature at NICU admission <36.0 degrees C (1.42; 1.15-1.76), respiratory distress syndrome (3.87; 2.99-5.01), proven late sepsis (1.33; 1.05-1.69), necrotizing enterocolitis (3.10; 2.09-4.60) and patent ductus arteriosus (1.69; 1.37-2.09).Conclusions: More than half of the VLBW infants born at public university level 3 Brazilian hospitals either die or survive with major morbidities.
C1 [Guinsburg, Ruth; Branco de Almeida, Maria Fernanda; de Castro, Junia Sampel] Univ Fed Sao Paulo, Escola Paulista Med, BR-01410 Sao Paulo, SP, Brazil.
   [Silveira, Rita C.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [de Siqueira Caldas, Jamil Pedro] Univ Estadual Campinas, Ctr Atencao Integral Saude Mulher, Hosp Mulher Prof Jose Aristodemo Pinotti, Campinas, SP, Brazil.
   [Fiori, Humberto Holmer] Pontificia Univ Catolica Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil.
   [do Vale, Marynea Silva] Univ Fed Maranhao, Univ Hosp, Sao Luis, MA, Brazil.
   [Steffen Abdallah, Vania Olivetti] Univ Fed Uberlandia, Fac Med, Hosp Clin, BR-38400 Uberlandia, MG, Brazil.
   [Monteiro Bigelli Cardoso, Laura Emilia] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil.
   [Alves Filho, Navantino] Fac Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil.
   [Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Acquesta, Ana Lucia] Hosp Geral Pirajussara, Sao Paulo, SP, Brazil.
   [Lopes Ferrari, Ligia S.] Univ Estadual Londrina, Univ Hosp, Londrina, PR, Brazil.
   [Bentlin, Maria Regina] Univ Estadual Paulista, Fac Med Botucatu, Botucatu, SP, Brazil.
   [Venzon, Paulyne Stadler] Univ Fed Parana, Dept Pediat, BR-80060000 Curitiba, Parana, Brazil.
   [Goncalves Ferri, Walusa Assad] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, SP, Brazil.
   [Meneses, Jucille do Amaral] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [De Albuquerque Diniz, Edna Maria] Univ Sao Paulo, Fac Med, Univ Hosp, Sao Paulo, SP, Brazil.
   [Toledo Zanardi, Dulce Maria] Hosp Estadual Sumare, Sumare, SP, Brazil.
   [Dos Santos, Cristina Nunes] Hosp Estadual Diadema, Sao Paulo, SP, Brazil.
   [Bandeira Duarte, Jose Luiz] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Santiago Rego, Maria Albertina] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
RP Guinsburg, R (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, R Vicente Felix 77 Apt 09, BR-01410 Sao Paulo, SP, Brazil.
EM ruthgbr@netpoint.com.br
RI de Siqueira Caldas, Jamil Pedro/I-8162-2017; de Siqueira Caldas, Jamil
   Pedro/AAS-9621-2020; Guinsburg, Ruth/F-1984-2013; Bentlin, Maria
   Regina/H-6282-2012
OI de Siqueira Caldas, Jamil Pedro/0000-0001-5292-2320; Guinsburg,
   Ruth/0000-0003-1967-9861; Bentlin, Maria Regina/0000-0001-7310-0895;
   Assad Goncalves Ferri, Walusa/0000-0002-7174-0044
FU Health Ministry of Brazil (Ministerio da Saude do Brasil) [MS/VIGISUS
   1755/2000, MS/FNS 274, FIOCRUZ/PDTSP]
FX BRAZILIAN NETWORK ON NEONATAL RESEARCH (Rede Brasileira de Pesquisas
   Neonatais RBPN). Health Ministry of Brazil (Ministerio da Saude do
   Brasil (MS/VIGISUS 1755/2000; MS/FNS 274; FIOCRUZ/PDTSP) funded this
   study. The authors declare no conflicts of interest. Ruth Guinsburg and
   Maria Fernanda Branco de Almeida conceptualized and designed the study,
   carried out all study's analyses, drafted the initial article, reviewed
   and revised the article, and approved the final article as submitted.
   Ana Lucia Acquesta, Cristina Nunes Dos Santos, Dulce Maria Toledo
   Zanardi, Edna Maria De Albuquerque Diniz, Humberto Holmer Fiori, Jamil
   Pedro de Siqueira Caldas, Jose 'Luiz Bandeira Duarte, Jucille do Amaral
   Meneses, Junia Sampel de Castro, Laura Emilia Monteiro Bigelli Cardoso,
   Ligia S. Lopes Ferrari, Maria Albertina Santiago Rego, Maria Elisabeth
   Moreira, Maria Regina Bentlin, Marynea Silva do Vale, Navantino Alves
   Filho, Paulyne Stadler Venzon, Rita C. Silveira, Vania Olivetti Steffen
   Abdallah, and Walusa Assad Goncalves Ferri: helped to design and plan
   the study, coordinated and supervised data collection at each site,
   critically reviewed the article, and approved the final article as
   submitted.
CR Alleman BW, 2013, PEDIATRICS, V132, pE175, DOI 10.1542/peds.2012-3707
   Ambalavanan N, 2012, PEDIATRICS, V130, pE115, DOI 10.1542/peds.2011-3693
   de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049
   Brasil. Ministerio da Saude. DATASUS, NASC VIV DESD 1994 B
   DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5
   European Neonatal Network, 2012, GEN REP VER LOW BIRT
   Fernandez R, 2014, ARCH ARGENT PEDIATR, V112, P405, DOI [10.1590/S0325-00752014000500004, 10.5546/aap.2014.405]
   Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991
   Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724
   Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114
   Lee SK, 2009, CAN MED ASSOC J, V181, P469, DOI 10.1503/cmaj.081727
   Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070
   Luu TM, 2009, PEDIATRICS, V123, P1037, DOI 10.1542/peds.2008-1162
   Malloy MH, 2008, PEDIATRICS, V122, P285, DOI 10.1542/peds.2007-2620
   Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   Payne NR, 2010, PEDIATRICS, V125, P437, DOI 10.1542/peds.2009-1272
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2
   Ruegger C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-17
   Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148
   Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124
   Shah PS, 2009, J PERINATOL, V29, P655, DOI 10.1038/jp.2009.71
   Simpson JM, 2003, QUAL SAF HEALTH CARE, V12, P257, DOI 10.1136/qhc.12.4.257
   Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216
   WHO, 2012, BORN TOO SOON GLOBAL
   World Health Organization, 1997, THERM PROT NEWB PRAC
NR 29
TC 17
Z9 17
U1 0
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD MAR 18
PY 2016
VL 29
IS 6
BP 1005
EP 1009
DI 10.3109/14767058.2015.1031740
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CY3PQ
UT WOS:000366322400028
PM 25812674
DA 2020-12-17
ER

PT J
AU de Freitas, BAC
   Lima, LM
   Moreira, MEL
   Priore, SE
   Henriques, BD
   Carlos, CFLV
   Sabino, JSN
   Franceschini, SDC
AF Chagas de Freitas, Brunnella Alcantara
   Lima, Luciana Moreira
   Lopes Moreira, Maria Elisabeth
   Priore, Silvia Eloiza
   Henriques, Bruno David
   Lisboa Valente Carlos, Carla Fernanda
   Nogueira Sabino, Jusceli Souza
   Castro Franceschini, Sylvia do Carmo
TI Micronutrient supplementation adherence and influence on the prevalences
   of anemia and iron, zinc and vitamin A deficiencies in preemies with a
   corrected age of six months
SO CLINICS
LA English
DT Article
DE Infant; Premature; Anemia, Iron Deficiency; Zinc Deficiency; Medication
   Adherence; Vitamin A; Micronutrients
ID PRETERM INFANTS; CHILDREN; THERAPY; PROGRAM; VICOSA; RISK; CITY
AB OBJECTIVE: To analyze adherence to the recommended iron, zinc and multivitamin supplementation guidelines for preemies, the factors associated with this adherence, and the influence of adherence on the occurrence of anemia and iron, zinc and vitamin A deficiencies.
   METHODS: This prospective cohort study followed 58 preemies born in 2014 until they reached six months corrected age. The preemies were followed at a referral secondary health service and represented 63.7% of the preterm infants born that year. Outcomes of interest included high or low adherence to iron, zinc and multivitamin supplementation guidelines; prevalence of anemia; and prevalences of iron, zinc, and vitamin A deficiencies. The prevalence ratios were calculated by Poisson regression.
   RESULTS: Thirty-eight (65.5%) preemies presented high adherence to micronutrient supplementation guidelines. At six months of corrected age, no preemie had vitamin A deficiency. The prevalences of anemia, iron deficiency and zinc deficiency were higher in the low-adherence group but also concerning in the high-adherence group. Preemies with low adherence to micronutrient supplementation guidelines were 2.5 times more likely to develop anemia and 3.1 times more likely to develop zinc deficiency. Low maternal education level increased the likelihood of nonadherence to all three supplements by 2.2 times.
   CONCLUSIONS: Low maternal education level was independently associated with low adherence to iron, zinc and vitamin A supplementation guidelines in preemies, which impacted the prevalences of anemia and iron and zinc deficiencies at six months of corrected age.
C1 [Chagas de Freitas, Brunnella Alcantara; Lima, Luciana Moreira; Henriques, Bruno David] Univ Fed Vicosa, Dept Med & Enfermagem, Vicosa, MG, Brazil.
   [Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Priore, Silvia Eloiza; Castro Franceschini, Sylvia do Carmo] Univ Fed Vicosa, Dept Nutr & Saude, Vicosa, MG, Brazil.
   [Lisboa Valente Carlos, Carla Fernanda; Nogueira Sabino, Jusceli Souza] Ctr Viva Vida Referencia Vicosa & Regiao Saude, Vicosa, MG, Brazil.
RP de Freitas, BAC (corresponding author), Univ Fed Vicosa, Dept Med & Enfermagem, Vicosa, MG, Brazil.
EM brunnella.freitas@ufv.br
RI Henriqu, Bruno David/AAJ-6276-2020; de+Freitas, Brunnella/AAJ-9146-2020;
   Lima, Luciana Moreira/X-7039-2018
OI de+Freitas, Brunnella/0000-0002-7863-0681; Lima, Luciana
   Moreira/0000-0001-5349-1577
CR Avery GB, 2005, AVERYS NEONATOLOGY P
   Azeredo CM, 2013, CIENC SAUDE COLETIVA, V18, P827, DOI 10.1590/S1413-81232013000300028
   Barone M, 2006, OSKIS PEDIAT PRINCIP, P2627
   Chopard Maria Renata T., 2010, Rev. Bras. Hematol. Hemoter., V32, P32
   [Departamento Cientifico de Neonatologia Sociedade Brasileira de Pediatria], 2012, SEG AMB PREM RISC
   Fares S, 2014, J MATERN-FETAL NEO M, V10, P1
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ferri C, 2014, J TROP PEDIATRICS, V60, P53, DOI 10.1093/tropej/fmt077
   Finch CW, 2015, NUTR CLIN PRACT, V30, P44, DOI 10.1177/0884533614563353
   Hotz C., 2004, Food and Nutrition Bulletin, V25, pS94
   Institute of Medicine (IOM), 2007, PRETERM BIRTH CAUSES, DOI [10.17226/11622, 10.17226/11622 .]
   Jin HX, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0121-y
   Jyotsna S, 2015, J CLIN DIAGN RES, V9, pSC1, DOI 10.7860/JCDR/2015/10449.5402
   Koletzko B, 2014, WORLD REV NUTR DIET
   Leal Luciana Pedrosa, 2010, Rev. Bras. Saude Mater. Infant., V10, P417, DOI 10.1590/S1519-38292010000400003
   Mactier H, 2005, ARCH DIS CHILD-FETAL, V90, P103, DOI 10.1136/adc.2004.057547
   Melo AMC, 2013, J PEDIAT-BRAZIL, V89, P75, DOI 10.1016/j.jped.2013.02.012
   [Ministerio de Salud (MS) Direccion General de Salud Departamento de Nutricion Fondo de las Naciones Unidas para la Infancia (UNICEF) Organizacion Panamericana de la Salud Panama], 2006, DIR GEN SAL
   Cotta RMM, 2011, CIENC SAUDE COLETIVA, V16, P4011, DOI 10.1590/S1413-81232011001100006
   Morton SB, 2014, NEW ZEAL MED J, V127, P62
   NATHAN DG, 2003, NATHAN OSKIS HEMATOL
   Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100
   Rao R, 2009, CLIN PERINATOL, V36, P27, DOI 10.1016/j.clp.2008.09.013
   Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007
   Schanler RJ, 2005, ACTA PAEDIATR, V94, P68, DOI 10.1080/08035320510043583
   Schneider JM, 2007, J AM DIET ASSOC, V107, P1924, DOI 10.1016/j.jada.2007.08.011
   Shah MD, 2009, PEDIATR CLIN N AM, V56, P1069, DOI 10.1016/j.pcl.2009.08.001
   Silva D, 2014, PROPED PROGRAMA ATUA, V1, P35
   Tudehope DI, 2013, J PEDIATR-US, V162, pS17, DOI 10.1016/j.jpeds.2012.11.049
   Uijterschout L, 2015, EUR J CLIN NUTR, V69, P598, DOI 10.1038/ejcn.2014.217
   WHO, 2014, WHONMHNHDMNM112
   WHO, 2011, WHONMHNHDMNM111
   World Health Organization, 2014, WHO GLOB DAT VIT A D
   World Health Organization, 2003, ADHERENCE LONG TERM
   World Health Organization, 2008, IND ASS INF YOUNG CH
   Yamada RT, 2014, CLINICS, V69, P792, DOI 10.6061/clinics/2014(12)01
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 37
TC 3
Z9 3
U1 2
U2 5
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2016
VL 71
IS 8
BP 440
EP 448
DI 10.6061/clinics/2016(08)06
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV4CK
UT WOS:000382872200006
PM 27626474
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Villela, LD
   Soares, FVM
   de Abranches, AD
   Gomes, SC
   Meio, MDBB
   Moreira, MEL
AF Villela, Leticia Duarte
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Gomes Junior, Saint-Clair
   Barbosa Baker Meio, Maria Dalva
   Lopes Moreira, Maria Elisabeth
TI Anthropometry and body composition of preemies at term age and term age
   weight
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA Portuguese
DT Article
DE Anthropometry; Body composition; Infant, premature; Infant, newborn
ID PRETERM INFANTS; MIDARM CIRCUMFERENCE; POSTNATAL-GROWTH; BIRTH;
   ADIPOSITY; NUTRITION; DETERMINANTS; MANAGEMENT; VELOCITY; CURVES
AB Objective
   To analyze growth and body composition of preemies at term gestational age and when they reach a weight of 3.0 to 3.5 kg.
   Methods
   This longitudinal study was conducted at Instituto Fernandes Figueira, Rio de Janeiro, and included 39 preemies with very low birth weight. Anthropometric measurements and bioelectrical impedance analysis were performed in 5 occasions: days 1 and 7 after birth; at birth weight recovery; at term-corrected gestational age; and at around three weeks of corrected gestational age (age needed to reach a weight of 3.0 to 3.5 kg). A reference group comprising 32 term newborns, appropriate for gestational age, was evaluated at day 2 after birth. Growth restriction was defined as a Z-score below -2 for weight, length, and head circumference.
   Results
   At term age, 71.8% of the preemies presented growth restriction for weight, 61.5% for length, and 25.6% for head circumference. When the preemies reached three weeks of corrected gestational age, triceps skinfold thickness and abdominal circumference were greater than those of the reference group, and length and percent of total body water were lower.
   Conclusion
   The anthropometric profile and total body water of preemies were different from those of term newborns, suggesting fat deposition. There was catch up growth between term age and three weeks of corrected gestational age, which was more evident for head circumference and weight.
C1 [Villela, Leticia Duarte; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Gomes Junior, Saint-Clair; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, BR-22250020 Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Fundacao Oswaldo Cruz, Unidade Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716,Bloco 2, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
RI de Abranches, Andrea Dunshee/ABA-8578-2020; Junior, Clair
   Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091
CR Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0
   Costa-Orvay JA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-140
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Meio MDBB, 2008, J PERINAT MED, V36, P354, DOI 10.1515/JPM.2008.058
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Belfort MB, 2013, J PEDIATR-US, V163, P1564, DOI 10.1016/j.jpeds.2013.06.032
   CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1459, DOI 10.1016/0002-9378(95)90478-6
   Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671
   Cooke R, 2011, ANN NUTR METAB, V58, P32, DOI 10.1159/000323385
   Cooke RJ, 2009, ACTA PAEDIATR, V98, P1269, DOI 10.1111/j.1651-2227.2009.01354.x
   Daly-Wolfe KM, 2015, PEDIATR RES, V78, P336, DOI 10.1038/pr.2015.103
   [Departamento Cientcfico de Nutrologia Sociedade Brasileira de Pediatria], 2009, AV NUTR CRIAN AD MAN
   Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368
   Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280
   Ehrenkranz RA, 2007, SEMIN PERINATOL, V31, P48, DOI 10.1053/j.semperi.2007.02.001
   Embleton ND, 2014, WORLD REV NUTR DIETE
   Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Gianni ML, 2012, EARLY HUM DEV, V88, pS13, DOI 10.1016/j.earlhumdev.2011.12.022
   Horbar JD, 2015, PEDIATRICS, V136, pE84, DOI 10.1542/peds.2015-0129
   Johnson MJ, 2012, PEDIATRICS, V130, pE640, DOI 10.1542/peds.2011-3379
   Kerkhof GF, 2012, NAT REV ENDOCRINOL, V8, P689, DOI 10.1038/nrendo.2012.168
   Leunissen RWJ, 2012, HORM RES PAEDIAT, V77, P394, DOI 10.1159/000338791
   Martin CR, 2009, PEDIATRICS, V124, P649, DOI 10.1542/peds.2008-3258
   Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840
   MAUER AM, 1985, PEDIATRICS, V75, P976
   Menezes CFB, 2014, REV NUTR, V27, P269, DOI [http://dx.doi.org/10.1590/1415-52732014000300001, DOI 10.1590/1415-52732014000300001]
   Modi N, 2006, PEDIATR RES, V60, P345, DOI 10.1203/01.pdr.0000232732.93000.52
   Moreira MEL, 1997, THESIS U SAO PAULO S
   Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8
   Okada T, 2015, PEDIATR RES, V77, P136, DOI 10.1038/pr.2014.164
   Olsen IE, 2015, PEDIATRICS, V135, pE572, DOI 10.1542/peds.2014-2777
   Rice MS, 2015, NUTR CLIN PRACT, V30, P625, DOI 10.1177/0884533615578917
   Rodriguez G, 2000, BIOL NEONATE, V77, P12, DOI 10.1159/000014189
   Roggero P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014489
   Roggero P, 2009, EARLY HUM DEV, V85, P349, DOI 10.1016/j.earlhumdev.2008.12.011
   SASANOW SR, 1986, J PEDIATR-US, V109, P311, DOI 10.1016/S0022-3476(86)80393-6
   Simon L, 2014, AM J CLIN NUTR, V100, P98, DOI 10.3945/ajcn.113.080945
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P427, DOI 10.1016/j.jped.2014.04.004
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P22, DOI 10.1016/j.jped.2013.05.007
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   Uauy R, 2014, WORLD REV NUTR DIETE
   Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C
   Villela LV, 2007, THESIS
NR 45
TC 2
Z9 2
U1 0
U2 8
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD NOV-DEC
PY 2015
VL 28
IS 6
BP 619
EP 629
DI 10.1590/1415-52732015000600005
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CY8PI
UT WOS:000366670400005
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU dos Santos, AMN
   Guinsburg, R
   de Almeida, MFB
   Procianoy, RS
   Marba, STM
   Ferri, WAG
   Rugolo, LMD
   Lopes, JMA
   Moreira, MEL
   Luz, JH
   Gonzalez, MRC
   Meneses, JD
   da Silva, RVC
   Abdallah, VOS
   Duarte, JLMB
   Marques, PF
   Rego, MAS
   Alves, N
   Krebs, VLJ
AF Nunes dos Santos, Amelia Miyashiro
   Guinsburg, Ruth
   Branco de Almeida, Maria Fernanda
   Procianoy, Renato Soibelman
   Martins Marba, Sergio Tadeu
   Goncalves Ferri, Walusa Assad
   de Souza Rugolo, Ligia MariaSuppo
   Andrade Lopes, Jose Maria
   Lopes Moreira, Maria Elisabeth
   Luz, Jorge Hecker
   Conde Gonzalez, Maria Rafaela
   Meneses, Jucille do Amaral
   Cavalcante da Silva, Regina Vieira
   Steffen Abdallah, Vania Olivetti
   Muniz Bandeira Duarte, Jose Luiz
   Marques, Patricia Franco
   Rego, Maria Albertina Santiago
   Alves Filho, Navantino
   Jornada Krebs, Vera Lucia
CA Brazilian Network Neonatal Res
TI Factors associated with red blood cell transfusions in
   very-low-birth-weight preterm infants in Brazilian neonatal units
SO BMC PEDIATRICS
LA English
DT Article
DE Very low birth weight infants; Neonatal intensive care unit; Anemia; Red
   blood cell transfusion; Risk factors
ID NECROTIZING ENTEROCOLITIS; INTRAVENTRICULAR HEMORRHAGE; ERYTHROCYTE
   TRANSFUSIONS; NEED; AGE; MORTALITY; SCORE
AB Background: Preterm infants in neonatal intensive care units frequently receive red blood cells (RBC) transfusions due to the anemia of prematurity. A number of variables related to gestational age, severity of illness and transfusion practices adopted in the neonatal unit where the neonate was born may contribute to the prescription of RBC transfusions. This study aimed to analyse the frequency and factors associated with RBC transfusions in very-low-birth-weight preterm infants.
   Methods: A prospective cohort of 4283 preterm infants (gestational age: 29.9 +/- 2.9 weeks; birth weight: 1084 +/- 275 g) carried out at 16 university hospitals in Brazil between January 2009 and December 2011 was analysed. Factors associated with RBC transfusions were evaluated using univariate and multiple logistic regression analysis.
   Results: A total of 2208 (51.6 %) infants received RBC transfusions (variation per neonatal unit: 34.1 % to 66.4 %). RBC transfusions were significantly associated with gestational age (OR: -1.098; 95% CI: -1.12 to -1.04), SNAPPE II score (1.01; 1.00-1.02), apnea (1.69; 1.34-2.14), pulmonary hemorrhage (2.65; 1.74-4.031), need for oxygen at 28 days of life (1.56; 1.17-2.08), clinical sepsis (3.22; 2.55-4.05), necrotising enterocolitis (3.80; 2.26-6.41), grades III/IV intraventricular hemorrhage (1.64; 1.05-2.58), mechanical ventilation (2.27; 1.74-2.97), use of umbilical catheter (1.86; 1.35-2.57), parenteral nutrition (2.06; 1.27-3.33), > 60 days of hospitalization (5.29; 4.02-6.95) and the neonatal unit where the neonate was born.
   Conclusions: The frequency of RBC transfusions varied among neonatal intensive care units. Even after adjusting for adverse health conditions and therapeutic interventions, the neonatal unit continued to influence transfusion practices in very-low birth-weight infants.
C1 [Nunes dos Santos, Amelia Miyashiro; Guinsburg, Ruth; Branco de Almeida, Maria Fernanda] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.
   [Procianoy, Renato Soibelman] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Martins Marba, Sergio Tadeu] Univ Estadual Campinas, Campinas, SP, Brazil.
   [Goncalves Ferri, Walusa Assad] Univ Sao Paulo, BR-14049 Ribeirao Preto, SP, Brazil.
   [de Souza Rugolo, Ligia MariaSuppo] Univ Estadual Paulista, Botucatu, SP, Brazil.
   [Andrade Lopes, Jose Maria; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, BR-22420040 Rio De Janeiro, RJ, Brazil.
   [Luz, Jorge Hecker] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Conde Gonzalez, Maria Rafaela] Univ Estadual Londrina, Londrina, PR, Brazil.
   [Meneses, Jucille do Amaral] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Cavalcante da Silva, Regina Vieira] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   [Steffen Abdallah, Vania Olivetti] Univ Fed Uberlandia, Belo Horizonte, MG, Brazil.
   [Muniz Bandeira Duarte, Jose Luiz] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, RJ, Brazil.
   [Marques, Patricia Franco] Univ Fed Maranhao, Sao Luis, MA, Brazil.
   [Rego, Maria Albertina Santiago] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Alves Filho, Navantino] Fac Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil.
   [Jornada Krebs, Vera Lucia] Univ Sao Paulo, Sao Paulo, SP, Brazil.
RP Moreira, MEL (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Ave Rui Barbosa 716, BR-22420040 Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Guinsburg, Ruth/F-1984-2013; Procianoy, Renato/I-5133-2014; dos Santos,
   Amelia/H-5986-2013; Bentlin, Maria Regina/H-6282-2012
OI Guinsburg, Ruth/0000-0003-1967-9861; Procianoy,
   Renato/0000-0001-8297-4164; dos Santos, Amelia/0000-0002-8407-1556;
   Bentlin, Maria Regina/0000-0001-7310-0895; Assad Goncalves Ferri,
   Walusa/0000-0002-7174-0044
FU Ministry of Health of Brazil [MS/VIGISUS 1755/2000, MS/FNS 274,
   FIOCRUZ/PDTSP]
FX The authors would like to thank the Ministry of Health of Brazil for
   funding (MS/VIGISUS 1755/2000; MS/FNS 274; FIOCRUZ/PDTSP).
CR Aher SM, 2012, COCHRANE DB SYST REV, V10
   Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   Backes CH, 2014, OBSTET GYNECOL, V124, P47, DOI 10.1097/AOG.0000000000000324
   Baer VL, 2011, TRANSFUSION, V51, P1933, DOI 10.1111/j.1537-2995.2011.03081.x
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Christensen RD, 2013, J MATERN-FETAL NEO M, V26, P60, DOI 10.3109/14767058.2013.830495
   Del Vecchio A, 2013, J MATERN-FETAL NEO M, V26, P77, DOI 10.3109/14767058.2013.830836
   Demirel G, 2012, TRANSFUSION MED, V22, P332, DOI 10.1111/j.1365-3148.2012.01170.x
   Dominguez KM, 2012, CLIN PERINATOL, V39, P387, DOI 10.1016/j.clp.2012.04.011
   dos Santos AMN, 2010, TRANSFUSION, V50, P150, DOI 10.1111/j.1537-2995.2009.02373.x
   Fabres J, 2006, TRANSFUSION, V46, P1915, DOI 10.1111/j.1537-2995.2006.00997.x
   Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991
   Guillen U, 2012, SEMIN PERINATOL, V36, P244, DOI 10.1053/j.semperi.2012.04.004
   Henry E, 2015, J PERINATOL, V35, P132, DOI 10.1038/jp.2014.171
   Horsch S, 2010, ARCH DIS CHILD-FETAL, V95, pF310, DOI 10.1136/adc.2009.161547
   Huhta J C, 1989, Cardiol Clin, V7, P239
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Khodabux CM, 2009, TRANSFUSION MED, V19, P195, DOI 10.1111/j.1365-3148.2009.00934.x
   Kirpalani H, 2012, SEMIN PERINATOL, V36, P269, DOI 10.1053/j.semperi.2012.04.007
   Kling PJ, 1997, ARCH PEDIAT ADOL MED, V151, P27, DOI 10.1001/archpedi.1997.02170380031005
   Madan Ashima, 2005, J Perinatol, V25, P21, DOI 10.1038/sj.jp.7211201
   Mahieu L, 2012, CLIN CHIM ACTA, V413, P325, DOI 10.1016/j.cca.2011.10.027
   MARTIN RJ, 1992, NEONATAL PERINATAL M, P810
   Mehler K, 2012, ACTA PAEDIATR, V101, P1232, DOI 10.1111/apa.12015
   Miller M, 1997, NEONATAL PERINATAL M, P1040
   Mimica AFMA, 2008, VOX SANG, V95, P106, DOI 10.1111/j.1423-0410.2008.01072.x
   Miyashiro AM, 2005, VOX SANG, V88, P107, DOI 10.1111/j.1423-0410.2005.00607.x
   Mohamed A, 2012, PEDIATRICS, V129, P529, DOI 10.1542/peds.2011-2872
   dos Santos AMN, 2011, J PEDIATR-US, V159, P371, DOI 10.1016/j.jpeds.2011.02.040
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   PETERSON HB, 1991, OBSTET GYNECOL, V78, P717
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   SAEZLLORENS X, 1993, J PEDIATR-US, V123, P497, DOI 10.1016/S0022-3476(05)80942-4
   Singh R, 2011, J PERINATOL, V31, P176, DOI 10.1038/jp.2010.145
   Venancio JP, 2007, J TROP PEDIATRICS, V53, P78, DOI 10.1093/tropej/fml062
   Venkatesh V, 2013, BRIT J HAEMATOL, V160, P421, DOI 10.1111/bjh.12095
   Wan-Huen P, 2013, J PERINATOL, V33, P786, DOI 10.1038/jp.2013.60
NR 37
TC 10
Z9 9
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD SEP 4
PY 2015
VL 15
AR 113
DI 10.1186/s12887-015-0432-6
PG 8
WC Pediatrics
SC Pediatrics
GA CQ9SF
UT WOS:000360954700003
PM 26341125
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Rangel, UV
   Gomes, SCD
   Costa, AMAM
   Moreira, MEL
AF Rangel, Uesliz Vianna
   dos Santos Gomes Junior, Saint Clair
   Aranha Magalhaes Costa, Ana Maria
   Lopes Moreira, Maria Elisabeth
TI Variables associated with peripherally inserted central catheter related
   infection in high risk newborn infants
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Newborn; Catheter-Related Infections; Catheter; Biomedical Technology
   Assessment
ID CENTRAL VENOUS CATHETERS
AB Objective: to relate the variables from a surveillance form for intravenous devices in high risk newborn infants with peripherally inserted central catheter related infection. Methodology: approximately 15 variables were studied, being associated with peripherally inserted central catheter related infection, this being defined by blood culture results. The variables analyzed were obtained from the surveillance forms used with intravenous devices, attached to the medical records of newborn infants weighing between 500 and 1,499 g. The statistical association was defined using the Chi-squared and Student t tests. The study was approved by the Research Ethics Committee of the Instituto Fernandes Figueira under process N. 140.703/12. Results: 63 medical records were analyzed. The infection rate observed was 25.4%. Of the variables analyzed, only three had a statistically-significant relationship with the blood culture - the use of drugs capable of inhibiting acid secretion, post-natal steroid use, and undertaking more than one invasive procedure (p-value of 0.0141, 0.0472 and 0.0277, respectively). Conclusion: the absence of significance of the variables of the form may be related to the quality of the records and to the absence of standardization. It is recommended that the teams be encouraged to adhere to the protocol and fill out the form.
C1 [Rangel, Uesliz Vianna; dos Santos Gomes Junior, Saint Clair; Aranha Magalhaes Costa, Ana Maria; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, BR-22250020 Rio De Janeiro, Brazil.
   [Rangel, Uesliz Vianna] Corpo Bombeiros Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RP Rangel, UV (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM ueslizrangel@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X
CR Advani S, 2011, CLIN INFECT DIS, V52, P1108, DOI 10.1093/cid/cir145
   Franceschi AT, 2010, REV LAT-AM ENFERM, V18, P196, DOI 10.1590/S0104-11692010000200009
   Gomes AVO, 2012, REV ELETR ENF, V14, P883
   Ministerio da Saude (BR). Agencia Nacional de Vigilancia Sanitaria (ANVISA), 2010, CRIT NAC INF REL ASS
   Njere I, 2011, J PEDIATR SURG, V46, P946, DOI 10.1016/j.jpedsurg.2011.02.037
   Nuntnarumit P, 2013, INFECT CONT HOSP EP, V34, P430, DOI 10.1086/669863
   O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003
   Reis AT, 2011, REV PESQUI-CUID FUND, V3, P2157, DOI 10.9789/2175-5361.2011.v3i3.2157-2163
   Reis AT, 2011, REV ENFERM UERJ, V19, P592
   Singh TP, 2010, J HEART LUNG TRANSPL, V29, P517, DOI 10.1016/j.healun.2009.11.601
   Sneath N, 2010, NEONATAL NETW, V29, P23, DOI 10.1891/0730-0832.29.1.23
   Terrin G, 2012, PEDIATRICS, V129, pE40, DOI 10.1542/peds.2011-0796
NR 12
TC 6
Z9 7
U1 0
U2 3
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PD SEP-OCT
PY 2014
VL 22
IS 5
BP 842
EP 847
DI 10.1590/0104-1169.3481.2488
PG 6
WC Nursing
SC Nursing
GA AW1UQ
UT WOS:000346076700019
PM 25493681
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zin, AA
   Magluta, C
   Pinto, MFT
   Entringer, AP
   Mendes-Gomes, MA
   Moreira, MEL
   Gilbert, C
AF Zin, Andrea A.
   Magluta, Cynthia
   Pinto, Marcia F. T.
   Entringer, Aline P.
   Mendes-Gomes, Maria A.
   Moreira, Maria E. L.
   Gilbert, Clare
TI Retinopathy of prematurity screening and treatment cost in Brazil
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Costs and cost analysis; retinopathy of prematurity; Brazil
ID VISUAL IMPAIRMENT; GLOBAL LEVELS; BLINDNESS; CHILDREN; BURDEN; RISK
AB Objective. To assess the additional cost of incorporating the detection and treatment of retinopathy of prematurity (ROP) into neonatal care services of Brazil's Unified Health System (SUS).
   Methods. A deterministic decision-tree simulation model was built to estimate the direct costs of screening for and treating ROP in neonatal intensive-care units (NICUs), based on data for 869 preterm infants with birth weight less than 1 500 g examined in six governmental NICUs in the capital city of Rio de Janeiro, where coverage was 52% and 8% of infants were treated. All of the parameters from this study were extrapolated to Brazilian newborn estimates in 2010. Costs of screening and treatment were estimated considering staff, equipment and maintenance, and training based on published data and expert opinion. A budget impact analysis was performed considering the population of preterm newborns, screening coverage, and the incidence of treatable ROP. One-and two-way sensitivity analyses were performed.
   Results. In Rio de Janeiro, unit costs per newborn were US$ 18 for each examination, US$ 398 per treatment, and US$ 29 for training. The estimated cost of ROP diagnosis and treatment for all at-risk infants NICUs was US$ 80 per infant. The additional cost to the SUS for one year would be US$ 556 640 for a ROP program with 52% coverage, increasing to US$ 856 320 for 80% coverage, and US$ 1.07 million or 100% coverage.
   Conclusions. The results of this study indicate that providing ROP care is affordable within the framework of the SUS in Brazil, and might be feasible elsewhere in Latin America, considering the evidence of the effectiveness of ROP treatment and the social benefits achieved.
C1 [Zin, Andrea A.; Magluta, Cynthia; Pinto, Marcia F. T.; Entringer, Aline P.; Mendes-Gomes, Maria A.; Moreira, Maria E. L.] Fundacao Oswaldo Cruz Fiocruz, Inst Fernandes Figueira, Dept Clin Res Child & Maternal Hlth, Rio De Janeiro, RJ, Brazil.
   [Gilbert, Clare] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Fernandes Figueira, Dept Clin Res Child & Maternal Hlth, Rio De Janeiro, RJ, Brazil.
EM zin.andrea@gmail.com
CR [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P646, DOI 10.2471/BLT.10.020910
   Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Carrion JZ, 2011, CLIN OPHTHALMOL, V5, P1687, DOI 10.2147/OPTH.S25166
   Childhood Blindness Subcommittee International Agency for the Prevention of Blindness-Latin America, 2011, GUID ROP SCREEN TREA
   Cryotherapy for Retinopathy of Prematurity Cooperative Group, 1988, PEDIATRICS, V81, P697
   Dave HB, 2012, AM J OPHTHALMOL, V154, P750, DOI 10.1016/j.ajo.2012.04.003
   Departamento de Ciencia e Tecnologia Secretaria de Ciencia Tecnologia e Insumos Estrategicos Ministerio da Saude (BR), 2009, DIR MET EST AV EC TE
   Departamento de Informatica do Sistema Unico de Saude Ministerio da Saude (BR), 2013, SIST APL EV VIT SIM
   Departamento de Informatica do Sistema Unico de Saude Ministerio da Saude (BR), 2014, SIGTAP SIST GER TAB
   Departamento de Informatica do Sistema Unico de Saude Ministerio da Saude (BR), 2013, NASC VIV
   Entringer AP, 2013, CAD SAUDE PUBLICA, V29, P1205, DOI 10.1590/S0102-311X2013001000017
   Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002
   Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009
   Haddad MAO, 2007, J PEDIAT OPHTH STRAB, V44, P232, DOI 10.3928/01913913-20070701-04
   International Monetary Fund, 2013, DAT STAT
   Kamholz KL, 2009, PEDIATRICS, V123, P262, DOI 10.1542/peds.2007-2725
   Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x
   Merritt T Allen, 2003, Semin Neonatol, V8, P95, DOI 10.1016/S1084-2756(02)00219-1
   Ministerio de Salud (AR), 2008, PREV CEG INF RET PRE
   Ministerio de Salud (CL), 2010, GUIA CLIN RET PREM
   O'Connor A, 2007, EYE, V21, P1254, DOI 10.1038/sj.eye.6702838
   PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471
   PATZ A, 1987, ARCH OPHTHALMOL-CHIC, V105, P905, DOI 10.1001/archopht.1987.01060070041024
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Wallace DK, 2012, J AAPOS, V16, P1, DOI 10.1016/j.jaapos.2011.11.003
   WHO, 2013, PREV BLINDN VIS IMP
   WHO, 2012, BORN TOO SOON GLOB A
   Zepeda-Romero LC, 2011, BRIT J OPHTHALMOL, V95, P1502, DOI 10.1136/bjophthalmol-2011-300015
   Zin A, 2014, LATINOAMERICA B TRIM
   Zin AA, 2010, PEDIATRICS, V126, pE410, DOI 10.1542/peds.2010-0090
NR 31
TC 6
Z9 6
U1 0
U2 1
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD JUL
PY 2014
VL 36
IS 1
BP 37
EP 43
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AP6GO
UT WOS:000342175800006
PM 25211676
DA 2020-12-17
ER

PT J
AU Moreira, MEL
AF Lopes Moreira, Maria Elisabeth
TI Pre-terms Delay: a group "almost" forgotten of new-borns
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Editorial Material
C1 Fiocruz MS, Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2014
VL 19
IS 7
BP 1980
EP 1980
DI 10.1590/1413-81232014194.10182012
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AM4CQ
UT WOS:000339800300001
PM 25014277
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Abranches, AD
   Soares, FVM
   Junior, SCG
   Moreira, MEL
AF Abranches, Andrea D.
   Soares, Fernanda V. M.
   Junior, Saint-Clair G.
   Moreira, Maria Elisabeth L.
TI Freezing and thawing effects on fat, protein, and lactose levels of
   human natural milk administered by gavage and continuous infusion
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Human milk; Nutrition; Newborn
ID STORAGE; MACRONUTRIENTS; PASTEURIZATION; NUTRIENTS
AB Objectives: to analyze the changes in human milk macronutrients: fat, protein, and lactose in natural human milk (raw), frozen and thawed, after administration simulation by gavage and continuous infusion.
   Method: an experimental study was performed with 34 human milk samples. The infrared spectrophotometry using the infrared analysis equipment MilkoScan Minor (R) (Foss, Denmark) equipment was used to analyze the macronutrients in human milk during the study phases. The analyses were performed in natural (raw) samples and after freezing and fast thawing following two steps: gavage and continuous infusion. The non-parametric Wilcoxon test for paired samples was used for the statistical analysis.
   Results: the fat content was significantly reduced after administration by continuous infusion (p < 0.001) during administration of both raw and thawed samples. No changes in protein and lactose content were observed between the two forms of infusion. However, the thawing process significantly increased the levels of lactose and milk protein.
   Conclusion: the route of administration by continuous infusion showed the greatest influence on fat loss among all the processes required for human milk administration. (C) 2014 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
C1 [Abranches, Andrea D.; Soares, Fernanda V. M.; Junior, Saint-Clair G.; Moreira, Maria Elisabeth L.] Inst Nacl Saude Mulher Crianca Adolescente Fernan, Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Inst Nacl Saude Mulher Crianca Adolescente Fernan, Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; 
FU FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro).
CR Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003
   BJORKSTEN B, 1980, BMJ-BRIT MED J, V281, P765, DOI 10.1136/bmj.281.6243.765
   Bortolozo EAF, 2004, REV PANAM SALUD PUBL, V16, P199, DOI 10.1590/S1020-49892004000900007
   Brasil, 2008, BANC LEIT HUM FUNC P
   Casadio YS, 2010, J HUM LACT, V26, P376, DOI 10.1177/0890334410376948
   Cavalcante Jorge Luís Pereira, 2005, Food Sci. Technol (Campinas), V25, P103, DOI 10.1590/S0101-20612005000100017
   Chang YC, 2012, PEDIATR NEONATOL, V53, P205, DOI 10.1016/j.pedneo.2012.04.009
   Cooper AR, 2013, ARCH DIS CHILD-FETAL, V98, pF539, DOI 10.1136/archdischild-2013-304422
   de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689
   Elizabeth KE, 2012, INDIAN PEDIATR, V49, P867, DOI 10.1007/s13312-012-0208-0
   Fonseca ALM, 2013, J PEDIAT-BRAZIL, V89, P346, DOI 10.1016/j.jped.2012.12.010
   GARZA C, 1982, EARLY HUM DEV, V6, P295, DOI 10.1016/0378-3782(82)90123-2
   Goes HCA, 2002, NUTRITION, V18, P590, DOI 10.1016/S0899-9007(02)00813-4
   Hamosh M, 1997, J PEDIATR GASTR NUTR, V24, P38, DOI 10.1097/00005176-199701000-00010
   Higgins RD, 2012, J PEDIATR-US, V160, P511, DOI 10.1016/j.jpeds.2011.12.024
   Kaylegian KE, 2007, J DAIRY SCI, V90, P602, DOI 10.3168/jds.S0022-0302(07)71543-6
   Leone CR, 2008, NUTR RECEMNASCIDO PR, P61
   Menjo A, 2009, ACTA PAEDIATR, V98, P380, DOI 10.1111/j.1651-2227.2008.01042.x
   Garcia-Lara NR, 2013, J PEDIATR GASTR NUTR, V57, P377, DOI 10.1097/MPG.0b013e31829d4f82
   Rogers SP, 2010, NUTRIENTS, V2, P230, DOI 10.3390/nu2030240
   Silva Roberta Claro da, 2007, Quím. Nova, V30, P1535, DOI 10.1590/S0100-40422007000700007
   STOCKS RJ, 1985, ARCH DIS CHILD, V60, P164, DOI 10.1136/adc.60.2.164
   Vieira Alan A., 2004, J. Pediatr. (Rio J.), V80, P490, DOI 10.1590/S0021-75572004000800011
   Vieira AA, 2011, EARLY HUM DEV, V87, P577, DOI 10.1016/j.earlhumdev.2011.04.016
   WARDELL JM, 1981, ACTA PAEDIATR SCAND, V70, P467, DOI 10.1111/j.1651-2227.1981.tb05724.x
   Wojcik KY, 2009, J AM DIET ASSOC, V109, P137, DOI 10.1016/j.jada.2008.10.008
NR 26
TC 11
Z9 14
U1 0
U2 12
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JUL-AUG
PY 2014
VL 90
IS 4
BP 384
EP 388
DI 10.1016/j.jped.2013.11.001
PG 5
WC Pediatrics
SC Pediatrics
GA AL9MX
UT WOS:000339466500009
PM 24690583
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lima, PAT
   de Carvalho, M
   da Costa, ACC
   Moreira, MEL
AF Tabicas Lima, Paola Azara
   de Carvalho, Manoel
   Carioca da Costa, Ana Carolina
   Lopes Moreira, Maria Elisabeth
TI Z-Score: Fenton 2013. Ten-year update reply
SO JORNAL DE PEDIATRIA
LA English
DT Letter
C1 [Tabicas Lima, Paola Azara; de Carvalho, Manoel; Carioca da Costa, Ana Carolina; Lopes Moreira, Maria Elisabeth] Fundacto Oswaldo Cruz FlOCRUZ, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
   [Tabicas Lima, Paola Azara; de Carvalho, Manoel; Lopes Moreira, Maria Elisabeth] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil.
   [Tabicas Lima, Paola Azara; de Carvalho, Manoel] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil.
   [Carioca da Costa, Ana Carolina] Fundacdo Oswald Cruz FIOCRUZ, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Lopes Moreira, Maria Elisabeth] Univ Sao Paulo, Sao Paulo, Brazil.
RP Moreira, MEL (corresponding author), Fundacto Oswaldo Cruz FlOCRUZ, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
CR Fenton Tanis R, 2003, BMC Pediatr, V3, P13
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Lima PAT, 2014, J PEDIAT-BRAZIL, V90, P22, DOI 10.1016/j.jped.2013.05.007
NR 3
TC 4
Z9 4
U1 0
U2 1
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JUL-AUG
PY 2014
VL 90
IS 4
BP 427
EP 428
DI 10.1016/j.jped.2014.04.004
PG 2
WC Pediatrics
SC Pediatrics
GA AL9MX
UT WOS:000339466500017
PM 24746810
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Moreira, MEL
AF Lopes Moreira, Maria Elisabeth
TI Late preterm births: an "almost" overlooked group of newborns
SO CIENCIA & SAUDE COLETIVA
LA English
DT Editorial Material
C1 Fiocruz MS, Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Rio De Janeiro, Brazil.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2014
VL 19
IS 7
BP 1981
EP 1981
DI 10.1590/1413-81232014194.10182012
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AM4CQ
UT WOS:000339800300002
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Krauss-Silva, L
   Almada-Horta, A
   Alves, MB
   Camacho, KG
   Moreira, MEL
   Braga, A
AF Krauss-Silva, Leticia
   Almada-Horta, Antonio
   Alves, Mariane B.
   Camacho, Karla G.
   Moreira, Maria Elizabeth L.
   Braga, Alcione
TI Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence
   in early pregnancy and risk of spontaneous preterm delivery, a
   prospective study in a low socioeconomic and multiethnic South American
   population
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Bacterial vaginosis; Spontaneous preterm delivery; Aerobic vaginitis;
   Vaginal pH level; Prevalence; Relative risk; Ethnicity
ID GRAM STAIN; BIRTH; PREDICTION; FLORA; COLONIZATION; ASSOCIATION;
   SYMPTOMS; WOMEN
AB Background: Bacterial vaginosis (BV) increases the risk of spontaneous preterm deliveries (PD) in developed countries. Its prevalence varies with ethnicity, socioeconomic conditions and gestational age. Aerobic vaginitis (AV) has also been implicated with spontaneous PD. The present study aimed to estimate the prevalence of asymptomatic BV, the accuracy of vaginal pH level to predict BV and to estimate the risk of spontaneous PD <34 and <37 weeks' gestation of BV and AV.
   Methods: Women attending prenatal public services in Rio de Janeiro were screened to select asymptomatic pregnant women, < 20 weeks' gestation, with no indication for elective PD and without risk factors of spontaneous PD. Vaginal smears of women with vaginal pH > = 4.5 were collected to determine the Nugent score; a sample of those smears was also classified according to a modified Donders' score. Primary outcomes were spontaneous PD < 34 and < 37 weeks' gestation and abortion.
   Results: Prevalence of asymptomatic BV was estimated in 28.1% (n = 1699); 42.4% of the smears were collected before 14 weeks' gestation. After an 8-week follow up, nearly 40% of the initially BV positive women became BV negative. The prevalence of BV among white and black women was 28.1% (95% CI: 24.6%-32.0%) and 32.5% (95% CI: 28.2%-37.2%), respectively. The sensitivity of vaginal pH= > 4.5 and = > 5.0 to predict BV status was 100% and 82%, correspondingly; the 5.0 cutoff value doubled the specificity, from 41% to 84%. The incidence of < 37 weeks' spontaneous PDs among BV pregnant women with a pH= > 4.5 was 3.8%. The RR of spontaneous PD < 34 and < 37 weeks among BV women with pH > = 4.5, as compared with those with intermediate state, were 1.24 and 1.86, respectively (Fisher's exact test, p value = 1; 0.52, respectively, both ns). No spontaneous case of PD or abortion was associated with severe or moderate AV.
   Conclusions: A high prevalence of asymptomatic BV was observed without statistically significant difference between black and white women. The RRs of spontaneous PD < 34 and < 37 weeks among women with BV, as compared with those with intermediate state were not statistically significant but were consistent with those found in the literature.
C1 [Krauss-Silva, Leticia; Camacho, Karla G.] Brazilian Hlth Minist, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Hlth Technol Assessment Unit, BR-21041210 Rio De Janeiro, Brazil.
   [Almada-Horta, Antonio] Univ Fed Rio de Janeiro, Sch Med, BR-21044020 Rio De Janeiro, Brazil.
   [Alves, Mariane B.] Univ Fed Rio de Janeiro, Inst Math, BR-21941909 Rio De Janeiro, Brazil.
   [Moreira, Maria Elizabeth L.] Brazilian Hlth Minist, Oswaldo Cruz Fdn, Fernandes Figueira Inst, Clin Res Unit, BR-22250020 Rio De Janeiro, Brazil.
   [Braga, Alcione] Procardiaco, PROCEP, BR-22280003 Rio De Janeiro, Brazil.
RP Krauss-Silva, L (corresponding author), Brazilian Hlth Minist, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Hlth Technol Assessment Unit, R Leopoldo Bulhoes 1480,Room 714, BR-21041210 Rio De Janeiro, Brazil.
EM leticiak@ensp.fiocruz.br; almadahorta@gmail.com;
   marianebranco@im.ufrj.br; pequenakgc@yahoo.com.br;
   bebeth@iff.fiocruz.br; alcionebraga@yahoo.com.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU FIOCRUZ/ Brazilian Health Ministry; SAS/Brazilian Health Ministry; Rio
   de Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Brazilian Health Ministry
FX The present study received grants from FIOCRUZ/ Brazilian Health
   Ministry, SAS/Brazilian Health Ministry and Rio de Janeiro State
   Research Foundation (FAPERJ). None of those institutions influenced the
   analysis and the interpretation of data, the writing of the manuscript
   or the decision to submit the manuscript for publication.; LKS and MELM
   work at the Brazilian Ministry of Health; AAH and MBA work at Rio de
   Janeiro Federal University. Those authors were also supported by the
   above federal grants. KGK and AB were supported by the Brazilian Health
   Ministry's grants.
CR Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91
   Cauci S, 2002, AM J OBSTET GYNECOL, V187, P877, DOI 10.1067/mob.2002.127454
   Cauci Sabina, 2004, Curr Infect Dis Rep, V6, P450, DOI 10.1007/s11908-004-0064-8
   Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x
   Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1111/j.1471-0528.2002.00432.x
   Donders GGG, 2000, J CLIN PATHOL, V53, P308, DOI 10.1136/jcp.53.4.308
   Goldenberg RL, 1996, AM J OBSTET GYNECOL, V174, P1618, DOI 10.1016/S0002-9378(96)70617-8
   Goldenberg RL, 2003, SEMIN PERINATOL, V27, P185, DOI 10.1016/S0146-0005(03)00017-X
   Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696
   Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gondo F, 2011, GYNECOL OBSTET INVES, V71, P158, DOI 10.1159/000316051
   Gratacos E, 1999, EUR J EPIDEMIOL, V15, P913, DOI 10.1023/A:1007673531595
   Hauth JC, 2003, AM J OBSTET GYNECOL, V188, P831, DOI 10.1067/mob.2003.184
   HAY PE, 1994, BRIT J OBSTET GYNAEC, V101, P1048, DOI 10.1111/j.1471-0528.1994.tb13580.x
   HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Honest H, 2004, BJOG-INT J OBSTET GY, V111, P409, DOI 10.1111/j.1471-0528.2004.00124.x
   Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248
   Kenyon C, 2013, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2013.05.006, DOI 10.1016/J.AJ0G.2013.05.006.[]
   Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017
   Klebanoff MA, 2004, AM J OBSTET GYNECOL, V190, P363, DOI 10.1016/j.ajog.2003.08.020
   Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565
   Krauss-Silva L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-239
   Krauss-Silva L, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-14
   KURKI T, 1992, OBSTET GYNECOL, V80, P173
   Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339
   Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95
   MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2
   Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047
   Nenadic DB, 2006, EUR J OBSTET GYN R B, V140, P165
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991
   Purwar M, 2001, J OBSTET GYNAECOL RE, V27, P175, DOI 10.1111/j.1447-0756.2001.tb01248.x
   Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121
   Schwebke JR, 1996, OBSTET GYNECOL, V88, P573, DOI 10.1016/0029-7844(96)00233-5
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P1150, DOI 10.1067/S0002-9378(03)00582-9
   Tolosa JE, 2006, AM J OBSTET GYNECOL, V195, P1198, DOI 10.1016/j.ajog.2006.08.016
   Waters TP, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.061
NR 38
TC 32
Z9 38
U1 0
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD MAR 19
PY 2014
VL 14
AR 107
DI 10.1186/1471-2393-14-107
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AE1AS
UT WOS:000333698200001
PM 24641730
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Gilbert, C
   Darlow, B
   Zin, A
   Sivasubramaniam, S
   Shah, S
   Gianini, N
   Beecroft, G
   Moreira, MEL
AF Gilbert, Clare
   Darlow, Brian
   Zin, Andrea
   Sivasubramaniam, Selvaraj
   Shah, Shaheen
   Gianini, Nicole
   Beecroft, Gina
   Lopes Moreira, Maria Elisabeth
TI Educating Neonatal Nurses in Brazil: A Before-and-After Study with
   Interrupted Time Series Analysis
SO NEONATOLOGY
LA English
DT Article
DE Preterm infants; Neonatal intensive care; Retinopathy of prematurity;
   Bronchopulmonary dysplasia; Interrupted time series; Complex
   intervention
ID RIO-DE-JANEIRO; SEVERE RETINOPATHY; ANTENATAL CORTICOSTEROIDS;
   PREMATURITY; CARE; COUNTRIES; UNITS
AB Background: Preterm birth contributes significantly to infant mortality and morbidity, including blindness from retinopathy of prematurity (ROP). Access to intensive neonatal care is expanding in many countries, but care is not always optimal, one factor being that nursing is often by inadequately trained nurse assistants. Objective: The aim of this study was to evaluate whether an educational package for nurses improves a range of outcomes including survival rates and severe ROP in 5 neonatal units in Rio de Janeiro, Brazil. Methods:The study design included an uncontrolled before-and-after study in 5 units, with interrupted time series analysis. Participatory approaches were used to develop a self-administered educational package for control of pain, oxygenation, infection, nutrition, and temperature and to improve supportive care ('POINTS of Care'). Educational materials and DVD clips were developed and training skills of nurse tutors were enhanced. There were two 1-year periods of data collection before and after a 3-month period of self-administration of the education package. Results: Overall, 74% of 401 nurses and nurse assistants were trained. A total of 679 and 563 infants were included in the pre- and post-training periods, respectively. Despite improvement in knowledge and nursing practices, such as the delivery and monitoring of oxygen, there was no change in survival (pre-training 80%, post-training 78.2%), severe ROP (1.6 vs. 2.8%), sepsis (11.3 vs. 12.3 cases per 1,000 infant days) or other outcomes. Outcomes worsened over the pre-intervention period but the change to an improvement after the intervention was not statistically significant. During the study period many trained staff left the units, but few were replaced. Conclusions: Future studies need to focus on barriers to implementation, team building, leadership and governance, as well as the acquisition of knowledge and skills. (C) 2014 S. Karger AG, Basel
C1 [Gilbert, Clare; Sivasubramaniam, Selvaraj; Shah, Shaheen] Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, London WC1E 7HT, England.
   [Darlow, Brian] Univ Otago, Dept Paediat, Christchurch, New Zealand.
   [Beecroft, Gina] Christchurch Womens Hosp, Neonatal Serv, Christchurch, New Zealand.
   [Zin, Andrea; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Dept Neonatol, Rio De Janeiro, Brazil.
   [Gianini, Nicole] Municipal Hlth Dept, Rio De Janeiro, Brazil.
RP Gilbert, C (corresponding author), Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Keppel St, London WC1E 7HT, England.
EM clare.gilbert@lshtm.ac.uk
CR Agarwal R, 2007, J PERINATOL, V27, P44, DOI 10.1038/sj.jp.7211620
   Althabe F, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-22
   Askie LM, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001077.PUB2
   Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205
   Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339
   Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106
   Darlow BA, 2005, BRIT J OPHTHALMOL, V89, P1592, DOI 10.1136/bjo.2005.073650
   Darlow BA, 2012, BMC NURS, V11, DOI 10.1186/1472-6955-11-3
   Darmstadt Gary L, 2005, J Perinatol, V25, P331, DOI 10.1038/sj.jp.7211283
   Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180
   Gill AW, 2009, J HOSP INFECT, V72, P155, DOI 10.1016/j.jhin.2009.02.018
   Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233
   Groothuis JR, 2012, ADV THER, V29, P297, DOI 10.1007/s12325-012-0015-y
   Grupo Colaborativo Neocosur, 2002, J Perinatol, V22, P2
   Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031
   MCCALL EM, 2010, COCHRANE DB SYST REV, V1
   Profit J, 2011, J PERINATOL, V31, P702, DOI 10.1038/jp.2011.12
   Quigley M, 2007, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD002971, DOI 10.1002/14651858.CD002971]
   Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576
   Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2
   Romero LC, 2010, THESIS LONDON
   Sherenian M, 2013, NEONATOLOGY, V104, P179, DOI 10.1159/000353458
   Stevens B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001069.pub3
   Sun B, 2012, NEONATOLOGY, V101, P77, DOI 10.1159/000329444
   Varughese S, 2008, BRIT J OPHTHALMOL, V92, P879, DOI 10.1136/bjo.2008.137588
   WHO, 2012, BORN TOO SOON GLOB A
   Wiswell TE, 2011, RESP CARE, V56, P1360, DOI 10.4187/respcare.01433
   Zin AA, 2010, PEDIATRICS, V126, pE410, DOI 10.1542/peds.2010-0090
NR 28
TC 4
Z9 4
U1 0
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-7800
EI 1661-7819
J9 NEONATOLOGY
JI Neonatology
PY 2014
VL 106
IS 3
BP 201
EP 208
DI 10.1159/000362532
PG 8
WC Pediatrics
SC Pediatrics
GA AQ6XI
UT WOS:000342956800006
PM 25012540
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   da Gama, SGN
   Pereira, APE
   da Silva, AAM
   Lansky, S
   Pinheiro, RD
   Goncalves, AD
   Leal, MD
AF Lopes Moreira, Maria Elisabeth
   Nogueira da Gama, Silvana Granado
   Esteves Pereira, Ana Paula
   Moura da Silva, Antonio Augusto
   Lansky, Sonia
   Pinheiro, Rossiclei de Souza
   Goncalves, Annelise de Carvalho
   Leal, Maria do Carmo
TI Clinical practices in the hospital care of healthy newborn infant in
   Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Newborn Infant; Medical Assistance; Child Care
ID SMALL-AREA VARIATIONS; NATIONAL-SURVEY; RECOMMENDATIONS; DELIVERY;
   QUALITY; IMPROVEMENT; BEHAVIOR; SCIENCE; LABOR; BABY
AB The aim of this study was to evaluate the care of healthy full-term newborns and to identify variations in childbirth care and practices in the first hour of life. We used data from the Birth in Brazil survey. Unadjusted and adjusted odds ratio (OR) of hospital-delivered care for the mother and during childbirth were estimated for the following outcomes: upper airways and gastric aspiration, use of inhaled oxygen, use of incubator, skin-to-skin contact after birth, rooming-in and breastfeeding in the delivery room and within the first hour of life. We observed wide variations in the care of healthy full-term newborn in the delivery room. Practices considered inadequate, such as use of inhaled oxygen, (9.5%) aspiration of airways (71.1%) and gastric suctioning (39.7%), and the use of incubator (8.8%) were excessively used. Breastfeeding in the delivery room was low (16%), even when the Baby-Friendly Hospital Initiative had been implemented (24%). The results suggest poor knowledge and compliance by health practitioners to good clinical practice. Such noncompliance was probably not due to the differences in resources, since most births take place in hospitals where the necessary resources are available.
C1 [Lopes Moreira, Maria Elisabeth; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Nogueira da Gama, Silvana Granado; Esteves Pereira, Ana Paula] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Ctr Ciencias Saude, Sao Luis, Brazil.
   [Lansky, Sonia] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Pinheiro, Rossiclei de Souza] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Goncalves, Annelise de Carvalho] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RP Moreira, MEL (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
RI Silva, Antonio A M/B-5410-2009
OI Silva, Antonio A M/0000-0003-4968-5138
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Science and Tecnology Department, Secretariat of Science,
   Tecnology, and Strategic Inputs, Brazilian Ministry of Health; National
   School of Public Health, Oswaldo Cruz Foundation (INOVA Project);
   Foundation for supporting Research in the State of Rio de Janeiro
   (Faperj)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX National Council for Scientific and Technological Development (CNPq);
   Science and Tecnology Department, Secretariat of Science, Tecnology, and
   Strategic Inputs, Brazilian Ministry of Health; National School of
   Public Health, Oswaldo Cruz Foundation (INOVA Project); and Foundation
   for supporting Research in the State of Rio de Janeiro (Faperj).
CR Abu Jawdeh E G, 2013, J Neonatal Perinatal Med, V6, P251, DOI 10.3233/NPM-1371013
   Acolet D, 2008, ARCH DIS CHILD-FETAL, V93, pF69, DOI 10.1136/adc.2006.094946
   Aguilar AM, 2011, EARLY HUM DEV, V87, pS13, DOI 10.1016/j.earlhumdev.2011.01.003
   Aliaga S, 2013, J PERINATOL, V33, P347, DOI 10.1038/jp.2012.119
   [Anonymous], 2007, AL SOBR PRAT INT AT
   Araújo Maria de Fátima Moura de, 2007, Rev Panam Salud Publica, V22, P91
   Belizan JM, 2007, LANCET, V370, P1599, DOI 10.1016/S0140-6736(07)61673-0
   Boccolini CS, 2011, REV SAUDE PUBL, V45, P69, DOI 10.1590/s0034-89102010005000051
   Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458
   Davis Peter, 2002, J Health Serv Res Policy, V7, P202, DOI 10.1258/135581902320432723
   Di Mario S, 2013, BREASTFEED MED, V8, P388, DOI 10.1089/bfm.2012.0157
   Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005
   Glover J A, 1938, Proc R Soc Med, V31, P1219
   Hill Z, 2010, TROP MED INT HEALTH, V15, P1118, DOI 10.1111/j.1365-3156.2010.02593.x
   Kiremitci S, 2011, RESUSCITATION, V82, P40, DOI 10.1016/j.resuscitation.2010.09.004
   Leal MDC, 2006, REV SAUDE PUBL, V40, P466, DOI 10.1590/S0034-89102006000300015
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   McKeever J, 2012, J HUM LACT, V28, P312, DOI 10.1177/0890334412440627
   Mercuri M, 2011, J EVAL CLIN PRACT, V17, P671, DOI 10.1111/j.1365-2753.2011.01689.x
   Ministerio da Saude, 2009, PESQ NAC DEM SAUD G
   Moore ER, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub2
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Parry JE, 2013, J HUM LACT, V29, P527, DOI 10.1177/0890334412474719
   Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127
   Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001
   Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254
   Luna MS, 2009, AN PEDIATR, V71, P349, DOI 10.1016/j.anpedi.2009.07.012
   Soll RF, 2010, CLIN PERINATOL, V37, P11, DOI 10.1016/j.clp.2010.01.002
   STANO M, 1993, HEALTH POLICY, V24, P9, DOI 10.1016/0168-8510(93)90084-3
   WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102
   Wennburg JE, 1996, SPINE, V21, P910, DOI 10.1097/00007632-199604150-00002
   Wibaut B, 2012, TRANSFUS CLIN BIOL, V19, P145, DOI 10.1016/j.tracli.2012.07.013
   Winberg J, 2005, DEV PSYCHOBIOL, V47, P217, DOI 10.1002/dev.20094
   Winniccot DW, 1999, BEBES SUAS MAES
   World Health Organization (WHO/UNICEF), 2009, BAB FRIENDL HOSP IN
NR 36
TC 18
Z9 28
U1 0
U2 9
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2014
VL 30
SU 1
DI 10.1590/0102-311X00145213
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AN8FH
UT WOS:000340838200019
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Lima, PAT
   de Carvalho, M
   da Costa, ACC
   Moreira, MEL
AF Tabicas Lima, Paola Azara
   de Carvalho, Manoel
   Carioca da Costa, Ana Carolina
   Lopes Moreira, Maria Elisabeth
TI Variables associated with extra uterine growth restriction in very low
   birth weight infants
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Premature; Growth; Malnutrition
ID PRETERM INFANT; RETARDATION; FAILURE
AB Objectives: to determine the rate of extrauterine growth restriction in very low birth weight infants and to evaluate the influence of perinatal variables, clinical practices, and neonatal morbidities on this outcome.
   Methods: a longitudinal study was performed in four neonatal units in the city of Rio de Janeiro. 570 very low birth weight infants were analyzed. The study included perinatal variables, variables related to clinical practices, and incident morbidities in these preterm infants. Extrauterine growth restriction was defined using z-scores for weight or head circumference <= -2 for corrected age. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) and R software.
   Results: this study comprised 570 infants, of which 49% were males, and 33% were small for gestational age (SGA). The mean weight and head circumference at birth were 1,113 +/- 267 g and 27 +/- 2 cm, respectively. The mean z-scores of birth weight and weight at discharge were -0.96 +/- 0.78 and -1.54 +/- 0.75, respectively; for head circumference, the mean z-scores at birth and at discharge were -0.63 +/- 1.18 and -0.45 +/- 0.94, respectively. The rate of extrauterine growth restriction considering the weight was 26% (149/570) and considering the head circumference, 5% (29/570). SGA was the variable with the greatest impact on both growth restriction for weight (PR = 4.33) and for head circumference (PR = 2.11) in adjusted analyses.
   Conclusion: extrauterine growth restriction was high in the population, especially for SGA newborns and those with neonatal morbidities. (C) 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
C1 [Tabicas Lima, Paola Azara; de Carvalho, Manoel; Lopes Moreira, Maria Elisabeth] Clin Perinatal Laranjeiras, Rio De Janeiro, RJ, Brazil.
   [Tabicas Lima, Paola Azara; de Carvalho, Manoel; Carioca da Costa, Ana Carolina; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira FIOCRUZ, Rio De Janeiro, RJ, Brazil.
   [Tabicas Lima, Paola Azara; de Carvalho, Manoel] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil.
   [Carioca da Costa, Ana Carolina] Escola Nacl Saude Publ FIOCRUZ, Rio De Janeiro, RJ, Brazil.
   [Lopes Moreira, Maria Elisabeth] Univ Sao Paulo, Sao Paulo, Brazil.
RP Moreira, MEL (corresponding author), Clin Perinatal Laranjeiras, Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
CR Anchieta Lêni M., 2004, J. Pediatr. (Rio J.), V80, P267, DOI 10.1590/S0021-75572004000500005
   Anchieta Lêni M., 2004, J. Pediatr. (Rio J.), V80, P417, DOI 10.1590/S0021-75572004000600014
   BARKER DJP, 1989, LANCET, V2, P577
   Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986
   Claudet I, 2012, ARCH PEDIATRIE, V19, P900, DOI 10.1016/j.arcped.2012.06.016
   Cooke Richard, 2005, J Perinatol, V25 Suppl 2, pS12, DOI 10.1038/sj.jp.7211310
   Cooke RJ, 2004, ARCH DIS CHILD-FETAL, V89, pF428, DOI 10.1136/adc.2001.004044
   Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2
   Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280
   Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270
   Fenton TR, 2007, EUR J CLIN NUTR, V61, P1380, DOI 10.1038/sj.ejcn.1602667
   Fenton Tanis R, 2003, BMC Pediatr, V3, P13
   Freitas BA, 2012, REV PEDIAT SOPERJ, V13, P4
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Goulart AL, 2011, REV ASSOC MED BRAS, V57, P269
   Hack M., 1997, NEONATAL PERINATAL M, P952
   IBM Corporation Released, 2011, IBM SPSS STAT WIND
   Kurtoglu S, 2012, J CLIN RES PEDIATR E, V4, P132, DOI [10.4274/Jcrpe.693, 10.4274/jcrpe.693]
   Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   Lucas Alan, 2005, J Perinatol, V25 Suppl 2, pS2, DOI 10.1038/sj.jp.7211308
   MAUER AM, 1985, PEDIATRICS, V75, P976
   Moreira ME, 1997, THESIS U SIDADE SAO
   Ornelas Sandra L., 2002, J. Pediatr. (Rio J.), V78, P230, DOI 10.1590/S0021-75572002000300012
   Procianoy Renato S., 2005, J. Pediatr. (Rio J.), V81, pS1, DOI 10.1590/S0021-75572005000200001
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Shan HM, 2009, EUR J PEDIATR, V168, P1055, DOI 10.1007/s00431-008-0885-9
   Sices L, 2007, PAED CHILD HEALT-CAN, V12, P22, DOI 10.1093/pch/12.1.22
   Vermont Oxford Network Database, 2009, MAN OP INF BORN 2010
NR 29
TC 29
Z9 37
U1 0
U2 4
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JAN-FEB
PY 2014
VL 90
IS 1
BP 22
EP 27
DI 10.1016/j.jped.2013.05.007
PG 6
WC Pediatrics
SC Pediatrics
GA AD0DL
UT WOS:000332904600005
PM 24156833
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU da Silva, AAM
   Leite, AJM
   Lamy, ZC
   Moreira, MEL
   Gurgel, RQ
   da Cunha, AJLA
   Leal, MD
AF Moura da Silva, Antonio Augusto
   Madeiro Leite, Alvaro Jorge
   Lamy, Zeni Carvalho
   Lopes Moreira, Maria Elisabeth
   Gurgel, Ricardo Queiroz
   Ledo Alves da Cunha, Antonio Jose
   Leal, Maria do Carmo
TI Neonatal near miss in the Birth in Brazil survey
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Maternal and Child Health; Infant Mortality; Low Birth Weight Infant;
   Parturition
ID CESAREAN DELIVERY; GLOBAL SURVEY; MORTALITY; PREGNANCY; RATES
AB This study used data from the Birth in Brazil survey, a nationwide hospital-based study of 24,197 postpartum women and their newborns, collected between February 2011 and July 2012. A three-stage cluster sampling design (hospitals, days, women) was used consisting of stratification by geographic region, type of municipality (capital or non-capital), and type of hospital financing. Logistic regression was used to identify variables that were potential predictors of neonatal mortality and neonatal near miss indicators. After testing nineteen variables, five were chosen to compose a set of neonatal near miss indicators (birth weight of less than 1,500g, Apgar score of less than 7 in the 5th minute of life, use of mechanical ventilation, gestational age of less than 32 weeks and congenital malformations). The neonatal near miss rate in the Birth in Brazil survey was 39.2 per thousand live births, three and a half times higher than the neonatal mortality rate (11.1 per thousand). These neonatal near miss indicators were able to identify situations with a high risk of neonatal death.
C1 [Moura da Silva, Antonio Augusto; Lamy, Zeni Carvalho] Univ Fed Maranhao, Ctr Ciencias Saude, BR-65020070 Sao Luis, MA, Brazil.
   [Madeiro Leite, Alvaro Jorge] Univ Fed Ceara, Fac Med, Fortaleza, Ceara, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Gurgel, Ricardo Queiroz] Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Aracaju, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
RP da Silva, AAM (corresponding author), Univ Fed Maranhao, Ctr Ciencias Saude, Dept Saude Publ, Rua Barao Itapary 155, BR-65020070 Sao Luis, MA, Brazil.
EM aamouradasilva@gmail.com
RI da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Lamy, Zeni
   Carvalho/AAP-6494-2020; Machado, MARCIA MT/J-9614-2014; Silva, Antonio A
   M/B-5410-2009; Gurgel, RQ/N-5105-2018
OI da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Machado, MARCIA
   MT/0000-0002-0149-5792; Silva, Antonio A M/0000-0003-4968-5138; Gurgel,
   RQ/0000-0001-9651-3713
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Science and Tecnology Department, Secretariat of Science,
   Tecnology, and Strategic Inputs, Brazilian Ministry of Health; National
   School of Public Health, Oswaldo Cruz Foundation (INOVA Project);
   Foundation for supporting Research in the State of Rio de Janeiro
   (FAPERJ)
FX National Council for Scientific and Technological Development (CNPq);
   Science and Tecnology Department, Secretariat of Science, Tecnology, and
   Strategic Inputs, Brazilian Ministry of Health; National School of
   Public Health, Oswaldo Cruz Foundation (INOVA Project); and Foundation
   for supporting Research in the State of Rio de Janeiro (FAPERJ).
CR Avenant T, 2009, BEST PRACT RES CL OB, V23, P369, DOI 10.1016/j.bpobgyn.2008.12.005
   Barros AJD, 2008, REV SAUDE PUBL, V42, P1, DOI 10.1590/s0034-89102008000100001
   Bettiol H, 2000, PAEDIATR PERINAT EP, V14, P30, DOI 10.1046/j.1365-3016.2000.00222.x
   Caldeira A P, 2001, J Pediatr (Rio J), V77, P461
   Camargo K R Jr, 2000, Cad Saude Publica, V16, P439
   da Silva ZP, 2010, CAD SAUDE PUBLICA, V26, P123, DOI 10.1590/S0102-311X2010000100013
   da Silva ZP, 2009, CAD SAUDE PUBLICA, V25, P1981, DOI 10.1590/S0102-311X2009000900012
   de Oliveira TG, 2012, EINSTEIN-SAO PAULO, V10, P22, DOI 10.1590/S1679-45082012000100006
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Goldani MZ, 2001, REV SAUDE PUBL, V35, P256, DOI 10.1590/S0034-89102001000300007
   Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213
   Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15
   de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013
   da Silva AAM, 2010, REV SAUDE PUBL, V44, P767, DOI 10.1590/S0034-89102010005000033
   Nascimento Renata Mota do, 2012, Cad. Saúde Pública, V28, P559
   Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101
   Pileggi C, 2010, J PEDIAT-BRAZIL, V86, P21, DOI 10.2223/JPED.1965
   Presidencia da Republica, 2010, OBJ DES MIL
   Say L, 2010, J PEDIAT-BRAZIL, V86, P1, DOI [10.2223/JPED.1978, 10.1590/S0021-75572010000100001]
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Signore C, 2008, CLIN PERINATOL, V35, P361, DOI 10.1016/j.clp.2008.03.009
   Sousa A, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-21
   Tracy SK, 2007, BIRTH-ISS PERINAT C, V34, P301, DOI 10.1111/j.1523-536X.2007.00188.x
   United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR
   Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55
   Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7
   World Health Organization, 2011, EV QUAL CAR SEV PREG
   Zanini RR, 2011, REV SAUDE PUBL, V45, P79, DOI 10.1590/s0034-89102011000100009
NR 28
TC 27
Z9 34
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2014
VL 30
SU 1
DI 10.1590/0102-311X00129613
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AN8FH
UT WOS:000340838200023
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Santos, MC
   Sa, C
   Gomes, SC
   Camacho, LA
   Moreira, ME
AF Santos, Maria Cristina
   Sa, Cynthia
   Gomes, Saint Clair, Jr.
   Camacho, Luiz Antonio
   Moreira, Maria Elisabeth
TI The efficacy of the use of intravenous human immunoglobulin in Brazilian
   newborns with rhesus hemolytic disease: a randomized double-blind trial
SO TRANSFUSION
LA English
DT Article
ID MANAGEMENT; THERAPY; HYPERBILIRUBINEMIA
AB BACKGROUND: The purpose of this study was to evaluate the efficacy of intravenous human immunoglobulin (IVIG) in the presence of high-intensity phototherapy in decreasing the need for exchange transfusion in newborns with rhesus hemolytic disease. STUDY DESIGN AND METHODS: We performed a randomized, double-blind, placebo-controlled trial. The trial included D+ newborns born at 32 weeks of gestational age or later with a positive direct antiglobulin test and whose mothers were Rh-alloimmunized and did or did not receive intrauterine transfusion. The newborns were randomly assigned to receive either IVIG at a dose of 500mg/kg or placebo (saline solution, 10mL/kg) during the first 6 hours of life. The primary outcome was the need for exchange transfusion. The criteria for exchange transfusion were total serum bilirubin (TSB) level at or above 340 mu mol/L (20mg/dL) or increasing by 8.5 mu mol/L/hr (0.5mg/dL/hr) despite intensive phototherapy. RESULTS: The trial included 92 newborns. There was no difference in the rate of exchange transfusion between groups: 6 of 46 (13%) in the IVIG group versus 7 of 46 (15.2%) in the placebo group (p=0.765). There were no significant differences between groups with respect to their need for exchange transfusion, phototherapy time, peak bilirubin, or length of hospital stay. There were no adverse events related to the drug or the form of administration. CONCLUSION: Nonspecific human immunoglobulin was not effective in preventing the need for exchange transfusion in neonates with rhesus hemolytic disease.
C1 Clin Res Unit, Transfus Med Unit, Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Ave Rui Barbosa 716 Flamengo, BR-22250020 Rio De Janeiro, Brazil.
EM bebethiff@gmail.com
RI Junior, Clair Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); PDTSP/Fiocruz, Rio de Janeiro, Brazil
FX The authors acknowledge FAPERJ and PDTSP/Fiocruz, Rio de Janeiro,
   Brazil, for financial support.
CR Alcock GS, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003313, DOI 10.1002/14651858.CD003313]
   Alpay F, 1999, ACTA PAEDIATR, V88, P216, DOI 10.1080/08035259950170420
   Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030
   Bowman J, 1997, SEMIN PERINATOL, V21, P39, DOI 10.1016/S0146-0005(97)80018-3
   DAGOGLU T, 1995, J INT MED RES, V23, P264
   Elalfy MS, 2011, EUR J PEDIATR, V170, P461, DOI 10.1007/s00431-010-1310-8
   Gottstein R, 2003, ARCH DIS CHILD-FETAL, V88, P6
   Jackson JC, 1997, PEDIATRICS, V99, P1
   Maisels MJ, 2004, PEDIATRICS, V114, P297
   Mollison PL, 1997, BLOOD TRANSFUSION CL, P390
   Nasseri F, 2006, SAUDI MED J, V27, P1827
   OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245
   Pishva N, 2000, IRN J MED SCI, V25, P129
   RUBO J, 1992, J PEDIATR-US, V121, P93, DOI 10.1016/S0022-3476(05)82551-X
   Sa CAM, 2009, REV PAUL PEDIAT, V2, P168
   Smits-Wintjens VEHJ, 2011, PEDIATRICS, V127, P680, DOI 10.1542/peds.2010-3242
   van Kamp IL, 2004, ACTA OBSTET GYN SCAN, V83, P731, DOI 10.1111/j.0001-6349.2004.00394.x
NR 17
TC 17
Z9 20
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
J9 TRANSFUSION
JI Transfusion
PD APR
PY 2013
VL 53
IS 4
BP 777
EP 782
DI 10.1111/j.1537-2995.2012.03827.x
PG 6
WC Hematology
SC Hematology
GA 123DI
UT WOS:000317368200016
PM 22882285
DA 2020-12-17
ER

PT J
AU Leal, MD
   da Silva, AAM
   Dias, MAB
   da Gama, SGN
   Rattner, D
   Moreira, ME
   Filha, MMT
   Domingues, RMSM
   Pereira, APE
   Torres, JA
   Bittencourt, SDA
   D'orsi, E
   Cunha, AJLA
   Leite, AJM
   Cavalcante, RS
   Lansky, S
   Diniz, CSG
   Szwarcwald, CL
AF Leal, Maria do Carmo
   Moura da Silva, Antonio Augusto
   Bastos Dias, Marcos Augusto
   Nogueira da Gama, Silvana Granado
   Rattner, Daphne
   Moreira, Maria Elizabeth
   Theme Filha, Mariza Miranda
   Soares Madeira Domingues, Rosa Maria
   Esteves Pereira, Ana Paula
   Torres, Jacqueline Alves
   Azevedo Bittencourt, Sonia Duarte
   D'orsi, Eleonora
   Cunha, Antonio J. L. A.
   Madeiro Leite, Alvaro Jorge
   Cavalcante, Rejane Silva
   Lansky, Sonia
   Grilo Diniz, Carmem Simone
   Szwarcwald, Celia Landmann
TI Birth in Brazil: national survey into labour and birth
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Caesarean section; Elective Caesarean section; Robson's groups; Near
   miss maternal morbidity; Near miss neonatal morbidity; Prematurity; Low
   birth weight; Brazil
ID CESAREAN-SECTION RATES; PRETERM BIRTHS; NEONATAL-MORTALITY; SOUTHEAST
   BRAZIL; UNITED-STATES; TERM INFANTS; RISK-FACTORS; DELIVERY; COHORTS;
   WEIGHT
AB Background: Caesarean section rates in Brazil have been steadily increasing. In 2009, for the first time, the number of children born by this type of procedure was greater than the number of vaginal births. Caesarean section is associated with a series of adverse effects on the women and newborn, and recent evidence suggests that the increasing rates of prematurity and low birth weight in Brazil are associated to the increasing rates of Caesarean section and labour induction.
   Methods: Nationwide hospital-based cohort study of postnatal women and their offspring with follow-up at 45 to 60 days after birth. The sample was stratified by geographic macro-region, type of the municipality and by type of hospital governance. The number of postnatal women sampled was 23,940, distributed in 191 municipalities throughout Brazil. Two electronic questionnaires were applied to the postnatal women, one baseline face-to-face and one follow-up telephone interview. Two other questionnaires were filled with information on patients' medical records and to assess hospital facilities. The primary outcome was the percentage of Caesarean sections (total, elective and according to Robson's groups). Secondary outcomes were: post-partum pain; breastfeeding initiation; severe/near miss maternal morbidity; reasons for maternal mortality; prematurity; low birth weight; use of oxygen use after birth and mechanical ventilation; admission to neonatal ICU; stillbirths; neonatal mortality; readmission in hospital; use of surfactant; asphyxia; severe/near miss neonatal morbidity. The association between variables were investigated using bivariate, stratified and multivariate model analyses. Statistical tests were applied according to data distribution and homogeneity of variances of groups to be compared. All analyses were taken into consideration for the complex sample design.
   Discussion: This study, for the first time, depicts a national panorama of labour and birth outcomes in Brazil. Regardless of the socioeconomic level, demand for Caesarean section appears to be based on the belief that the quality of obstetric care is closely associated to the technology used in labour and birth. Within this context, it was justified to conduct a nationwide study to understand the reasons that lead pregnant women to submit to Caesarean sections and to verify any association between this type of birth and it's consequences on postnatal health.
C1 [Leal, Maria do Carmo; Nogueira da Gama, Silvana Granado; Theme Filha, Mariza Miranda; Soares Madeira Domingues, Rosa Maria; Esteves Pereira, Ana Paula; Azevedo Bittencourt, Sonia Duarte] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21041210 Rio De Janeiro, RJ, Brazil.
   [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Maranhao, Brazil.
   [Bastos Dias, Marcos Augusto; Moreira, Maria Elizabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, BR-21041210 Rio De Janeiro, RJ, Brazil.
   [Rattner, Daphne] Univ Brasilia, Brasilia, DF, Brazil.
   [Torres, Jacqueline Alves] Agencia Nacl Saude Suplementar, Rio De Janeiro, Brazil.
   [D'orsi, Eleonora] Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil.
   [Cunha, Antonio J. L. A.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Madeiro Leite, Alvaro Jorge] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Cavalcante, Rejane Silva] Fed Univ Para, BR-66059 Belem, Para, Brazil.
   [Lansky, Sonia] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Grilo Diniz, Carmem Simone] Univ Sao Paulo, Sao Paulo, Brazil.
   [Szwarcwald, Celia Landmann] Fundacao Oswaldo Cruz, Inst Comunicacao & Informacao Cient & Tecnol Saud, BR-21041210 Rio De Janeiro, RJ, Brazil.
RP Leal, MD (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-21041210 Rio De Janeiro, RJ, Brazil.
EM duca@fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; d'Orsi,
   Eleonora/D-1905-2015; Domingues, Rosa/AAS-3606-2020; Machado, MARCIA
   MT/J-9614-2014; Silva, Antonio A M/B-5410-2009
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Domingues,
   Rosa/0000-0001-5722-8127; Machado, MARCIA MT/0000-0002-0149-5792; Silva,
   Antonio A M/0000-0003-4968-5138; Miranda Theme Filha,
   Mariza/0000-0002-7075-9819
FU National Council for Scientific and Tecnological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); National School of Public Health - Fiocruz, Brazil
FX This research received financial support from the National Council for
   Scientific and Tecnological Development (CNPq) and National School of
   Public Health - Fiocruz, Brazil.
CR Associacao Brasileira de Empresas de Pesquisa (ABEP), 2008, AD CCEB 2008
   Avenant T, 2009, BEST PRACT RES CL OB, V23, P369, DOI 10.1016/j.bpobgyn.2008.12.005
   Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI 10.1590/s0034-89102011005000039
   Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4
   Barros FC, 2008, CAD SAUDE PUBLICA, V24, pS390, DOI 10.1590/S0102-311X2008001500004
   Dias MAB, 2008, CIENC SAUDE COLETIVA, V13, P1521, DOI 10.1590/S1413-81232008000500017
   Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942
   Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18
   Bettiol H, 2000, PAEDIATR PERINAT EP, V14, P30, DOI 10.1046/j.1365-3016.2000.00222.x
   Bogg L, 2010, SOC SCI MED, V70, P1544, DOI 10.1016/j.socscimed.2010.01.026
   de Almeida S, 2008, CAD SAUDE PUBLICA, V24, P2909, DOI 10.1590/S0102-311X2008001200020
   Freitas PF, 2005, REV SAUDE PUBL, V39, P761, DOI 10.1590/S0034-89102005000500010
   Gomes UA, 1999, INT J EPIDEMIOL, V28, P687, DOI 10.1093/ije/28.4.687
   Grytten J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-267
   Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007
   Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE
   Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3
   IBGE, 1997, FUND I BRAS GEOGR ES
   Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df
   Klemetti R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.032
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Leal Maria do Carmo, 2004, Cad. Saúde Pública, V20, pS20
   Leal MD, 2005, REV SAUDE PUBL, V39, P100, DOI 10.1590/s0034-89102005000100013
   Lee YM, 2008, CLIN PERINATOL, V35, P505, DOI 10.1016/j.clp.2008.07.006
   Little R. J. A., 2002, STAT ANAL MISSING DA
   Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x
   Malloy MH, 2008, PEDIATRICS, V122, P285, DOI 10.1542/peds.2007-2620
   Malloy MH, 2009, BIRTH-ISS PERINAT C, V36, P26, DOI 10.1111/j.1523-536X.2008.00292.x
   Robson MS, 2001, FETAL MATERNAL MED R, V12, P23, DOI DOI 10.1017/S0965539501000122
   Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6
   Silva AAM, 1998, B WORLD HEALTH ORGAN, V76, P73
   Silva AAM, 2005, PAEDIATR PERINAT EP, V19, P43, DOI 10.1111/j.1365-3016.2004.00624.x
   Silva AAM, 2004, INT J EPIDEMIOL, V33, P821, DOI 10.1093/ije/dyh101
   Silva AAM, 2001, PAEDIATR PERINAT EP, V15, P257, DOI 10.1046/j.1365-3016.2001.00358.x
   Simoes E, 2005, GYNECOL OBSTET INVES, V60, P213, DOI 10.1159/000087208
   Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286
   Sreevidya S, 2003, BJOG-INT J OBSTET GY, V110, P106, DOI 10.1046/j.1471-0528.2003.02006.x
   Stanton Cynthia, 2008, Bull World Health Organ, V86, pA
   Sufang G, 2007, B WORLD HEALTH ORGAN, V85, P755, DOI 10.2471/BLT.06.035808
   Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429
   de Andrade CLT, 2008, CAD SAUDE PUBLICA, V24, P2564, DOI 10.1590/S0102-311X2008001100011
   Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x
   Tomashek KM, 2007, J PEDIAT, V151, P450
   Tracy SK, 2007, BIRTH-ISS PERINAT C, V34, P301, DOI 10.1111/j.1523-536X.2007.00188.x
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55
   Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7
   Wylie BJ, 2008, CLIN PERINATOL, V35, P571, DOI 10.1016/j.clp.2008.06.002
NR 48
TC 98
Z9 108
U1 0
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD AUG 22
PY 2012
VL 9
AR 15
DI 10.1186/1742-4755-9-15
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 070KH
UT WOS:000313504500001
PM 22913663
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Toro-Ramos, T
   Meio, MDBB
   Morsch, DS
   Moreira, MEL
   do Carmo, MT
   Sichieri, R
   Hoffman, DJ
AF Toro-Ramos, Tatiana
   Barbosa Baker Meio, Maria Dalva
   Morsch, Denise Streit
   Lopes Moreira, Maria Elizabeth
   do Carmo, Maria Tavares
   Sichieri, Rosely
   Hoffman, Daniel J.
TI Effects of polyunsaturated fatty acids on cognitive-linguistic
   development of premature infants
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 21-25, 2012
CL San Diego, CA
C1 [Toro-Ramos, Tatiana; Hoffman, Daniel J.] Rutgers State Univ, New Brunswick, NJ 08903 USA.
   [Barbosa Baker Meio, Maria Dalva; Morsch, Denise Streit; Lopes Moreira, Maria Elizabeth] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [do Carmo, Maria Tavares] Univ Fed Rio de Janeiro, Josue de Castro Nutr Inst, Rio De Janeiro, Brazil.
   [Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
NR 0
TC 0
Z9 0
U1 0
U2 7
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2012
VL 26
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 032IZ
UT WOS:000310711306624
DA 2020-12-17
ER

PT J
AU Krauss-Silva, L
   Moreira, MEL
   Alves, MB
   Braga, A
   Camacho, KG
   Batista, MRR
   Almada-Horta, A
   Rebello, MR
   Guerra, F
AF Krauss-Silva, Leticia
   Moreira, Maria Elizabeth L.
   Alves, Mariane B.
   Braga, Alcione
   Camacho, Karla G.
   Batista, Maria Rosa R.
   Almada-Horta, Antonio
   Rebello, Maria R.
   Guerra, Fernando
TI A randomised controlled trial of probiotics for the prevention of
   spontaneous preterm delivery associated with bacterial vaginosis:
   preliminary results
SO TRIALS
LA English
DT Article
ID FETAL INFLAMMATORY RESPONSE; PLACEBO-CONTROLLED TRIAL; UMBILICAL-CORD
   PLASMA; PROINFLAMMATORY CYTOKINES; PREGNANT-WOMEN; VAGINAL FLORA; BIRTH;
   INFECTION; RISK; METRONIDAZOLE
AB Background: Bacterial vaginosis increases the risk of spontaneous preterm delivery at less than 34 weeks of gestation.
   Objective: The purpose of this study was to evaluate the efficacy of the early administration of selected lactobacilli strains (probiotics) to pregnant women with asymptomatic bacterial vaginosis/intermediate-degree infections to prevent spontaneous premature delivery and associated neonatal morbidity.
   Methods/Design: Asymptomatic pregnant women at less than 20 weeks of gestation, with no indication of elective preterm delivery, with a vaginal pH >= 4.5 and Nugent score > 3 were randomly assigned to the placebo or intervention group (oral administration of selected lactobacilli up to the 24th to 26th week of gestation). The randomisation was stratified for the history of premature delivery (HPD) and blocked. The allocation was concealed, and the participating health professionals and patients were blinded. The primary outcome was preterm delivery (<34 to <32 weeks), and the secondary outcomes were associated neonatal complications.
   Results: In total, 4,204 pregnant women were screened; 320 and 324 individuals were respectively randomly assigned to the placebo and intervention groups, and 62% finished the trial. None of the randomised patients were lost to follow-up. For the non-HPD stratum, the intent-to-treat relative risks of spontaneous premature birth at < 34 and < 37 weeks' gestation were 0.33 (0.03, 3.16) and 0.49 (0.17, 1.44), respectively, and they were nonsignificant (ns) with p = 0.31 and 0.14. The corresponding actual treatment figures were zero and 0.32 (0.09, 1.19), which were ns with p = 0.12 and 0.06. The intent-to-treat relative risk of spontaneous premature birth at < 37 weeks of gestation for the trial as a whole, including HPD and non-HPD participants, was 0.69 (0.26, 1.78), p = 0.30 (ns). The neonatal complications under evaluation occurred in only one infant (< 34 weeks; placebo group) who presented with respiratory distress syndrome and suspected early neonatal sepsis. The recorded adverse events were minor and relatively non-specific.
   Conclusions: The efficacy of the tested probiotics to prevent preterm delivery among women without a history of preterm delivery was not determined because the study sample was insufficient to estimate statistically significant intent-to-treat effects; additional studies are needed to evaluate this intervention among these women.
C1 [Krauss-Silva, Leticia; Alves, Mariane B.; Camacho, Karla G.; Rebello, Maria R.] Brazilian Hlth Minist, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Hlth Technol Assessment Unit, BR-21041210 Rio De Janeiro, Brazil.
   [Moreira, Maria Elizabeth L.] Brazilian Hlth Minist, Oswaldo Cruz Fdn, Fernandes Figueira Inst, Clin Res Unit, BR-22250020 Rio De Janeiro, Brazil.
   [Alves, Mariane B.] Univ Fed Rio de Janeiro, Inst Math, BR-21941909 Rio De Janeiro, Brazil.
   [Braga, Alcione] PROCEP, BR-22280003 Rio De Janeiro, Brazil.
   [Batista, Maria Rosa R.; Guerra, Fernando] Brazilian Hlth Minist, Fernandes Figueira Inst, Oswaldo Cruz Fdn, Dept Obstet & Gynecol, BR-22250020 Rio De Janeiro, Brazil.
   [Almada-Horta, Antonio] Univ Fed Rio de Janeiro, Sch Med, BR-21044020 Rio De Janeiro, Brazil.
RP Krauss-Silva, L (corresponding author), Brazilian Hlth Minist, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Hlth Technol Assessment Unit, R Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, Brazil.
EM leticiak@ensp.fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU FIOCRUZ/Brazilian Health Ministry; SAS/Brazilian Health Ministry; State
   of Rio de Janeiro Research Foundation; Brazilian Health Ministry
FX The trial was supported by grants from FIOCRUZ/Brazilian Health
   Ministry, SAS/Brazilian Health Ministry, and the State of Rio de Janeiro
   Research Foundation.; the Brazilian Health Ministry and the State of Rio
   de Janeiro Research Foundation.
CR *AG HEALTHC RES QU, 2000, AHRQ PUBL
   Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012
   Andrews WW, 2003, OBSTET GYNECOL, V101, P847, DOI 10.1016/S0029-7844(03)00172-8
   Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011
   Campos Mônica Rodrigues, 2004, Cad. Saúde Pública, V20, pS34, DOI 10.1590/S0102-311X2004000700004
   Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802
   Cauci Sabina, 2004, Curr Infect Dis Rep, V6, P450, DOI 10.1007/s11908-004-0064-8
   CLOHERTY JP, 2004, MANUAL NEONATAL CARE
   de Vrese M, 2002, BRIT J NUTR, V88, pS59, DOI 10.1079/BJN2002630
   Famularo G, 2001, MED HYPOTHESES, V56, P421, DOI 10.1054/mehy.2000.1195
   Genc MR, 2004, AM J OBSTET GYNECOL, V190, P1191, DOI 10.1016/j.ajog.2003.11.007
   Goldenberg RL, 2003, SEMIN PERINATOL, V27, P185, DOI 10.1016/S0146-0005(03)00017-X
   Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8
   Hauth JC, 2003, AM J OBSTET GYNECOL, V188, P831, DOI 10.1067/mob.2003.184
   Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603
   Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248
   Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006
   Kalinka J, 2005, AM J REPROD IMMUNOL, V54, P70, DOI 10.1111/j.1600-0897.2005.00289.x
   Klebanoff MA, 2004, AM J OBSTET GYNECOL, V190, P363, DOI 10.1016/j.ajog.2003.08.020
   Klein LL, 2004, AM J OBSTET GYNECOL, V190, P1493, DOI 10.1016/j.ajog.2004.03.014
   Krauss-Silva L, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-14
   Leal Maria do Carmo, 2004, Cad. Saúde Pública, V20, pS20
   MCGREGOR JA, 1990, AM J OBSTET GYNECOL, V163, P1580, DOI 10.1016/0002-9378(90)90632-H
   McLean NW, 2000, J MED MICROBIOL, V49, P543, DOI 10.1099/0022-1317-49-6-543
   MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2
   Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9
   Mercer BM, 1996, AM J OBSTET GYNECOL, V174, P1885, DOI 10.1016/S0002-9378(96)70225-9
   Moher D., 2010, BMJ, V340
   Monga M, 1995, Infect Dis Obstet Gynecol, V3, P37, DOI 10.1155/S1064744995000287
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991
   PAHLSON C, 1991, MED HYPOTHESES, V36, P126, DOI 10.1016/0306-9877(91)90253-U
   Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528
   Reid G, 2004, J CLIN GASTROENTEROL, V38, pS94, DOI 10.1097/01.mcg.0000128923.68543.7f
   Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0
   Reid G, 2003, AM J OBSTET GYNECOL, V189, P1202, DOI 10.1067/S0002-9378(03)00495-2
   Reid G, 2001, FEMS IMMUNOL MED MIC, V32, P37, DOI 10.1111/j.1574-695X.2001.tb00531.x
   Reid G, 2001, J INFECT DIS, V183, pS77, DOI 10.1086/318841
   Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1111/j.1574-695X.2001.tb01549.x
   Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6
   Romero R, 2004, AM J OBSTET GYNECOL, V190, P1509, DOI 10.1016/j.ajog.2004.01.002
   Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121
   Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32
   Shalev E, 2002, ISRAEL MED ASSOC J, V4, P357
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P1150, DOI 10.1067/S0002-9378(03)00582-9
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P560, DOI 10.1067/S0002-9378(03)00518-0
   Vermont Oxford Network, 2000, DAT MAN OP REL 5 0
   Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035
   Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1
   Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9
NR 51
TC 30
Z9 35
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD NOV 8
PY 2011
VL 12
AR 239
DI 10.1186/1745-6215-12-239
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 895LM
UT WOS:000300497700001
PM 22059409
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Peixoto, FM
   Rodrigues, JF
   Sa, CAM
   Nakamura-Pereira, M
   Moreira, MEL
   Lobato, G
AF Peixoto-Filho, Fernando Maia
   Rodrigues, Julia F.
   Sa, Cynthia A. M.
   Nakamura-Pereira, Marcos
   Moreira, Maria Elizabeth L.
   Lobato, Gustavo
TI Reassessing the value of cardiofemoral index in the management of Rh(D)
   alloimmunized pregnancies: a pilot study
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Letter
ID FETAL ANEMIA
C1 [Peixoto-Filho, Fernando Maia; Rodrigues, Julia F.; Nakamura-Pereira, Marcos; Lobato, Gustavo] Oswaldo Cruz Fdn IFF FIOCRUZ, Fernandes Figueira Inst, Dept Obstet, Fetal Med Unit, BR-22250020 Rio De Janeiro, Brazil.
   [Sa, Cynthia A. M.; Moreira, Maria Elizabeth L.] Oswaldo Cruz Fdn IFF FIOCRUZ, Fernandes Figueira Inst, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
RP Peixoto, FM (corresponding author), Oswaldo Cruz Fdn IFF FIOCRUZ, Fernandes Figueira Inst, Dept Obstet, Fetal Med Unit, Ave Rui Barbosa 716,3 Andar, BR-22250020 Rio De Janeiro, Brazil.
EM peixotofilho@iff.fiocruz.br
RI Peixoto-Filho, Fernando Maia/AAG-1052-2020; Nakamura-Pereira,
   Marcos/X-1107-2019; Nakamura-Pereira, Marcos/O-4496-2014; Moreira, Maria
   Elisabeth Lopes/AAA-3775-2020; PEIXOTO-FILHO, FERNANDO MAIA/J-8848-2015
OI Peixoto-Filho, Fernando Maia/0000-0001-8521-6393; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; PEIXOTO-FILHO, FERNANDO
   MAIA/0000-0001-8521-6393
CR Cabral ACV, 2008, INT J GYNECOL OBSTET, V100, P60, DOI 10.1016/j.ijgo.2007.06.048
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703
   Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102
   Pretlove SJ, 2009, BJOG-INT J OBSTET GY, V116, P1558, DOI 10.1111/j.1471-0528.2009.02255.x
   Cabral ACV, 2010, INT J GYNECOL OBSTET, V111, P205, DOI 10.1016/j.ijgo.2010.07.017
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD NOV
PY 2011
VL 159
IS 1
BP 242
EP 243
DI 10.1016/j.ejogrb.2011.07.021
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 863XY
UT WOS:000298202800056
PM 21824708
DA 2020-12-17
ER

PT J
AU de Almeida, MBD
   de Almeida, JAG
   Moreira, MEL
   Novak, FR
AF de Mattos de Almeida, Mariangela Bartha
   Guerra de Almeida, Joao Aprigio
   Lopes Moreira, Maria Elisabeth
   Novak, Franz Reis
TI Adequacy of human milk viscosity to respond to infants with dysphagia:
   experimental study
SO JOURNAL OF APPLIED ORAL SCIENCE
LA English
DT Article
DE Deglutition disorders; Dysphagia; Deglutition; Human milk; Viscosity;
   Rheology
AB Neonatal nutrition is an important subject in health in the short, medium and long term. In preternn newborns, nutrition assumes a predominant role for the child's overall development. Babies with uncoordinated swallowing or respiration may not have the necessary oral abilities to suck the mother's breast and will need to implement different feeding practices; one of them is changing the consistency of the milk offered. Objectives: Determine viscosity variations of untreated human and pasteurized milk without and with thickening to adapt the diet to the needs of dysphagic infants hospitalized in the Neonatal Intensive Cara Unit (NICU). Material and Methods: The authors altered the viscosity of natural infant powdered milk and, after thickening, determined and adopted a thickening standard for human milk. Untreated human and pasteurized milk was thickened in concentrations of 2%, 3%, 5% and 7% and the viscosity were determined every 20 minutes for a period of 60 minutes at a temperature of 37 degrees C. Results: The infant lactose formula thickened at concentrations of 2% and 3% produced viscosities of 8.97cP and 27.73 cP, respectively. The increases were significantly different after 1 hour. Inversely, untreated human milk at 2%, 3%, 5% and 7% produced diminished viscosity over time; the changes were more accentuated in the first 20 minutes. In pasteurized human milk, the 2% concentration had no variation in viscosity, but with the 3%, 5% and 7% concentrations, there was a significant decrease in the first 20 minutes with stability observed in the subsequent times. Conclusion: In powdered milk, the viscosity increases over time; the viscosity in human milk diminishes. The results point out the importance not only of considering the concentration of the thickener but also the time being administered after its addition to effectively treat dysphagic infants.
C1 [Guerra de Almeida, Joao Aprigio] Oswaldo Cruz Fdn FIOCRUZ, Fernandes Figueira Inst, Ibero Amer Program Human Milk, Rio De Janeiro, RJ, Brazil.
   [Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn FIOCRUZ, Fernandes Figueira Inst, Dept Neonatol, Rio De Janeiro, RJ, Brazil.
   [Novak, Franz Reis] Oswaldo Cruz Fdn FIOCRUZ, Fernandes Figueira Inst, Natl Reference Ctr Human Milk Bank, Rio De Janeiro, RJ, Brazil.
RP de Almeida, MBD (corresponding author), Setor Fonoaudiol Hosp, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM marianbartha@iff.fiocruz.br
FU Foundation for the Support of Research of the State of Rio de Janeiro
   (FAPERJ) - Brazil [E- 26/102.873/2008]
FX The authors wish to thank the Foundation for the Support of Research of
   the State of Rio de Janeiro (FAPERJ) - Brazil for the financial support
   (Process: E- 26/102.873/2008).
CR *ABNT, 1986, 5849 ABNT NBR
   ALMEIDA JAG, 1999, AMAMENTACAO HIBRIDO
   American Dietetic Association (ADA)-ADA, 2002, NAT DYSPH DIET STAND
   *BRAS ANVISA, 2008, BANC LEIT HUM FUNC P
   BROCK R, 1998, NEONATOLOGIA CONVITE, P67
   Camelo Junior JS, 2008, NUTR RECEM NASCIDO P, P11
   GOMES FP, 1978, CURSO ESTATISTICA EX
   Moreira MEL, 2010, CIENC SAUDE COLETIVA, V15, P321, DOI 10.1590/S1413-81232010000200002
   Martinez F E, 2001, J Pediatr (Rio J), V77 Suppl 1, pS32
   Martins EC, 2009, J PEDIAT-BRAZIL, V85, P157, DOI [10.2223/JPED.1878, 10.1590/S0021-75572009000200012]
   Mercado-Deane MG, 2001, PEDIATR RADIOL, V31, P423, DOI 10.1007/s002470100456
   MOREIRA AR, 2005, THESIS U PORTO PORTO
   Neiva Flávia Cristina Brisque, 2006, Pró-Fono R. Atual. Cient., V18, P141, DOI 10.1590/S0104-56872006000200003
   Newman LA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e106
   SOUZA BB, 2003, NUTRICAO DISFAGIA GU
NR 15
TC 22
Z9 23
U1 0
U2 15
PU UNIV SAO PAULO FAC ODONTOLOGIA BAURU
PI BAURU-SP
PA AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL
SN 1678-7757
J9 J APPL ORAL SCI
JI J. Appl. Oral Sci.
PD NOV-DEC
PY 2011
VL 19
IS 6
BP 554
EP 559
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 874ZR
UT WOS:000298998500003
PM 22230987
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Rocha, AD
   Lopes, JMD
   Ramos, JRM
   Gomes, SC
   Lucena, SL
   Medeiros, A
   Moreira, MEL
AF Rocha, Adriana Duarte
   de Andrade Lopes, Jose Maria
   Moraes Ramos, Jose Roberto
   Gomes, Saint Clair, Jr.
   Lucena, Sabrina Lopes
   Medeiros, Annielle
   Lopes Moreira, Maria Elisabeth
TI Development of a technique for evaluating temporal parameters of sucking
   in breastfeeding preterm newborns
SO EARLY HUMAN DEVELOPMENT
LA English
DT Article
DE Preterm infants; Breastfeeding; Sucking patterns
ID BIRTH-WEIGHT INFANTS; NUTRITIVE SUCKING; PATTERNS; SWALLOW
AB Aims: The aim of the current study was to developed and test the reliability of a technique for measuring temporal parameters of sucking in breastfeeding infants.
   Methods: The technique was developed using a cohort of 11 term and 12 preterm infants, and subsequently evaluated using a cohort of 43 preterm infants. Measurements related to sucking pressure in the term and preterm infants were acquired. The signals were recorded for 5 min. saved on a computer, and stored for analysis. For purposes of analysis, the minute with the highest quality signal was chosen. Signal analysis was performed by two researchers, and inter- and intra-observer agreement was assessed. The newborns in the sample had different gestational ages.
   Results: A technique was developed for the analysis of temporal parameters of sucking during breastfeeding and evaluated in 43 preterm infants with different gestational ages for the following variables: number of bursts per minute, number of sucks per burst, sucking rate, pause rate, and duration of pauses. The intra-observer agreement was 0.85 and the inter-observer agreement was 0.85.
   Conclusions: The technique that was developed and validated proved capable of measuring temporal parameters of sucking in breastfeeding newborns. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Rocha, Adriana Duarte; de Andrade Lopes, Jose Maria; Moraes Ramos, Jose Roberto; Gomes, Saint Clair, Jr.; Lucena, Sabrina Lopes; Medeiros, Annielle; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, BR-22250020 Flamengo Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Ave Rui Barbosa 716, BR-22250020 Flamengo Rio De Janeiro, Brazil.
EM rochachirol@gmail.com; jlopesma@uol.com.br; joseroberto@iff.fiocruz.br;
   scgomes@iff.fiocruz.br; pesquisaclinica@iff.fiocruz.br;
   pesquisaclinica@iff.fiocruz.br; bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X
FU FaperjCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX Financial support: Faperj.
CR Brazelton T. B., 1984, NEONATAL BEHAV ASSES
   BULLOCK F, 1990, DEV MED CHILD NEUROL, V32, P669
   Cunha M, 2009, EARLY HUM DEV, V85, P125, DOI 10.1016/j.earlhumdev.2008.07.003
   DEMONTERICE D, 1992, NURS RES, V41, P342
   Gewolb IH, 2003, DEV MED CHILD NEUROL, V45, P344, DOI 10.1017/S001216220300063X
   Gewolb IH, 2001, DEV MED CHILD NEUROL, V43, P22, DOI 10.1017/S0012162201000044
   Gomes Cristiane F., 2006, J. Pediatr. (Rio J.), V82, P103, DOI [10.2223/JPED.1456, 10.1590/S0021-75572006000200005]
   HACK M, 1985, EARLY HUM DEV, V11, P133, DOI 10.1016/0378-3782(85)90100-8
   Hafstrom M, 1997, ACTA PAEDIATR, V86, P82, DOI 10.1111/j.1651-2227.1997.tb08838.x
   Lau C, 2000, ACTA PAEDIATR, V89, P846, DOI 10.1080/080352500750043765
   Lau C, 1997, J PEDIATR-US, V130, P561, DOI 10.1016/S0022-3476(97)70240-3
   Lau C, 2001, DYSPHAGIA, V16, P58, DOI 10.1007/s004550000043
   MATHEW OP, 1984, PEDIATRICS, V106, P810
   MEDOFFCOOPER B, 1993, NURS RES, V42, P100
   Mizuno K, 2003, J PEDIATR-US, V142, P36, DOI 10.1067/mpd.2003.mpd0312
   WOLFF PH, 1968, PEDIATRICS, V42, P943
NR 16
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-3782
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD AUG
PY 2011
VL 87
IS 8
BP 545
EP 548
DI 10.1016/j.earlhumdev.2011.04.008
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 805LE
UT WOS:000293727100006
PM 21602000
DA 2020-12-17
ER

PT J
AU Vieira, AA
   Soares, FVM
   Pimenta, HP
   Abranches, AD
   Moreira, MEL
AF Vieira, Alan Araujo
   Mendes Soares, Fernanda Valente
   Pimenta, Hellen Porto
   Abranches, Andrea Dunshee
   Lopes Moreira, Maria Elisabeth
TI Analysis of the influence of pasteurization, freezing/thawing, and offer
   processes on human milk's macronutrient concentrations
SO EARLY HUMAN DEVELOPMENT
LA English
DT Article
DE Human milk; Pasteurization; Infrared analyzer
ID BIRTH-WEIGHT INFANTS; DONOR BREAST-MILK; FAT; FORTIFICATION; BANKING;
   BENEFIT
AB Introduction: The macronutrient concentrations of human milk could be influenced by the various processes used in human milk bank.
   Aims: To determine the effect of various process (Holder pasteurization, freezing and thawing and feeding method) on the macronutrient concentration of human milk.
   Methods: The samples of donated fresh human milk were studied before and after each process (Holder pasteurization, freezing and thawing and feeding method) until their delivery to newborn infants. Fifty-seven raw human milk samples were analyzed in the first step (pasteurization) and 228 in the offer step. Repeated measurements of protein, fat and lactose amounts were made in samples of human milk using an Infrared analyzer. The influence of repeated processes on the mean concentration of macronutrients in donor human milk was analyzed by repeated measurements ANOVA, using R statistical package.
   Results: The most variable macronutrient concentration in the analyzed samples was fat (reduction of 59%). There was a significant reduction of fat and protein mean concentrations following pasteurization (5.5 and 3.9%, respectively). The speed at which the milk was thawed didn't cause a significant variation in the macronutrients concentrations. However, the continuous infusion delivery significantly reduced the fat concentration. When the influence of repeated processes was analyzed, the fat and protein concentrations varied significantly (reduction of 56.6% and 10.1% respectively) (P<0.05). Lactose didn't suffer significant reductions in all steps.
   Conclusion: The repeated processes that donor human milk is submitted before delivery to newborn infants cause a reduction in the fat and protein concentration. The magnitude of this decrease is higher on the fat concentration and it needs to be considered when this processed milk is used to feed preterm infants. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Vieira, Alan Araujo; Mendes Soares, Fernanda Valente; Pimenta, Hellen Porto; Abranches, Andrea Dunshee; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, BR-22540020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Av Rui Barbosa 716, BR-22540020 Rio De Janeiro, Brazil.
EM alanmari@uninet.com.br; fevalente@gmail.com; hellenpimenta@gmail.com;
   bebeth@iff.fiocruz.br
RI de Abranches, Andrea Dunshee/ABA-8578-2020
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX Acknowledge financial support: CNPq.
CR [Anonymous], NATL NETWORK HUMAN M
   BELLE RCD, 1979, J PEDIATR-US, V94, P472
   Boyd CA, 2007, ARCH DIS CHILD-FETAL, V92, pF169, DOI 10.1136/adc.2005.089490
   Cooke RJ, 2006, J PERINATOL, V26, P591, DOI 10.1038/sj.jp.7211576
   Fidler N, 2001, ADV EXP MED BIOL, V501, P485
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012
   Henderson TR, 1998, J PEDIATR-US, V132, P876, DOI 10.1016/S0022-3476(98)70323-3
   Leaf A, 2009, PEDIAT CHILD HLTH, V19, P395
   Metha NR, 1998, J PEDIAT, V112, P474
   MICHAELSEN KF, 1988, J PEDIATR GASTR NUTR, V7, P229, DOI 10.1097/00005176-198803000-00013
   MICHAELSEN KF, 1990, J PEDIATR GASTR NUTR, V11, P229, DOI 10.1097/00005176-199008000-00013
   Modi N, 2006, BRIT MED J, V333, P1133, DOI 10.1136/bmj.39034.651563.80
   Molto-Puigmarti C, 2011, FOOD CHEM, V124, P697, DOI 10.1016/j.foodchem.2010.05.079
   Morales Y, 2007, SEMIN PERINATOL, V31, P83, DOI 10.1053/j.semperi.2007.02.002
   POLBERGER S, 1993, J PEDIATR GASTR NUTR, V17, P283, DOI 10.1097/00005176-199310000-00009
   PRENTICE A, 1981, BRIT J NUTR, V45, P483, DOI 10.1079/BJN19810127
   Shanler RJ, 2001, CLIN PERINATOL, V48, P206
   Shanler RJ, 1985, CLIN PERINATOL, V22, P207
   STOCKS RJ, 1985, ARCH DIS CHILD, V60, P164, DOI 10.1136/adc.60.2.164
   THOMAS MR, 1986, J PEDIATR GASTR NUTR, V5, P597, DOI 10.1097/00005176-198607000-00016
   Thomaz ACP, 1999, NUTR RES, V19, P483, DOI 10.1016/S0271-5317(99)00015-9
   Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212
   Tully MR, 2004, J HUM LACT, V20, P75, DOI 10.1177/0890334403261115
   Updegrove K, 2005, NEWBORN INFANT NURS, V5, P27, DOI 10.1053/j.nainr.2005.02.005
   Vieira Alan A., 2004, J. Pediatr. (Rio J.), V80, P490, DOI 10.1590/S0021-75572004000800011
   Weber A, 2001, ACTA PAEDIATR, V90, P772, DOI 10.1080/080352501750315681
   Wojcik KY, 2009, J AM DIET ASSOC, V109, P137, DOI 10.1016/j.jada.2008.10.008
   Ye AQ, 2004, J DAIRY RES, V71, P471, DOI 10.1017/S0022029904000512
NR 29
TC 83
Z9 87
U1 0
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-3782
EI 1872-6232
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD AUG
PY 2011
VL 87
IS 8
BP 577
EP 580
DI 10.1016/j.earlhumdev.2011.04.016
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 805LE
UT WOS:000293727100012
PM 21592688
DA 2020-12-17
ER

PT J
AU Carvalho, PRN
   Moreira, MEL
   Sa, RAM
   Lopes, LM
AF Nassar Carvalho, Paulo Roberto
   Lopes Moreira, Maria Elizabeth
   Moreira Sa, Renato Augusto
   Lopes, Laudelino Marques
TI SNAPPE-II application in newborns with very low birth weight: evaluation
   of adverse outcomes in severe placental dysfunction
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE Doppler; neonatal morbidity; premature; severity score; very low birth
   weight
ID NEONATAL ACUTE PHYSIOLOGY; ILLNESS SEVERITY; VENOUS DOPPLER; RISK;
   INDEX; PREDICTORS; FETUSES; BLOOD; SCORE; FLOW
AB Aim: The aim of this study was to evaluate the ability of the admission Score for Neonatal Acute Physiology - Perinatal Extension-II (SNAPPE-II) to predict adverse outcome among premature very low birth weight (BW) infants with abnormal Doppler blood flow in the uterus secondary to severe placental insufficiency of early onset.
   Methods: A total of 86 neonates, weighing between 360 and 1498 g, were studied. Descriptive statistics of the population were reported. The areas under the receiver operating characteristics curves for the SNAPPE-II were calculated. The calibration of the model was assessed using the technique of Hosmer-Lemeshow. Adverse outcome was defined as mortality or the development of the following diagnoses: (1) periventricular-intraventricular hemorrhage (PIH); (2) retinopathy of prematurity stage 3 or 4; (3) periventricular leukomalacia; (4) bronchopulmonary dysplasia; (5) necrotizing enterocolitis (NEC).
   Results: The SNAPPE-II area under curve was 0.86 (95% CI: 0.78-0.94) for mortality and 0.76 (95% CI: 0.65-0.86) for the prediction of adverse outcomes. Analyzing each morbidity variable, the SNAPPE-II AUC varied between 0.51 for NEC and 0.72 for PIH.
   Conclusion: SNAPPE-II shows accuracy in the prediction of adverse outcome for this highly selective group of very low BW infants compromised by severe placental insufficiency.
C1 [Nassar Carvalho, Paulo Roberto; Lopes Moreira, Maria Elizabeth; Moreira Sa, Renato Augusto; Lopes, Laudelino Marques] Clin Perinatal Barra, BR-22775040 Rio De Janeiro, Brazil.
   [Lopes Moreira, Maria Elizabeth] Inst Fernandes Figueira FIOCRUZ, Dept Neonatol, Rio De Janeiro, Brazil.
   [Moreira Sa, Renato Augusto] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Lopes, Laudelino Marques] St Joseph Hlth Care, Dept Obstet & Gynaecol, London, ON, Canada.
RP Carvalho, PRN (corresponding author), Clin Perinatal Barra, Av Emb Abelardo Bueno 201 Barra Tijuca, BR-22775040 Rio De Janeiro, Brazil.
EM paulonassar@cpdt.com.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; de Sa, Renato Augusto
   Moreira/B-4778-2014; Lopes, Laudelino/F-7968-2013
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; MOREIRA DE SA,
   RENATO A/0000-0001-6357-7702; Lopes, Laudelino/0000-0002-5046-145X
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX This work was support in part by FAPERJ.
CR Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x
   ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
   Baschat AA, 2004, ULTRASOUND OBST GYN, V23, P111, DOI 10.1002/uog.989
   Baschat AA, 2000, ULTRASOUND OBST GYN, V16, P407, DOI 10.1046/j.1469-0705.2000.00284.x
   Baschat AA, 2007, OBSTET GYNECOL, V109, P253, DOI 10.1097/01.AOG.0000253215.79121.75
   Bilardo CM, 2004, ULTRASOUND OBST GYN, V23, P119, DOI 10.1002/uog.965
   COCKBURN F, 1993, LANCET, V342, P193
   Dammann O, 2010, NEONATOLOGY, V97, P71, DOI 10.1159/000232588
   Dammann O, 2009, PEDIATRICS, V124, pE1001, DOI 10.1542/peds.2008-3233
   Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8
   Fortes JB, 2009, OPHTHALMOLOGICA, V223, P177, DOI 10.1159/000197114
   Gagliardi L, 2004, ARCH DIS CHILD-FETAL, V89, pF419, DOI 10.1136/adc.2003.031286
   Hecher K, 2001, ULTRASOUND OBST GYN, V18, P564, DOI 10.1046/j.0960-7692.2001.00590.x
   Lim L, 2008, J MATERN-FETAL NEO M, V21, P415, DOI 10.1080/14767050802046481
   de Sa RAM, 2007, PRENATAL DIAG, V27, P1129, DOI 10.1002/pd.1846
   Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1
   Pollack MM, 2000, PEDIATRICS, V105, P1051, DOI 10.1542/peds.105.5.1051
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   RICHARDSON DK, 1993, PEDIATRICS, V91, P969
   RICHARDSON DK, 1993, PEDIATRICS, V91, P617
   Rizzo G, 1996, ULTRASOUND OBST GYN, V7, P401, DOI 10.1046/j.1469-0705.1996.07060401.x
   Schwarze A, 2005, ULTRASOUND OBST GYN, V25, P573, DOI 10.1002/uog.1914
   Turam OM, 2008, ULTRASOUND OBST GYN, V32, P160, DOI 10.1002/uog.5386
   Vermont Oxford Network Database, 2009, VERMONT OXFORD NETWO, P50
   WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb07932.x
   Zupancic JAF, 2007, PEDIATRICS, V119, pE156, DOI 10.1542/peds.2005-2957
NR 26
TC 6
Z9 7
U1 0
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD MAY
PY 2011
VL 39
IS 3
BP 343
EP 347
DI 10.1515/JPM.2010.141
PG 5
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 761WT
UT WOS:000290432900020
PM 21314235
DA 2020-12-17
ER

PT J
AU de Carvalho, M
   Mochdece, CC
   Sa, CAM
   Moreira, MEL
AF de Carvalho, Manoel
   Mochdece, Christieny Chaipp
   Moura Sa, Cynthia Amaral
   Lopes Moreira, Maria Elisabeth
TI High-intensity phototherapy for the treatment of severe nonhaemolytic
   neonatal hyperbilirubinemia
SO ACTA PAEDIATRICA
LA English
DT Article
DE Brainstem evoked response audiometry; Exchange transfusion; Neonatal
   hyperbilirubinaemia; Phototherapy
ID NEAR-TERM; JAUNDICE; MANAGEMENT; BILIRUBIN
AB Aim:
   To describe the clinical approach to term and near-term newborn infants with severe hyperbilirubinaemia and to analyse the effect of high-intensity phototherapy on total serum bilirubin (TSB) levels.
   Methods:
   We analysed a cohort of 116 newborn infants with severe nonhaemolytic hyperbilirubinaemia (TSB >= 20 mg/dL/342 mu mol/L). All patients were treated with high-intensity phototherapy. The main outcomes were reduction in TSB levels in the first 24 h of phototherapy, incidence of exchange transfusion, pathological brainstem auditory evoked responses and pathological findings on neurological examination at discharge.
   Results:
   The mean birth weight and gestational age were 3161 +/- 466 g and 37.8 +/- 1.6 weeks. Mean initial TSB concentration was 22.4 +/- 2.4 mg/dL. Per cent decreases in TSB after 2, 4, 6, 12, 18 and 24 h of phototherapy were 9.4%, 16%, 23%, 40%, 44% and 50%, respectively. No infant was treated with exchange transfusion. Brainstem evoked response audiometry (BAER) was performed in 100% of the patients, and in three of them, this examination was altered. However, when repeated 3 months later, these BAER examinations were normal. Neurological examination was normal in all patients.
   Conclusions:
   High-intensity phototherapy significantly reduces TSB in nonhaemolytic severe hyperbilirubinaemia and decreases the need for exchange transfusion.
C1 [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Clin Perinatal Laranjeiras, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Clin Perinatal Laranjeiras, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
CR CARG AK, 1995, PEDIATRICS, V95, P914
   De Carvalho M, 1999, ACTA PAEDIATR, V88, P768
   DECARVALHO M, 1995, J PEDIATR-US, V127, P337
   Hansen TWR, 2010, ACTA PAEDIATR, V99, P1117, DOI 10.1111/j.1651-2227.2010.01898.x
   Hansen TWR, 1997, ACTA PAEDIATR, V86, P843
   Hart G, 2005, ARCH DIS CHILD-FETAL, V90, pF437, DOI 10.1136/adc.2004.068015
   Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376
   Maisels MJ, 2004, PEDIATRICS, V114, P297
   Martins BMR, 2007, J PEDIAT-BRAZIL, V83, P253, DOI [10.2223/JPED.1637, 10.1590/S0021-75572007000400011]
   Mreihil K, 2010, PEDIATR RES, V67, P656, DOI 10.1203/PDR.0b013e3181dcedc0
   Patra K, 2004, J PEDIATR-US, V144, P626, DOI 10.1016/j.jpeds.2004.01.054
   Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018
   Sarici SU, 2004, PEDIATRICS, V113, P775, DOI 10.1542/peds.113.4.775
   SEIDMAN DS, 1995, PEDIATRICS, V96, P727
   Smitherman H, 2006, SEMIN FETAL NEONAT M, V11, P214, DOI 10.1016/j.siny.2006.02.002
NR 15
TC 13
Z9 14
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD APR
PY 2011
VL 100
IS 4
BP 620
EP 623
DI 10.1111/j.1651-2227.2011.02170.x
PG 4
WC Pediatrics
SC Pediatrics
GA 735WR
UT WOS:000288451800032
PM 21251060
DA 2020-12-17
ER

PT J
AU de Carvalho, M
   Torrao, CT
   Moreira, MEL
AF de Carvalho, Manoel
   Torrao, Carolina Turano
   Lopes Moreira, Maria Elisabeth
TI Mist and water condensation inside incubators reduce the efficacy of
   phototherapy
SO ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION
LA English
DT Article
ID LOW-BIRTH-WEIGHT; PRETERM INFANTS; HEAT SHIELDS; IRRADIANCE; INTENSITY;
   LIGHT
AB Objective To measure the irradiance in humidified incubator under three different overhead phototherapy devices.
   Design/methods The effective irradiance of three phototherapy devices was assessed by taking a series of irradiance measurements in the illuminated field. Measurements were made with a fixed bandwidth broadband radiometer (380-530 nm). The distance between the light source and the radiometer was 35 cm for the daylight fluorescent lamp, 40 cm for the light emitting diode (LED) and 50 cm for the halogen phototherapy. A double-wall incubator was kept at 36 degrees C and set at three different levels of humidity (60-70%, 80% and equal or above 90%).
   Results The irradiance under the overhead daylight fluorescent lamp phototherapy did not change with the increasing humidity. However, above 90% humidity, when water vapour inside the incubator was so saturated to the point of totally condensing in the incubator walls, the measured irradiance decreased 15% of the initial values with the blue LED phototherapy and 45% with the halogen spotlight phototherapy.
   Conclusions Highly humidified incubators are frequently used to treat very low birthweight infants. Health professionals should be aware that mist and water condensation inside an incubator may significantly reduce the efficacy of treatment.
C1 [de Carvalho, Manoel; Torrao, Carolina Turano; Lopes Moreira, Maria Elisabeth] Clin Perinatal Laranjeiras, Dept Neonatol, BR-22240002 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Clin Perinatal Laranjeiras, Dept Neonatol, Rua Laranjeiras 445, BR-22240002 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
CR Baumgart S, 2009, J NEONATAL PERINATAL, V2, P1, DOI DOI 10.3233/NPM-2009-0041
   Chien C H, 1996, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V37, P92
   DECARVALHO M, 1995, J PERINAT MED, V23, P315, DOI 10.1515/jpme.1995.23.4.315
   DECARVALHO M, 2001, J PEDIAT, V77, P71
   EGGERT P, 1984, EUR J PEDIATR, V142, P58, DOI 10.1007/BF00442593
   Facchini F P, 2001, J Pediatr (Rio J), V77, P67
   Gaylord M S, 2001, J Perinatol, V21, P438, DOI 10.1038/sj.jp.7210561
   Hart G, 2005, ARCH DIS CHILD-FETAL, V90, pF437, DOI 10.1136/adc.2004.068015
   KARSDON J, 1986, ACTA PAEDIATR SCAND, V75, P555, DOI 10.1111/j.1651-2227.1986.tb10249.x
   Kim SM, 2010, PEDIATRICS, V125, pE137, DOI 10.1542/peds.2008-2997
   KJARTANSSON S, 1992, ACTA PAEDIATR, V81, P764, DOI 10.1111/j.1651-2227.1992.tb12099.x
   Martins BMR, 2007, J PEDIAT-BRAZIL, V83, P253, DOI [10.2223/JPED.1637, 10.1590/S0021-75572007000400011]
   Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024
   Rutter N, 2000, Semin Neonatol, V5, P281, DOI 10.1053/siny.2000.0014
   Stokowski Laura A, 2006, Adv Neonatal Care, V6, P303, DOI 10.1016/j.adnc.2006.08.004
   STUTCHFIELD PR, 1988, ARCH DIS CHILD, V63, P552, DOI 10.1136/adc.63.5.552
NR 16
TC 3
Z9 3
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1359-2998
EI 1468-2052
J9 ARCH DIS CHILD-FETAL
JI Arch. Dis. Child.-Fetal Neonatal Ed.
PD MAR
PY 2011
VL 96
IS 2
BP F138
EP F140
DI 10.1136/adc.2010.189423
PG 3
WC Pediatrics
SC Pediatrics
GA 729XE
UT WOS:000287986800014
PM 20847196
DA 2020-12-17
ER

PT J
AU Zin, AA
   Moreira, MEL
   Bunce, C
   Darlow, BA
   Gilbert, CE
AF Zin, Andrea A.
   Lopes Moreira, Maria Elisabeth
   Bunce, Catey
   Darlow, Brian A.
   Gilbert, Clare E.
TI Retinopathy of Prematurity in 7 Neonatal Units in Rio de Janeiro:
   Screening Criteria and Workload Implications
SO PEDIATRICS
LA English
DT Article
DE retinopathy of prematurity; Brazil; screening criteria; workload
ID ASSOCIATION; AMERICAN; INFANTS; RATES
AB OBJECTIVES: The goals were to determine optimal screening criteria for retinopathy of prematurity (ROP) in 7 neonatal units in Rio de Janeiro, Brazil, and to explore the workload implications of applying different criteria.
   METHODS: Infants with birth weights of <= 2000 g or gestational age of <37 weeks were examined by 3 ophthalmologists in 7 of the largest units in Rio de Janeiro, during a 34-month period. ROP was classified by using the international classification, and laser treatment was given to infants developing type 1 ROP.
   RESULTS: A total of 3437 (87%) of 3953 eligible infants were examined, of whom 124 (3.6% [range: 2.1%-7.8%]) were treated. Eleven infants were treated for aggressive posterior ROP. Appropriate screening criteria for the 2 NICUs with high survival rates (ie, >= 80% among infants with birth weights of <1500 g) would be <= 1500 g or <32 weeks. For NICUs with low survival rates (ie, <80%), appropriate criteria would be <= 1500 g or <= 35 weeks. UK, US, and previous Brazilian criteria would all miss infants needing treatment.
   CONCLUSIONS: ROP programs in Brazil should use the wider criteria of <= 1500 g or <= 35 weeks until further evidence-based criteria become available, although this would mean a slight increase in workload across the city, compared with use of the narrower criteria in the better units. Whether survival rates can be used as a proxy to indicate screening criteria requires further investigation. Pediatrics 2010; 126: e410-e417
C1 [Zin, Andrea A.; Lopes Moreira, Maria Elisabeth] Fernandes Figueira Inst, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
   [Bunce, Catey] Moorfields Eye Hosp, London, England.
   [Darlow, Brian A.] Univ Otago, Sch Med & Hlth Sci, Dept Paediat, Christchurch, New Zealand.
   [Gilbert, Clare E.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England.
RP Zin, AA (corresponding author), Fernandes Figueira Inst, Dept Neonatol, Fiocruz Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Osman, Sanha A/B-4056-2012
OI Bunce, Catey/0000-0002-0935-3713
FU Thrasher Research Fund [02819-6]
FX This study was funded by the Thrasher Research Fund (award 02819-6).; We
   are very grateful to the Municipal Secretary of Health of Rio de Janeiro
   and to the Hospital of the Servants of the State for facilitating and
   supporting this study; to Drs Mario Motta and Cristina Goncalves, who
   examined study infants; to research assistant Joao Luis Coelho, who
   compiled data from recording forms; and to Selvaraj Sivasubramaniam, who
   provided statistical support.
CR [Anonymous], 1990, Q B COLL OPHTHAL AUT, P6
   Bouzas L, 2007, An Pediatr (Barc), V66, P551, DOI 10.1157/13107388
   Brennan R, 2003, EYE, V17, P183, DOI 10.1038/sj.eye.6700296
   British Association of Perinatal Medicine, 2001, STAND HOSP PROV NEON
   Bull MJ, 2001, PEDIATRICS, V107, P1480
   Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063
   Darlow BA, 2005, BRIT J OPHTHALMOL, V89, P1592, DOI 10.1136/bjo.2005.073650
   Fielder AR, 2002, EYE, V16, P285, DOI 10.1038/sj.eye.6700131
   Fierson WM, 1997, PEDIATRICS, V100, P273, DOI 10.1542/peds.100.2.273
   Flores-Santos R, 2007, ARCH MED RES, V38, P440, DOI 10.1016/j.arcmed.2006.12.002
   Filho JBF, 2007, J PEDIAT-BRAZIL, V83, P209, DOI 10.2223/JPED.1611
   Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180
   Gilbert C, 1997, LANCET, V350, P12, DOI 10.1016/S0140-6736(97)01107-0
   Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009
   Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991
   Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684
   Graziano R M, 1997, J Pediatr (Rio J), V73, P377
   Haines L, 2002, EYE, V16, P33, DOI 10.1038/sj.eye.6700030
   Jalali S, 2006, AM J OPHTHALMOL, V141, P966, DOI 10.1016/j.ajo.2005.12.016
   Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749
   PATZ A, 1987, ARCH OPHTHALMOL-CHIC, V105, P905, DOI 10.1001/archopht.1987.01060070041024
   *SECT OPHTH AM AC, 2006, PEDIATRICS, V118, P1324
   Trinavarat A, 2004, JPN J OPHTHALMOL, V48, P50, DOI 10.1007/s10384-003-0014-2
   Vyas J, 2000, ARCH DIS CHILD-FETAL, V82, pF145, DOI 10.1136/fn.82.2.F145
   Wilkinson AR, 2008, EARLY HUM DEV, V84, P71, DOI 10.1016/j.earlhumdev.2007.12.004
   Wilkinson AR, 1996, EARLY HUM DEV, V46, P239
   Zin A, 2001, Community Eye Health, V14, P58
   Zin Andrea, 2007, Arq. Bras. Oftalmol., V70, P875, DOI 10.1590/S0004-27492007000500028
NR 28
TC 48
Z9 54
U1 0
U2 6
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD AUG
PY 2010
VL 126
IS 2
BP E410
EP E417
DI 10.1542/peds.2010-0090
PG 8
WC Pediatrics
SC Pediatrics
GA 634FO
UT WOS:000280565700045
PM 20660549
DA 2020-12-17
ER

PT J
AU Krauss-Silva, L
   Moreira, MEL
   Alves, MB
   Rezende, MR
   Braga, A
   Camacho, KG
   Batista, MRR
   Savastano, C
   Almada-Horta, A
   Guerra, F
AF Krauss-Silva, Leticia
   Moreira, Maria Elizabeth L.
   Alves, Mariane B.
   Rezende, Maria R.
   Braga, Alcione
   Camacho, Karla G.
   Batista, Maria Rosa R.
   Savastano, Clarisse
   Almada-Horta, Antonio
   Guerra, Fernando
TI Randomized controlled trial of probiotics for the prevention of
   spontaneous preterm delivery associated with intrauterine infection:
   study protocol
SO REPRODUCTIVE HEALTH
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; GARDNERELLA-VAGINALIS HEMOLYSIN; FETAL
   INFLAMMATORY RESPONSE; AMNIOTIC-FLUID INFECTION; PLACEBO-CONTROLLED
   TRIAL; UMBILICAL-CORD PLASMA; WHITE-MATTER LESIONS; BACTERIAL VAGINOSIS;
   GRAM STAIN; IMMUNOGLOBULIN-A
AB Background: Spontaneous preterm deliveries that occur before the 34th week of gestation, and particularly before the 32nd week of gestation, have been strongly associated to intrauterine infection, ascending from vagina, and represent the largest portion of neonatal deaths and neurological problems. Bacterial vaginosis, characterized by a diminished or absent flora of lactobacilli and increased colonization of several anaerobic or facultative microorganisms, increases two times the risk of preterm delivery before the 34th week. Trials of antibiotics failed to show efficacy and effectiveness against spontaneous preterm birth related to bacterial vaginosis. Some studies indicate benefit from selected probiotics to treat genitourinary infections, including bacterial vaginosis.
   Objective: The purpose of this study is to evaluate the effectiveness of the early administration of selected probiotics to pregnant women with asymptomatic bacterial vaginosis/intermediate degree infection to reduce the occurrence of spontaneous preterm delivery and related neonatal mortality and morbidity.
   Methods/Design: Women attending public prenatal care services in Rio de Janeiro will be screened to select asymptomatic pregnant women, less than 20 weeks' gestation, with no indication of elective preterm delivery. Those with vaginal pH > = 4.5 and a Nugent score between 4 and 10 (intermediate degree infection or bacterial vaginosis) will be randomized to either the placebo or the intervention group, after written informed consent. Intervention consists in the use of probiotics, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, 2 capsules a day, each capsule containing more than one million bacilli of each strain, for 6-12 weeks, up to the 24th-25th wk of gestation. Ancillary analyses include quantification of selected cervicovaginal cytokines and genotyping of selected polymorphisms. The randomization process is stratified for history of preterm delivery and blocked. Allocation concealment was designed as well as blinding of women, caregivers and outcome evaluators. The study will be supervised by an independent monitoring committee. Outcomes under study are preterm delivery (< 34- < 32 weeks of gestation) and associated neonatal complications: early neonatal sepsis, bronchopulmonary dysplasia, periventricular leukomalacia, necrotizing enterocolitis, and prematurity-related retinopathy; definitions were adapted from those recommended by the 2002 version of the Vermont-Oxford Network. Trial registration at NIH register: NCT00303082.
C1 [Krauss-Silva, Leticia; Alves, Mariane B.; Rezende, Maria R.; Camacho, Karla G.] Brazilian Hlth Minist, Oswaldo Cruz Fdn, Natl Sch Publ Hlth, Hlth Technol Assessment Unit, BR-21041210 Rio De Janeiro, Brazil.
   [Moreira, Maria Elizabeth L.; Savastano, Clarisse] Brazilian Hlth Minist, Oswaldo Cruz Fdn, Fernandes Figueira Inst, Clin Res Unit, BR-22250020 Rio De Janeiro, Brazil.
   [Alves, Mariane B.] Univ Fed Rio de Janeiro, Inst Math, BR-21941909 Rio De Janeiro, Brazil.
   [Braga, Alcione] PROCEP, BR-22280003 Rio De Janeiro, Brazil.
   [Batista, Maria Rosa R.; Guerra, Fernando] Brazilian Hlth Minist, Oswaldo Cruz Fdn, Fernandes Figueira Inst, Dept Obstet & Gynecol, BR-22250020 Rio De Janeiro, Brazil.
   [Almada-Horta, Antonio] Univ Fed Rio de Janeiro, Sch Med, BR-21044020 Rio De Janeiro, Brazil.
RP Krauss-Silva, L (corresponding author), Brazilian Hlth Minist, Oswaldo Cruz Fdn, Natl Sch Publ Hlth, Hlth Technol Assessment Unit, R Leopoldo Bulhoes 1480, BR-21041210 Rio De Janeiro, Brazil.
EM leticiak@ensp.fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
CR Agency for Healthcare Research and Quality, 2000, 01E021 AG HEALTHC RE
   Andrews WW, 2003, OBSTET GYNECOL, V101, P847, DOI 10.1016/S0029-7844(03)00172-8
   Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021
   Berkowitz GS, 1998, EPIDEMIOLOGY, V9, P279, DOI 10.1097/00001648-199805000-00011
   Campos Mônica Rodrigues, 2004, Cad. Saúde Pública, V20, pS34, DOI 10.1590/S0102-311X2004000700004
   Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802
   Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2
   Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023
   Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003
   Cauci S, 2002, AM J OBSTET GYNECOL, V187, P877, DOI 10.1067/mob.2002.127454
   Cauci S, 1996, AM J OBSTET GYNECOL, V175, P1601, DOI 10.1016/S0002-9378(96)70112-6
   Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505
   Cauci Sabina, 2004, Curr Infect Dis Rep, V6, P450, DOI 10.1007/s11908-004-0064-8
   de Vrese M, 2002, BRIT J NUTR, V88, pS59, DOI 10.1079/BJN2002630
   Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1111/j.1471-0528.2002.00432.x
   Famularo G, 2001, MED HYPOTHESES, V56, P421, DOI 10.1054/mehy.2000.1195
   Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002, GUID EV PROB FOOD RE
   Genc MR, 2004, AM J OBSTET GYNECOL, V190, P1191, DOI 10.1016/j.ajog.2003.11.007
   Ghezzi F, 1998, EUR J OBSTET GYN R B, V78, P5, DOI 10.1016/S0301-2115(97)00236-4
   Goldenberg RL, 2003, SEMIN PERINATOL, V27, P185, DOI 10.1016/S0146-0005(03)00017-X
   Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696
   Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8
   Hauth JC, 2003, AM J OBSTET GYNECOL, V188, P831, DOI 10.1067/mob.2003.184
   Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603
   Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7
   Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248
   Isolauri E, 2004, BEST PRACT RES CL GA, V18, P299, DOI 10.1016/j.bpg.2003.10.006
   Klebanoff MA, 2004, AM J OBSTET GYNECOL, V190, P363, DOI 10.1016/j.ajog.2003.08.020
   Klein LL, 2004, AM J OBSTET GYNECOL, V190, P1493, DOI 10.1016/j.ajog.2004.03.014
   Larsen B, 2001, CLIN INFECT DIS, V32, pE69, DOI 10.1086/318710
   Leal Maria do Carmo, 2004, Cad. Saúde Pública, V20, pS20
   Lewit EM, 2004, DIRECT COST LOW BIRT
   Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001
   MCGREGOR JA, 1990, AM J OBSTET GYNECOL, V163, P1580, DOI 10.1016/0002-9378(90)90632-H
   McLean NW, 2000, J MED MICROBIOL, V49, P543, DOI 10.1099/0022-1317-49-6-543
   MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2
   Mercer BM, 1996, AM J OBSTET GYNECOL, V174, P1885, DOI 10.1016/S0002-9378(96)70225-9
   MORRISON AS, 1998, MODERN EPIDEMIOLOGY
   Nenadic DB, 2006, EUR J OBSTET GYN R B, V140, P165
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991
   Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528
   Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273
   Reid G, 2004, J CLIN GASTROENTEROL, V38, pS94, DOI 10.1097/01.mcg.0000128923.68543.7f
   Reid G, 2003, FEMS IMMUNOL MED MIC, V35, P131, DOI 10.1016/S0928-8244(02)00465-0
   Reid G, 2003, AM J OBSTET GYNECOL, V189, P1202, DOI 10.1067/S0002-9378(03)00495-2
   Reid G, 2001, FEMS IMMUNOL MED MIC, V32, P37, DOI 10.1111/j.1574-695X.2001.tb00531.x
   Reid G, 1999, APPL ENVIRON MICROB, V65, P3763
   Reid G, 2001, J INFECT DIS, V183, pS77, DOI 10.1086/318841
   Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1111/j.1574-695X.2001.tb01549.x
   Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6
   Romero R, 2004, AM J OBSTET GYNECOL, V190, P1509, DOI 10.1016/j.ajog.2004.01.002
   Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schwebke JR, 1996, OBSTET GYNECOL, V88, P573, DOI 10.1016/0029-7844(96)00233-5
   Shalev E, 2002, ISRAEL MED ASSOC J, V4, P357
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P915, DOI 10.1067/S0002-9378(03)00843-3
   Simhan HN, 2003, OBSTET GYNECOL, V102, P162, DOI 10.1016/S0029-7844(03)00406-X
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P1150, DOI 10.1067/S0002-9378(03)00582-9
   Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P560, DOI 10.1067/S0002-9378(03)00518-0
   Weiss NS, 1998, MODERN EPIDEMIOLOGY
   Yoon B H, 2003, J Matern Fetal Neonatal Med, V13, P32, DOI 10.1080/jmf.13.1.32.38
   Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035
   Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1
   Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0
   Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9
NR 65
TC 6
Z9 9
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JUN 30
PY 2010
VL 7
AR 14
DI 10.1186/1742-4755-7-14
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V27IO
UT WOS:000208607100001
PM 20591191
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Soares, FVM
   Meio, MDBB
   Abranches, AD
   Gomes, SC
AF Moreira, M. E. L.
   Soares, F. V. M.
   Meio, M. D. B. B.
   Abranches, A. D.
   Gomes Junior, S. C.
TI Energy expenditure in very low birth weight newborns: a comparison
   between small and appropriate-for-gestational-age
SO ACTA PAEDIATRICA
LA English
DT Article
DE Indirect calorimetry; Nutritional status; Preterm neonates; Resting
   energy expenditure
ID INDIRECT CALORIMETRY; INFANTS; GROWTH
AB Aims:
   To compare resting energy expenditure (REE) in small- and appropriate-for-gestational-age very low birth weight newborns after reaching corrected at-term age.
   Methods:
   Observational study that included all clinically stable very low birth weight newborns admitted to a neonatal intensive care unit. The newborns were classified as small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA). Resting energy expenditure was measured using indirect calorimetry when the newborns reached at-term age.
   Results:
   A total of 51 newborns, of which 23 were SGA and 28 AGA, were included. There was no statistically significant difference in REE between the two groups, although the observed levels were higher than the reference values.
   Conclusion:
   There is no statistical difference in resting expenditure energy between SGA and AGA infants when they reached term. The higher energy expenditure found in both groups may be explained by other factors related to prematurity and its complications and requires further investigation.
C1 [Moreira, M. E. L.; Soares, F. V. M.; Meio, M. D. B. B.; Abranches, A. D.; Gomes Junior, S. C.] Fiocruz MS, Dept Neonatol, IFF, BR-21045900 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; BARBOSA BAKER MEIO, MARIA
   DALVA/0000-0002-7290-9091
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); PAPESNational Council for Scientific and Technological
   Development (CNPq)
FX This study received financial support from CNPq/PAPES.
CR BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Bauer J, 2009, AM J CLIN NUTR, V90, P1517, DOI 10.3945/ajcn.2009.28304
   BOEHM G, 1989, ACTA PAEDIATR SCAND, V78, P677, DOI 10.1111/j.1651-2227.1989.tb11125.x
   BROOKE OG, 1982, ACTA PAEDIATR SCAND, P67
   CHESSEX P, 1984, PEDIATR RES, V18, P709, DOI 10.1203/00006450-198408000-00006
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Hay WW, 2007, J PEDIAT, V83, P490, DOI [10.1590/S0021-75572007000800003, 10.2223/JPED.1730]
   Hulzebos CV, 2007, SEMIN FETAL NEONAT M, V12, P2, DOI 10.1016/j.siny.2006.10.008
   Kleinman RE, 2004, PEDIAT NUTR HDB
   KRAMER MS, 2001, PEDIAT ELECT J, V118
   MICHELI JL, 1994, ACTA PAEDIATR, V83, P35, DOI 10.1111/j.1651-2227.1994.tb13396.x
   Moreira MEL, 2007, J PERINAT MED, V35, P71, DOI 10.1515/JPM.2007.011
   PICAUD JC, 1994, ACTA PAEDIATR, V83, P54, DOI 10.1111/j.1651-2227.1994.tb13399.x
   Soares FVM, 2007, J PEDIAT-BRAZIL, V83, P567, DOI 10.1590/S0021-75572007000800015
   Thureen PJ, 1998, J APPL PHYSIOL, V85, P223
   van Goudoever JB, 2000, AM J CLIN NUTR, V71, P816
NR 16
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD MAY
PY 2010
VL 99
IS 5
BP 651
EP 653
DI 10.1111/j.1651-2227.2010.01686.x
PG 3
WC Pediatrics
SC Pediatrics
GA 575AG
UT WOS:000276034800007
PM 20105144
DA 2020-12-17
ER

PT J
AU Moreira, MEL
AF Moreira, Maria Elisabeth Lopes
TI Health problems in childhood: challenges from treatment to prevention
SO CIENCIA & SAUDE COLETIVA
LA English
DT Editorial Material
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAR
PY 2010
VL 15
IS 2
BP 319
EP 319
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 594XJ
UT WOS:000277574100001
PM 20414592
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Goldani, MZ
AF Lopes Moreira, Maria Elisabeth
   Goldani, Marcelo Zubaran
TI Child is the father of man: new challenges for child health
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Pediatrics; Child care; Demography; Research
ID DEVELOPMENTAL ORIGINS; OBESITY; DISEASE
AB This paper offers an analysis of current demographic and epidemiological context in which the child falls and addresses the need to the reformulation of the health services intended for child care, pointing also to the question of the need to produce new knowledge that help them in a new pediatrics care. The knowledge that child care needs to be expanded to take into account acute problems and disease prevention in the long run, even in adulthood, introduces a new field for pediatrics that also demands the formation of new researchers who can give the children opportunities to be included in research on drugs and other therapeutic proposals addressed to them. In conclusion, health care strategies concentrated particularly on children with all their specificity, a growing and developing human being, need to be implemented in the health services so that they can grow well and become healthy adults.
C1 [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Goldani, Marcelo Zubaran] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
RI Goldani, Marcelo Zubaran/U-8596-2019
CR Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518
   Bogin B., 1999, PATTERNS HUMAN GROWT
   *BRAS MIN SAUD BEN, 1996, DIM PROC REPR SAUD C
   *BRAS MIN SAUD CEB, 2008, DIM PROC REPR SAUD C
   Dunton GF, 2009, OBES REV, V10, P393, DOI 10.1111/j.1467-789X.2009.00572.x
   Forrest CB, 1997, JAMA-J AM MED ASSOC, V277, P1787, DOI 10.1001/jama.277.22.1787
   Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8
   Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102
   GORTMAKER SL, 1984, PEDIATR CLIN N AM, V31, P3
   Hochberg Z, 2009, EUR J ENDOCRINOL, V160, P135, DOI 10.1530/EJE-08-0445
   Lucas Alan, 2005, J Perinatol, V25 Suppl 2, pS2, DOI 10.1038/sj.jp.7211308
   MACFARLANE A, 1979, J MATERNAL CHILD HLT, V337, P3339
   Martinez-Castaldi C, 2008, PEDIATRICS, V122, P52, DOI 10.1542/peds.2007-2849
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI [10.1590/S0034-89102009000100005, 10.1590/s0034-89102009000100005]
   Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x
   PUFFER RR, 1988, PUBLICACION CIENTIFI, V504
   Shaul PW, 2007, PEDIATR RES, V61, P506, DOI 10.1203/pdr.0b013e3180337279
   Silveira PP, 2007, J PEDIAT, V83, P494, DOI 10.1590/S0021-75572007000800004
   Silveira PP, 2005, LANCET, V366, P451, DOI 10.1016/S0140-6736(05)67054-7
   Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425
   Ward RM, 2007, CLIN PHARMACOL THER, V81, P477, DOI 10.1038/sj.clpt.6100109
NR 23
TC 18
Z9 25
U1 0
U2 0
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAR
PY 2010
VL 15
IS 2
BP 321
EP 327
DI 10.1590/S1413-81232010000200002
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 594XJ
UT WOS:000277574100002
PM 20414593
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Meio, MDBB
   Moreira, MEL
   Sichieri, R
   Moura, AS
AF Barbosa Baker Meio, Maria Dalva
   Lopes Moreira, Maria Elizabeth
   Sichieri, Rosely
   Moura, Anibal Sanchez
TI Reduction of IGF-binding protein-3 as a potential marker of
   intra-uterine growth restriction
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE IGF-binding protein-3; insulin-like growth factor-I; small for
   gestational age
ID FOR-GESTATIONAL-AGE; UMBILICAL-CORD SERUM; FACTOR-I; INSULIN-RESISTANCE;
   BIRTH-WEIGHT; SHORT CHILDREN; POSTNATAL-GROWTH; HORMONAL STATUS;
   INFANTS; RETARDATION
AB Background: Growth factor-binding proteins influence the growth of infants starting in utero. Adaptation of the fetus to an adverse uterine environment is associated with changes in the growth hormone-growth factor-insulin axis.
   Aims: To evaluate serum levels of IGF-I and IGFBP-3 in small and appropriate for gestational age newborn infants. Methods: Fifty-four newborn infants, small (SGA, n=28) or appropriate (AGA, n=26) for gestational age were matched by gestational age and sex. Blood was collected on the first day of life, and anthropometric measurements were taken at birth. The serum levels of IGF-I and IGFBP-3 were compared, and correlated with the anthropometric measurements.
   Results: On the first day of life, mean serum IGFBP-3 levels were significantly lower in SGA babies and correlated with weight, length, head circumference, and ponderal index (weight/length 3) (P<0.0001). In contrast, no associations were found between IGF-I serum levels and these anthropometric measurements.
   Conclusion: Our data show that SGA babies have significantly reduced IGFBP-3 concentrations at birth.
C1 [Barbosa Baker Meio, Maria Dalva] Fundacao Oswaldo Cruz, Dept Neonatol, Inst Fernandes Figueira, BR-22421020 Rio De Janeiro, Brazil.
   [Lopes Moreira, Maria Elizabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, BR-22420040 Rio De Janeiro, Brazil.
   [Sichieri, Rosely] Univ Estado Rio de Janeiro, Inst Social Med, BR-20550012 Rio De Janeiro, Brazil.
   [Moura, Anibal Sanchez] Univ Estado Rio de Janeiro, IBRAG, Dept Ciencias Fisiol, Lab Fisiol Nutr & Desenvolvimento, BR-20550030 Rio De Janeiro, Brazil.
RP Meio, MDBB (corresponding author), Fundacao Oswaldo Cruz, Dept Neonatol, Inst Fernandes Figueira, Ave Rui Barbosa 717,Rua Nascimento Silva 111-502, BR-22421020 Rio De Janeiro, Brazil.
EM mdmeio@centroin.com.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; BARBOSA BAKER MEIO,
   MARIA DALVA/0000-0002-7290-9091
CR Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080
   Barrios V, 1996, HORM RES, V46, P130, DOI 10.1159/000185009
   Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967
   Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121
   Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098
   Cutfield WS, 2004, GROWTH HORM IGF RES, V14, pS130, DOI 10.1016/j.ghir.2004.03.028
   Geary MPP, 2003, J CLIN ENDOCR METAB, V88, P3708, DOI 10.1210/jc.2002-022006
   GIUDICE LC, 1995, J CLIN ENDOCR METAB, V80, P1548, DOI 10.1210/jc.80.5.1548
   Gluckman PD, 1996, ACTA PAEDIATR, V85, P3, DOI 10.1111/j.1651-2227.1996.tb14282.x
   Gohlke BC, 2004, HORM RES, V61, P200, DOI 10.1159/000076552
   Hofman PL, 2004, GROWTH HORM IGF RES, V14, pS136, DOI 10.1016/j.ghir.2004.03.029
   Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402
   HUICHEN L, 2002, NUTRITION, V18, P604
   Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778
   Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Langford K, 1998, HUM REPROD, V13, P1389, DOI 10.1093/humrep/13.5.1389
   LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001
   Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253
   Leger J, 1996, PEDIATR RES, V40, P101, DOI 10.1203/00006450-199607000-00018
   Leger J, 1997, BRIT MED J, V315, P341
   Lo HC, 2002, NUTRITION, V18, P604, DOI 10.1016/S0899-9007(01)00811-5
   Malamitsi-Puchner A, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/42646
   Mamelle N, 2006, EUR J PEDIATR, V165, P717, DOI 10.1007/s00431-005-0045-4
   Martinez-Cordero C, 2006, ARCH MED RES, V37, P490, DOI 10.1016/j.arcmed.2005.11.004
   Modi N, 2006, PEDIATR RES, V60, P345, DOI 10.1203/01.pdr.0000232732.93000.52
   Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019
   Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4
   VARVARIGOU A, 1994, BIOL NEONATE, V65, P94, DOI 10.1159/000244034
   VERHAEGHE J, 1993, AM J OBSTET GYNECOL, V169, P89, DOI 10.1016/0002-9378(93)90137-8
   Verkauskiene R, 2007, EUR J ENDOCRINOL, V157, P605, DOI 10.1530/EJE-07-0286
   WANG HS, 1991, J ENDOCRINOL, V129, P459, DOI 10.1677/joe.0.1290459
   Woods KA, 2002, PEDIATR RES, V51, P76, DOI 10.1203/00006450-200201000-00014
NR 33
TC 5
Z9 5
U1 0
U2 0
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD NOV
PY 2009
VL 37
IS 6
BP 689
EP 693
DI 10.1515/JPM.2009.122
PG 5
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 519IG
UT WOS:000271758700015
PM 19591553
DA 2020-12-17
ER

PT J
AU Paula, GD
   da Silva, LGP
   Moreira, MEL
   Bonfim, O
AF Paula, Glaucio de Moraes
   Pessoa da Silva, Luiz Guilherme
   Lopes Moreira, Maria Elizabeth
   Bonfim, Olga
TI Repercussions of premature rupture of fetal membranes on neonatal
   morbidity and mortality
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Premature Rupture Fetal Membranes; Neonatal Mortality (Public Health);
   Morbidity
ID LOW-BIRTH-WEIGHT; CLINICAL-SIGNIFICANCE; PRETERM RUPTURE;
   GESTATIONAL-AGE; RISK-FACTORS; INFANTS; INFLAMMATION; DEATH;
   CHORIOAMNIONITIS; ANTIBIOTICS
AB The objective of this study was to analyze factors associated with death and survival with sequelae in neonates after premature rupture of fetal membranes (PROM). An observational historical cohort study analyzed charts of patients with PROM at <= 34 weeks gestation. The variables were compared with neonatal death and survival with sequelae as the outcomes. In both groups, the data were submitted to bivariate analysis, and the variables showing significance were submitted to logistic regression. The final multivariate model for fetal death showed statistical significance for the following: chorioamnionitis; 5-minute Apgar score <= 5; birth weight <= 1,000g; and cardiopulmonary resuscitation. Survival with sequela was associated with: cervical colonization; patent ductus arteriosus; 5-minute Apgar score <= 5; and birth weight <= 1,000g. Infections, very low birth weight, and peripartum asphyxia were the principal variables associated with the target outcomes among newborns from gestations involving PROM.
C1 [Paula, Glaucio de Moraes] Hosp Geral Bonsucesso, BR-21041030 Rio De Janeiro, Brazil.
   [Pessoa da Silva, Luiz Guilherme; Lopes Moreira, Maria Elizabeth; Bonfim, Olga] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Pessoa da Silva, Luiz Guilherme] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil.
RP Paula, GD (corresponding author), Hosp Geral Bonsucesso, Av Londres 616, BR-21041030 Rio De Janeiro, Brazil.
EM glauciomp@hotmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
CR Abhay Bang, 2002, Economic and Political Weekly, V37, P4947
   ANDERSON CL, 2000, MANUAL NEONATOLOGIA, P680
   Andrews WW, 2003, OBSTET GYNECOL, V101, P847, DOI 10.1016/S0029-7844(03)00172-8
   Baptista M J, 1999, Rev Port Cardiol, V18, P1095
   Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005
   Caravale B, 2003, PEDIATR NEUROL, V29, P18, DOI 10.1016/S0887-8994(03)00046-8
   Chard T, 2001, EUR J OBSTET GYN R B, V95, P114, DOI 10.1016/S0301-2115(00)00366-3
   Cornette L, 2004, Semin Fetal Neonatal Med, V9, P459, DOI 10.1016/j.siny.2004.08.004
   Dammann O, 2005, BJOG-INT J OBSTET GY, V112, P4, DOI 10.1111/j.1471-0528.2005.00576.x
   Dorling J, 2006, EARLY HUM DEV, V82, P117, DOI 10.1016/j.earlhumdev.2005.10.019
   Elimian A, 2000, OBSTET GYNECOL, V96, P333, DOI 10.1016/S0029-7844(00)00928-5
   Fang S, 2005, EARLY HUM DEV, V81, P889, DOI 10.1016/j.earlhumdev.2005.09.004
   Furman B, 2000, EUR J OBSTET GYN R B, V92, P209, DOI 10.1016/S0301-2115(99)00257-2
   Furman B, 2001, J Matern Fetal Med, V10, P107
   Goldenberg RL, 2006, AM J OBSTET GYNECOL, V194, P650, DOI 10.1016/j.ajog.2006.01.004
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007
   Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8
   Hagberg H, 2005, BJOG-INT J OBSTET GY, V112, P16, DOI 10.1111/j.1471-0528.2005.00578.x
   Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042
   Hnat MD, 2005, AM J OBSTET GYNECOL, V193, P164, DOI 10.1016/j.ajog.2004.10.625
   Kallapur SG, 2006, PAEDIATR RESPIR REV, V7, P110, DOI 10.1016/j.prrv.2006.03.005
   Kenyon S, 2004, OBSTET GYNECOL, V104, P1051, DOI 10.1097/01.AOG.0000143268.36682.21
   Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9
   Mercer BM, 1997, INFECT DIS CLIN N AM, V11, P177, DOI 10.1016/S0891-5520(05)70348-2
   Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002
   Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694
   Ng PC, 2003, ARCH DIS CHILD-FETAL, V88, P209
   Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109
   OLIVEIRA RG, 2002, BLACK BOOK MANUAL RE, V1, P446
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   Pasquier JC, 2007, EUR J OBSTET GYN R B, V135, P21, DOI 10.1016/j.ejogrb.2006.10.020
   Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001
   Shankaran S, 2002, AM J OBSTET GYNECOL, V186, P796, DOI 10.1067/mob.2002.121652
   Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085
   Shimada S, 2003, PEDIATR INT, V45, P255, DOI 10.1046/j.1442-200X.2003.01713.x
   SNYDER EV, 2000, MANUAL NEONATOLOGIA, P543
   Spitz B, 1999, J PERINAT MED, V27, P451, DOI 10.1515/JPM.1999.060
   Watts JL, 2006, ARCH DIS CHILD-FETAL, V91, pF221, DOI 10.1136/adc.2005.071928
   Wharton KN, 2004, EARLY HUM DEV, V77, P77, DOI 10.1016/j.earlhumdev.2004.02.001
NR 39
TC 16
Z9 16
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD NOV
PY 2008
VL 24
IS 11
BP 2521
EP 2531
DI 10.1590/S0102-311X2008001100007
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 386ZQ
UT WOS:000261921900007
PM 19009132
OA DOAJ Gold
DA 2020-12-17
ER

PT J
AU Maroun, SLC
   Marliere, RCC
   Barcellus, RC
   Barbosa, CN
   Ramos, JRM
   Moreira, MEL
AF Maroun, Samara L. C.
   Marliere, Roberta C. C.
   Barcellus, Rovena C.
   Barbosa, Claudia N.
   Ramos, Jose R. M.
   Moreira, Maria E. L.
TI Case report: vertical dengue infection
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID PREGNANCY; TRANSMISSION
AB Objectives: To report a case of vertical dengue infection in a newborn from Rio de Janeiro, Brazil, and to review the literature concerning this problem.
   Description: We report a case of vertical dengue infection. Female neonate, birth weight 3,940 g, term, was admitted to a neonatal intensive care unit on the fifth day of life with fever and erythematous rash. Her mother had had dengue fever 3 days before delivery. Her platelet count was 38,000, dropping to 15,000. She did not have any hemorrhagic episodes, including cerebral hemorrhages. Anti-dengue antibodies (IgM) were positive in the mother and infant. Dengue type 2 was detected in the infant using polymerase chain reaction.
   Comments: This report emphasizes that pediatricians should be aware of the possibility of vertical dengue infection so that early management can be instituted.
C1 [Ramos, Jose R. M.; Moreira, Maria E. L.] Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
CR Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Chotigeat Uraiwan, 2003, J Med Assoc Thai, V86 Suppl 3, pS628
   Choudhry S P, 2004, Indian Pediatr, V41, P397
   Fatimil Luthful Ehsan, 2003, Southeast Asian J Trop Med Public Health, V34, P800
   Fernandez R, 1994, Rev Cubana Med Trop, V46, P76
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2006, SINT IND SOC 2006
   Janjindamai Waricha, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P793
   Petdachai Witaya, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P403
   Phongsamart W, 2008, PEDIATR INFECT DIS J, V27, P500, DOI 10.1097/INF.0b013e318167917a
   RESTREPO BN, 2004, BIOMEDICA, V24, P334
   SHARMA JB, 1992, INT J GYNECOL OBSTET, V39, P291, DOI 10.1016/0020-7292(92)90260-P
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002
   Witayathawornwong Prasonk, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P797
NR 15
TC 18
Z9 23
U1 0
U2 4
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD NOV-DEC
PY 2008
VL 84
IS 6
BP 556
EP 559
DI 10.2223/JPED.1826
PG 4
WC Pediatrics
SC Pediatrics
GA 398CT
UT WOS:000262710000014
PM 18949127
OA Bronze
DA 2020-12-17
ER

PT J
AU Pimenta, HP
   Moreira, MEL
   Rocha, AD
   Gomes, SC
   Pinto, LW
   Lucena, SL
AF Pimenta, Hellen P.
   Moreira, Maria E. L.
   Rocha, Adriana Duarte
   Gomes Junior, Saint Clair
   Pinto, Liana W.
   Lucena, Sabrina Lopes
TI Effects of non-nutritive sucking and oral stimulation on breastfeeding
   rates for preterm, low birth weight infants: a randomized clinical trial
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID IMPACT; PREVALENCE; PROGRAM
AB Objective: To determine the influence of non-nutritive sucking and oral stimulation programs on breastfeeding rates at discharge, at 3 and at 6 months of corrected age in preterm infants with very low birth weight.
   Methods: Preterm infants were randomized into experimental and control groups. Ninety-eight preterm infants were randomized and 96 remained in the study until reaching the corrected age of 6 months. The experimental group received sensory-motor-oral stimulation and non-nutritive sucking, while infants in the control group received a sham stimulation program. Both were administered from reaching enteral feeding (100 kcal/kg/day) until the beginning of oral feeding.
   Results: Fifty-nine infants (61.5%) were breastfeeding at the time of hospital discharge, 31 (36.9%) at 3 months, and only 18 (20.5%) at 6 months of corrected age. At discharge, 46.9% of the control group and 76.5% of the experimental group were breastfeeding. There were statistically significant differences between rates of breastfeeding at discharge (47 vs. 76%), 3 months (18 vs. 47%) and 6 months after discharge (10 vs. 27%). The experimental group showed significantly higher rates of breastfeeding (p < 0.05).
   Conclusion: Non-nutritive sucking, associated with oral stimulation programs, can contribute to the improvement of breastfeeding rates among preterm infants with very low birth weight.
C1 [Pimenta, Hellen P.] Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Inst Fernandes Figueira, Dept Neonatol, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Deparlamento de Ciencia e Tecnologia (Decit); Brazilian Ministry
   of Health
FX CNPq and Deparlamento de Ciencia e Tecnologia (Decit), Brazilian
   Ministry of Health.
CR Akerstrom S, 2007, ACTA PAEDIATR, V96, P1450, DOI 10.1111/j.1651-2227.2007.00502.x
   Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Caldeira AP, 2007, J PEDIAT-BRAZIL, V83, P127, DOI 10.2223/JPED.1596
   Cardoso LO, 2008, J PEDIAT-BRAZIL, V84, P147, DOI [10.2223/JPED.1774, 10.1590/S0021-75572008000200010]
   Chaves RG, 2007, J PEDIAT-BRAZIL, V83, P241, DOI [10.2223/JPED.1610, 10.1590/S0021-75572007000400009]
   Dall'Oglio I, 2007, ACTA PAEDIATR, V96, P1626, DOI 10.1111/j.1651-2227.2007.00495.x
   Nascimento Maria Beatriz R. do, 2004, J. Pediatr. (Rio J.), V80, ps163, DOI 10.1590/S0021-75572004000700008
   Friedman L. M., 1998, FUNDAMENTALS CLIN TR
   Fucile S, 2005, DEV MED CHILD NEUROL, V47, P158, DOI 10.1017/S0012162205000290
   Fucile S, 2002, J PEDIATR-US, V141, P230, DOI 10.1067/mpd.2002.125731
   Medoff-Cooper B, 2005, J PERINAT NEONAT NUR, V19, P265, DOI 10.1097/00005237-200507000-00013
   Pickler RH, 1996, NURS RES, V45, P132, DOI 10.1097/00006199-199605000-00002
   Pinelli J., 2005, COCHRANE DB SYST REV, V19
   Rocha AD, 2007, EARLY HUM DEV, V83, P385, DOI 10.1016/j.earlhumdev.2006.08.003
   Santoro W, 2007, J PEDIAT-BRAZIL, V83, P541, DOI 10.2223/JPED.1724
   Sweet Linda, 2006, Breastfeed Rev, V14, P5
   XAVIER CC, 1991, REV SAUDE PUBL, V25, P381, DOI 10.1590/S0034-89101991000500010
NR 19
TC 33
Z9 43
U1 0
U2 14
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2008
VL 84
IS 5
BP 423
EP 427
DI 10.2223/JPED.1839
PG 5
WC Pediatrics
SC Pediatrics
GA 374TQ
UT WOS:000261067000008
PM 18923786
OA Green Published, Other Gold
DA 2020-12-17
ER

PT J
AU Lamy, F
   da Silva, AAM
   Lamy, ZC
   Gomes, MASM
   Moreira, MEL
AF Lamy Filho, Fernando
   Moura da Silva, Antonio Augusto
   Lamy, Zeni Carvalho
   Sousa Mendes Gomes, Maria Auxiliadora
   Lopes Moreira, Maria Elizabeth
CA Grp Avaliacao Metodo Canguru
   Rede Brasileira Pesquisas Neonata
TI Evaluation of the neonatal outcomes of the kangaroo mother method in
   Brazil
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; SKIN CONTACT; CARE; INFANTS; SEVERITY;
   FOLLOW
AB Objective: To evaluate the results of the kangaroo mother method in Brazil.
   Methods: A prospective cohort study comparing 16 units that have or do not have the second phase of the kangaroo mother method: eight were national centers of excellence for the kangaroo mother method (Study group) and eight were part of the Brazilian Neonatal Research Network (control group). A total of 985 newborn infants with birth weights of 500 to 1,749 g were enrolled. Multivariate analyses employed multiple linear regression and Poisson regression with robust adjustment.
   Results: The adjusted analysis (controlled for birth weight, gestational age, Score for Neonatal Acute Physiology Perinatal Extension 11, Neonatal Therapeutic Intervention Scoring System, and maternal age and educational level) demonstrated that mean length of hospital stay (p = 0.14) and intercurrent clinical conditions in the intermediate or kangaroo unit were equal for both groups. Weight (p = 0.012), length (p = 0.039) and head circumference (p = 0.006) at 36 weeks' corrected gestational age were all lower at the kangaroo units. The kangaroo units exhibited superior performance in relation to exclusive breastfeeding at discharge (69.2 vs. 23.8%, p = 0.022).
   Conclusions: The evidence suggests that the humanization strategy adopted by the Brazilian Ministry of Health is a safe alternative to conventional treatment and a good strategy for promoting breastfeeding.
C1 [Lamy Filho, Fernando] Univ Fed Maranhao, Dept Med 3, Sao Luis, MA, Brazil.
   [Moura da Silva, Antonio Augusto; Lamy, Zeni Carvalho] Univ Fed Maranhao, Dept Saude Publ, Sao Luis, MA, Brazil.
   [Sousa Mendes Gomes, Maria Auxiliadora; Lopes Moreira, Maria Elizabeth] Fiocruz MS, Inst Fernandes Figueira, BR-21045900 Rio De Janeiro, Brazil.
RP Lamy, F (corresponding author), Univ Hosp, Unidade Maternoinfantil, Serv Neonatol, Rua Silva Jardim,215-3 Andar, BR-65021000 Sao Luis, MA, Brazil.
EM lamyfilho@gmail.com
RI Lamy, Zeni Carvalho/AAP-6494-2020; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Silva, Antonio A M/B-5410-2009; FILHO, FERNANDO
   LAMY/I-3633-2013
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Silva, Antonio A
   M/0000-0003-4968-5138; 
FU Brazilian Ministry of Health; Pan American Health Organization
FX This research was carried out by the Child Health and Breastfeeding
   technical section of the Brazilian Ministry of Health and financed by
   the Brazilian Ministry of Health and the Pan American Health
   Organization.
CR Anderson G C, 1991, J Perinatol, V11, P216
   ANDERSON GC, 1986, AM J NURS, V86, P1000, DOI 10.2307/3425567
   ANDERSON GC, 1986, AM J NURS, V86, P807, DOI 10.2307/3425389
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   *BRAS MIN SAUD, 1999, NORM AT HUM REC NASC
   *BRAS MIN SAUD, 2000, NOR MAT HUM REC BAIX
   Cattaneo A, 1998, ACTA PAEDIATR, V87, P976, DOI 10.1080/080352598750031653
   Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682
   Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072
   CONDEAGUDELO A, 2007, RESUMOS REVISOES SIS
   Feldman R, 2002, DEV PSYCHOL, V38, P194, DOI 10.1037//0012-1649.38.2.194
   GRAY JE, 1992, PEDIATRICS, V90, P561
   Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14
   Kadam Sandeep, 2005, Indian Journal of Pediatrics, V72, P35, DOI 10.1007/BF02760578
   Kirsten GF, 2001, PEDIATR CLIN N AM, V48, P443, DOI 10.1016/S0031-3955(08)70036-1
   LAMY ZC, 2000, THESIS FUNDACAO O CR
   Ludington-Hoe SM, 2006, PEDIATRICS, V117, pE909, DOI 10.1542/peds.2004-1422
   Martin Ancel A, 2001, An Esp Pediatr, V55, P99
   MATHELIN C, 1999, OSORRISO GIOCONDA CL
   Penalva Olga, 2006, J. Pediatr. (Rio J.), V82, P33, DOI 10.1590/S0021-75572006000100008
   Ramanathan K., 2001, Indian Journal of Pediatrics, V68, P1019, DOI 10.1007/BF02722345
   REY E, 1983, MANEJO RACIONAL NINO
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Roberts K L, 2000, Neonatal Netw, V19, P31
   Ruiz-Pelaez JG, 2004, BMJ-BRIT MED J, V329, P1179, DOI 10.1136/bmj.329.7475.1179
   SLOAN NL, 1994, LANCET, V344, P782, DOI 10.1016/S0140-6736(94)92341-8
   Venancio Sonia Isoyama, 2004, J. Pediatr. (Rio J.), V80, ps173, DOI 10.1590/S0021-75572004000700009
   Walsh-Sukys M, 2001, J Perinatol, V21, P230, DOI 10.1038/sj.jp.7200534
   WALSHSUKYS M, 2001, J PERINATOL, V21, P572
NR 29
TC 22
Z9 28
U1 1
U2 17
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD SEP-OCT
PY 2008
VL 84
IS 5
BP 428
EP 435
DI 10.2223/JPED.1821
PG 8
WC Pediatrics
SC Pediatrics
GA 374TQ
UT WOS:000261067000009
PM 18923784
OA Bronze
DA 2020-12-17
ER

PT J
AU Meio, MDBB
   Sichieri, R
   Soares, FV
   Moreira, MEL
AF Barbosa Baker Meio, Maria Dalva
   Sichieri, Rosely
   Soares, Fernando V.
   Moreira, Maria Elizabeth L.
TI Total body water in small- and appropriate-for gestational age newborns
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE body composition; growth; small for gestational age newborns
ID PRETERM INFANTS; FLUID COMPARTMENTS; WEIGHT CHANGE; BIRTH-WEIGHT;
   FULL-TERM; GROWTH
AB Objectives: To ascertain total body water in small for gestational age (SGA) and appropriate for gestational age (AGA) newborns.
   Methods: SGA and AGA babies were matched by gestational age and studied from birth to term age. Criteria for exclusions were genetic syndromes, malformations, and congenital infections. Bioelectrical impedance was performed at two days of life (term infants), or at seven days of life and term age (preterm infants). Weight and length were measured by trained interviewers, and Z-score, weight/length ratio and Rohrer ponderal index was calculated.
   Results: Of the 54 infants evaluated, 28 were SGA (17 preterm) and 26 were AGA (15 preterm). Total body water was greater in SGA preterm babies at seven days of age (P=0.058) and at term age (P < 0.0001). Weight/length ratio and Rohrer ponderal index increased towards term. Weight Z-score and anthropometric measures at term were significantly smaller in SGA babies. Being SGA and variation in Rohrer ponderal index influenced the variations in total body water.
   Conclusions: SGA babies had greater total body water, and both groups presented insufficient increase in body solid mass, stressing the importance of nutritional support during neonatal care.
C1 [Barbosa Baker Meio, Maria Dalva; Moreira, Maria Elizabeth L.] Inst Fernandes Figueira Fiocruz, Dept Neonatol, Rio De Janeiro, Brazil.
   [Sichieri, Rosely] Univ Fed Rio de Janeiro, Inst Social Med, Rio De Janeiro, Brazil.
RP Meio, MDBB (corresponding author), Inst Fernandes Figueira Fiocruz, Dept Neonatol, Avenida Rui Barbosa 717 Flamengo, Rio De Janeiro, Brazil.
EM mdmeio@centroin.com.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; BARBOSA BAKER MEIO,
   MARIA DALVA/0000-0002-7290-9091
CR BAUER K, 1993, J PEDIATR-US, V123, P301, DOI 10.1016/S0022-3476(05)81707-X
   BRANS YW, 1986, CLIN PERINATOL, V13, P403
   BRANS YW, 1986, BIOL NEONATE, V50, P231, DOI 10.1159/000242604
   Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280
   Ellis KJ, 1999, NUTRITION, V15, P874, DOI 10.1016/S0899-9007(99)00147-1
   GRANDE RM, 1999, INT J ANTHR, V14, P153
   Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V83, pF56, DOI 10.1136/fn.83.1.F56
   HEIMLER R, 1993, J PEDIATR-US, V122, P110, DOI 10.1016/S0022-3476(05)83502-4
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253
   Lingwood BE, 2000, PHYSIOL MEAS, V21, P251, DOI 10.1088/0967-3334/21/2/305
   MACLENNAN AH, 1983, EARLY HUM DEV, V8, P21, DOI 10.1016/0378-3782(83)90030-0
   MICHELI JL, 1994, ACTA PAEDIATR, V83, P35, DOI 10.1111/j.1651-2227.1994.tb13396.x
   Olhager E, 2006, ACTA PAEDIATR, V95, P21, DOI 10.1080/08035250500323731
   Olhager E, 2003, ACTA PAEDIATR, V92, P1327, DOI 10.1080/08035250310005396
   Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF123, DOI 10.1136/fn.77.2.F123
   YAU KIT, 1993, EARLY HUM DEV, V33, P117
NR 17
TC 6
Z9 6
U1 0
U2 0
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD JUL
PY 2008
VL 36
IS 4
BP 354
EP 358
DI 10.1515/JPM.2008.058
PG 5
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 334CZ
UT WOS:000258201200014
PM 18598127
DA 2020-12-17
ER

PT J
AU Lerner, RBDME
   de Carvalho, M
   Vieira, AA
   Lopes, JMDA
   Moreira, MEL
AF Melo Escovedo Lerner, Renata Bandeira de
   de Carvalho, Manoel
   Vieira, Alan Araujo
   de Andrade Lopes, Jose Maria
   Lopes Moreira, Maria Elisabeth
TI Medication errors in a neonatal intensive care unit
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID ADVERSE EVENTS; HOSPITALIZED-PATIENTS; INCIDENTS; SAFETY
AB Objective: To determine the incidence and type of medical errors in a newborn intensive care unit and the relationship between the error and the patient's clinical status.
   Methods: We reviewed the medical charts, during the first 7 days of hospitalization, of all high-risk newborn infants admitted for a period of 3 months.
   Results: Seventy-three patients were admitted during the study period. Their mean birth weight was 2,140 g (640-5,020 g) and mean gestational age was 34 weeks (25-40 weeks). Of 73 medical charts analyzed, 40 (55%) had one or more errors. A total of 365 days of hospitalization was analyzed and 95 medical errors were detected (one error per 3.9 days of hospitalization). The most frequent error was associated with medication use (84.2%). Use of therapeutic procedures (drugs, phototherapy, etc.) without proper prescription in the patient's chart (commission error) accounted for 7.4% of the errors, and incidence of omission errors was 8.4%. Incidence of medical errors was significantly higher in newborn infants with lower gestational age.
   Conclusions: Incidence of errors in the care of high-risk newborn infants is elevated. Strategies to improve education of health professionals involved in the care and development of local culture by disseminating clear accessible algorithms to guide behavior when errors occur must be encouraged.
C1 [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Dept Neonatol, Inst Fernandes Figueira, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Dept Neonatol, Inst Fernandes Figueira, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM bebeth@iff.fiocruz.br
CR *AM SOC HOSP PHARM, 1993, AM J HOSP PHARM, V50, P305
   BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604
   Chedoe I, 2007, DRUG SAFETY, V30, P503, DOI 10.2165/00002018-200730060-00004
   Cimino Michael A, 2004, Pediatr Crit Care Med, V5, P124, DOI 10.1097/01.PCC.0000112371.26138.E8
   Carvalho Manoel de, 2002, J. Pediatr. (Rio J.), V78, P261, DOI 10.1590/S0021-75572002000400004
   Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846
   Grant MJC, 2007, J NURS CARE QUAL, V22, P213, DOI 10.1097/01.NCQ.0000277777.35395.e0
   KOHN LT, 2000, ERR HUMAN
   Lehmann CU, 2005, CLIN PERINATOL, V32, P107, DOI 10.1016/j.clp.2004.10.003
   Mendes Izabel, 2006, J. Pediatr. (Rio J.), V82, P371, DOI [10.2223/JPED.1535, 10.1590/S0021-75572006000600011]
   Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608
   Ross LM, 2000, ARCH DIS CHILD, V83, P492, DOI 10.1136/adc.83.6.492
   Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565
   Simons SL, 2006, NEONATAL NETW, V25, P445, DOI 10.1891/0730-0832.25.6.445
   Slonim AD, 2003, PEDIATRICS, V111, P617, DOI 10.1542/peds.111.3.617
   Suresh G, 2004, PEDIATRICS, V113, P1609, DOI 10.1542/peds.113.6.1609
   VINCER MJ, 1989, AM J DIS CHILD, V143, P737, DOI 10.1001/archpedi.1989.02150180119032
   Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x
   Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774
   YOUNG TE, 2005, NEOFAX MANUAL DRUGS
NR 20
TC 6
Z9 9
U1 0
U2 4
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAR-APR
PY 2008
VL 84
IS 2
BP 166
EP 170
DI 10.2223/JPED.1757
PG 5
WC Pediatrics
SC Pediatrics
GA 295QB
UT WOS:000255487900013
PM 18372936
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Meio, MDBB
   Sichieri, R
   Soares, FV
   Moreira, MEL
AF Meio, Maria Dalva Barbosa Baker
   Sichieri, Rosely
   Soares, Fernanda V.
   Moreira, Maria Elizabeth L.
TI Total body water in small- and appropriate- for gestational age newborns
   (vol 36, pg 354, 2008)
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Correction
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
CR Meio MDBB, 2008, J PERINAT MED, V36, P354, DOI 10.1515/JPM.2008.058
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
J9 J PERINAT MED
JI J. Perinat. Med.
PY 2008
VL 36
IS 5
BP 461
EP 461
DI 10.1515/JPM.2008.104
PG 1
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 357SC
UT WOS:000259865600014
DA 2020-12-17
ER

PT J
AU Soares, FVM
   Moreira, MEL
   Abranches, AD
   Ramos, JRM
   Gomes, SCS
AF Soares, Fernanda V. M.
   Moreira, Maria E. L.
   Abranches, Andrea D.
   Ramos, Jose R. M.
   Gomes, Saint C. S., Jr.
TI Indirect calorimetry: a tool to adjust energy expenditure in very low
   birth weight infants
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID PRETERM; MILK
AB Objective: To determine the resting metabolic rate in very low birth weight infants through indirect calorimetry.
   Methods: Cross-sectional study including 29 clinically stable very low birth weight infants receiving an enteral diet > 100 kcal/kg/day. Malnutrition was defined as weight-for-age z score <= - 2 SD. Resting energy expenditure was measured using open circuit indirect calorimetry.
   Results: At the time of the examination, mean weight was 1,564 +/- 393 g and corrected gestational age was 35 +/- 3 weeks. Malnutrition was diagnosed in 62.1% of the preterm infants. The mean resting metabolic rate was 57.01 +/- 7.76 kcal/kg/day.
   Conclusion: Since resting energy expenditure is the main caloric component of total energy expenditure, the high resting metabolic rate observed may have a strong impact on the development of malnutrition during hospitalization.
C1 [Soares, Fernanda V. M.; Moreira, Maria E. L.; Gomes, Saint C. S., Jr.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Posgrad Saude Crianca & Mulher, Rio De Janeiro, RJ, Brazil.
   [Abranches, Andrea D.] FAPERJ, Convenio Fdn Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Ramos, Jose R. M.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Program Posgrad, Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Dept Neonatol, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; 
CR BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Bauer K, 2003, J PEDIATR-US, V142, P390, DOI 10.1067/mpd.2003.143
   [FAO WHO UNU Expert Consultation], 1985, WHO TECHN REP SER
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Hay WW, 2006, J PERINATOL, V26, pS13, DOI 10.1038/sj.jp.7211426
   Kashyap S, 2006, NEONATAL NUTRITION AND METABOLISM, 2ND EDITION, P134, DOI 10.1017/CBO9780511544712.013
   KLEINMAN RE, 2004, PEDIAT NUTR HDB, P36
   Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35
   Moreira MEL, 2007, J PERINAT MED, V35, P71, DOI 10.1515/JPM.2007.011
   PUTET G, 1984, J PEDIATR-US, V105, P79, DOI 10.1016/S0022-3476(84)80368-6
   SCOPES JW, 1966, ARCH DIS CHILD, V41, P407, DOI 10.1136/adc.41.218.407
   Thureen PJ, 2003, J PEDIATR-US, V142, P366, DOI 10.1067/mpd.2003.198
   Thureen PJ, 1998, J APPL PHYSIOL, V85, P223
   WHO Expert Committee on Physical Status, 1995, PHYS STAT US INT ANT
   Ziegler EE, 2001, ACTA PAEDIATR, V90, P720, DOI 10.1080/08035250117346
NR 15
TC 7
Z9 8
U1 0
U2 3
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD NOV-DEC
PY 2007
VL 83
IS 6
BP 567
EP 570
DI 10.1590/S0021-75572007000800015
PG 4
WC Pediatrics
SC Pediatrics
GA 281OK
UT WOS:000254507100015
PM 18000631
OA Green Published, Other Gold
DA 2020-12-17
ER

PT J
AU De Carvalho, M
   Moreira, MEL
   Lopes, JMA
   Martins, BMR
AF de Carvalho, Manoel
   Moreira, Maria E. L.
   Lopes, Jose M. A.
   Martins, Bianca M. R.
TI Efficacy of new microprocessed phototherapy system with five high
   intensity light emitting diodes (Super LED) - Reply
SO JORNAL DE PEDIATRIA
LA English
DT Letter
ID BILIRUBIN
C1 [de Carvalho, Manoel; Moreira, Maria E. L.; Martins, Bianca M. R.] Fiocruz MS, Fdn Oswaldo Cruz, Posgrad Saude Crianca & Mulher, Programa Saude Crianca & Mulher, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Lopes, Jose M. A.] Clin Perinatal Laranjeiras, Rio De Janeiro, RJ, Brazil.
RP de Carvalho, M (corresponding author), Fiocruz MS, Fdn Oswaldo Cruz, Posgrad Saude Crianca & Mulher, Programa Saude Crianca & Mulher, BR-21045900 Rio De Janeiro, RJ, Brazil.
CR ENNEVER JF, 1984, PEDIATR RES, V18, P667, DOI 10.1203/00006450-198407000-00021
   ENNEVER JF, 1987, J CLIN INVEST, V79, P1674, DOI 10.1172/JCI113006
   Martins BMR, 2007, J PEDIAT-BRAZIL, V83, P253, DOI [10.2223/JPED.1637, 10.1590/S0021-75572007000400011]
   ONISHI S, 1986, BIOCHEM J, V236, P23, DOI 10.1042/bj2360023
   SBRANA G, 1987, PEDIATRICS, V80, P395
   Vreman HJ, 1998, PEDIATR RES, V44, P804, DOI 10.1203/00006450-199811000-00027
NR 6
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
J9 J PEDIAT
JI J. Pediatr.
PD NOV-DEC
PY 2007
VL 83
IS 6
BP 577
EP 577
DI 10.2223/JPED.1733
PG 1
WC Pediatrics
SC Pediatrics
GA 281OK
UT WOS:000254507100020
PM 18074066
OA Bronze
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Villela, LD
AF Moreira, M. E. L.
   Villela, L. D.
TI Growth and body composition of pre term very low birth weight (VLBW)
   infants
SO ACTA PAEDIATRICA
LA English
DT Meeting Abstract
C1 [Moreira, M. E. L.; Villela, L. D.] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD OCT
PY 2007
VL 96
SU 456
BP 138
EP 138
PG 1
WC Pediatrics
SC Pediatrics
GA 245AR
UT WOS:000251907200356
DA 2020-12-17
ER

PT J
AU Zin, AA
   Gilbert, C
   Moreira, MEL
AF Zin, A. A.
   Gilbert, C.
   Moreira, M. E. L.
TI Screening guidelines implications of severe retinopathy of prematurity
   (ROP) in Rio de Janeiro, Brazil
SO ACTA PAEDIATRICA
LA English
DT Meeting Abstract
C1 [Zin, A. A.; Moreira, M. E. L.] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Gilbert, C.] London Sch Hyg & Trop Med, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD OCT
PY 2007
VL 96
SU 456
BP 176
EP 176
PG 1
WC Pediatrics
SC Pediatrics
GA 245AR
UT WOS:000251907200453
DA 2020-12-17
ER

PT J
AU Gianini, NM
   Gomes, SC
   Moreira, MEL
AF Gianini, N. M.
   Gomes, S. C., Jr.
   Moreira, M. E. L.
TI Influence of clinical and nutritional practices in postnatal growth
   restriction in very low birth weight infants
SO ACTA PAEDIATRICA
LA English
DT Meeting Abstract
C1 [Gomes, S. C., Jr.; Moreira, M. E. L.] Inst Fernandes Figueira Fiocruz, Fiocruz, Brazil.
RI Junior, Clair Gomes/F-7579-2012
OI Junior, Clair Gomes/0000-0002-1554-943X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD OCT
PY 2007
VL 96
SU 456
BP 188
EP 188
PG 1
WC Pediatrics
SC Pediatrics
GA 245AR
UT WOS:000251907200486
DA 2020-12-17
ER

PT J
AU Meio, MDBB
   Sichieri, R
   Soares, FVM
   Abranches, AD
   Moreira, MEL
AF Meio, M. D. B. B.
   Sichieri, R.
   Soares, F. V. M.
   Abranches, A. D.
   Moreira, M. E. L.
TI Total body water in small for gestational age newborn infants compared
   with normally grown newborns
SO ACTA PAEDIATRICA
LA English
DT Meeting Abstract
C1 [Meio, M. D. B. B.; Soares, F. V. M.; Abranches, A. D.; Moreira, M. E. L.] Inst Fernandes Figueira Fiocruz, Dept Neonatol, Fiocruz, Brazil.
   [Sichieri, R.] Univ Estado Rio De Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD OCT
PY 2007
VL 96
SU 456
BP 189
EP 189
PG 1
WC Pediatrics
SC Pediatrics
GA 245AR
UT WOS:000251907200488
DA 2020-12-17
ER

PT J
AU Soares, FVM
   Abranches, AD
   Ramos, JRM
   Gomes, SC
   Moreira, MEL
AF Soares, F. V. M.
   Abranches, A. D.
   Ramos, J. R. M.
   Gomes, S. C., Jr.
   Moreira, M. E. L.
TI Indirect calorimetry: a tool for nutritional evaluation in very low
   birth weight infants
SO ACTA PAEDIATRICA
LA English
DT Meeting Abstract
C1 [Soares, F. V. M.; Abranches, A. D.; Ramos, J. R. M.; Gomes, S. C., Jr.; Moreira, M. E. L.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RI Junior, Clair Gomes/F-7579-2012; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Junior, Clair Gomes/0000-0002-1554-943X; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0803-5253
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD OCT
PY 2007
VL 96
SU 456
BP 189
EP 189
PG 1
WC Pediatrics
SC Pediatrics
GA 245AR
UT WOS:000251907200487
DA 2020-12-17
ER

PT J
AU Sa, CA
   Santos, MC
   Moreira, ME
AF Sa, C. A.
   Santos, M. C.
   Moreira, M. E.
TI Adverse events related to exchange transfusion in newborn infants with
   hemolytic disease secondary to rhesus alloimmunization
SO TRANSFUSION
LA English
DT Meeting Abstract
CT 60th Annual Meeting of the American-Association-of-Blood-Banks
CY OCT 20-23, 2007
CL Anaheim, CA
SP Amer Assoc Blood Banks
C1 Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
EM crispessoa@uol.com.br
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2007
VL 47
IS 3
SU S
BP 135A
EP 135A
PG 1
WC Hematology
SC Hematology
GA 209OJ
UT WOS:000249397600396
DA 2020-12-17
ER

PT J
AU Rocha, AD
   Moreira, MEL
   Pimenta, HP
   Ramos, JRM
   Lucena, SL
AF Rocha, Adriana Duarte
   Lopes Moreira, Maria Elisabeth
   Pimenta, Hellen Porto
   Moraes Ramos, Jose Roberto
   Lucena, Sabrina Lopes
TI A randomized study of the efficacy of sensory-motor-oral stimulation and
   non-nutritive sucking in very low birthweight infant
SO EARLY HUMAN DEVELOPMENT
LA English
DT Article
DE non-nutritive sucking; preterm infants
ID PRETERM INFANTS; PREMATURE-INFANTS; TUBE; GROWTH
AB To assess if sensory-motor-oral stimulation and non-nutritive sucking gavage feeding enhances the oral feeding performance of preterm infants born between 26 and 32 weeks of gestational age.
   Study design: Very low birthweight infants (n = 98) were randomized into a experimental and control group. Preterm infants in the experimental group received sensory-motor-oral stimulation and non-nutritive sucking and infants in the control group received a sham stimulation program. Both were administered from when they reached enteral diet (100 kcal/kg/day) until the beginning of oral diet. Primary outcome was length of hospital stay.
   Results: Independent oral feeding was attained significantly earlier in the experimental group than the control group, 38 +/- 16 days of life (mean +/- S.D.) versus 47 +/- 17 days of life, respectively (P < 0.001) There was significant difference in length of hospital stay between the two groups (41.9 +/- 17 (mean +/- S.D.) versus 52.3 +/- 19 days (P < 0.01)).
   Conclusion: Sensory-motor-oral stimulation, together with early non-nutritive sucking (as soon as the newborn reaches full diet and is clinically stable) in very low birthweight preterm infants, as long as they are clinically stable, in this study, earlier initiation of oral feeding and earlier hospital discharge. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
EM rochaechirol@yahoo.com.br; bebeth@iff.fiocruz.br;
   hellenpimenta@gmail.com; josermaramos@uol.com.br;
   sabrinalucena@hotmail.com
CR Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   BERNBAUM JC, 1983, PEDIATRICS, V71, P41
   BIER JAB, 1993, AM J DIS CHILD, V147, P858, DOI 10.1001/archpedi.1993.02160320060020
   BULOCK F, 1990, DEV MED CHILD NEUROL, V32, P669
   DIPIETRO JA, 1994, PEDIATR RES, V36, P207, DOI 10.1203/00006450-199408000-00012
   EISHIMA K, 1991, EARLY HUM DEV, V27, P163, DOI 10.1016/0378-3782(91)90192-6
   FIELD T, 1982, PEDIATRICS, V70, P381
   Finan DS, 1998, EARLY HUM DEV, V52, P181, DOI 10.1016/S0378-3782(98)00029-2
   Fucile S, 2002, J PEDIATR-US, V141, P230, DOI 10.1067/mpd.2002.125731
   Gardner S L, 1991, J Pediatr Health Care, V5, P122, DOI 10.1016/0891-5245(91)90022-I
   HACK M, 1990, DEV MED CHILD NEURAL, V32, P669
   Measel C P, 1979, JOGN Nurs, V8, P265, DOI 10.1111/j.1552-6909.1979.tb00960.x
   Medoff-Cooper B, 1995, Image J Nurs Sch, V27, P195, DOI 10.1111/j.1547-5069.1995.tb00858.x
   Pickler RH, 1996, NURS RES, V45, P132, DOI 10.1097/00006199-199605000-00002
   PINELLI J, 2005, NICHD COCHRANE NEONA
   SEHGAL S K, 1990, Indian Pediatrics, V27, P263
   Steer Peter A., 1992, P94
   WIDSTROM AM, 1988, J PEDIATR GASTR NUTR, V7, P517, DOI 10.1097/00005176-198807000-00007
NR 19
TC 63
Z9 74
U1 0
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-3782
EI 1872-6232
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD JUN
PY 2007
VL 83
IS 6
BP 385
EP 388
DI 10.1016/j.earlhumdev.2006.08.003
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 170HV
UT WOS:000246654700006
PM 16979854
DA 2020-12-17
ER

PT J
AU Martins, BMR
   de Carvalho, M
   Moreira, MEL
   Lopes, JMA
AF Martins, Bianca M. R.
   de Carvalho, Manoel
   Moreira, Maria E. L.
   Lopes, Jose M. A.
TI Efficacy of new microprocessed phototherapy system with five high
   intensity light emitting diodes (Super LED)
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID NEONATAL HYPERBILIRUBINEMIA; JAUNDICE
AB Objectives: To evaluate the efficacy of a microprocessed phototherapy (PT) system with five high intensity light emitting diodes (Super LED) for the treatment of neonatal hyperbilirubinemia of premature infants.
   Methods: Pandomized clinical trial using Super LED phototherapy in the study group and twin halogen spotlight phototherapy in the control group. A stratified blocked randomization, based on birth weight, was performed. The duration of phototherapy and the rate of decrease of total serum bilirubin (TSB) concentration in the first 24 hours of treatment were the main outcome measures.
   Results: We studied 88 infants, 44 in the Super LED group and 44 in the halogen spotlight PT group. The demographic characteristics of the patients in both groups were similar. Infants in the Super LED group had a similar mean initial serum bilirubin level (10. 1 +/- 2.4 mg%) to those receiving halogen spotlight treatment (10.9 +/- 2.0 mg%). After 24 hours of treatment, the decrease in total serum bilirubin levels was significantly greater in the Super LED group (27.9 vs. 10.7%, p < 0.01) and duration of phototherapy was significantly shorter in this group (36.8 h vs. 63.8 h, p < 0.01). After 24 hours of treatment, a significantly greater number of patients receiving Super LED phototherapy had reached serum bilirubin concentrations low enough to allow withdrawal of treatment (23 vs. 10, p < 0.01).
   Conclusions: Our results demonstrate that the efficacy of Super LED phototherapy for treating hyperbilirubinemia in premature infants was significantly better than halogen phototherapy.
C1 [Martins, Bianca M. R.] Fiocruz MS, Fdn Oswaldo Cruz, Programa Sauda Crianca & Mulher, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [de Carvalho, Manoel; Moreira, Maria E. L.] Fiocruz MS, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Lopes, Jose M. A.] Clin Perinatal Laranjeiras, Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Dept Neonatol, Avenida Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM bebeth@iff.fiocruz.br
CR Bhutani VK, 2004, SEMIN PERINATOL, V28, P319, DOI 10.1053/j.semperi.2004.09.006
   CARVALHO M, 1992, J PEDIAT RIO J, V68, P289
   CARVALHO M, 1996, J PEDIAT RIO J, V72, P151
   Chang YS, 2005, J KOREAN MED SCI, V20, P61, DOI 10.3346/jkms.2005.20.1.61
   DECARVALHO M, 1993, J PEDIAT RIO J, V69, P186
   ENNEVER JF, 1984, PEDIATR RES, V18, P667, DOI 10.1203/00006450-198407000-00021
   Facchini F P, 2001, J Pediatr (Rio J), V77, P67
   Hart G, 2005, ARCH DIS CHILD-FETAL, V90, pF437, DOI 10.1136/adc.2004.068015
   Maisels M J, 2001, J Perinatol, V21 Suppl 1, pS93, DOI 10.1038/sj.jp.7210642
   Maisels MJ, 1996, PEDIATRICS, V98, P283
   Rosenberger WF, 2002, RANDOMIZATION CLIN T
   Seidman Daniel S, 2003, J Perinatol, V23, P123, DOI 10.1038/sj.jp.7210862
   Seidman DS, 2000, J PEDIATR-US, V136, P771, DOI 10.1067/mpd.2000.105651
   TAN KL, 1994, J PEDIATR-US, V125, P607, DOI 10.1016/S0022-3476(94)70019-2
   TAN KL, 1977, J PEDIATR-US, V90, P448, DOI 10.1016/S0022-3476(77)80714-2
   Vreman HJ, 2004, SEMIN PERINATOL, V28, P326, DOI 10.1053/j.semperi.2004.09.003
   Vreman HJ, 1998, PEDIATR RES, V44, P804, DOI 10.1203/00006450-199811000-00027
NR 17
TC 23
Z9 27
U1 0
U2 5
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAY-JUN
PY 2007
VL 83
IS 3
BP 253
EP 258
DI 10.2223/JPED.1637
PG 6
WC Pediatrics
SC Pediatrics
GA 281OE
UT WOS:000254506400011
PM 17551656
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Bhering, CA
   Mochdece, CC
   Moreira, MEL
   Rocco, JR
   Sant'Anna, GM
AF Bhering, Carlos A.
   Mochdece, Christieny C.
   Moreira, Maria E. L.
   Rocco, Jose R.
   Sant'Anna, Guilherme M.
TI Bronchopulmonary dysplasia prediction model for 7-day-old infants
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID CHRONIC LUNG-DISEASE; DUCTUS-ARTERIOSUS; RISK-FACTORS; PROPHYLAXIS;
   VALIDATION
AB Objective: To develop a predictive model capable of identifying which premature infants have the greatest probability of presenting bronchopulmonary dysplasia (BPD), based on assessment at the end of their first week of life.
   Methods: Data were collected retrospectively from January 1998 to July 2001, and prospectively from August 2001 to July 2003. All children born at the institution with gestational age < 34 weeks and birth weight < 1,500 g were included. The principal risk factors for BPD were subjected to univariate analysis followed by logistic regression. Significant variables were used to construct a formula to calculate the probability of BPD. The model was calibrated and its discriminative power assessed using receiver operating characteristic (ROC) curves. Between August 2003 and July 2005 the model was then applied to a different population for validation.
   Results: The sample comprised 247 children, of whom 68 developed BPD, classified as follows: mild = 35 (51.4%), moderate = 20 (29.4%) and severe = 8 (11.7%). Four variables maintained significance with relation to BPD: gestational age <= 30 weeks, persistent ductus arteriosus, mechanical ventilation > 2 days and loss of > 15% of birth weight on the seventh day of life. Where patients exhibited all of these variables, the model had a 93.7% probability of being correct. The model was further validated when using another sample of 61 newborns; similar figures were obtained.
   Conclusions: At the end of the first week of life, the predictive model developed from our population was capable of identifying newborn infants at increased risk of developing BPD with a high degree of sensitivity.
C1 [Bhering, Carlos A.] Univ Severino Sombra, Vassouras, RJ, Brazil.
   [Bhering, Carlos A.; Mochdece, Christieny C.; Moreira, Maria E. L.; Sant'Anna, Guilherme M.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Rocco, Jose R.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Sant'Anna, Guilherme M.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
RP Bhering, CA (corresponding author), Univ Severino Sombra, Vassouras, RJ, Brazil.
RI Sant'Anna, Guilherme/U-1409-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
CR Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062
   BALLARD RA, 2006, PEDIATR RES, V31, pA53
   Bose CL, 2006, J PEDIATR-US, V148, P713, DOI 10.1016/j.jpeds.2006.03.015
   Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE
   Cohen A, 1983, Am J Perinatol, V1, P21
   Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659
   Mello Rosane R. de, 2004, J. Pediatr. (Rio J.), V80, P503, DOI 10.1590/S0021-75572004000800013
   Doyle LW, 2005, PEDIATRICS, V115, P655, DOI 10.1542/peds.2004-1238
   EHRENKRANZ R, 1995, PEDIAT RES, V37, pA330
   Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249
   Finer NN, 2004, PEDIATRICS, V114, P651, DOI 10.1542/peds.2004-0394
   Harrell FE, 2001, REGRESSION MODELING
   Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264
   Jobe AH, 2006, J PEDIATR-US, V148, p2A
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   KALENGA M, 1995, PEDIATR RES, V37, P783, DOI 10.1203/00006450-199506000-00018
   LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284
   Marshall DD, 1999, PEDIATRICS, V104, P1345, DOI 10.1542/peds.104.6.1345
   Mataloun Marta M. G. B., 2006, J. Pediatr. (Rio J.), V82, P179, DOI [10.1590/S0021-75572006000300005, 10.2223/JPED.1471]
   Monte Luciana F Velloso, 2005, J Pediatr (Rio J), V81, P99, DOI 10.1590/S0021-75572005000300004
   Oh W, 2005, J PEDIATR-US, V147, P786, DOI 10.1016/j.jpeds.2005.06.039
   PALTA M, 1991, J PEDIATR-US, V119, P285, DOI 10.1016/S0022-3476(05)80746-2
   PALTA M, 1990, PEDIATRICS, V86, P714
   Romagnoli C, 1998, INTENS CARE MED, V24, P476, DOI 10.1007/s001340050599
   Rozycki HJ, 1996, PEDIATR PULM, V21, P345, DOI 10.1002/(SICI)1099-0496(199606)21:6<345::AID-PPUL1>3.0.CO;2-K
   Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065
   Schmidt B, 2002, LANCET, V360, P492, DOI 10.1016/S0140-6736(02)09658-7
   Schmidt B, 2006, J PEDIATR-US, V148, P730, DOI 10.1016/j.jpeds.2006.01.047
   SINKIN RA, 1990, PEDIATRICS, V86, P728
   SOSENKO IRS, 1991, SEMIN PERINATOL, V15, P462
NR 30
TC 22
Z9 29
U1 0
U2 2
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAR-APR
PY 2007
VL 83
IS 2
BP 163
EP 170
DI 10.2223/JPED.1599
PG 8
WC Pediatrics
SC Pediatrics
GA 281OB
UT WOS:000254506000011
PM 17380230
OA Bronze
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Vieira, AA
   Soares, FVM
   Lopes, RB
   Gomes, P
   Abranches, AD
   Lopes, JMA
AF Moreira, Maria E. L.
   Vieira, Alan A.
   Mendes Soares, Fernanda V.
   Lopes, Renata Bastos
   Gomes, Plinio
   Abranches, Andrea D.
   Lopes, Jose M. A.
TI Determining the least time required for measuring energy expenditure in
   premature neonates
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Article
DE indirect calorimetry; preterm infants
ID BIRTH-WEIGHT INFANTS; CARBON-DIOXIDE PRODUCTION; PRETERM INFANTS;
   INDIRECT CALORIMETRY; OXYGEN-CONSUMPTION; METABOLIC-RATE; STEADY-STATE;
   VARIABILITY; ACCURACY; BALANCE
AB Objective: To compare 0, consumption, CO, production, respiratory quotient and resting metabolic rate in premature neonates measured for 5 and 10 min steady-state periods and 15 and 20 min non-steady-state periods versus a 2-h measurement period.
   Methods: A prospective study with neonates evaluated by indirect calorimetry. The measurements from the 5, 10, 15, and 20 min periods were taken based on the printout data from the IC monitor at an interval of 1 h before the beginning feeding and were contained in the 2-h measurement. The 5- and 10-min measurements followed the steady-state criterion.
   Results: We evaluated 35 premature neonates appropriate for gestational age (born at 28-34 weeks' gestation). Mean age was 20 days 9 (median 14 days) and mean weight was 1530 270 g (median 1510 g). There was no statistically significant difference between mean VO2, VCO2, respiratory quotient and energy expenditure at 5, 10, 15, and 20 min and 2 h.
   Conclusions: The 5 and 10 min steady-state measurements or a measurement of more than 15 min without reaching steady state produce results similar to those of 2 h measurements.
C1 Fiocruz MS, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
RP Moreira, MEL (corresponding author), Fiocruz MS, Dept Neonatol, BR-22250020 Rio De Janeiro, Brazil.
EM bebete@globo.com
RI Lopes, Jose Manuel/J-7428-2013; de Abranches, Andrea
   Dunshee/ABA-8578-2020
OI Lopes, Jose Manuel/0000-0001-8597-3474; 
CR *AM AC PED, 2004, PED NUTR HDB
   Bauer J, 1996, J PEDIATR-US, V129, P608, DOI 10.1016/S0022-3476(96)70129-4
   Bauer J, 2001, PEDIATRICS, V107, P660, DOI 10.1542/peds.107.4.660
   Bauer K, 1997, PEDIATR RES, V41, P139, DOI 10.1203/00006450-199701000-00022
   BELL EF, 1986, PEDIATR RES, V20, P646, DOI 10.1203/00006450-198607000-00013
   Bodamer OAF, 1997, EUR J PEDIATR, V156, pS24, DOI 10.1007/PL00014266
   DeMarie MP, 1999, J PERINAT MED, V27, P465, DOI 10.1515/JPM.1999.062
   Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368
   Ehrenkranz RA, 1999, PEDIATRICS, V104, P280, DOI 10.1542/peds.104.2.280
   FREYMOND D, 1986, PEDIATR RES, V20, P503
   Gianini Nicole M., 2005, J. Pediatr. (Rio J.), V81, P34, DOI [10.2223/JPED.1280, 10.1590/S0021-75572005000100008]
   Hay WW, 2006, J PERINATOL, V26, pS13, DOI 10.1038/sj.jp.7211426
   Joosten KFM, 1999, CLIN NUTR, V18, P149, DOI 10.1016/S0261-5614(99)80004-1
   Kingdon CC, 2000, ARCH DIS CHILD-FETAL, V83, pF50, DOI 10.1136/fn.83.1.F50
   Lubetzky R, 2003, J PEDIATR-US, V143, P750, DOI 10.1067/S0022-3476(03)00532-8
   Lucas Alan, 2005, J Perinatol, V25 Suppl 2, pS2, DOI 10.1038/sj.jp.7211308
   MARKS KH, 1987, PEDIATR RES, V21, P66, DOI 10.1203/00006450-198701000-00015
   McClave SA, 2003, JPEN-PARENTER ENTER, V27, P16, DOI 10.1177/014860710302700116
   Miller E, 2004, IEEE INTELL SYST, V19, P95, DOI 10.1109/MIS.2004.19
   PENCHARZ PB, 1995, J PEDIATR-US, V127, P269
   Perring J, 2000, PEDIATR RES, V48, P518, DOI 10.1203/00006450-200010000-00016
   Reeves MM, 2004, J APPL PHYSIOL, V97, P130, DOI 10.1152/japplphysiol.01212.2003
   Reid C L, 1998, Curr Opin Clin Nutr Metab Care, V1, P281, DOI 10.1097/00075197-199805000-00008
   SCHULZE K, 1986, PEDIATR RES, V20, P422, DOI 10.1203/00006450-198605000-00009
   SEALE JL, 1995, AM J CLIN NUTR, V62, P1042
   SHORTLAND GJ, 1992, ARCH DIS CHILD-FETAL, V67, P1207, DOI 10.1136/adc.67.10_Spec_No.1207
   Thureen PJ, 2003, J PEDIATR-US, V142, P366, DOI 10.1067/mpd.2003.198
   Thureen PJ, 1998, J APPL PHYSIOL, V85, P223
   Thureen PJ, 1997, CRIT CARE MED, V25, P171, DOI 10.1097/00003246-199701000-00031
   ULTMAN JS, 1981, J APPL PHYSIOL, V50, P210
NR 30
TC 7
Z9 7
U1 0
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PY 2007
VL 35
IS 1
BP 71
EP 75
DI 10.1515/JPM.2007.011
PG 5
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA 143KE
UT WOS:000244719300011
PM 17313314
DA 2020-12-17
ER

PT J
AU Braz, RRT
   Moreira, MEL
   de Carvalho, M
   Lopes, JMA
   Rodrigues, MA
   Cabral, JAO
   Motta, MM
AF Braz, R. R. T.
   Moreira, M. E. L.
   de Carvalho, M.
   Lopes, J. M. A.
   Rodrigues, M. A.
   Cabral, J. A. O.
   Motta, M. M.
TI Effect of light reduction on the incidence of retinopathy of prematurity
SO ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION
LA English
DT Article
AB The effect of ocular protection on the incidence of retinopathy of prematurity was tested in 188 newborns weighing less than 1600 g in a randomised controlled trial. No effect of ambient light reduction on the incidence of retinopathy of prematurity was shown.
C1 Fundacao Oswaldo Cruz, Inst Fernandes Figuera, Dept Neonatol, Rio De Janeiro, Brazil.
   Laranjeuras Perimatal Clin, Neonatal Intens Care Unit, Rio De Janeiro, Brazil.
RP Lopes, JMA (corresponding author), Rua Aperana 77 101, BR-22450190 Rio De Janeiro, Brazil.
EM jlopesma@uol.com.br
CR ACKERMAN B, 1989, PEDIATRICS, V4, P357
   GLASS P, 1985, NEW ENGL J MED, V313, P401, DOI 10.1056/NEJM198508153130701
   PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471
   Phelps DL, 2001, COCHRANE DATABASE SY
   Reynolds JD, 1998, NEW ENGL J MED, V338, P1572, DOI 10.1056/NEJM199805283382202
   SEIBERTH V, 1994, AM J OPHTHALMOL, V15, P118
NR 6
TC 8
Z9 8
U1 0
U2 3
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1359-2998
J9 ARCH DIS CHILD-FETAL
JI Arch. Dis. Child.-Fetal Neonatal Ed.
PD NOV
PY 2006
VL 91
IS 6
BP F443
EP F444
DI 10.1136/adc.2005.088518
PG 2
WC Pediatrics
SC Pediatrics
GA 099EY
UT WOS:000241577300014
PM 16547078
OA Green Published
DA 2020-12-17
ER

PT J
AU Rocha, AD
   Vieira, AA
   Moreira, MEL
   Pimenta, HR
   De Carvalho, M
   Lucena, S
   Lopes, JMA
AF Rocha, AD
   Vieira, AA
   Moreira, MEL
   Pimenta, HR
   De Carvalho, M
   Lucena, S
   Lopes, JMA
TI Comparison of energy content of fresh human milk and frozen/thawed human
   milk offered to preterm infants
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Societies
CY MAY   04, 2004
CL San Francisco, CA
SP Pediatr Acad Soc
C1 Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2004
VL 55
IS 4
SU S
MA 2213
BP 389A
EP 389A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 808TJ
UT WOS:000220591102279
DA 2020-12-17
ER

PT J
AU Vieira, AA
   Moreira, MEL
   Lopes, RB
   Schiapacassa, BV
   De Carvalho, M
   Lopes, JMA
AF Vieira, AA
   Moreira, MEL
   Lopes, RB
   Schiapacassa, BV
   De Carvalho, M
   Lopes, JMA
TI Effect of infant position on energy expenditure (EE) in neonates
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Societies
CY MAY   04, 2004
CL San Francisco, CA
SP Pediatr Acad Soc
C1 Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2004
VL 55
IS 4
SU S
MA 2499
BP 440A
EP 440A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 808TJ
UT WOS:000220591102564
DA 2020-12-17
ER

PT J
AU Bhering, CA
   Rocco, JR
   Moreira, MEL
   Sant'Anna, G
AF Bhering, CA
   Rocco, JR
   Moreira, MEL
   Sant'Anna, G
TI Bronchopulmonary dysplasia in very low birth weight infants: Incidence,
   risk factors and a propose of a probability model
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Societies
CY MAY   04, 2004
CL San Francisco, CA
SP Pediatr Acad Soc
C1 Univ Fed Rio de Janeiro, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
RI Sant'Anna, Guilherme/U-1409-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2004
VL 55
IS 4
SU S
MA 2826
BP 498A
EP 498A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 808TJ
UT WOS:000220591102891
DA 2020-12-17
ER

PT J
AU Lopes, JMA
   De Carvalho, M
   Moreira, MEL
   Danielle, N
   Fernanda, B
   Silvia, T
   Patricia, L
AF Lopes, JMA
   De Carvalho, M
   Moreira, MEL
   Danielle, N
   Fernanda, B
   Silvia, T
   Patricia, L
TI Neonatal practices in a NICU(neonatal intensive care unit) and
   BPD(bronchopulmonary dysplasia) incidence
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Societies
CY MAY   04, 2004
CL San Francisco, CA
SP Pediatr Acad Soc
C1 Clin Perinatal Laranjeiras, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2004
VL 55
IS 4
SU S
MA 2827
BP 498A
EP 498A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 808TJ
UT WOS:000220591102892
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Vieira, AA
   Carvalho, MD
AF Moreira, MEL
   Vieira, AA
   Carvalho, MD
TI Evaluation of clinical and laboratorial factors associated with neonatal
   sepsis using logistic regression
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Society
CY MAY 03-06, 2003
CL SEATTLE, WASHINGTON
SP Pediat Acad Soc, Amer Pediat Soc, Soc Pediat Res, Ambulatory Pediat Assoc, Tulane Univ Hlth Sci Ctr, Ctr Continuing Educ
C1 Inst Fernandes Figueira Fiocruz, FIOCRUZ, Rio De Janeiro, Brazil.
   Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2003
VL 53
IS 4
SU S
MA 1812
BP 317A
EP 318A
PN 2
PG 2
WC Pediatrics
SC Pediatrics
GA 661PA
UT WOS:000181897901811
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Oliveira, MCB
   Campos, MR
AF Moreira, MEL
   Oliveira, MCB
   Campos, MR
TI Long-term assessment of growth in survivors of neonatal intensive care
   units (NICUs)
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Society
CY MAY 03-06, 2003
CL SEATTLE, WASHINGTON
SP Pediat Acad Soc, Amer Pediat Soc, Soc Pediat Res, Ambulatory Pediat Assoc, Tulane Univ Hlth Sci Ctr, Ctr Continuing Educ
C1 Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
   Secretaria Municipal Saude, Rio De Janeiro, Brazil.
   ENSP, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2003
VL 53
IS 4
SU S
MA 2803
BP 496A
EP 496A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 661PA
UT WOS:000181897902800
DA 2020-12-17
ER

PT J
AU Moreira, MEL
   Gianini, NM
   De Carvalho, M
AF Moreira, MEL
   Gianini, NM
   De Carvalho, M
TI The impact of nutritional practices on weight gain in very low birth
   weight (VLBW)
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the Pediatric-Academic-Society
CY MAY 03-06, 2003
CL SEATTLE, WASHINGTON
SP Pediat Acad Soc, Amer Pediat Soc, Soc Pediat Res, Ambulatory Pediat Assoc, Tulane Univ Hlth Sci Ctr, Ctr Continuing Educ
C1 Fiocruz MS, Inst Fernandes Figueira, BR-21045900 Rio De Janeiro, Brazil.
   CETRIN, Rio De Janeiro, Brazil.
   Clin Perinatal Laranjeiras, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2003
VL 53
IS 4
SU S
MA 2804
BP 496A
EP 496A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 661PA
UT WOS:000181897902801
DA 2020-12-17
ER

PT J
AU Quirino, MRS
   Jorge, AOC
   Moreira, M
   Moreira, ME
AF Quirino, MRS
   Jorge, AOC
   Moreira, M
   Moreira, ME
TI Accidents evaluation of dental practice of Taubate University.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
CT 18th Annual Meeting of the International-Association-for-Dental-Research
CY SEP 02-05, 2001
CL SAO PAULO, BRAZIL
SP Int Assoc Dent Res
C1 UNITAU, Sch Dent, Sao Paulo, Brazil.
   UNITAU, Univ Hosp, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2002
VL 81
SI B
BP B155
EP B155
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 632HM
UT WOS:000180217901109
DA 2020-12-17
ER

PT J
AU De Carvalho, M
   De Luca, A
   Moreira, MEL
AF De Carvalho, M
   De Luca, A
   Moreira, MEL
TI Fat and energy content of pooled banked human milk fed to preterm
   infants
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
C1 Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 2002
VL 51
IS 4
SU S
MA 2348
BP 403A
EP 403A
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 536RA
UT WOS:000174714602346
DA 2020-12-17
ER

PT J
AU SantAnna, GM
   Ramos, JRM
   Moreira, MEL
   Bomfim, O
   Leme, JH
   Lopes, JMA
AF SantAnna, GM
   Ramos, JRM
   Moreira, MEL
   Bomfim, O
   Leme, JH
   Lopes, JMA
TI Endotracheal intubation (EOT) in the delivery room: Should it be a
   routine procedure for the extreme low birth weight infant?
SO PEDIATRIC RESEARCH
LA English
DT Meeting Abstract
C1 Inst Fernandes Figueira, Rio De Janeiro, Brazil.
RI Sant'Anna, Guilherme/U-1409-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT PEDIATRIC RESEARCH FOUNDATION, INC
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 USA
SN 0031-3998
J9 PEDIATR RES
JI Pediatr. Res.
PD APR
PY 1999
VL 45
IS 4
MA 1310
BP 223A
EP 223A
DI 10.1203/00006450-199904020-01327
PN 2
PG 1
WC Pediatrics
SC Pediatrics
GA 182AQ
UT WOS:000079476701311
OA Bronze
DA 2020-12-17
ER

EF